id	sid	tid	token	lemma	pos
ajlm-1563	1	1	abstract	abstract	ADJ
ajlm-1563	1	2	introduction	introduction	NOUN
ajlm-1563	1	3	methods	method	NOUN
ajlm-1563	1	4	results	result	VERB
ajlm-1563	1	5	discussion	discussion	NOUN
ajlm-1563	1	6	acknowledgements	acknowledgement	NOUN
ajlm-1563	1	7	references	reference	NOUN
ajlm-1563	1	8	about	about	ADP
ajlm-1563	1	9	the	the	DET
ajlm-1563	1	10	author(s	author(s	NOUN
ajlm-1563	1	11	)	)	PUNCT
ajlm-1563	1	12	fred	fred	PROPN
ajlm-1563	1	13	maate	maate	PROPN
ajlm-1563	1	14	department	department	PROPN
ajlm-1563	1	15	of	of	ADP
ajlm-1563	1	16	pathology	pathology	NOUN
ajlm-1563	1	17	and	and	CCONJ
ajlm-1563	1	18	microbiology	microbiology	NOUN
ajlm-1563	1	19	,	,	PUNCT
ajlm-1563	1	20	adult	adult	NOUN
ajlm-1563	1	21	and	and	CCONJ
ajlm-1563	1	22	emergency	emergency	NOUN
ajlm-1563	1	23	hospital	hospital	NOUN
ajlm-1563	1	24	,	,	PUNCT
ajlm-1563	1	25	university	university	NOUN
ajlm-1563	1	26	teaching	teaching	NOUN
ajlm-1563	1	27	hospitals	hospital	NOUN
ajlm-1563	1	28	,	,	PUNCT
ajlm-1563	1	29	lusaka	lusaka	PROPN
ajlm-1563	1	30	,	,	PUNCT
ajlm-1563	1	31	zambia	zambia	PROPN
ajlm-1563	1	32	department	department	PROPN
ajlm-1563	1	33	of	of	ADP
ajlm-1563	1	34	pathology	pathology	PROPN
ajlm-1563	1	35	and	and	CCONJ
ajlm-1563	1	36	microbiology	microbiology	NOUN
ajlm-1563	1	37	,	,	PUNCT
ajlm-1563	1	38	school	school	NOUN
ajlm-1563	1	39	of	of	ADP
ajlm-1563	1	40	medicine	medicine	NOUN
ajlm-1563	1	41	,	,	PUNCT
ajlm-1563	1	42	university	university	PROPN
ajlm-1563	1	43	of	of	ADP
ajlm-1563	1	44	zambia	zambia	PROPN
ajlm-1563	1	45	,	,	PUNCT
ajlm-1563	1	46	lusaka	lusaka	PROPN
ajlm-1563	1	47	,	,	PUNCT
ajlm-1563	1	48	zambia	zambia	PROPN
ajlm-1563	1	49	peter	peter	PROPN
ajlm-1563	1	50	julius	julius	PROPN
ajlm-1563	1	51	department	department	PROPN
ajlm-1563	1	52	of	of	ADP
ajlm-1563	1	53	pathology	pathology	NOUN
ajlm-1563	1	54	and	and	CCONJ
ajlm-1563	1	55	microbiology	microbiology	NOUN
ajlm-1563	1	56	,	,	PUNCT
ajlm-1563	1	57	school	school	NOUN
ajlm-1563	1	58	of	of	ADP
ajlm-1563	1	59	medicine	medicine	NOUN
ajlm-1563	1	60	,	,	PUNCT
ajlm-1563	1	61	university	university	PROPN
ajlm-1563	1	62	of	of	ADP
ajlm-1563	1	63	zambia	zambia	PROPN
ajlm-1563	1	64	,	,	PUNCT
ajlm-1563	1	65	lusaka	lusaka	PROPN
ajlm-1563	1	66	,	,	PUNCT
ajlm-1563	1	67	zambia	zambia	PROPN
ajlm-1563	1	68	stepfanie	stepfanie	PROPN
ajlm-1563	1	69	siyumbwa	siyumbwa	PROPN
ajlm-1563	1	70	department	department	PROPN
ajlm-1563	1	71	of	of	ADP
ajlm-1563	1	72	pathology	pathology	PROPN
ajlm-1563	1	73	and	and	CCONJ
ajlm-1563	1	74	microbiology	microbiology	NOUN
ajlm-1563	1	75	,	,	PUNCT
ajlm-1563	1	76	adult	adult	NOUN
ajlm-1563	1	77	and	and	CCONJ
ajlm-1563	1	78	emergency	emergency	NOUN
ajlm-1563	1	79	hospital	hospital	NOUN
ajlm-1563	1	80	,	,	PUNCT
ajlm-1563	1	81	university	university	NOUN
ajlm-1563	1	82	teaching	teaching	NOUN
ajlm-1563	1	83	hospitals	hospital	NOUN
ajlm-1563	1	84	,	,	PUNCT
ajlm-1563	1	85	lusaka	lusaka	PROPN
ajlm-1563	1	86	,	,	PUNCT
ajlm-1563	1	87	zambia	zambia	PROPN
ajlm-1563	1	88	leeya	leeya	PROPN
ajlm-1563	1	89	pinder	pinder	PROPN
ajlm-1563	1	90	department	department	PROPN
ajlm-1563	1	91	of	of	ADP
ajlm-1563	1	92	obstetrics	obstetric	NOUN
ajlm-1563	1	93	and	and	CCONJ
ajlm-1563	1	94	gynecology	gynecology	NOUN
ajlm-1563	1	95	,	,	PUNCT
ajlm-1563	1	96	university	university	NOUN
ajlm-1563	1	97	of	of	ADP
ajlm-1563	1	98	washington	washington	PROPN
ajlm-1563	1	99	,	,	PUNCT
ajlm-1563	1	100	seattle	seattle	PROPN
ajlm-1563	1	101	,	,	PUNCT
ajlm-1563	1	102	washington	washington	PROPN
ajlm-1563	1	103	,	,	PUNCT
ajlm-1563	1	104	united	united	PROPN
ajlm-1563	1	105	states	states	PROPN
ajlm-1563	1	106	trevor	trevor	PROPN
ajlm-1563	1	107	kaile	kaile	PROPN
ajlm-1563	1	108	department	department	PROPN
ajlm-1563	1	109	of	of	ADP
ajlm-1563	1	110	pathology	pathology	NOUN
ajlm-1563	1	111	and	and	CCONJ
ajlm-1563	1	112	microbiology	microbiology	NOUN
ajlm-1563	1	113	,	,	PUNCT
ajlm-1563	1	114	school	school	NOUN
ajlm-1563	1	115	of	of	ADP
ajlm-1563	1	116	medicine	medicine	NOUN
ajlm-1563	1	117	,	,	PUNCT
ajlm-1563	1	118	university	university	PROPN
ajlm-1563	1	119	of	of	ADP
ajlm-1563	1	120	zambia	zambia	PROPN
ajlm-1563	1	121	,	,	PUNCT
ajlm-1563	1	122	lusaka	lusaka	PROPN
ajlm-1563	1	123	,	,	PUNCT
ajlm-1563	1	124	zambia	zambia	PROPN
ajlm-1563	1	125	mulindi	mulindi	PROPN
ajlm-1563	1	126	mwanahamuntu	mwanahamuntu	PROPN
ajlm-1563	1	127	department	department	PROPN
ajlm-1563	1	128	of	of	ADP
ajlm-1563	1	129	obstetrics	obstetric	NOUN
ajlm-1563	1	130	and	and	CCONJ
ajlm-1563	1	131	gynaecology	gynaecology	NOUN
ajlm-1563	1	132	,	,	PUNCT
ajlm-1563	1	133	women	woman	NOUN
ajlm-1563	1	134	and	and	CCONJ
ajlm-1563	1	135	newborn	newborn	ADJ
ajlm-1563	1	136	hospital	hospital	NOUN
ajlm-1563	1	137	,	,	PUNCT
ajlm-1563	1	138	university	university	NOUN
ajlm-1563	1	139	teaching	teaching	NOUN
ajlm-1563	1	140	hospitals	hospital	NOUN
ajlm-1563	1	141	,	,	PUNCT
ajlm-1563	1	142	lusaka	lusaka	PROPN
ajlm-1563	1	143	,	,	PUNCT
ajlm-1563	1	144	zambia	zambia	PROPN
ajlm-1563	1	145	groesbeck	groesbeck	PROPN
ajlm-1563	1	146	parham	parham	PROPN
ajlm-1563	1	147	department	department	PROPN
ajlm-1563	1	148	of	of	ADP
ajlm-1563	1	149	obstetrics	obstetric	NOUN
ajlm-1563	1	150	and	and	CCONJ
ajlm-1563	1	151	gynecology	gynecology	NOUN
ajlm-1563	1	152	,	,	PUNCT
ajlm-1563	1	153	university	university	NOUN
ajlm-1563	1	154	of	of	ADP
ajlm-1563	1	155	north	north	PROPN
ajlm-1563	1	156	carolina	carolina	PROPN
ajlm-1563	1	157	at	at	ADP
ajlm-1563	1	158	chapel	chapel	PROPN
ajlm-1563	1	159	hill	hill	PROPN
ajlm-1563	1	160	,	,	PUNCT
ajlm-1563	1	161	chapel	chapel	NOUN
ajlm-1563	1	162	hill	hill	PROPN
ajlm-1563	1	163	,	,	PUNCT
ajlm-1563	1	164	north	north	PROPN
ajlm-1563	1	165	carolina	carolina	PROPN
ajlm-1563	1	166	,	,	PUNCT
ajlm-1563	1	167	united	united	PROPN
ajlm-1563	1	168	states	states	PROPN
ajlm-1563	1	169	citation	citation	PROPN
ajlm-1563	1	170	maate	maate	VERB
ajlm-1563	2	1	f	f	X
ajlm-1563	2	2	,	,	PUNCT
ajlm-1563	2	3	julius	julius	PROPN
ajlm-1563	2	4	p	p	PROPN
ajlm-1563	2	5	,	,	PUNCT
ajlm-1563	2	6	siyumbwa	siyumbwa	PROPN
ajlm-1563	2	7	s	s	PROPN
ajlm-1563	2	8	,	,	PUNCT
ajlm-1563	2	9	et	et	PROPN
ajlm-1563	2	10	al	al	PROPN
ajlm-1563	2	11	.	.	PROPN
ajlm-1563	2	12	high	high	ADJ
ajlm-1563	2	13	-	-	PUNCT
ajlm-1563	2	14	risk	risk	NOUN
ajlm-1563	2	15	human	human	ADJ
ajlm-1563	2	16	papillomavirus	papillomavirus	NOUN
ajlm-1563	2	17	-	-	PUNCT
ajlm-1563	2	18	associated	associate	VERB
ajlm-1563	2	19	vulvar	vulvar	NOUN
ajlm-1563	2	20	neoplasia	neoplasia	NOUN
ajlm-1563	2	21	among	among	ADP
ajlm-1563	2	22	women	woman	NOUN
ajlm-1563	2	23	living	live	VERB
ajlm-1563	2	24	with	with	ADP
ajlm-1563	2	25	human	human	ADJ
ajlm-1563	2	26	immunodeficiency	immunodeficiency	NOUN
ajlm-1563	2	27	virus	virus	NOUN
ajlm-1563	2	28	in	in	ADP
ajlm-1563	2	29	zambia	zambia	PROPN
ajlm-1563	2	30	.	.	PUNCT
ajlm-1563	3	1	afr	afr	PROPN
ajlm-1563	3	2	j	j	PROPN
ajlm-1563	3	3	lab	lab	PROPN
ajlm-1563	3	4	med	med	PROPN
ajlm-1563	3	5	.	.	PUNCT
ajlm-1563	4	1	2022;11(1	2022;11(1	NUM
ajlm-1563	4	2	)	)	PUNCT
ajlm-1563	4	3	,	,	PUNCT
ajlm-1563	4	4	a1563	a1563	PROPN
ajlm-1563	4	5	.	.	PROPN
ajlm-1563	4	6	https://doi.org/10.4102/ajlm.v11i1.1563	https://doi.org/10.4102/ajlm.v11i1.1563	AUX
ajlm-1563	4	7	original	original	ADJ
ajlm-1563	4	8	research	research	NOUN
ajlm-1563	4	9	high	high	ADJ
ajlm-1563	4	10	-	-	PUNCT
ajlm-1563	4	11	risk	risk	NOUN
ajlm-1563	4	12	human	human	ADJ
ajlm-1563	4	13	papillomavirus	papillomavirus	NOUN
ajlm-1563	4	14	-	-	PUNCT
ajlm-1563	4	15	associated	associate	VERB
ajlm-1563	4	16	vulvar	vulvar	NOUN
ajlm-1563	4	17	neoplasia	neoplasia	NOUN
ajlm-1563	4	18	among	among	ADP
ajlm-1563	4	19	women	woman	NOUN
ajlm-1563	4	20	living	live	VERB
ajlm-1563	4	21	with	with	ADP
ajlm-1563	4	22	human	human	ADJ
ajlm-1563	4	23	immunodeficiency	immunodeficiency	NOUN
ajlm-1563	4	24	virus	virus	NOUN
ajlm-1563	4	25	in	in	ADP
ajlm-1563	4	26	zambia	zambia	PROPN
ajlm-1563	4	27	fred	fred	PROPN
ajlm-1563	4	28	maate	maate	PROPN
ajlm-1563	4	29	,	,	PUNCT
ajlm-1563	4	30	peter	peter	PROPN
ajlm-1563	4	31	julius	julius	PROPN
ajlm-1563	4	32	,	,	PUNCT
ajlm-1563	4	33	stepfanie	stepfanie	PROPN
ajlm-1563	4	34	siyumbwa	siyumbwa	PROPN
ajlm-1563	4	35	,	,	PUNCT
ajlm-1563	4	36	leeya	leeya	NOUN
ajlm-1563	4	37	pinder	pinder	NOUN
ajlm-1563	4	38	,	,	PUNCT
ajlm-1563	4	39	trevor	trevor	NOUN
ajlm-1563	4	40	kaile	kaile	NOUN
ajlm-1563	4	41	,	,	PUNCT
ajlm-1563	4	42	mulindi	mulindi	PROPN
ajlm-1563	4	43	mwanahamuntu	mwanahamuntu	VERB
ajlm-1563	4	44	,	,	PUNCT
ajlm-1563	4	45	groesbeck	groesbeck	PROPN
ajlm-1563	4	46	parham	parham	PROPN
ajlm-1563	4	47	received	receive	VERB
ajlm-1563	4	48	:	:	PUNCT
ajlm-1563	4	49	21	21	NUM
ajlm-1563	4	50	feb	feb	NOUN
ajlm-1563	4	51	.	.	PROPN
ajlm-1563	4	52	2021	2021	NUM
ajlm-1563	4	53	;	;	PUNCT
ajlm-1563	4	54	accepted	accept	VERB
ajlm-1563	4	55	:	:	PUNCT
ajlm-1563	4	56	24	24	NUM
ajlm-1563	4	57	feb	feb	NOUN
ajlm-1563	4	58	.	.	PROPN
ajlm-1563	4	59	2022	2022	NUM
ajlm-1563	4	60	;	;	PUNCT
ajlm-1563	4	61	published	publish	VERB
ajlm-1563	4	62	:	:	PUNCT
ajlm-1563	4	63	12	12	NUM
ajlm-1563	4	64	may	may	AUX
ajlm-1563	4	65	2022	2022	NUM
ajlm-1563	4	66	copyright	copyright	NOUN
ajlm-1563	4	67	:	:	PUNCT
ajlm-1563	4	68	©	©	PROPN
ajlm-1563	4	69	2022	2022	NUM
ajlm-1563	4	70	.	.	PUNCT
ajlm-1563	5	1	the	the	DET
ajlm-1563	5	2	author(s	author(s	PROPN
ajlm-1563	5	3	)	)	PUNCT
ajlm-1563	5	4	.	.	PUNCT
ajlm-1563	6	1	licensee	licensee	NOUN
ajlm-1563	6	2	:	:	PUNCT
ajlm-1563	6	3	aosis	aosis	NOUN
ajlm-1563	6	4	.	.	PUNCT
ajlm-1563	7	1	this	this	PRON
ajlm-1563	7	2	is	be	AUX
ajlm-1563	7	3	an	an	DET
ajlm-1563	7	4	open	open	ADJ
ajlm-1563	7	5	access	access	NOUN
ajlm-1563	7	6	article	article	NOUN
ajlm-1563	7	7	distributed	distribute	VERB
ajlm-1563	7	8	under	under	ADP
ajlm-1563	7	9	the	the	DET
ajlm-1563	7	10	terms	term	NOUN
ajlm-1563	7	11	of	of	ADP
ajlm-1563	7	12	the	the	DET
ajlm-1563	7	13	creative	creative	ADJ
ajlm-1563	7	14	commons	common	NOUN
ajlm-1563	7	15	attribution	attribution	NOUN
ajlm-1563	7	16	license	license	NOUN
ajlm-1563	7	17	,	,	PUNCT
ajlm-1563	7	18	which	which	PRON
ajlm-1563	7	19	permits	permit	VERB
ajlm-1563	7	20	unrestricted	unrestricted	ADJ
ajlm-1563	7	21	use	use	NOUN
ajlm-1563	7	22	,	,	PUNCT
ajlm-1563	7	23	distribution	distribution	NOUN
ajlm-1563	7	24	,	,	PUNCT
ajlm-1563	7	25	and	and	CCONJ
ajlm-1563	7	26	reproduction	reproduction	NOUN
ajlm-1563	7	27	in	in	ADP
ajlm-1563	7	28	any	any	DET
ajlm-1563	7	29	medium	medium	NOUN
ajlm-1563	7	30	,	,	PUNCT
ajlm-1563	7	31	provided	provide	VERB
ajlm-1563	7	32	the	the	DET
ajlm-1563	7	33	original	original	ADJ
ajlm-1563	7	34	work	work	NOUN
ajlm-1563	7	35	is	be	AUX
ajlm-1563	7	36	properly	properly	ADV
ajlm-1563	7	37	cited	cite	VERB
ajlm-1563	7	38	.	.	PUNCT
ajlm-1563	8	1	abstract	abstract	ADJ
ajlm-1563	8	2	background	background	NOUN
ajlm-1563	8	3	:	:	PUNCT
ajlm-1563	8	4	globally	globally	ADV
ajlm-1563	8	5	,	,	PUNCT
ajlm-1563	8	6	women	woman	NOUN
ajlm-1563	8	7	living	live	VERB
ajlm-1563	8	8	with	with	ADP
ajlm-1563	8	9	hiv	hiv	PROPN
ajlm-1563	8	10	have	have	VERB
ajlm-1563	8	11	a	a	DET
ajlm-1563	8	12	higher	high	ADJ
ajlm-1563	8	13	risk	risk	NOUN
ajlm-1563	8	14	of	of	ADP
ajlm-1563	8	15	vulvar	vulvar	NOUN
ajlm-1563	8	16	neoplasia	neoplasia	NOUN
ajlm-1563	8	17	than	than	ADP
ajlm-1563	8	18	hiv	hiv	NOUN
ajlm-1563	8	19	-	-	PUNCT
ajlm-1563	8	20	negative	negative	ADJ
ajlm-1563	8	21	women	woman	NOUN
ajlm-1563	8	22	.	.	PUNCT
ajlm-1563	9	1	vulvar	vulvar	NOUN
ajlm-1563	9	2	neoplasia	neoplasia	NOUN
ajlm-1563	9	3	among	among	ADP
ajlm-1563	9	4	women	woman	NOUN
ajlm-1563	9	5	living	live	VERB
ajlm-1563	9	6	with	with	ADP
ajlm-1563	9	7	hiv	hiv	PROPN
ajlm-1563	9	8	has	have	AUX
ajlm-1563	9	9	not	not	PART
ajlm-1563	9	10	previously	previously	ADV
ajlm-1563	9	11	been	be	AUX
ajlm-1563	9	12	characterised	characterise	VERB
ajlm-1563	9	13	in	in	ADP
ajlm-1563	9	14	zambia	zambia	PROPN
ajlm-1563	9	15	.	.	PUNCT
ajlm-1563	10	1	objective	objective	NOUN
ajlm-1563	10	2	:	:	PUNCT
ajlm-1563	10	3	this	this	DET
ajlm-1563	10	4	study	study	NOUN
ajlm-1563	10	5	determined	determine	VERB
ajlm-1563	10	6	the	the	DET
ajlm-1563	10	7	clinical	clinical	ADJ
ajlm-1563	10	8	and	and	CCONJ
ajlm-1563	10	9	pathologic	pathologic	ADJ
ajlm-1563	10	10	features	feature	NOUN
ajlm-1563	10	11	of	of	ADP
ajlm-1563	10	12	vulvar	vulvar	NOUN
ajlm-1563	10	13	neoplasia	neoplasia	NOUN
ajlm-1563	10	14	among	among	ADP
ajlm-1563	10	15	women	woman	NOUN
ajlm-1563	10	16	living	live	VERB
ajlm-1563	10	17	with	with	ADP
ajlm-1563	10	18	hiv	hiv	PROPN
ajlm-1563	10	19	at	at	ADP
ajlm-1563	10	20	the	the	DET
ajlm-1563	10	21	university	university	NOUN
ajlm-1563	10	22	teaching	teaching	NOUN
ajlm-1563	10	23	hospital	hospital	NOUN
ajlm-1563	10	24	,	,	PUNCT
ajlm-1563	10	25	lusaka	lusaka	PROPN
ajlm-1563	10	26	,	,	PUNCT
ajlm-1563	10	27	zambia	zambia	PROPN
ajlm-1563	10	28	.	.	PUNCT
ajlm-1563	11	1	methods	method	NOUN
ajlm-1563	11	2	:	:	PUNCT
ajlm-1563	11	3	we	we	PRON
ajlm-1563	11	4	conducted	conduct	VERB
ajlm-1563	11	5	a	a	DET
ajlm-1563	11	6	cross	cross	ADJ
ajlm-1563	11	7	-	-	ADJ
ajlm-1563	11	8	sectional	sectional	ADJ
ajlm-1563	11	9	study	study	NOUN
ajlm-1563	11	10	of	of	ADP
ajlm-1563	11	11	vulvar	vulvar	NOUN
ajlm-1563	11	12	lesions	lesion	NOUN
ajlm-1563	11	13	among	among	ADP
ajlm-1563	11	14	53	53	NUM
ajlm-1563	11	15	women	woman	NOUN
ajlm-1563	11	16	living	live	VERB
ajlm-1563	11	17	with	with	ADP
ajlm-1563	11	18	hiv	hiv	PROPN
ajlm-1563	11	19	who	who	PRON
ajlm-1563	11	20	presented	present	VERB
ajlm-1563	11	21	with	with	ADP
ajlm-1563	11	22	vulvar	vulvar	NOUN
ajlm-1563	11	23	lesions	lesion	NOUN
ajlm-1563	11	24	between	between	ADP
ajlm-1563	11	25	july	july	PROPN
ajlm-1563	11	26	2017	2017	NUM
ajlm-1563	11	27	and	and	CCONJ
ajlm-1563	11	28	february	february	PROPN
ajlm-1563	11	29	2018	2018	NUM
ajlm-1563	11	30	.	.	PUNCT
ajlm-1563	12	1	the	the	DET
ajlm-1563	12	2	study	study	NOUN
ajlm-1563	12	3	assessed	assess	VERB
ajlm-1563	12	4	clinical	clinical	ADJ
ajlm-1563	12	5	and	and	CCONJ
ajlm-1563	12	6	histological	histological	ADJ
ajlm-1563	12	7	characteristics	characteristic	NOUN
ajlm-1563	12	8	and	and	CCONJ
ajlm-1563	12	9	prevalence	prevalence	NOUN
ajlm-1563	12	10	of	of	ADP
ajlm-1563	12	11	high	high	ADJ
ajlm-1563	12	12	-	-	PUNCT
ajlm-1563	12	13	risk	risk	NOUN
ajlm-1563	12	14	human	human	ADJ
ajlm-1563	12	15	papillomavirus	papillomavirus	NOUN
ajlm-1563	12	16	(	(	PUNCT
ajlm-1563	12	17	hrhpv	hrhpv	NOUN
ajlm-1563	12	18	)	)	PUNCT
ajlm-1563	12	19	.	.	PUNCT
ajlm-1563	13	1	results	result	NOUN
ajlm-1563	13	2	:	:	PUNCT
ajlm-1563	13	3	twenty	twenty	NUM
ajlm-1563	13	4	-	-	PUNCT
ajlm-1563	13	5	one	one	NUM
ajlm-1563	13	6	patients	patient	NOUN
ajlm-1563	13	7	were	be	AUX
ajlm-1563	13	8	diagnosed	diagnose	VERB
ajlm-1563	13	9	with	with	ADP
ajlm-1563	13	10	vulvar	vulvar	ADJ
ajlm-1563	13	11	squamous	squamous	ADJ
ajlm-1563	13	12	cell	cell	NOUN
ajlm-1563	13	13	carcinoma	carcinoma	NOUN
ajlm-1563	13	14	(	(	PUNCT
ajlm-1563	13	15	vscc	vscc	NOUN
ajlm-1563	13	16	)	)	PUNCT
ajlm-1563	13	17	,	,	PUNCT
ajlm-1563	13	18	20	20	NUM
ajlm-1563	13	19	with	with	ADP
ajlm-1563	13	20	usual	usual	ADJ
ajlm-1563	13	21	vulvar	vulvar	NOUN
ajlm-1563	13	22	intraepithelial	intraepithelial	ADJ
ajlm-1563	13	23	neoplasm	neoplasm	NOUN
ajlm-1563	13	24	(	(	PUNCT
ajlm-1563	13	25	uvin	uvin	NOUN
ajlm-1563	13	26	)	)	PUNCT
ajlm-1563	13	27	,	,	PUNCT
ajlm-1563	13	28	and	and	CCONJ
ajlm-1563	13	29	the	the	DET
ajlm-1563	13	30	rest	rest	NOUN
ajlm-1563	13	31	with	with	ADP
ajlm-1563	13	32	either	either	CCONJ
ajlm-1563	13	33	benign	benign	ADJ
ajlm-1563	13	34	lesions	lesion	NOUN
ajlm-1563	13	35	or	or	CCONJ
ajlm-1563	13	36	non	non	ADJ
ajlm-1563	13	37	-	-	ADJ
ajlm-1563	13	38	neoplastic	neoplastic	ADJ
ajlm-1563	13	39	lesions	lesion	NOUN
ajlm-1563	13	40	(	(	PUNCT
ajlm-1563	13	41	nnl	nnl	NOUN
ajlm-1563	13	42	)	)	PUNCT
ajlm-1563	13	43	.	.	PUNCT
ajlm-1563	14	1	participants	participant	NOUN
ajlm-1563	14	2	’	'	PUNCT
ajlm-1563	14	3	mean	mean	VERB
ajlm-1563	14	4	age	age	NOUN
ajlm-1563	14	5	was	be	AUX
ajlm-1563	14	6	40	40	NUM
ajlm-1563	14	7	years	year	NOUN
ajlm-1563	14	8	.	.	PUNCT
ajlm-1563	15	1	patients	patient	NOUN
ajlm-1563	15	2	with	with	ADP
ajlm-1563	15	3	vscc	vscc	PROPN
ajlm-1563	15	4	were	be	AUX
ajlm-1563	15	5	significantly	significantly	ADV
ajlm-1563	15	6	older	old	ADJ
ajlm-1563	15	7	than	than	ADP
ajlm-1563	15	8	those	those	PRON
ajlm-1563	15	9	with	with	ADP
ajlm-1563	15	10	nnl	nnl	PROPN
ajlm-1563	15	11	(	(	PUNCT
ajlm-1563	15	12	mean	mean	ADJ
ajlm-1563	15	13	(	(	PUNCT
ajlm-1563	15	14	s.d	s.d	PROPN
ajlm-1563	15	15	.	.	PROPN
ajlm-1563	15	16	):	):	PUNCT
ajlm-1563	15	17	43	43	NUM
ajlm-1563	15	18	(	(	PUNCT
ajlm-1563	15	19	21	21	NUM
ajlm-1563	15	20	)	)	PUNCT
ajlm-1563	15	21	vs	vs	ADP
ajlm-1563	15	22	33	33	NUM
ajlm-1563	15	23	(	(	PUNCT
ajlm-1563	15	24	10	10	NUM
ajlm-1563	15	25	)	)	PUNCT
ajlm-1563	15	26	,	,	PUNCT
ajlm-1563	15	27	p	p	X
ajlm-1563	15	28	=	=	NOUN
ajlm-1563	15	29	0.004	0.004	NUM
ajlm-1563	15	30	)	)	PUNCT
ajlm-1563	15	31	.	.	PUNCT
ajlm-1563	16	1	the	the	DET
ajlm-1563	16	2	prevalence	prevalence	NOUN
ajlm-1563	16	3	of	of	ADP
ajlm-1563	16	4	hrhpv	hrhpv	NOUN
ajlm-1563	16	5	was	be	AUX
ajlm-1563	16	6	88.9	88.9	NUM
ajlm-1563	16	7	%	%	NOUN
ajlm-1563	16	8	in	in	ADP
ajlm-1563	16	9	vscc	vscc	ADJ
ajlm-1563	16	10	patients	patient	NOUN
ajlm-1563	16	11	and	and	CCONJ
ajlm-1563	16	12	100.0	100.0	NUM
ajlm-1563	16	13	%	%	NOUN
ajlm-1563	16	14	in	in	ADP
ajlm-1563	16	15	high	high	ADJ
ajlm-1563	16	16	-	-	PUNCT
ajlm-1563	16	17	grade	grade	NOUN
ajlm-1563	16	18	squamous	squamous	ADJ
ajlm-1563	16	19	intraepithelial	intraepithelial	ADJ
ajlm-1563	16	20	lesion	lesion	NOUN
ajlm-1563	16	21	patients	patient	NOUN
ajlm-1563	16	22	.	.	PUNCT
ajlm-1563	17	1	hpv16	hpv16	NOUN
ajlm-1563	17	2	was	be	AUX
ajlm-1563	17	3	the	the	DET
ajlm-1563	17	4	most	most	ADV
ajlm-1563	17	5	common	common	ADJ
ajlm-1563	17	6	(	(	PUNCT
ajlm-1563	17	7	52.6	52.6	NUM
ajlm-1563	17	8	%	%	NOUN
ajlm-1563	17	9	)	)	PUNCT
ajlm-1563	17	10	genotype	genotype	NOUN
ajlm-1563	17	11	.	.	PUNCT
ajlm-1563	18	1	the	the	DET
ajlm-1563	18	2	clinical	clinical	ADJ
ajlm-1563	18	3	features	feature	NOUN
ajlm-1563	18	4	of	of	ADP
ajlm-1563	18	5	neoplasia	neoplasia	NOUN
ajlm-1563	18	6	were	be	AUX
ajlm-1563	18	7	similar	similar	ADJ
ajlm-1563	18	8	to	to	ADP
ajlm-1563	18	9	those	those	PRON
ajlm-1563	18	10	of	of	ADP
ajlm-1563	18	11	nnl	nnl	PROPN
ajlm-1563	18	12	.	.	PROPN
ajlm-1563	18	13	conclusion	conclusion	NOUN
ajlm-1563	18	14	:	:	PUNCT
ajlm-1563	18	15	vscc	vscc	PROPN
ajlm-1563	18	16	was	be	AUX
ajlm-1563	18	17	significantly	significantly	ADV
ajlm-1563	18	18	more	more	ADV
ajlm-1563	18	19	common	common	ADJ
ajlm-1563	18	20	among	among	ADP
ajlm-1563	18	21	women	woman	NOUN
ajlm-1563	18	22	aged	age	VERB
ajlm-1563	18	23	≥	≥	NUM
ajlm-1563	18	24	40	40	NUM
ajlm-1563	18	25	years	year	NOUN
ajlm-1563	18	26	.	.	PUNCT
ajlm-1563	19	1	hrhpv	hrhpv	PROPN
ajlm-1563	19	2	in	in	ADP
ajlm-1563	19	3	vscc	vscc	NOUN
ajlm-1563	19	4	and	and	CCONJ
ajlm-1563	19	5	high	high	ADJ
ajlm-1563	19	6	-	-	PUNCT
ajlm-1563	19	7	grade	grade	NOUN
ajlm-1563	19	8	squamous	squamous	ADJ
ajlm-1563	19	9	intraepithelial	intraepithelial	ADJ
ajlm-1563	19	10	lesions	lesion	NOUN
ajlm-1563	19	11	was	be	AUX
ajlm-1563	19	12	high	high	ADJ
ajlm-1563	19	13	.	.	PUNCT
ajlm-1563	20	1	women	woman	NOUN
ajlm-1563	20	2	with	with	ADP
ajlm-1563	20	3	vulvar	vulvar	NOUN
ajlm-1563	20	4	lesions	lesion	NOUN
ajlm-1563	20	5	,	,	PUNCT
ajlm-1563	20	6	especially	especially	ADV
ajlm-1563	20	7	those	those	PRON
ajlm-1563	20	8	aged	aged	ADJ
ajlm-1563	20	9	>	>	X
ajlm-1563	20	10	40	40	NUM
ajlm-1563	20	11	years	year	NOUN
ajlm-1563	20	12	,	,	PUNCT
ajlm-1563	20	13	should	should	AUX
ajlm-1563	20	14	be	be	AUX
ajlm-1563	20	15	evaluated	evaluate	VERB
ajlm-1563	20	16	for	for	ADP
ajlm-1563	20	17	vulvar	vulvar	NOUN
ajlm-1563	20	18	cancer	cancer	NOUN
ajlm-1563	20	19	.	.	PUNCT
ajlm-1563	21	1	young	young	ADJ
ajlm-1563	21	2	girls	girl	NOUN
ajlm-1563	21	3	should	should	AUX
ajlm-1563	21	4	be	be	AUX
ajlm-1563	21	5	vaccinated	vaccinate	VERB
ajlm-1563	21	6	to	to	PART
ajlm-1563	21	7	prevent	prevent	VERB
ajlm-1563	21	8	vulvar	vulvar	NOUN
ajlm-1563	21	9	cancer	cancer	NOUN
ajlm-1563	21	10	.	.	PUNCT
ajlm-1563	22	1	keywords	keyword	NOUN
ajlm-1563	22	2	:	:	PUNCT
ajlm-1563	22	3	vulvar	vulvar	NOUN
ajlm-1563	22	4	neoplasia	neoplasia	NOUN
ajlm-1563	22	5	;	;	PUNCT
ajlm-1563	22	6	vulvar	vulvar	NOUN
ajlm-1563	22	7	cancer	cancer	NOUN
ajlm-1563	22	8	;	;	PUNCT
ajlm-1563	22	9	human	human	ADJ
ajlm-1563	22	10	papillomavirus	papillomavirus	NOUN
ajlm-1563	22	11	virus	virus	NOUN
ajlm-1563	22	12	;	;	PUNCT
ajlm-1563	22	13	hiv	hiv	PROPN
ajlm-1563	22	14	;	;	PUNCT
ajlm-1563	22	15	zambia	zambia	PROPN
ajlm-1563	22	16	.	.	PUNCT
ajlm-1563	23	1	introduction	introduction	NOUN
ajlm-1563	23	2	vulvar	vulvar	NOUN
ajlm-1563	23	3	intraepithelial	intraepithelial	ADJ
ajlm-1563	23	4	neoplasia	neoplasia	NOUN
ajlm-1563	23	5	(	(	PUNCT
ajlm-1563	23	6	vin	vin	NOUN
ajlm-1563	23	7	)	)	PUNCT
ajlm-1563	23	8	is	be	AUX
ajlm-1563	23	9	a	a	DET
ajlm-1563	23	10	precursor	precursor	NOUN
ajlm-1563	23	11	of	of	ADP
ajlm-1563	23	12	vulvar	vulvar	ADJ
ajlm-1563	23	13	squamous	squamous	ADJ
ajlm-1563	23	14	cell	cell	NOUN
ajlm-1563	23	15	carcinoma	carcinoma	NOUN
ajlm-1563	23	16	(	(	PUNCT
ajlm-1563	23	17	vscc).1	vscc).1	NOUN
ajlm-1563	23	18	two	two	NUM
ajlm-1563	23	19	types	type	NOUN
ajlm-1563	23	20	of	of	ADP
ajlm-1563	23	21	vin	vin	NOUN
ajlm-1563	23	22	have	have	AUX
ajlm-1563	23	23	been	be	AUX
ajlm-1563	23	24	described	describe	VERB
ajlm-1563	23	25	:	:	PUNCT
ajlm-1563	23	26	differentiated	differentiated	ADJ
ajlm-1563	23	27	vin	vin	NOUN
ajlm-1563	23	28	and	and	CCONJ
ajlm-1563	23	29	usual	usual	ADJ
ajlm-1563	23	30	vulvar	vulvar	NOUN
ajlm-1563	23	31	intraepithelial	intraepithelial	ADJ
ajlm-1563	23	32	neoplasia	neoplasia	NOUN
ajlm-1563	23	33	(	(	PUNCT
ajlm-1563	23	34	uvin	uvin	NOUN
ajlm-1563	23	35	)	)	PUNCT
ajlm-1563	23	36	.	.	PUNCT
ajlm-1563	24	1	usual	usual	ADJ
ajlm-1563	24	2	vin	vin	NOUN
ajlm-1563	24	3	occurs	occur	VERB
ajlm-1563	24	4	in	in	ADP
ajlm-1563	24	5	young	young	ADJ
ajlm-1563	24	6	women	woman	NOUN
ajlm-1563	24	7	and	and	CCONJ
ajlm-1563	24	8	is	be	AUX
ajlm-1563	24	9	associated	associate	VERB
ajlm-1563	24	10	with	with	ADP
ajlm-1563	24	11	high	high	ADJ
ajlm-1563	24	12	-	-	PUNCT
ajlm-1563	24	13	risk	risk	NOUN
ajlm-1563	24	14	human	human	ADJ
ajlm-1563	24	15	papillomavirus	papillomavirus	NOUN
ajlm-1563	24	16	(	(	PUNCT
ajlm-1563	24	17	hrhpv	hrhpv	NOUN
ajlm-1563	24	18	)	)	PUNCT
ajlm-1563	25	1	infection.2,3	infection.2,3	ADJ
ajlm-1563	25	2	differentiated	differentiated	ADJ
ajlm-1563	25	3	vin	vin	NOUN
ajlm-1563	25	4	occurs	occur	VERB
ajlm-1563	25	5	in	in	ADP
ajlm-1563	25	6	older	old	ADJ
ajlm-1563	25	7	women	woman	NOUN
ajlm-1563	25	8	and	and	CCONJ
ajlm-1563	25	9	is	be	AUX
ajlm-1563	25	10	not	not	PART
ajlm-1563	25	11	associated	associate	VERB
ajlm-1563	25	12	with	with	ADP
ajlm-1563	25	13	hrhpv4	hrhpv4	NOUN
ajlm-1563	25	14	but	but	CCONJ
ajlm-1563	25	15	is	be	AUX
ajlm-1563	25	16	associated	associate	VERB
ajlm-1563	25	17	with	with	ADP
ajlm-1563	25	18	chronic	chronic	ADJ
ajlm-1563	25	19	inflammatory	inflammatory	ADJ
ajlm-1563	25	20	disorders	disorder	NOUN
ajlm-1563	25	21	such	such	ADJ
ajlm-1563	25	22	as	as	ADP
ajlm-1563	25	23	lichen	lichen	NOUN
ajlm-1563	25	24	sclerosus	sclerosus	NOUN
ajlm-1563	25	25	and	and	CCONJ
ajlm-1563	25	26	squamous	squamous	ADJ
ajlm-1563	25	27	cell	cell	NOUN
ajlm-1563	25	28	hyperplasia.5,6	hyperplasia.5,6	NOUN
ajlm-1563	25	29	by	by	ADP
ajlm-1563	25	30	definition	definition	NOUN
ajlm-1563	25	31	,	,	PUNCT
ajlm-1563	25	32	hrhpvs	hrhpv	NOUN
ajlm-1563	25	33	are	be	AUX
ajlm-1563	25	34	those	those	PRON
ajlm-1563	25	35	that	that	PRON
ajlm-1563	25	36	are	be	AUX
ajlm-1563	25	37	associated	associate	VERB
ajlm-1563	25	38	with	with	ADP
ajlm-1563	25	39	cervical	cervical	ADJ
ajlm-1563	25	40	and	and	CCONJ
ajlm-1563	25	41	anogenital	anogenital	ADJ
ajlm-1563	25	42	cancers	cancer	NOUN
ajlm-1563	25	43	,	,	PUNCT
ajlm-1563	25	44	including	include	VERB
ajlm-1563	25	45	vulvar	vulvar	NOUN
ajlm-1563	25	46	cancer.7	cancer.7	PROPN
ajlm-1563	25	47	in	in	ADP
ajlm-1563	25	48	2005	2005	NUM
ajlm-1563	25	49	,	,	PUNCT
ajlm-1563	25	50	the	the	DET
ajlm-1563	25	51	international	international	ADJ
ajlm-1563	25	52	agency	agency	NOUN
ajlm-1563	25	53	for	for	ADP
ajlm-1563	25	54	research	research	NOUN
ajlm-1563	25	55	on	on	ADP
ajlm-1563	25	56	cancer	cancer	NOUN
ajlm-1563	25	57	defined	define	VERB
ajlm-1563	25	58	13	13	NUM
ajlm-1563	25	59	genotypes	genotype	NOUN
ajlm-1563	25	60	of	of	ADP
ajlm-1563	25	61	hpv	hpv	NOUN
ajlm-1563	25	62	as	as	ADP
ajlm-1563	25	63	high	high	ADJ
ajlm-1563	25	64	-	-	PUNCT
ajlm-1563	25	65	risk	risk	NOUN
ajlm-1563	25	66	/	/	SYM
ajlm-1563	25	67	carcinogenic	carcinogenic	NOUN
ajlm-1563	25	68	;	;	PUNCT
ajlm-1563	25	69	these	these	PRON
ajlm-1563	25	70	include	include	VERB
ajlm-1563	25	71	genotypes	genotype	NOUN
ajlm-1563	25	72	16	16	NUM
ajlm-1563	25	73	,	,	PUNCT
ajlm-1563	25	74	18	18	NUM
ajlm-1563	25	75	,	,	PUNCT
ajlm-1563	25	76	31	31	NUM
ajlm-1563	25	77	,	,	PUNCT
ajlm-1563	25	78	33	33	NUM
ajlm-1563	25	79	,	,	PUNCT
ajlm-1563	25	80	35	35	NUM
ajlm-1563	25	81	,	,	PUNCT
ajlm-1563	25	82	39	39	NUM
ajlm-1563	25	83	,	,	PUNCT
ajlm-1563	25	84	45	45	NUM
ajlm-1563	25	85	,	,	PUNCT
ajlm-1563	25	86	51	51	NUM
ajlm-1563	25	87	,	,	PUNCT
ajlm-1563	25	88	52	52	NUM
ajlm-1563	25	89	,	,	PUNCT
ajlm-1563	25	90	56	56	NUM
ajlm-1563	25	91	,	,	PUNCT
ajlm-1563	25	92	58	58	NUM
ajlm-1563	25	93	,	,	PUNCT
ajlm-1563	25	94	59	59	NUM
ajlm-1563	25	95	and	and	CCONJ
ajlm-1563	25	96	68.8	68.8	NUM
ajlm-1563	25	97	other	other	ADJ
ajlm-1563	25	98	genotypes	genotype	NOUN
ajlm-1563	25	99	not	not	PART
ajlm-1563	25	100	related	relate	VERB
ajlm-1563	25	101	to	to	ADP
ajlm-1563	25	102	cancer	cancer	NOUN
ajlm-1563	25	103	,	,	PUNCT
ajlm-1563	25	104	such	such	ADJ
ajlm-1563	25	105	as	as	ADP
ajlm-1563	25	106	hpv6	hpv6	PROPN
ajlm-1563	25	107	and	and	CCONJ
ajlm-1563	25	108	11	11	NUM
ajlm-1563	25	109	,	,	PUNCT
ajlm-1563	25	110	are	be	AUX
ajlm-1563	25	111	said	say	VERB
ajlm-1563	25	112	to	to	PART
ajlm-1563	25	113	be	be	AUX
ajlm-1563	25	114	low	low	ADJ
ajlm-1563	25	115	-	-	PUNCT
ajlm-1563	25	116	risk	risk	NOUN
ajlm-1563	25	117	,	,	PUNCT
ajlm-1563	25	118	and	and	CCONJ
ajlm-1563	25	119	these	these	PRON
ajlm-1563	25	120	are	be	AUX
ajlm-1563	25	121	known	know	VERB
ajlm-1563	25	122	to	to	PART
ajlm-1563	25	123	cause	cause	VERB
ajlm-1563	25	124	benign	benign	ADJ
ajlm-1563	25	125	exophytic	exophytic	ADJ
ajlm-1563	25	126	lesions	lesion	NOUN
ajlm-1563	25	127	such	such	ADJ
ajlm-1563	25	128	as	as	ADP
ajlm-1563	25	129	condyloma	condyloma	PROPN
ajlm-1563	25	130	acuminatum.9	acuminatum.9	PROPN
ajlm-1563	25	131	vscc	vscc	NOUN
ajlm-1563	25	132	is	be	AUX
ajlm-1563	25	133	the	the	DET
ajlm-1563	25	134	most	most	ADV
ajlm-1563	25	135	common	common	ADJ
ajlm-1563	25	136	histologic	histologic	ADJ
ajlm-1563	25	137	type	type	NOUN
ajlm-1563	25	138	of	of	ADP
ajlm-1563	25	139	vulvar	vulvar	NOUN
ajlm-1563	25	140	cancer	cancer	NOUN
ajlm-1563	25	141	.	.	PUNCT
ajlm-1563	26	1	it	it	PRON
ajlm-1563	26	2	accounts	account	VERB
ajlm-1563	26	3	for	for	SCONJ
ajlm-1563	26	4	95	95	NUM
ajlm-1563	26	5	%	%	NOUN
ajlm-1563	26	6	of	of	ADP
ajlm-1563	26	7	malignant	malignant	ADJ
ajlm-1563	26	8	tumours	tumour	NOUN
ajlm-1563	26	9	of	of	ADP
ajlm-1563	26	10	the	the	DET
ajlm-1563	26	11	vulva.2,10	vulva.2,10	NUM
ajlm-1563	26	12	two	two	NUM
ajlm-1563	26	13	forms	form	NOUN
ajlm-1563	26	14	of	of	ADP
ajlm-1563	26	15	vscc	vscc	NOUN
ajlm-1563	26	16	have	have	AUX
ajlm-1563	26	17	been	be	AUX
ajlm-1563	26	18	established	establish	VERB
ajlm-1563	26	19	,	,	PUNCT
ajlm-1563	26	20	including	include	VERB
ajlm-1563	26	21	the	the	DET
ajlm-1563	26	22	hrhpv	hrhpv	NOUN
ajlm-1563	26	23	-	-	PUNCT
ajlm-1563	26	24	associated	associate	VERB
ajlm-1563	26	25	warty	warty	NOUN
ajlm-1563	26	26	and	and	CCONJ
ajlm-1563	26	27	basaloid	basaloid	ADJ
ajlm-1563	26	28	vscc	vscc	NOUN
ajlm-1563	26	29	and	and	CCONJ
ajlm-1563	26	30	the	the	DET
ajlm-1563	26	31	non	non	ADJ
ajlm-1563	26	32	-	-	ADJ
ajlm-1563	26	33	hrhpv	hrhpv	ADJ
ajlm-1563	26	34	-	-	PUNCT
ajlm-1563	26	35	associated	associate	VERB
ajlm-1563	26	36	keratinising	keratinising	NOUN
ajlm-1563	26	37	vscc.11,12	vscc.11,12	VERB
ajlm-1563	26	38	warty	warty	NOUN
ajlm-1563	26	39	and	and	CCONJ
ajlm-1563	26	40	basaloid	basaloid	PROPN
ajlm-1563	26	41	vscc	vscc	PROPN
ajlm-1563	26	42	arise	arise	NOUN
ajlm-1563	26	43	from	from	ADP
ajlm-1563	26	44	uvin	uvin	NOUN
ajlm-1563	26	45	,	,	PUNCT
ajlm-1563	26	46	while	while	SCONJ
ajlm-1563	26	47	keratinising	keratinise	VERB
ajlm-1563	26	48	vscc	vscc	NOUN
ajlm-1563	26	49	arises	arise	VERB
ajlm-1563	26	50	from	from	ADP
ajlm-1563	26	51	differentiated	differentiated	ADJ
ajlm-1563	26	52	vin.5	vin.5	NOUN
ajlm-1563	26	53	globally	globally	ADV
ajlm-1563	26	54	,	,	PUNCT
ajlm-1563	26	55	vulvar	vulvar	NOUN
ajlm-1563	26	56	cancer	cancer	NOUN
ajlm-1563	26	57	is	be	AUX
ajlm-1563	26	58	more	more	ADV
ajlm-1563	26	59	common	common	ADJ
ajlm-1563	26	60	among	among	ADP
ajlm-1563	26	61	elderly	elderly	ADJ
ajlm-1563	26	62	women	woman	NOUN
ajlm-1563	26	63	above	above	ADP
ajlm-1563	26	64	60	60	NUM
ajlm-1563	26	65	years.13,14,15	years.13,14,15	NOUN
ajlm-1563	26	66	however	however	ADV
ajlm-1563	26	67	,	,	PUNCT
ajlm-1563	26	68	over	over	ADP
ajlm-1563	26	69	the	the	DET
ajlm-1563	26	70	last	last	ADJ
ajlm-1563	26	71	two	two	NUM
ajlm-1563	26	72	decades	decade	NOUN
ajlm-1563	26	73	,	,	PUNCT
ajlm-1563	26	74	its	its	PRON
ajlm-1563	26	75	incidence	incidence	NOUN
ajlm-1563	26	76	has	have	AUX
ajlm-1563	26	77	increased	increase	VERB
ajlm-1563	26	78	,	,	PUNCT
ajlm-1563	26	79	particularly	particularly	ADV
ajlm-1563	26	80	among	among	ADP
ajlm-1563	26	81	young	young	ADJ
ajlm-1563	26	82	women	woman	NOUN
ajlm-1563	26	83	,	,	PUNCT
ajlm-1563	26	84	and	and	CCONJ
ajlm-1563	26	85	this	this	PRON
ajlm-1563	26	86	is	be	AUX
ajlm-1563	26	87	attributed	attribute	VERB
ajlm-1563	26	88	to	to	ADP
ajlm-1563	26	89	infection	infection	NOUN
ajlm-1563	26	90	with	with	ADP
ajlm-1563	26	91	hpv.16,17,18,19	hpv.16,17,18,19	PROPN
ajlm-1563	26	92	in	in	ADP
ajlm-1563	26	93	zambia	zambia	PROPN
ajlm-1563	26	94	,	,	PUNCT
ajlm-1563	26	95	vulvar	vulvar	NOUN
ajlm-1563	26	96	cancer	cancer	NOUN
ajlm-1563	26	97	was	be	AUX
ajlm-1563	26	98	the	the	DET
ajlm-1563	26	99	second	second	ADJ
ajlm-1563	26	100	most	most	ADV
ajlm-1563	26	101	common	common	ADJ
ajlm-1563	26	102	gynaecologic	gynaecologic	NOUN
ajlm-1563	26	103	malignancy	malignancy	NOUN
ajlm-1563	26	104	in	in	ADP
ajlm-1563	26	105	2018.20	2018.20	NUM
ajlm-1563	26	106	between	between	ADP
ajlm-1563	26	107	2007	2007	NUM
ajlm-1563	26	108	and	and	CCONJ
ajlm-1563	26	109	2014	2014	NUM
ajlm-1563	26	110	,	,	PUNCT
ajlm-1563	26	111	the	the	DET
ajlm-1563	26	112	age	age	NOUN
ajlm-1563	26	113	-	-	PUNCT
ajlm-1563	26	114	standardised	standardise	VERB
ajlm-1563	26	115	incidence	incidence	NOUN
ajlm-1563	26	116	rate	rate	NOUN
ajlm-1563	26	117	of	of	ADP
ajlm-1563	26	118	the	the	DET
ajlm-1563	26	119	disease	disease	NOUN
ajlm-1563	26	120	was	be	AUX
ajlm-1563	26	121	1.5	1.5	NUM
ajlm-1563	26	122	per	per	ADP
ajlm-1563	26	123	100	100	NUM
ajlm-1563	26	124	000	000	NUM
ajlm-1563	26	125	women.21	women.21	NOUN
ajlm-1563	26	126	also	also	ADV
ajlm-1563	26	127	,	,	PUNCT
ajlm-1563	26	128	it	it	PRON
ajlm-1563	26	129	was	be	AUX
ajlm-1563	26	130	reported	report	VERB
ajlm-1563	26	131	recently	recently	ADV
ajlm-1563	26	132	that	that	SCONJ
ajlm-1563	26	133	the	the	DET
ajlm-1563	26	134	disease	disease	NOUN
ajlm-1563	26	135	peaked	peak	VERB
ajlm-1563	26	136	in	in	ADP
ajlm-1563	26	137	the	the	DET
ajlm-1563	26	138	reproductive	reproductive	ADJ
ajlm-1563	26	139	age	age	NOUN
ajlm-1563	26	140	group	group	NOUN
ajlm-1563	26	141	(	(	PUNCT
ajlm-1563	26	142	20–40	20–40	NUM
ajlm-1563	26	143	years	year	NOUN
ajlm-1563	26	144	old).21	old).21	VERB
ajlm-1563	26	145	there	there	PRON
ajlm-1563	26	146	is	be	VERB
ajlm-1563	26	147	substantial	substantial	ADJ
ajlm-1563	26	148	evidence	evidence	NOUN
ajlm-1563	26	149	that	that	SCONJ
ajlm-1563	26	150	hiv	hiv	PROPN
ajlm-1563	26	151	positivity	positivity	NOUN
ajlm-1563	26	152	is	be	AUX
ajlm-1563	26	153	associated	associate	VERB
ajlm-1563	26	154	with	with	ADP
ajlm-1563	26	155	hpv	hpv	ADJ
ajlm-1563	26	156	infection	infection	NOUN
ajlm-1563	26	157	;	;	PUNCT
ajlm-1563	26	158	one	one	NUM
ajlm-1563	26	159	in	in	ADP
ajlm-1563	26	160	every	every	DET
ajlm-1563	26	161	four	four	NUM
ajlm-1563	26	162	women	woman	NOUN
ajlm-1563	26	163	with	with	ADP
ajlm-1563	26	164	vulvar	vulvar	NOUN
ajlm-1563	26	165	cancer	cancer	NOUN
ajlm-1563	26	166	in	in	ADP
ajlm-1563	26	167	zambia	zambia	PROPN
ajlm-1563	26	168	was	be	AUX
ajlm-1563	26	169	hiv	hiv	PROPN
ajlm-1563	26	170	-	-	PUNCT
ajlm-1563	26	171	positive.21,22,23	positive.21,22,23	PROPN
ajlm-1563	26	172	however	however	ADV
ajlm-1563	26	173	,	,	PUNCT
ajlm-1563	26	174	little	little	ADJ
ajlm-1563	26	175	is	be	AUX
ajlm-1563	26	176	known	know	VERB
ajlm-1563	26	177	about	about	ADP
ajlm-1563	26	178	the	the	DET
ajlm-1563	26	179	clinical	clinical	ADJ
ajlm-1563	26	180	and	and	CCONJ
ajlm-1563	26	181	pathological	pathological	ADJ
ajlm-1563	26	182	presentation	presentation	NOUN
ajlm-1563	26	183	of	of	ADP
ajlm-1563	26	184	vulvar	vulvar	NOUN
ajlm-1563	26	185	cancer	cancer	NOUN
ajlm-1563	26	186	and	and	CCONJ
ajlm-1563	26	187	other	other	ADJ
ajlm-1563	26	188	vulvar	vulvar	NOUN
ajlm-1563	26	189	lesions	lesion	NOUN
ajlm-1563	26	190	in	in	ADP
ajlm-1563	26	191	zambia	zambia	PROPN
ajlm-1563	26	192	,	,	PUNCT
ajlm-1563	26	193	particularly	particularly	ADV
ajlm-1563	26	194	among	among	ADP
ajlm-1563	26	195	women	woman	NOUN
ajlm-1563	26	196	living	live	VERB
ajlm-1563	26	197	with	with	ADP
ajlm-1563	26	198	hiv	hiv	PROPN
ajlm-1563	26	199	.	.	PUNCT
ajlm-1563	27	1	this	this	DET
ajlm-1563	27	2	study	study	NOUN
ajlm-1563	27	3	aimed	aim	VERB
ajlm-1563	27	4	to	to	PART
ajlm-1563	27	5	compare	compare	VERB
ajlm-1563	27	6	the	the	DET
ajlm-1563	27	7	clinicopathologic	clinicopathologic	ADJ
ajlm-1563	27	8	features	feature	NOUN
ajlm-1563	27	9	and	and	CCONJ
ajlm-1563	27	10	risk	risk	NOUN
ajlm-1563	27	11	factors	factor	NOUN
ajlm-1563	27	12	of	of	ADP
ajlm-1563	27	13	vulvar	vulvar	NOUN
ajlm-1563	27	14	neoplasia	neoplasia	NOUN
ajlm-1563	27	15	with	with	ADP
ajlm-1563	27	16	those	those	PRON
ajlm-1563	27	17	of	of	ADP
ajlm-1563	27	18	non	non	ADJ
ajlm-1563	27	19	-	-	ADJ
ajlm-1563	27	20	neoplastic	neoplastic	ADJ
ajlm-1563	27	21	lesions	lesion	NOUN
ajlm-1563	27	22	(	(	PUNCT
ajlm-1563	27	23	nnl	nnl	NOUN
ajlm-1563	27	24	)	)	PUNCT
ajlm-1563	27	25	among	among	ADP
ajlm-1563	27	26	women	woman	NOUN
ajlm-1563	27	27	living	live	VERB
ajlm-1563	27	28	with	with	ADP
ajlm-1563	27	29	hiv	hiv	PROPN
ajlm-1563	27	30	.	.	PUNCT
ajlm-1563	28	1	it	it	PRON
ajlm-1563	28	2	also	also	ADV
ajlm-1563	28	3	aimed	aim	VERB
ajlm-1563	28	4	to	to	PART
ajlm-1563	28	5	determine	determine	VERB
ajlm-1563	28	6	the	the	DET
ajlm-1563	28	7	prevalence	prevalence	NOUN
ajlm-1563	28	8	of	of	ADP
ajlm-1563	28	9	hrhpv	hrhpv	ADJ
ajlm-1563	28	10	infection	infection	NOUN
ajlm-1563	28	11	among	among	ADP
ajlm-1563	28	12	vulvar	vulvar	ADJ
ajlm-1563	28	13	neoplasia	neoplasia	ADJ
ajlm-1563	28	14	patients	patient	NOUN
ajlm-1563	28	15	.	.	PUNCT
ajlm-1563	29	1	this	this	DET
ajlm-1563	29	2	information	information	NOUN
ajlm-1563	29	3	would	would	AUX
ajlm-1563	29	4	provide	provide	VERB
ajlm-1563	29	5	etiological	etiological	ADJ
ajlm-1563	29	6	and	and	CCONJ
ajlm-1563	29	7	clinical	clinical	ADJ
ajlm-1563	29	8	context	context	NOUN
ajlm-1563	29	9	to	to	PART
ajlm-1563	29	10	vulvar	vulvar	VERB
ajlm-1563	29	11	neoplasia	neoplasia	NOUN
ajlm-1563	29	12	in	in	ADP
ajlm-1563	29	13	zambia	zambia	PROPN
ajlm-1563	29	14	and	and	CCONJ
ajlm-1563	29	15	identify	identify	VERB
ajlm-1563	29	16	areas	area	NOUN
ajlm-1563	29	17	for	for	ADP
ajlm-1563	29	18	further	further	ADJ
ajlm-1563	29	19	research	research	NOUN
ajlm-1563	29	20	and	and	CCONJ
ajlm-1563	29	21	any	any	DET
ajlm-1563	29	22	challenges	challenge	NOUN
ajlm-1563	29	23	associated	associate	VERB
ajlm-1563	29	24	with	with	ADP
ajlm-1563	29	25	vulvar	vulvar	NOUN
ajlm-1563	29	26	neoplasia	neoplasia	NOUN
ajlm-1563	29	27	.	.	PUNCT
ajlm-1563	30	1	methods	method	NOUN
ajlm-1563	30	2	ethical	ethical	ADJ
ajlm-1563	30	3	considerations	consideration	NOUN
ajlm-1563	30	4	this	this	DET
ajlm-1563	30	5	study	study	NOUN
ajlm-1563	30	6	was	be	AUX
ajlm-1563	30	7	approved	approve	VERB
ajlm-1563	30	8	by	by	ADP
ajlm-1563	30	9	the	the	DET
ajlm-1563	30	10	university	university	PROPN
ajlm-1563	30	11	of	of	ADP
ajlm-1563	30	12	zambia	zambia	PROPN
ajlm-1563	30	13	biomedical	biomedical	PROPN
ajlm-1563	30	14	research	research	PROPN
ajlm-1563	30	15	ethics	ethic	NOUN
ajlm-1563	30	16	committee	committee	PROPN
ajlm-1563	30	17	(	(	PUNCT
ajlm-1563	30	18	reference	reference	NOUN
ajlm-1563	30	19	:	:	PUNCT
ajlm-1563	30	20	015	015	NUM
ajlm-1563	30	21	-	-	SYM
ajlm-1563	30	22	12	12	NUM
ajlm-1563	30	23	-	-	SYM
ajlm-1563	30	24	16	16	NUM
ajlm-1563	30	25	)	)	PUNCT
ajlm-1563	30	26	,	,	PUNCT
ajlm-1563	30	27	the	the	DET
ajlm-1563	30	28	national	national	PROPN
ajlm-1563	30	29	health	health	PROPN
ajlm-1563	30	30	research	research	PROPN
ajlm-1563	30	31	authority	authority	NOUN
ajlm-1563	30	32	,	,	PUNCT
ajlm-1563	30	33	and	and	CCONJ
ajlm-1563	30	34	the	the	DET
ajlm-1563	30	35	university	university	NOUN
ajlm-1563	30	36	of	of	ADP
ajlm-1563	30	37	north	north	PROPN
ajlm-1563	30	38	carolina	carolina	PROPN
ajlm-1563	30	39	at	at	ADP
ajlm-1563	30	40	chapel	chapel	PROPN
ajlm-1563	30	41	hill	hill	PROPN
ajlm-1563	30	42	institutional	institutional	PROPN
ajlm-1563	30	43	review	review	PROPN
ajlm-1563	30	44	board	board	NOUN
ajlm-1563	30	45	(	(	PUNCT
ajlm-1563	30	46	reference	reference	NOUN
ajlm-1563	30	47	:	:	PUNCT
ajlm-1563	30	48	irb	irb	PROPN
ajlm-1563	30	49	:	:	PUNCT
ajlm-1563	30	50	16	16	NUM
ajlm-1563	30	51	-	-	SYM
ajlm-1563	30	52	3422	3422	NUM
ajlm-1563	30	53	)	)	PUNCT
ajlm-1563	30	54	.	.	PUNCT
ajlm-1563	31	1	permission	permission	NOUN
ajlm-1563	31	2	to	to	PART
ajlm-1563	31	3	conduct	conduct	VERB
ajlm-1563	31	4	the	the	DET
ajlm-1563	31	5	study	study	NOUN
ajlm-1563	31	6	was	be	AUX
ajlm-1563	31	7	obtained	obtain	VERB
ajlm-1563	31	8	from	from	ADP
ajlm-1563	31	9	the	the	DET
ajlm-1563	31	10	management	management	NOUN
ajlm-1563	31	11	of	of	ADP
ajlm-1563	31	12	the	the	DET
ajlm-1563	31	13	university	university	NOUN
ajlm-1563	31	14	teaching	teaching	NOUN
ajlm-1563	31	15	hospitals	hospital	NOUN
ajlm-1563	31	16	.	.	PUNCT
ajlm-1563	32	1	participants	participant	NOUN
ajlm-1563	32	2	provided	provide	VERB
ajlm-1563	32	3	written	write	VERB
ajlm-1563	32	4	informed	inform	VERB
ajlm-1563	32	5	consent	consent	NOUN
ajlm-1563	32	6	to	to	PART
ajlm-1563	32	7	participate	participate	VERB
ajlm-1563	32	8	in	in	ADP
ajlm-1563	32	9	the	the	DET
ajlm-1563	32	10	study	study	NOUN
ajlm-1563	32	11	.	.	PUNCT
ajlm-1563	33	1	to	to	PART
ajlm-1563	33	2	maintain	maintain	VERB
ajlm-1563	33	3	confidentiality	confidentiality	NOUN
ajlm-1563	33	4	,	,	PUNCT
ajlm-1563	33	5	no	no	DET
ajlm-1563	33	6	identifying	identify	VERB
ajlm-1563	33	7	information	information	NOUN
ajlm-1563	33	8	was	be	AUX
ajlm-1563	33	9	collected	collect	VERB
ajlm-1563	33	10	and	and	CCONJ
ajlm-1563	33	11	participant	participant	ADJ
ajlm-1563	33	12	data	datum	NOUN
ajlm-1563	33	13	were	be	AUX
ajlm-1563	33	14	de	de	ADJ
ajlm-1563	33	15	-	-	VERB
ajlm-1563	33	16	identified	identify	VERB
ajlm-1563	33	17	using	use	VERB
ajlm-1563	33	18	unique	unique	ADJ
ajlm-1563	33	19	codes	code	NOUN
ajlm-1563	33	20	before	before	ADP
ajlm-1563	33	21	storage	storage	NOUN
ajlm-1563	33	22	in	in	ADP
ajlm-1563	33	23	a	a	DET
ajlm-1563	33	24	password	password	NOUN
ajlm-1563	33	25	-	-	PUNCT
ajlm-1563	33	26	protected	protect	VERB
ajlm-1563	33	27	computer	computer	NOUN
ajlm-1563	33	28	accessed	access	VERB
ajlm-1563	33	29	only	only	ADV
ajlm-1563	33	30	by	by	ADP
ajlm-1563	33	31	the	the	DET
ajlm-1563	33	32	principal	principal	ADJ
ajlm-1563	33	33	investigator	investigator	NOUN
ajlm-1563	33	34	.	.	PUNCT
ajlm-1563	34	1	data	datum	NOUN
ajlm-1563	34	2	from	from	ADP
ajlm-1563	34	3	participants	participant	NOUN
ajlm-1563	34	4	who	who	PRON
ajlm-1563	34	5	withdrew	withdraw	VERB
ajlm-1563	34	6	from	from	ADP
ajlm-1563	34	7	the	the	DET
ajlm-1563	34	8	study	study	NOUN
ajlm-1563	34	9	were	be	AUX
ajlm-1563	34	10	completely	completely	ADV
ajlm-1563	34	11	removed	remove	VERB
ajlm-1563	34	12	.	.	PUNCT
ajlm-1563	35	1	study	study	NOUN
ajlm-1563	35	2	design	design	NOUN
ajlm-1563	35	3	and	and	CCONJ
ajlm-1563	35	4	setting	set	VERB
ajlm-1563	35	5	this	this	PRON
ajlm-1563	35	6	was	be	AUX
ajlm-1563	35	7	a	a	DET
ajlm-1563	35	8	cross	cross	ADJ
ajlm-1563	35	9	-	-	ADJ
ajlm-1563	35	10	sectional	sectional	ADJ
ajlm-1563	35	11	hospital	hospital	NOUN
ajlm-1563	35	12	-	-	PUNCT
ajlm-1563	35	13	based	base	VERB
ajlm-1563	35	14	clinical	clinical	ADJ
ajlm-1563	35	15	and	and	CCONJ
ajlm-1563	35	16	laboratory	laboratory	NOUN
ajlm-1563	35	17	study	study	NOUN
ajlm-1563	35	18	conducted	conduct	VERB
ajlm-1563	35	19	between	between	ADP
ajlm-1563	35	20	july	july	PROPN
ajlm-1563	35	21	2017	2017	NUM
ajlm-1563	35	22	and	and	CCONJ
ajlm-1563	35	23	february	february	PROPN
ajlm-1563	35	24	2018	2018	NUM
ajlm-1563	35	25	at	at	ADP
ajlm-1563	35	26	the	the	DET
ajlm-1563	35	27	university	university	NOUN
ajlm-1563	35	28	teaching	teaching	NOUN
ajlm-1563	35	29	hospital	hospital	NOUN
ajlm-1563	35	30	’s	’s	PART
ajlm-1563	35	31	women	woman	NOUN
ajlm-1563	35	32	and	and	CCONJ
ajlm-1563	35	33	new	new	ADJ
ajlm-1563	35	34	born	bear	VERB
ajlm-1563	35	35	hospital	hospital	NOUN
ajlm-1563	35	36	,	,	PUNCT
ajlm-1563	35	37	lusaka	lusaka	PROPN
ajlm-1563	35	38	,	,	PUNCT
ajlm-1563	35	39	zambia	zambia	PROPN
ajlm-1563	35	40	.	.	PUNCT
ajlm-1563	36	1	the	the	DET
ajlm-1563	36	2	hospital	hospital	NOUN
ajlm-1563	36	3	is	be	AUX
ajlm-1563	36	4	the	the	DET
ajlm-1563	36	5	country	country	NOUN
ajlm-1563	36	6	’s	’s	PART
ajlm-1563	36	7	largest	large	ADJ
ajlm-1563	36	8	public	public	ADJ
ajlm-1563	36	9	tertiary	tertiary	ADJ
ajlm-1563	36	10	hospital	hospital	NOUN
ajlm-1563	36	11	for	for	ADP
ajlm-1563	36	12	obstetric	obstetric	ADJ
ajlm-1563	36	13	,	,	PUNCT
ajlm-1563	36	14	gynaecologic	gynaecologic	NOUN
ajlm-1563	36	15	,	,	PUNCT
ajlm-1563	36	16	and	and	CCONJ
ajlm-1563	36	17	neonatal	neonatal	ADJ
ajlm-1563	36	18	care	care	NOUN
ajlm-1563	36	19	.	.	PUNCT
ajlm-1563	37	1	women	woman	NOUN
ajlm-1563	37	2	attending	attend	VERB
ajlm-1563	37	3	the	the	DET
ajlm-1563	37	4	university	university	NOUN
ajlm-1563	37	5	teaching	teaching	NOUN
ajlm-1563	37	6	hospital	hospital	NOUN
ajlm-1563	37	7	’s	’s	PART
ajlm-1563	37	8	gynaecologic	gynaecologic	PROPN
ajlm-1563	37	9	clinic	clinic	NOUN
ajlm-1563	37	10	between	between	ADP
ajlm-1563	37	11	july	july	PROPN
ajlm-1563	37	12	2017	2017	NUM
ajlm-1563	37	13	and	and	CCONJ
ajlm-1563	37	14	february	february	PROPN
ajlm-1563	37	15	2018	2018	NUM
ajlm-1563	37	16	were	be	AUX
ajlm-1563	37	17	recruited	recruit	VERB
ajlm-1563	37	18	.	.	PUNCT
ajlm-1563	38	1	the	the	DET
ajlm-1563	38	2	sample	sample	NOUN
ajlm-1563	38	3	size	size	NOUN
ajlm-1563	38	4	was	be	AUX
ajlm-1563	38	5	determined	determine	VERB
ajlm-1563	38	6	using	use	VERB
ajlm-1563	38	7	the	the	DET
ajlm-1563	38	8	fisher	fisher	PROPN
ajlm-1563	38	9	formula	formula	NOUN
ajlm-1563	38	10	:	:	PUNCT
ajlm-1563	38	11	z2	z2	PROPN
ajlm-1563	38	12	p	p	NOUN
ajlm-1563	38	13	(	(	PUNCT
ajlm-1563	38	14	1	1	NUM
ajlm-1563	38	15	−	−	PROPN
ajlm-1563	38	16	p)/d2	p)/d2	NOUN
ajlm-1563	38	17	based	base	VERB
ajlm-1563	38	18	on	on	ADP
ajlm-1563	38	19	an	an	DET
ajlm-1563	38	20	assumed	assumed	ADJ
ajlm-1563	38	21	prevalence	prevalence	NOUN
ajlm-1563	38	22	(	(	PUNCT
ajlm-1563	38	23	p	p	NOUN
ajlm-1563	38	24	)	)	PUNCT
ajlm-1563	38	25	of	of	ADP
ajlm-1563	38	26	3.6	3.6	NUM
ajlm-1563	38	27	%	%	NOUN
ajlm-1563	38	28	,	,	PUNCT
ajlm-1563	38	29	a	a	DET
ajlm-1563	38	30	z	z	NOUN
ajlm-1563	38	31	score	score	NOUN
ajlm-1563	38	32	of	of	ADP
ajlm-1563	38	33	1.96	1.96	NUM
ajlm-1563	38	34	and	and	CCONJ
ajlm-1563	38	35	a	a	DET
ajlm-1563	38	36	margin	margin	NOUN
ajlm-1563	38	37	of	of	ADP
ajlm-1563	38	38	error	error	NOUN
ajlm-1563	38	39	(	(	PUNCT
ajlm-1563	38	40	d	d	NOUN
ajlm-1563	38	41	)	)	PUNCT
ajlm-1563	38	42	of	of	ADP
ajlm-1563	38	43	±5	±5	NOUN
ajlm-1563	38	44	%	%	NOUN
ajlm-1563	38	45	.	.	PUNCT
ajlm-1563	39	1	women	woman	NOUN
ajlm-1563	39	2	who	who	PRON
ajlm-1563	39	3	were	be	AUX
ajlm-1563	39	4	aged	age	VERB
ajlm-1563	39	5	18	18	NUM
ajlm-1563	39	6	years	year	NOUN
ajlm-1563	39	7	or	or	CCONJ
ajlm-1563	39	8	older	old	ADJ
ajlm-1563	39	9	,	,	PUNCT
ajlm-1563	39	10	presented	present	VERB
ajlm-1563	39	11	with	with	ADP
ajlm-1563	39	12	a	a	DET
ajlm-1563	39	13	vulvar	vulvar	NOUN
ajlm-1563	39	14	lesion	lesion	NOUN
ajlm-1563	39	15	and	and	CCONJ
ajlm-1563	39	16	were	be	AUX
ajlm-1563	39	17	documented	document	VERB
ajlm-1563	39	18	as	as	ADP
ajlm-1563	39	19	hiv	hiv	NOUN
ajlm-1563	39	20	-	-	PUNCT
ajlm-1563	39	21	positive	positive	ADJ
ajlm-1563	39	22	were	be	AUX
ajlm-1563	39	23	included	include	VERB
ajlm-1563	39	24	in	in	ADP
ajlm-1563	39	25	the	the	DET
ajlm-1563	39	26	study	study	NOUN
ajlm-1563	39	27	.	.	PUNCT
ajlm-1563	40	1	women	woman	NOUN
ajlm-1563	40	2	who	who	PRON
ajlm-1563	40	3	were	be	AUX
ajlm-1563	40	4	unwilling	unwilling	ADJ
ajlm-1563	40	5	to	to	PART
ajlm-1563	40	6	undergo	undergo	VERB
ajlm-1563	40	7	a	a	DET
ajlm-1563	40	8	punch	punch	NOUN
ajlm-1563	40	9	biopsy	biopsy	NOUN
ajlm-1563	40	10	and	and	CCONJ
ajlm-1563	40	11	had	have	VERB
ajlm-1563	40	12	a	a	DET
ajlm-1563	40	13	previous	previous	ADJ
ajlm-1563	40	14	diagnosis	diagnosis	NOUN
ajlm-1563	40	15	of	of	ADP
ajlm-1563	40	16	vulvar	vulvar	NOUN
ajlm-1563	40	17	cancer	cancer	NOUN
ajlm-1563	40	18	and	and	CCONJ
ajlm-1563	40	19	a	a	DET
ajlm-1563	40	20	history	history	NOUN
ajlm-1563	40	21	of	of	ADP
ajlm-1563	40	22	bleeding	bleed	VERB
ajlm-1563	40	23	disorder	disorder	NOUN
ajlm-1563	40	24	were	be	AUX
ajlm-1563	40	25	excluded	exclude	VERB
ajlm-1563	40	26	.	.	PUNCT
ajlm-1563	41	1	a	a	DET
ajlm-1563	41	2	total	total	NOUN
ajlm-1563	41	3	of	of	ADP
ajlm-1563	41	4	56	56	NUM
ajlm-1563	41	5	women	woman	NOUN
ajlm-1563	41	6	were	be	AUX
ajlm-1563	41	7	approached	approach	VERB
ajlm-1563	41	8	,	,	PUNCT
ajlm-1563	41	9	of	of	ADP
ajlm-1563	41	10	which	which	PRON
ajlm-1563	41	11	53	53	NUM
ajlm-1563	41	12	were	be	AUX
ajlm-1563	41	13	recruited	recruit	VERB
ajlm-1563	41	14	for	for	ADP
ajlm-1563	41	15	the	the	DET
ajlm-1563	41	16	study	study	NOUN
ajlm-1563	41	17	;	;	PUNCT
ajlm-1563	41	18	two	two	NUM
ajlm-1563	41	19	were	be	AUX
ajlm-1563	41	20	ineligible	ineligible	ADJ
ajlm-1563	41	21	and	and	CCONJ
ajlm-1563	41	22	one	one	NUM
ajlm-1563	41	23	did	do	AUX
ajlm-1563	41	24	not	not	PART
ajlm-1563	41	25	consent	consent	VERB
ajlm-1563	41	26	.	.	PUNCT
ajlm-1563	42	1	demographic	demographic	ADJ
ajlm-1563	42	2	information	information	NOUN
ajlm-1563	42	3	,	,	PUNCT
ajlm-1563	42	4	frequency	frequency	NOUN
ajlm-1563	42	5	of	of	ADP
ajlm-1563	42	6	selected	select	VERB
ajlm-1563	42	7	risk	risk	NOUN
ajlm-1563	42	8	factors	factor	NOUN
ajlm-1563	42	9	(	(	PUNCT
ajlm-1563	42	10	smoking	smoking	NOUN
ajlm-1563	42	11	,	,	PUNCT
ajlm-1563	42	12	age	age	NOUN
ajlm-1563	42	13	at	at	ADP
ajlm-1563	42	14	first	first	ADJ
ajlm-1563	42	15	sexual	sexual	ADJ
ajlm-1563	42	16	intercourse	intercourse	NOUN
ajlm-1563	42	17	,	,	PUNCT
ajlm-1563	42	18	number	number	NOUN
ajlm-1563	42	19	of	of	ADP
ajlm-1563	42	20	lifetime	lifetime	NOUN
ajlm-1563	42	21	sexual	sexual	ADJ
ajlm-1563	42	22	partners	partner	NOUN
ajlm-1563	42	23	,	,	PUNCT
ajlm-1563	42	24	alcohol	alcohol	NOUN
ajlm-1563	42	25	use	use	NOUN
ajlm-1563	42	26	,	,	PUNCT
ajlm-1563	42	27	and	and	CCONJ
ajlm-1563	42	28	oral	oral	ADJ
ajlm-1563	42	29	contraceptive	contraceptive	ADJ
ajlm-1563	42	30	use	use	NOUN
ajlm-1563	42	31	)	)	PUNCT
ajlm-1563	42	32	,	,	PUNCT
ajlm-1563	42	33	and	and	CCONJ
ajlm-1563	42	34	a	a	DET
ajlm-1563	42	35	comprehensive	comprehensive	ADJ
ajlm-1563	42	36	clinical	clinical	ADJ
ajlm-1563	42	37	history	history	NOUN
ajlm-1563	42	38	were	be	AUX
ajlm-1563	42	39	obtained	obtain	VERB
ajlm-1563	42	40	using	use	VERB
ajlm-1563	42	41	a	a	DET
ajlm-1563	42	42	structured	structured	ADJ
ajlm-1563	42	43	questionnaire	questionnaire	NOUN
ajlm-1563	42	44	.	.	PUNCT
ajlm-1563	43	1	cd4	cd4	PROPN
ajlm-1563	43	2	count	count	NOUN
ajlm-1563	43	3	tests	test	NOUN
ajlm-1563	43	4	were	be	AUX
ajlm-1563	43	5	conducted	conduct	VERB
ajlm-1563	43	6	or	or	CCONJ
ajlm-1563	43	7	results	result	NOUN
ajlm-1563	43	8	obtained	obtain	VERB
ajlm-1563	43	9	from	from	ADP
ajlm-1563	43	10	patients	patient	NOUN
ajlm-1563	43	11	’	'	PUNCT
ajlm-1563	43	12	medical	medical	ADJ
ajlm-1563	43	13	records	record	NOUN
ajlm-1563	43	14	if	if	SCONJ
ajlm-1563	43	15	the	the	DET
ajlm-1563	43	16	test	test	NOUN
ajlm-1563	43	17	was	be	AUX
ajlm-1563	43	18	done	do	VERB
ajlm-1563	43	19	within	within	ADP
ajlm-1563	43	20	the	the	DET
ajlm-1563	43	21	last	last	ADJ
ajlm-1563	43	22	six	six	NUM
ajlm-1563	43	23	months	month	NOUN
ajlm-1563	43	24	.	.	PUNCT
ajlm-1563	44	1	clinical	clinical	ADJ
ajlm-1563	44	2	examinations	examination	NOUN
ajlm-1563	44	3	of	of	ADP
ajlm-1563	44	4	the	the	DET
ajlm-1563	44	5	vulva	vulva	NOUN
ajlm-1563	44	6	were	be	AUX
ajlm-1563	44	7	conducted	conduct	VERB
ajlm-1563	44	8	and	and	CCONJ
ajlm-1563	44	9	the	the	DET
ajlm-1563	44	10	characteristics	characteristic	NOUN
ajlm-1563	44	11	of	of	ADP
ajlm-1563	44	12	the	the	DET
ajlm-1563	44	13	vulvar	vulvar	NOUN
ajlm-1563	44	14	lesions	lesion	NOUN
ajlm-1563	44	15	were	be	AUX
ajlm-1563	44	16	recorded	record	VERB
ajlm-1563	44	17	.	.	PUNCT
ajlm-1563	45	1	the	the	DET
ajlm-1563	45	2	sizes	size	NOUN
ajlm-1563	45	3	of	of	ADP
ajlm-1563	45	4	the	the	DET
ajlm-1563	45	5	vulvar	vulvar	NOUN
ajlm-1563	45	6	lesions	lesion	NOUN
ajlm-1563	45	7	were	be	AUX
ajlm-1563	45	8	determined	determine	VERB
ajlm-1563	45	9	using	use	VERB
ajlm-1563	45	10	a	a	DET
ajlm-1563	45	11	measuring	measure	VERB
ajlm-1563	45	12	tape	tape	NOUN
ajlm-1563	45	13	.	.	PUNCT
ajlm-1563	46	1	biopsy	biopsy	NOUN
ajlm-1563	46	2	and	and	CCONJ
ajlm-1563	46	3	histopathological	histopathological	ADJ
ajlm-1563	46	4	analysis	analysis	NOUN
ajlm-1563	46	5	tissues	tissue	NOUN
ajlm-1563	46	6	for	for	ADP
ajlm-1563	46	7	histologic	histologic	ADJ
ajlm-1563	46	8	diagnosis	diagnosis	NOUN
ajlm-1563	46	9	were	be	AUX
ajlm-1563	46	10	collected	collect	VERB
ajlm-1563	46	11	using	use	VERB
ajlm-1563	46	12	keyes	keye	NOUN
ajlm-1563	46	13	’	'	PUNCT
ajlm-1563	46	14	punch	punch	VERB
ajlm-1563	46	15	biopsy	biopsy	NOUN
ajlm-1563	46	16	forceps	forceps	NOUN
ajlm-1563	46	17	under	under	ADP
ajlm-1563	46	18	local	local	ADJ
ajlm-1563	46	19	anaesthesia	anaesthesia	NOUN
ajlm-1563	46	20	and	and	CCONJ
ajlm-1563	46	21	aseptic	aseptic	ADJ
ajlm-1563	46	22	conditions	condition	NOUN
ajlm-1563	46	23	.	.	PUNCT
ajlm-1563	47	1	the	the	DET
ajlm-1563	47	2	tissues	tissue	NOUN
ajlm-1563	47	3	were	be	AUX
ajlm-1563	47	4	preserved	preserve	VERB
ajlm-1563	47	5	in	in	ADP
ajlm-1563	47	6	10	10	NUM
ajlm-1563	47	7	%	%	NOUN
ajlm-1563	47	8	neutral	neutral	ADJ
ajlm-1563	47	9	buffered	buffer	VERB
ajlm-1563	47	10	formalin	formalin	NOUN
ajlm-1563	47	11	and	and	CCONJ
ajlm-1563	47	12	transported	transport	VERB
ajlm-1563	47	13	to	to	ADP
ajlm-1563	47	14	the	the	DET
ajlm-1563	47	15	pathology	pathology	NOUN
ajlm-1563	47	16	laboratory	laboratory	NOUN
ajlm-1563	47	17	of	of	ADP
ajlm-1563	47	18	the	the	DET
ajlm-1563	47	19	university	university	NOUN
ajlm-1563	47	20	teaching	teaching	NOUN
ajlm-1563	47	21	hospital	hospital	NOUN
ajlm-1563	47	22	’s	’s	PART
ajlm-1563	47	23	adult	adult	NOUN
ajlm-1563	47	24	and	and	CCONJ
ajlm-1563	47	25	emergency	emergency	NOUN
ajlm-1563	47	26	hospital	hospital	NOUN
ajlm-1563	47	27	.	.	PUNCT
ajlm-1563	48	1	the	the	DET
ajlm-1563	48	2	tissues	tissue	NOUN
ajlm-1563	48	3	were	be	AUX
ajlm-1563	48	4	processed	process	VERB
ajlm-1563	48	5	in	in	ADP
ajlm-1563	48	6	the	the	DET
ajlm-1563	48	7	laboratory	laboratory	NOUN
ajlm-1563	48	8	according	accord	VERB
ajlm-1563	48	9	to	to	ADP
ajlm-1563	48	10	standard	standard	ADJ
ajlm-1563	48	11	protocols	protocol	NOUN
ajlm-1563	48	12	,	,	PUNCT
ajlm-1563	48	13	after	after	ADP
ajlm-1563	48	14	which	which	PRON
ajlm-1563	48	15	the	the	DET
ajlm-1563	48	16	histologic	histologic	ADJ
ajlm-1563	48	17	evaluation	evaluation	NOUN
ajlm-1563	48	18	was	be	AUX
ajlm-1563	48	19	conducted	conduct	VERB
ajlm-1563	48	20	by	by	ADP
ajlm-1563	48	21	three	three	NUM
ajlm-1563	48	22	pathologists	pathologist	NOUN
ajlm-1563	48	23	.	.	PUNCT
ajlm-1563	49	1	based	base	VERB
ajlm-1563	49	2	on	on	ADP
ajlm-1563	49	3	the	the	DET
ajlm-1563	49	4	classification	classification	NOUN
ajlm-1563	49	5	of	of	ADP
ajlm-1563	49	6	the	the	DET
ajlm-1563	49	7	international	international	ADJ
ajlm-1563	49	8	society	society	NOUN
ajlm-1563	49	9	for	for	ADP
ajlm-1563	49	10	the	the	DET
ajlm-1563	49	11	study	study	NOUN
ajlm-1563	49	12	of	of	ADP
ajlm-1563	49	13	vulvovaginal	vulvovaginal	ADJ
ajlm-1563	49	14	disease	disease	NOUN
ajlm-1563	49	15	(	(	PUNCT
ajlm-1563	49	16	2015),24	2015),24	NUM
ajlm-1563	49	17	the	the	DET
ajlm-1563	49	18	lesions	lesion	NOUN
ajlm-1563	49	19	were	be	AUX
ajlm-1563	49	20	classified	classify	VERB
ajlm-1563	49	21	as	as	ADP
ajlm-1563	49	22	nnl	nnl	PROPN
ajlm-1563	49	23	,	,	PUNCT
ajlm-1563	49	24	condylomata	condylomata	ADJ
ajlm-1563	49	25	acuminatum	acuminatum	NOUN
ajlm-1563	49	26	,	,	PUNCT
ajlm-1563	49	27	uvin	uvin	NOUN
ajlm-1563	49	28	,	,	PUNCT
ajlm-1563	49	29	or	or	CCONJ
ajlm-1563	49	30	vscc	vscc	NOUN
ajlm-1563	49	31	.	.	PUNCT
ajlm-1563	50	1	nnl	nnl	NOUN
ajlm-1563	50	2	types	type	NOUN
ajlm-1563	50	3	included	include	VERB
ajlm-1563	50	4	acute	acute	ADJ
ajlm-1563	50	5	non	non	ADJ
ajlm-1563	50	6	-	-	ADJ
ajlm-1563	50	7	specific	specific	ADJ
ajlm-1563	50	8	inflammation	inflammation	NOUN
ajlm-1563	50	9	,	,	PUNCT
ajlm-1563	50	10	chronic	chronic	ADJ
ajlm-1563	50	11	non	non	ADJ
ajlm-1563	50	12	-	-	ADJ
ajlm-1563	50	13	specific	specific	ADJ
ajlm-1563	50	14	inflammation	inflammation	NOUN
ajlm-1563	50	15	and	and	CCONJ
ajlm-1563	50	16	herpes	herpe	NOUN
ajlm-1563	50	17	simplex	simplex	NOUN
ajlm-1563	50	18	ulcer	ulcer	NOUN
ajlm-1563	50	19	.	.	PUNCT
ajlm-1563	51	1	usual	usual	ADJ
ajlm-1563	51	2	vin	vin	NOUN
ajlm-1563	51	3	types	type	NOUN
ajlm-1563	51	4	included	include	VERB
ajlm-1563	51	5	low	low	ADJ
ajlm-1563	51	6	-	-	PUNCT
ajlm-1563	51	7	grade	grade	NOUN
ajlm-1563	51	8	squamous	squamous	ADJ
ajlm-1563	51	9	intraepithelial	intraepithelial	ADJ
ajlm-1563	51	10	lesion	lesion	NOUN
ajlm-1563	51	11	(	(	PUNCT
ajlm-1563	51	12	lsil	lsil	PROPN
ajlm-1563	51	13	)	)	PUNCT
ajlm-1563	51	14	and	and	CCONJ
ajlm-1563	51	15	high	high	ADJ
ajlm-1563	51	16	-	-	PUNCT
ajlm-1563	51	17	grade	grade	NOUN
ajlm-1563	51	18	squamous	squamous	ADJ
ajlm-1563	51	19	intraepithelial	intraepithelial	ADJ
ajlm-1563	51	20	lesion	lesion	NOUN
ajlm-1563	51	21	(	(	PUNCT
ajlm-1563	51	22	hsil	hsil	NOUN
ajlm-1563	51	23	)	)	PUNCT
ajlm-1563	51	24	.	.	PUNCT
ajlm-1563	52	1	the	the	DET
ajlm-1563	52	2	pathologists	pathologist	NOUN
ajlm-1563	52	3	diagnosed	diagnose	VERB
ajlm-1563	52	4	the	the	DET
ajlm-1563	52	5	vulvar	vulvar	NOUN
ajlm-1563	52	6	lesions	lesion	NOUN
ajlm-1563	52	7	as	as	ADP
ajlm-1563	52	8	lsil	lsil	NOUN
ajlm-1563	52	9	if	if	SCONJ
ajlm-1563	52	10	the	the	DET
ajlm-1563	52	11	dysplastic	dysplastic	ADJ
ajlm-1563	52	12	cellular	cellular	ADJ
ajlm-1563	52	13	changes	change	NOUN
ajlm-1563	52	14	were	be	AUX
ajlm-1563	52	15	limited	limit	VERB
ajlm-1563	52	16	to	to	ADP
ajlm-1563	52	17	the	the	DET
ajlm-1563	52	18	lower	low	ADJ
ajlm-1563	52	19	third	third	NOUN
ajlm-1563	52	20	of	of	ADP
ajlm-1563	52	21	the	the	DET
ajlm-1563	52	22	epithelium	epithelium	NOUN
ajlm-1563	52	23	,	,	PUNCT
ajlm-1563	52	24	and	and	CCONJ
ajlm-1563	52	25	hsil	hsil	NOUN
ajlm-1563	52	26	if	if	SCONJ
ajlm-1563	52	27	the	the	DET
ajlm-1563	52	28	dysplastic	dysplastic	ADJ
ajlm-1563	52	29	cellular	cellular	ADJ
ajlm-1563	52	30	changes	change	NOUN
ajlm-1563	52	31	involved	involve	VERB
ajlm-1563	52	32	up	up	ADP
ajlm-1563	52	33	to	to	ADP
ajlm-1563	52	34	or	or	CCONJ
ajlm-1563	52	35	greater	great	ADJ
ajlm-1563	52	36	than	than	ADP
ajlm-1563	52	37	the	the	DET
ajlm-1563	52	38	upper	upper	ADJ
ajlm-1563	52	39	two	two	NUM
ajlm-1563	52	40	-	-	PUNCT
ajlm-1563	52	41	thirds	third	NOUN
ajlm-1563	52	42	of	of	ADP
ajlm-1563	52	43	the	the	DET
ajlm-1563	52	44	epithelium	epithelium	NOUN
ajlm-1563	52	45	.	.	PUNCT
ajlm-1563	53	1	detection	detection	NOUN
ajlm-1563	53	2	of	of	ADP
ajlm-1563	53	3	high	high	ADJ
ajlm-1563	53	4	-	-	PUNCT
ajlm-1563	53	5	risk	risk	NOUN
ajlm-1563	53	6	human	human	ADJ
ajlm-1563	53	7	papillomavirus	papillomavirus	NOUN
ajlm-1563	53	8	punch	punch	NOUN
ajlm-1563	53	9	biopsies	biopsy	NOUN
ajlm-1563	53	10	for	for	ADP
ajlm-1563	53	11	the	the	DET
ajlm-1563	53	12	polymerase	polymerase	NOUN
ajlm-1563	53	13	chain	chain	NOUN
ajlm-1563	53	14	reaction	reaction	NOUN
ajlm-1563	53	15	test	test	NOUN
ajlm-1563	53	16	were	be	AUX
ajlm-1563	53	17	collected	collect	VERB
ajlm-1563	53	18	during	during	ADP
ajlm-1563	53	19	the	the	DET
ajlm-1563	53	20	collection	collection	NOUN
ajlm-1563	53	21	of	of	ADP
ajlm-1563	53	22	tissue	tissue	NOUN
ajlm-1563	53	23	for	for	ADP
ajlm-1563	53	24	histology	histology	NOUN
ajlm-1563	53	25	.	.	PUNCT
ajlm-1563	54	1	each	each	DET
ajlm-1563	54	2	tissue	tissue	NOUN
ajlm-1563	54	3	was	be	AUX
ajlm-1563	54	4	preserved	preserve	VERB
ajlm-1563	54	5	in	in	ADP
ajlm-1563	54	6	a	a	DET
ajlm-1563	54	7	1.5	1.5	NUM
ajlm-1563	54	8	ml	ml	NOUN
ajlm-1563	54	9	microcentrifuge	microcentrifuge	ADJ
ajlm-1563	54	10	tube	tube	NOUN
ajlm-1563	54	11	containing	contain	VERB
ajlm-1563	54	12	qiagen	qiagen	NOUN
ajlm-1563	54	13	buffer	buffer	NOUN
ajlm-1563	54	14	atl	atl	PROPN
ajlm-1563	54	15	(	(	PUNCT
ajlm-1563	54	16	qiagen	qiagen	PROPN
ajlm-1563	54	17	,	,	PUNCT
ajlm-1563	54	18	germantown	germantown	PROPN
ajlm-1563	54	19	,	,	PUNCT
ajlm-1563	54	20	maryland	maryland	PROPN
ajlm-1563	54	21	,	,	PUNCT
ajlm-1563	54	22	united	united	PROPN
ajlm-1563	54	23	states	states	PROPN
ajlm-1563	54	24	)	)	PUNCT
ajlm-1563	54	25	and	and	CCONJ
ajlm-1563	54	26	stored	store	VERB
ajlm-1563	54	27	in	in	ADP
ajlm-1563	54	28	a	a	DET
ajlm-1563	54	29	refrigerator	refrigerator	NOUN
ajlm-1563	54	30	at	at	ADP
ajlm-1563	54	31	–	–	PUNCT
ajlm-1563	54	32	80	80	NUM
ajlm-1563	54	33	°	°	NOUN
ajlm-1563	54	34	c	c	NOUN
ajlm-1563	54	35	.	.	PUNCT
ajlm-1563	55	1	samples	sample	NOUN
ajlm-1563	55	2	were	be	AUX
ajlm-1563	55	3	allowed	allow	VERB
ajlm-1563	55	4	to	to	PART
ajlm-1563	55	5	defrost	defrost	VERB
ajlm-1563	55	6	at	at	ADP
ajlm-1563	55	7	room	room	NOUN
ajlm-1563	55	8	temperature	temperature	NOUN
ajlm-1563	55	9	,	,	PUNCT
ajlm-1563	55	10	mixed	mix	VERB
ajlm-1563	55	11	with	with	ADP
ajlm-1563	55	12	20	20	NUM
ajlm-1563	55	13	µl	µl	NOUN
ajlm-1563	55	14	of	of	ADP
ajlm-1563	55	15	proteinase	proteinase	NOUN
ajlm-1563	55	16	k	k	PROPN
ajlm-1563	55	17	,	,	PUNCT
ajlm-1563	55	18	and	and	CCONJ
ajlm-1563	55	19	then	then	ADV
ajlm-1563	55	20	incubated	incubate	VERB
ajlm-1563	55	21	and	and	CCONJ
ajlm-1563	55	22	vortexed	vortexe	VERB
ajlm-1563	55	23	to	to	PART
ajlm-1563	55	24	ensure	ensure	VERB
ajlm-1563	55	25	a	a	DET
ajlm-1563	55	26	complete	complete	ADJ
ajlm-1563	55	27	mixture	mixture	NOUN
ajlm-1563	55	28	.	.	PUNCT
ajlm-1563	56	1	total	total	ADJ
ajlm-1563	56	2	dna	dna	PROPN
ajlm-1563	56	3	was	be	AUX
ajlm-1563	56	4	extracted	extract	VERB
ajlm-1563	56	5	from	from	ADP
ajlm-1563	56	6	the	the	DET
ajlm-1563	56	7	pre	pre	ADJ
ajlm-1563	56	8	-	-	ADJ
ajlm-1563	56	9	lysed	lysed	ADJ
ajlm-1563	56	10	samples	sample	NOUN
ajlm-1563	56	11	using	use	VERB
ajlm-1563	56	12	the	the	DET
ajlm-1563	56	13	nuclisens	nuclisen	NOUN
ajlm-1563	56	14	®	®	NOUN
ajlm-1563	56	15	easymag	easymag	NOUN
ajlm-1563	56	16	™	™	VERB
ajlm-1563	56	17	automated	automate	VERB
ajlm-1563	56	18	extraction	extraction	NOUN
ajlm-1563	56	19	machine	machine	NOUN
ajlm-1563	56	20	(	(	PUNCT
ajlm-1563	56	21	biomerieux	biomerieux	PROPN
ajlm-1563	56	22	,	,	PUNCT
ajlm-1563	56	23	inc	inc	PROPN
ajlm-1563	56	24	,	,	PUNCT
ajlm-1563	56	25	marcy	marcy	PROPN
ajlm-1563	56	26	i’etoile	i’etoile	PROPN
ajlm-1563	56	27	,	,	PUNCT
ajlm-1563	56	28	france	france	PROPN
ajlm-1563	56	29	)	)	PUNCT
ajlm-1563	56	30	according	accord	VERB
ajlm-1563	56	31	to	to	ADP
ajlm-1563	56	32	the	the	DET
ajlm-1563	56	33	manufacturer	manufacturer	NOUN
ajlm-1563	56	34	’s	’s	PART
ajlm-1563	56	35	protocol	protocol	NOUN
ajlm-1563	56	36	.	.	PUNCT
ajlm-1563	57	1	the	the	DET
ajlm-1563	57	2	elution	elution	NOUN
ajlm-1563	57	3	volume	volume	NOUN
ajlm-1563	57	4	was	be	AUX
ajlm-1563	57	5	100	100	NUM
ajlm-1563	57	6	µl	µl	NOUN
ajlm-1563	57	7	.	.	PUNCT
ajlm-1563	58	1	polymerase	polymerase	NOUN
ajlm-1563	58	2	chain	chain	NOUN
ajlm-1563	58	3	reaction	reaction	NOUN
ajlm-1563	58	4	for	for	ADP
ajlm-1563	58	5	the	the	DET
ajlm-1563	58	6	detection	detection	NOUN
ajlm-1563	58	7	of	of	ADP
ajlm-1563	58	8	high	high	ADJ
ajlm-1563	58	9	-	-	PUNCT
ajlm-1563	58	10	risk	risk	NOUN
ajlm-1563	58	11	hpv	hpv	NOUN
ajlm-1563	58	12	was	be	AUX
ajlm-1563	58	13	carried	carry	VERB
ajlm-1563	58	14	out	out	ADP
ajlm-1563	58	15	using	use	VERB
ajlm-1563	58	16	the	the	DET
ajlm-1563	58	17	xpert	xpert	PROPN
ajlm-1563	58	18	®	®	PROPN
ajlm-1563	58	19	hpv	hpv	PROPN
ajlm-1563	58	20	platform	platform	PROPN
ajlm-1563	58	21	(	(	PUNCT
ajlm-1563	58	22	cepheid	cepheid	PROPN
ajlm-1563	58	23	,	,	PUNCT
ajlm-1563	58	24	sunnyvale	sunnyvale	PROPN
ajlm-1563	58	25	,	,	PUNCT
ajlm-1563	58	26	california	california	PROPN
ajlm-1563	58	27	,	,	PUNCT
ajlm-1563	58	28	united	united	PROPN
ajlm-1563	58	29	states	states	PROPN
ajlm-1563	58	30	)	)	PUNCT
ajlm-1563	58	31	.	.	PUNCT
ajlm-1563	59	1	to	to	PART
ajlm-1563	59	2	do	do	VERB
ajlm-1563	59	3	this	this	PRON
ajlm-1563	59	4	,	,	PUNCT
ajlm-1563	59	5	100	100	NUM
ajlm-1563	59	6	µl	µl	ADP
ajlm-1563	59	7	of	of	ADP
ajlm-1563	59	8	each	each	DET
ajlm-1563	59	9	extracted	extract	VERB
ajlm-1563	59	10	sample	sample	NOUN
ajlm-1563	59	11	was	be	AUX
ajlm-1563	59	12	mixed	mix	VERB
ajlm-1563	59	13	with	with	ADP
ajlm-1563	59	14	900	900	NUM
ajlm-1563	59	15	µl	µl	NOUN
ajlm-1563	59	16	of	of	ADP
ajlm-1563	59	17	the	the	DET
ajlm-1563	59	18	thin	thin	ADJ
ajlm-1563	59	19	prep	prep	NOUN
ajlm-1563	59	20	solution	solution	NOUN
ajlm-1563	59	21	(	(	PUNCT
ajlm-1563	59	22	hologic	hologic	PROPN
ajlm-1563	59	23	,	,	PUNCT
ajlm-1563	59	24	marlborough	marlborough	PROPN
ajlm-1563	59	25	,	,	PUNCT
ajlm-1563	59	26	massachusetts	massachusetts	PROPN
ajlm-1563	59	27	,	,	PUNCT
ajlm-1563	59	28	united	united	PROPN
ajlm-1563	59	29	states	states	PROPN
ajlm-1563	59	30	)	)	PUNCT
ajlm-1563	59	31	,	,	PUNCT
ajlm-1563	59	32	allowed	allow	VERB
ajlm-1563	59	33	to	to	PART
ajlm-1563	59	34	homogenise	homogenise	VERB
ajlm-1563	59	35	,	,	PUNCT
ajlm-1563	59	36	and	and	CCONJ
ajlm-1563	59	37	then	then	ADV
ajlm-1563	59	38	transferred	transfer	VERB
ajlm-1563	59	39	into	into	ADP
ajlm-1563	59	40	a	a	DET
ajlm-1563	59	41	cartridge	cartridge	NOUN
ajlm-1563	59	42	.	.	PUNCT
ajlm-1563	60	1	the	the	DET
ajlm-1563	60	2	cartridge	cartridge	NOUN
ajlm-1563	60	3	was	be	AUX
ajlm-1563	60	4	loaded	load	VERB
ajlm-1563	60	5	into	into	ADP
ajlm-1563	60	6	the	the	DET
ajlm-1563	60	7	gene	gene	NOUN
ajlm-1563	60	8	xpert	xpert	PROPN
ajlm-1563	60	9	pcr	pcr	PROPN
ajlm-1563	60	10	machine	machine	NOUN
ajlm-1563	60	11	(	(	PUNCT
ajlm-1563	60	12	cepheid	cepheid	PROPN
ajlm-1563	60	13	,	,	PUNCT
ajlm-1563	60	14	sunnyvale	sunnyvale	PROPN
ajlm-1563	60	15	,	,	PUNCT
ajlm-1563	60	16	california	california	PROPN
ajlm-1563	60	17	,	,	PUNCT
ajlm-1563	60	18	united	united	PROPN
ajlm-1563	60	19	states	states	PROPN
ajlm-1563	60	20	)	)	PUNCT
ajlm-1563	60	21	and	and	CCONJ
ajlm-1563	60	22	run	run	VERB
ajlm-1563	60	23	according	accord	VERB
ajlm-1563	60	24	to	to	ADP
ajlm-1563	60	25	the	the	DET
ajlm-1563	60	26	manufacturer	manufacturer	NOUN
ajlm-1563	60	27	’s	’s	PART
ajlm-1563	60	28	protocol	protocol	NOUN
ajlm-1563	60	29	.	.	PUNCT
ajlm-1563	61	1	results	result	NOUN
ajlm-1563	61	2	were	be	AUX
ajlm-1563	61	3	exported	export	VERB
ajlm-1563	61	4	to	to	ADP
ajlm-1563	61	5	a	a	DET
ajlm-1563	61	6	disc	disc	NOUN
ajlm-1563	61	7	and	and	CCONJ
ajlm-1563	61	8	transferred	transfer	VERB
ajlm-1563	61	9	to	to	ADP
ajlm-1563	61	10	a	a	DET
ajlm-1563	61	11	computer	computer	NOUN
ajlm-1563	61	12	.	.	PUNCT
ajlm-1563	62	1	xpert	xpert	PROPN
ajlm-1563	62	2	hpv	hpv	PROPN
ajlm-1563	62	3	detects	detect	VERB
ajlm-1563	62	4	the	the	DET
ajlm-1563	62	5	presence	presence	NOUN
ajlm-1563	62	6	of	of	ADP
ajlm-1563	62	7	high	high	ADJ
ajlm-1563	62	8	-	-	PUNCT
ajlm-1563	62	9	risk	risk	NOUN
ajlm-1563	62	10	hpv	hpv	NOUN
ajlm-1563	62	11	and	and	CCONJ
ajlm-1563	62	12	the	the	DET
ajlm-1563	62	13	following	follow	VERB
ajlm-1563	62	14	hpv	hpv	ADJ
ajlm-1563	62	15	genotypes	genotype	NOUN
ajlm-1563	62	16	:	:	PUNCT
ajlm-1563	62	17	hpv16	hpv16	NOUN
ajlm-1563	62	18	,	,	PUNCT
ajlm-1563	62	19	hpv18_45	hpv18_45	NUM
ajlm-1563	62	20	,	,	PUNCT
ajlm-1563	62	21	and	and	CCONJ
ajlm-1563	62	22	other	other	ADJ
ajlm-1563	62	23	hpvs	hpv	NOUN
ajlm-1563	62	24	,	,	PUNCT
ajlm-1563	62	25	including	include	VERB
ajlm-1563	62	26	p3	p3	PROPN
ajlm-1563	62	27	(	(	PUNCT
ajlm-1563	62	28	hpv31	hpv31	PROPN
ajlm-1563	62	29	,	,	PUNCT
ajlm-1563	62	30	hpv33	hpv33	ADV
ajlm-1563	62	31	,	,	PUNCT
ajlm-1563	62	32	hpv35	hpv35	NOUN
ajlm-1563	62	33	,	,	PUNCT
ajlm-1563	62	34	hpv52	hpv52	ADJ
ajlm-1563	62	35	,	,	PUNCT
ajlm-1563	62	36	hpv58	hpv58	PROPN
ajlm-1563	62	37	)	)	PUNCT
ajlm-1563	62	38	,	,	PUNCT
ajlm-1563	62	39	p4	p4	ADJ
ajlm-1563	62	40	(	(	PUNCT
ajlm-1563	62	41	hpv51	hpv51	PROPN
ajlm-1563	62	42	,	,	PUNCT
ajlm-1563	62	43	hpv59	hpv59	PROPN
ajlm-1563	62	44	)	)	PUNCT
ajlm-1563	62	45	,	,	PUNCT
ajlm-1563	62	46	and	and	CCONJ
ajlm-1563	62	47	p5	p5	PROPN
ajlm-1563	62	48	(	(	PUNCT
ajlm-1563	62	49	hpv39	hpv39	PROPN
ajlm-1563	62	50	,	,	PUNCT
ajlm-1563	62	51	hpv56	hpv56	PROPN
ajlm-1563	62	52	,	,	PUNCT
ajlm-1563	62	53	hpv66	hpv66	NOUN
ajlm-1563	62	54	,	,	PUNCT
ajlm-1563	62	55	hpv68	hpv68	PROPN
ajlm-1563	62	56	)	)	PUNCT
ajlm-1563	62	57	.	.	PUNCT
ajlm-1563	63	1	statistical	statistical	ADJ
ajlm-1563	63	2	analysis	analysis	NOUN
ajlm-1563	63	3	all	all	DET
ajlm-1563	63	4	data	datum	NOUN
ajlm-1563	63	5	management	management	NOUN
ajlm-1563	63	6	was	be	AUX
ajlm-1563	63	7	done	do	VERB
ajlm-1563	63	8	using	use	VERB
ajlm-1563	63	9	excel	excel	NOUN
ajlm-1563	63	10	(	(	PUNCT
ajlm-1563	63	11	microsoft	microsoft	PROPN
ajlm-1563	63	12	corporation	corporation	PROPN
ajlm-1563	63	13	,	,	PUNCT
ajlm-1563	63	14	redmond	redmond	PROPN
ajlm-1563	63	15	,	,	PUNCT
ajlm-1563	63	16	washington	washington	PROPN
ajlm-1563	63	17	,	,	PUNCT
ajlm-1563	63	18	united	united	PROPN
ajlm-1563	63	19	states	states	PROPN
ajlm-1563	63	20	)	)	PUNCT
ajlm-1563	63	21	and	and	CCONJ
ajlm-1563	63	22	data	datum	NOUN
ajlm-1563	63	23	analyses	analysis	NOUN
ajlm-1563	63	24	were	be	AUX
ajlm-1563	63	25	carried	carry	VERB
ajlm-1563	63	26	out	out	ADP
ajlm-1563	63	27	using	use	VERB
ajlm-1563	63	28	statistical	statistical	ADJ
ajlm-1563	63	29	package	package	NOUN
ajlm-1563	63	30	for	for	ADP
ajlm-1563	63	31	social	social	ADJ
ajlm-1563	63	32	sciences	science	NOUN
ajlm-1563	63	33	version	version	NOUN
ajlm-1563	63	34	22	22	NUM
ajlm-1563	63	35	(	(	PUNCT
ajlm-1563	63	36	international	international	ADJ
ajlm-1563	63	37	business	business	NOUN
ajlm-1563	63	38	machines	machine	NOUN
ajlm-1563	63	39	corporation	corporation	PROPN
ajlm-1563	63	40	,	,	PUNCT
ajlm-1563	63	41	armonk	armonk	PROPN
ajlm-1563	63	42	new	new	PROPN
ajlm-1563	63	43	york	york	PROPN
ajlm-1563	63	44	,	,	PUNCT
ajlm-1563	63	45	united	united	PROPN
ajlm-1563	63	46	states	states	PROPN
ajlm-1563	63	47	)	)	PUNCT
ajlm-1563	63	48	.	.	PUNCT
ajlm-1563	64	1	clinical	clinical	ADJ
ajlm-1563	64	2	features	feature	NOUN
ajlm-1563	64	3	(	(	PUNCT
ajlm-1563	64	4	symptoms	symptom	NOUN
ajlm-1563	64	5	,	,	PUNCT
ajlm-1563	64	6	and	and	CCONJ
ajlm-1563	64	7	signs	sign	NOUN
ajlm-1563	64	8	)	)	PUNCT
ajlm-1563	64	9	,	,	PUNCT
ajlm-1563	64	10	demographic	demographic	ADJ
ajlm-1563	64	11	features	feature	NOUN
ajlm-1563	64	12	and	and	CCONJ
ajlm-1563	64	13	risk	risk	NOUN
ajlm-1563	64	14	factors	factor	NOUN
ajlm-1563	64	15	of	of	ADP
ajlm-1563	64	16	uvin	uvin	NOUN
ajlm-1563	64	17	and	and	CCONJ
ajlm-1563	64	18	vscc	vscc	NOUN
ajlm-1563	64	19	were	be	AUX
ajlm-1563	64	20	compared	compare	VERB
ajlm-1563	64	21	with	with	ADP
ajlm-1563	64	22	those	those	PRON
ajlm-1563	64	23	of	of	ADP
ajlm-1563	64	24	nnl	nnl	PROPN
ajlm-1563	64	25	using	use	VERB
ajlm-1563	64	26	chi	chi	NOUN
ajlm-1563	64	27	-	-	PUNCT
ajlm-1563	64	28	square	square	NOUN
ajlm-1563	64	29	or	or	CCONJ
ajlm-1563	64	30	fisher	fisher	NOUN
ajlm-1563	64	31	’s	’s	PART
ajlm-1563	64	32	exact	exact	ADJ
ajlm-1563	64	33	tests	test	NOUN
ajlm-1563	64	34	of	of	ADP
ajlm-1563	64	35	association	association	NOUN
ajlm-1563	64	36	.	.	PUNCT
ajlm-1563	65	1	we	we	PRON
ajlm-1563	65	2	excluded	exclude	VERB
ajlm-1563	65	3	condyloma	condyloma	NOUN
ajlm-1563	65	4	acuminatum	acuminatum	NOUN
ajlm-1563	65	5	from	from	ADP
ajlm-1563	65	6	the	the	DET
ajlm-1563	65	7	comparative	comparative	ADJ
ajlm-1563	65	8	analysis	analysis	NOUN
ajlm-1563	65	9	because	because	SCONJ
ajlm-1563	65	10	of	of	ADP
ajlm-1563	65	11	its	its	PRON
ajlm-1563	65	12	benign	benign	ADJ
ajlm-1563	65	13	nature	nature	NOUN
ajlm-1563	65	14	.	.	PUNCT
ajlm-1563	66	1	the	the	DET
ajlm-1563	66	2	continuous	continuous	ADJ
ajlm-1563	66	3	variables	variable	NOUN
ajlm-1563	66	4	(	(	PUNCT
ajlm-1563	66	5	age	age	NOUN
ajlm-1563	66	6	,	,	PUNCT
ajlm-1563	66	7	age	age	NOUN
ajlm-1563	66	8	at	at	ADP
ajlm-1563	66	9	first	first	ADJ
ajlm-1563	66	10	sexual	sexual	ADJ
ajlm-1563	66	11	intercourse	intercourse	NOUN
ajlm-1563	66	12	,	,	PUNCT
ajlm-1563	66	13	duration	duration	NOUN
ajlm-1563	66	14	of	of	ADP
ajlm-1563	66	15	antiretroviral	antiretroviral	ADJ
ajlm-1563	66	16	therapy	therapy	NOUN
ajlm-1563	66	17	[	[	X
ajlm-1563	66	18	art	art	NOUN
ajlm-1563	66	19	]	]	PUNCT
ajlm-1563	66	20	,	,	PUNCT
ajlm-1563	66	21	number	number	NOUN
ajlm-1563	66	22	of	of	ADP
ajlm-1563	66	23	lifetime	lifetime	NOUN
ajlm-1563	66	24	sexual	sexual	ADJ
ajlm-1563	66	25	partners	partner	NOUN
ajlm-1563	66	26	,	,	PUNCT
ajlm-1563	66	27	and	and	CCONJ
ajlm-1563	66	28	duration	duration	NOUN
ajlm-1563	66	29	of	of	ADP
ajlm-1563	66	30	symptoms	symptom	NOUN
ajlm-1563	66	31	in	in	ADP
ajlm-1563	66	32	years	year	NOUN
ajlm-1563	66	33	)	)	PUNCT
ajlm-1563	66	34	were	be	AUX
ajlm-1563	66	35	tested	test	VERB
ajlm-1563	66	36	for	for	ADP
ajlm-1563	66	37	normality	normality	NOUN
ajlm-1563	66	38	using	use	VERB
ajlm-1563	66	39	the	the	DET
ajlm-1563	66	40	shapiro	shapiro	PROPN
ajlm-1563	66	41	-	-	PUNCT
ajlm-1563	66	42	wilk	wilk	NOUN
ajlm-1563	66	43	test	test	NOUN
ajlm-1563	66	44	.	.	PUNCT
ajlm-1563	67	1	the	the	DET
ajlm-1563	67	2	means	mean	NOUN
ajlm-1563	67	3	of	of	ADP
ajlm-1563	67	4	the	the	DET
ajlm-1563	67	5	continuous	continuous	ADJ
ajlm-1563	67	6	variables	variable	NOUN
ajlm-1563	67	7	that	that	PRON
ajlm-1563	67	8	were	be	AUX
ajlm-1563	67	9	normally	normally	ADV
ajlm-1563	67	10	distributed	distribute	VERB
ajlm-1563	67	11	(	(	PUNCT
ajlm-1563	67	12	age	age	NOUN
ajlm-1563	68	1	[	[	X
ajlm-1563	68	2	p	p	X
ajlm-1563	68	3	=	=	VERB
ajlm-1563	68	4	0.969	0.969	NUM
ajlm-1563	68	5	]	]	PUNCT
ajlm-1563	68	6	and	and	CCONJ
ajlm-1563	68	7	duration	duration	NOUN
ajlm-1563	68	8	of	of	ADP
ajlm-1563	68	9	art	art	NOUN
ajlm-1563	68	10	[	[	X
ajlm-1563	68	11	p	p	X
ajlm-1563	68	12	=	=	PUNCT
ajlm-1563	68	13	0.070	0.070	NUM
ajlm-1563	68	14	]	]	PUNCT
ajlm-1563	68	15	)	)	PUNCT
ajlm-1563	68	16	were	be	AUX
ajlm-1563	68	17	compared	compare	VERB
ajlm-1563	68	18	using	use	VERB
ajlm-1563	68	19	levine	levine	PROPN
ajlm-1563	68	20	’s	’s	PART
ajlm-1563	68	21	t	t	PROPN
ajlm-1563	68	22	-	-	PUNCT
ajlm-1563	68	23	test	test	NOUN
ajlm-1563	68	24	between	between	ADP
ajlm-1563	68	25	the	the	DET
ajlm-1563	68	26	diagnostic	diagnostic	ADJ
ajlm-1563	68	27	categories	category	NOUN
ajlm-1563	68	28	vscc	vscc	ADJ
ajlm-1563	68	29	and	and	CCONJ
ajlm-1563	68	30	nnl	nnl	NOUN
ajlm-1563	68	31	,	,	PUNCT
ajlm-1563	68	32	as	as	ADV
ajlm-1563	68	33	well	well	ADV
ajlm-1563	68	34	as	as	ADP
ajlm-1563	68	35	between	between	ADP
ajlm-1563	68	36	uvin	uvin	PROPN
ajlm-1563	68	37	and	and	CCONJ
ajlm-1563	68	38	nnl	nnl	PROPN
ajlm-1563	68	39	.	.	PROPN
ajlm-1563	68	40	medians	median	NOUN
ajlm-1563	68	41	and	and	CCONJ
ajlm-1563	68	42	interquartile	interquartile	NOUN
ajlm-1563	68	43	ranges	range	NOUN
ajlm-1563	68	44	were	be	AUX
ajlm-1563	68	45	reported	report	VERB
ajlm-1563	68	46	for	for	ADP
ajlm-1563	68	47	variables	variable	NOUN
ajlm-1563	68	48	(	(	PUNCT
ajlm-1563	68	49	number	number	NOUN
ajlm-1563	68	50	of	of	ADP
ajlm-1563	68	51	lifetime	lifetime	NOUN
ajlm-1563	68	52	sexual	sexual	ADJ
ajlm-1563	68	53	partners	partner	NOUN
ajlm-1563	68	54	and	and	CCONJ
ajlm-1563	68	55	duration	duration	NOUN
ajlm-1563	68	56	of	of	ADP
ajlm-1563	68	57	symptoms	symptom	NOUN
ajlm-1563	68	58	)	)	PUNCT
ajlm-1563	68	59	that	that	PRON
ajlm-1563	68	60	were	be	AUX
ajlm-1563	68	61	not	not	PART
ajlm-1563	68	62	normally	normally	ADV
ajlm-1563	68	63	distributed	distribute	VERB
ajlm-1563	68	64	.	.	PUNCT
ajlm-1563	69	1	the	the	DET
ajlm-1563	69	2	median	median	ADJ
ajlm-1563	69	3	duration	duration	NOUN
ajlm-1563	69	4	of	of	ADP
ajlm-1563	69	5	symptoms	symptom	NOUN
ajlm-1563	69	6	and	and	CCONJ
ajlm-1563	69	7	the	the	DET
ajlm-1563	69	8	median	median	ADJ
ajlm-1563	69	9	number	number	NOUN
ajlm-1563	69	10	of	of	ADP
ajlm-1563	69	11	lifetime	lifetime	NOUN
ajlm-1563	69	12	sexual	sexual	ADJ
ajlm-1563	69	13	partners	partner	NOUN
ajlm-1563	69	14	were	be	AUX
ajlm-1563	69	15	compared	compare	VERB
ajlm-1563	69	16	using	use	VERB
ajlm-1563	69	17	mood	mood	NOUN
ajlm-1563	69	18	’s	’s	PART
ajlm-1563	69	19	median	median	ADJ
ajlm-1563	69	20	test	test	NOUN
ajlm-1563	69	21	between	between	ADP
ajlm-1563	69	22	the	the	DET
ajlm-1563	69	23	diagnostic	diagnostic	ADJ
ajlm-1563	69	24	categories	category	NOUN
ajlm-1563	69	25	vscc	vscc	ADJ
ajlm-1563	69	26	and	and	CCONJ
ajlm-1563	69	27	nnl	nnl	NOUN
ajlm-1563	69	28	,	,	PUNCT
ajlm-1563	69	29	as	as	ADV
ajlm-1563	69	30	well	well	ADV
ajlm-1563	69	31	as	as	ADP
ajlm-1563	69	32	between	between	ADP
ajlm-1563	69	33	uvin	uvin	PROPN
ajlm-1563	69	34	and	and	CCONJ
ajlm-1563	69	35	nnl	nnl	PROPN
ajlm-1563	69	36	.	.	PROPN
ajlm-1563	69	37	results	result	VERB
ajlm-1563	69	38	histologic	histologic	PROPN
ajlm-1563	69	39	diagnoses	diagnose	VERB
ajlm-1563	69	40	histologic	histologic	ADJ
ajlm-1563	69	41	types	type	NOUN
ajlm-1563	69	42	of	of	ADP
ajlm-1563	69	43	vulvar	vulvar	NOUN
ajlm-1563	69	44	lesions	lesion	NOUN
ajlm-1563	69	45	included	include	VERB
ajlm-1563	69	46	vscc	vscc	NOUN
ajlm-1563	69	47	(	(	PUNCT
ajlm-1563	69	48	21/53	21/53	NUM
ajlm-1563	69	49	,	,	PUNCT
ajlm-1563	69	50	39.6	39.6	NUM
ajlm-1563	69	51	%	%	NOUN
ajlm-1563	69	52	)	)	PUNCT
ajlm-1563	69	53	,	,	PUNCT
ajlm-1563	69	54	uvin	uvin	X
ajlm-1563	69	55	(	(	PUNCT
ajlm-1563	69	56	20/53	20/53	NUM
ajlm-1563	69	57	,	,	PUNCT
ajlm-1563	69	58	37.7	37.7	NUM
ajlm-1563	69	59	%	%	NOUN
ajlm-1563	69	60	)	)	PUNCT
ajlm-1563	69	61	,	,	PUNCT
ajlm-1563	69	62	nnl	nnl	X
ajlm-1563	69	63	(	(	PUNCT
ajlm-1563	69	64	9/53	9/53	NUM
ajlm-1563	69	65	,	,	PUNCT
ajlm-1563	69	66	17.0	17.0	NUM
ajlm-1563	69	67	%	%	NOUN
ajlm-1563	69	68	)	)	PUNCT
ajlm-1563	69	69	and	and	CCONJ
ajlm-1563	69	70	condyloma	condyloma	VERB
ajlm-1563	69	71	acuminatum	acuminatum	NOUN
ajlm-1563	69	72	(	(	PUNCT
ajlm-1563	69	73	3/53	3/53	NUM
ajlm-1563	69	74	,	,	PUNCT
ajlm-1563	69	75	5.7	5.7	NUM
ajlm-1563	69	76	%	%	NOUN
ajlm-1563	69	77	)	)	PUNCT
ajlm-1563	69	78	.	.	PUNCT
ajlm-1563	70	1	vscc	vscc	PROPN
ajlm-1563	70	2	followed	follow	VERB
ajlm-1563	70	3	by	by	ADP
ajlm-1563	70	4	uvin	uvin	PROPN
ajlm-1563	70	5	were	be	AUX
ajlm-1563	70	6	the	the	DET
ajlm-1563	70	7	sole	sole	ADJ
ajlm-1563	70	8	types	type	NOUN
ajlm-1563	70	9	of	of	ADP
ajlm-1563	70	10	cancer	cancer	NOUN
ajlm-1563	70	11	and	and	CCONJ
ajlm-1563	70	12	premalignant	premalignant	ADJ
ajlm-1563	70	13	disease	disease	NOUN
ajlm-1563	70	14	identified	identify	VERB
ajlm-1563	70	15	(	(	PUNCT
ajlm-1563	70	16	figure	figure	NOUN
ajlm-1563	70	17	1	1	NUM
ajlm-1563	70	18	)	)	PUNCT
ajlm-1563	70	19	.	.	PUNCT
ajlm-1563	71	1	two	two	NUM
ajlm-1563	71	2	types	type	NOUN
ajlm-1563	71	3	of	of	ADP
ajlm-1563	71	4	uvin	uvin	NOUN
ajlm-1563	71	5	were	be	AUX
ajlm-1563	71	6	reported	report	VERB
ajlm-1563	71	7	:	:	PUNCT
ajlm-1563	71	8	hsil	hsil	NOUN
ajlm-1563	71	9	(	(	PUNCT
ajlm-1563	71	10	14/20	14/20	NUM
ajlm-1563	71	11	,	,	PUNCT
ajlm-1563	71	12	70.0	70.0	NUM
ajlm-1563	71	13	%	%	NOUN
ajlm-1563	71	14	)	)	PUNCT
ajlm-1563	71	15	and	and	CCONJ
ajlm-1563	71	16	lsil	lsil	PROPN
ajlm-1563	71	17	(	(	PUNCT
ajlm-1563	71	18	6/20	6/20	NUM
ajlm-1563	71	19	,	,	PUNCT
ajlm-1563	71	20	30.0	30.0	NUM
ajlm-1563	71	21	%	%	NOUN
ajlm-1563	71	22	)	)	PUNCT
ajlm-1563	71	23	.	.	PUNCT
ajlm-1563	72	1	the	the	DET
ajlm-1563	72	2	types	type	NOUN
ajlm-1563	72	3	of	of	ADP
ajlm-1563	72	4	nnl	nnl	PROPN
ajlm-1563	72	5	included	include	VERB
ajlm-1563	72	6	chronic	chronic	ADJ
ajlm-1563	72	7	non	non	ADJ
ajlm-1563	72	8	-	-	ADJ
ajlm-1563	72	9	specific	specific	ADJ
ajlm-1563	72	10	inflammation	inflammation	NOUN
ajlm-1563	72	11	(	(	PUNCT
ajlm-1563	72	12	7/9	7/9	NUM
ajlm-1563	72	13	,	,	PUNCT
ajlm-1563	72	14	77.8	77.8	NUM
ajlm-1563	72	15	%	%	NOUN
ajlm-1563	72	16	)	)	PUNCT
ajlm-1563	72	17	,	,	PUNCT
ajlm-1563	72	18	acute	acute	ADJ
ajlm-1563	72	19	inflammation	inflammation	NOUN
ajlm-1563	72	20	(	(	PUNCT
ajlm-1563	72	21	1/9	1/9	NUM
ajlm-1563	72	22	,	,	PUNCT
ajlm-1563	72	23	11.1	11.1	NUM
ajlm-1563	72	24	%	%	NOUN
ajlm-1563	72	25	)	)	PUNCT
ajlm-1563	72	26	,	,	PUNCT
ajlm-1563	72	27	and	and	CCONJ
ajlm-1563	72	28	herpes	herpe	NOUN
ajlm-1563	72	29	simplex	simplex	NOUN
ajlm-1563	72	30	ulcer	ulcer	NOUN
ajlm-1563	72	31	(	(	PUNCT
ajlm-1563	72	32	1/9	1/9	NUM
ajlm-1563	72	33	,	,	PUNCT
ajlm-1563	72	34	11.1	11.1	NUM
ajlm-1563	72	35	%	%	NOUN
ajlm-1563	72	36	)	)	PUNCT
ajlm-1563	72	37	(	(	PUNCT
ajlm-1563	72	38	figure	figure	NOUN
ajlm-1563	72	39	2	2	NUM
ajlm-1563	72	40	)	)	PUNCT
ajlm-1563	72	41	.	.	PUNCT
ajlm-1563	73	1	data	datum	NOUN
ajlm-1563	73	2	from	from	ADP
ajlm-1563	73	3	the	the	DET
ajlm-1563	73	4	three	three	NUM
ajlm-1563	73	5	participants	participant	NOUN
ajlm-1563	73	6	with	with	ADP
ajlm-1563	73	7	condyloma	condyloma	NOUN
ajlm-1563	73	8	acuminatum	acuminatum	NOUN
ajlm-1563	73	9	were	be	AUX
ajlm-1563	73	10	excluded	exclude	VERB
ajlm-1563	73	11	from	from	ADP
ajlm-1563	73	12	downstream	downstream	ADJ
ajlm-1563	73	13	analyses	analysis	NOUN
ajlm-1563	73	14	.	.	PUNCT
ajlm-1563	74	1	the	the	DET
ajlm-1563	74	2	vscc	vscc	ADJ
ajlm-1563	74	3	cases	case	NOUN
ajlm-1563	74	4	were	be	AUX
ajlm-1563	74	5	either	either	CCONJ
ajlm-1563	74	6	warty	warty	NOUN
ajlm-1563	74	7	(	(	PUNCT
ajlm-1563	74	8	19/21	19/21	NUM
ajlm-1563	74	9	,	,	PUNCT
ajlm-1563	74	10	90.5	90.5	NUM
ajlm-1563	74	11	%	%	NOUN
ajlm-1563	74	12	)	)	PUNCT
ajlm-1563	74	13	or	or	CCONJ
ajlm-1563	74	14	basaloid	basaloid	NOUN
ajlm-1563	74	15	types	type	NOUN
ajlm-1563	74	16	(	(	PUNCT
ajlm-1563	74	17	2/21	2/21	NUM
ajlm-1563	74	18	,	,	PUNCT
ajlm-1563	74	19	9.5	9.5	NUM
ajlm-1563	74	20	%	%	NOUN
ajlm-1563	74	21	)	)	PUNCT
ajlm-1563	74	22	.	.	PUNCT
ajlm-1563	75	1	no	no	DET
ajlm-1563	75	2	keratinising	keratinise	VERB
ajlm-1563	75	3	squamous	squamous	ADJ
ajlm-1563	75	4	cell	cell	NOUN
ajlm-1563	75	5	carcinoma	carcinoma	NOUN
ajlm-1563	75	6	was	be	AUX
ajlm-1563	75	7	observed	observe	VERB
ajlm-1563	75	8	.	.	PUNCT
ajlm-1563	76	1	among	among	ADP
ajlm-1563	76	2	the	the	DET
ajlm-1563	76	3	warty	warty	NOUN
ajlm-1563	76	4	vscc	vscc	NOUN
ajlm-1563	76	5	,	,	PUNCT
ajlm-1563	76	6	two	two	NUM
ajlm-1563	76	7	cases	case	NOUN
ajlm-1563	76	8	(	(	PUNCT
ajlm-1563	76	9	2/19	2/19	NUM
ajlm-1563	76	10	,	,	PUNCT
ajlm-1563	76	11	10.5	10.5	NUM
ajlm-1563	76	12	%	%	NOUN
ajlm-1563	76	13	)	)	PUNCT
ajlm-1563	76	14	were	be	AUX
ajlm-1563	76	15	moderately	moderately	ADV
ajlm-1563	76	16	differentiated	differentiate	VERB
ajlm-1563	76	17	(	(	PUNCT
ajlm-1563	76	18	grade	grade	NOUN
ajlm-1563	76	19	2	2	NUM
ajlm-1563	76	20	)	)	PUNCT
ajlm-1563	76	21	and	and	CCONJ
ajlm-1563	76	22	17	17	NUM
ajlm-1563	76	23	(	(	PUNCT
ajlm-1563	76	24	17/19	17/19	NUM
ajlm-1563	76	25	,	,	PUNCT
ajlm-1563	76	26	89.5	89.5	NUM
ajlm-1563	76	27	%	%	NOUN
ajlm-1563	76	28	)	)	PUNCT
ajlm-1563	76	29	were	be	AUX
ajlm-1563	76	30	poorly	poorly	ADV
ajlm-1563	76	31	differentiated	differentiate	VERB
ajlm-1563	76	32	(	(	PUNCT
ajlm-1563	76	33	grade	grade	NOUN
ajlm-1563	76	34	3	3	NUM
ajlm-1563	76	35	)	)	PUNCT
ajlm-1563	76	36	.	.	PUNCT
ajlm-1563	77	1	on	on	ADP
ajlm-1563	77	2	the	the	DET
ajlm-1563	77	3	other	other	ADJ
ajlm-1563	77	4	hand	hand	NOUN
ajlm-1563	77	5	,	,	PUNCT
ajlm-1563	77	6	all	all	DET
ajlm-1563	77	7	of	of	ADP
ajlm-1563	77	8	the	the	DET
ajlm-1563	77	9	basaloid	basaloid	NOUN
ajlm-1563	77	10	(	(	PUNCT
ajlm-1563	77	11	2/2	2/2	NUM
ajlm-1563	77	12	,	,	PUNCT
ajlm-1563	77	13	100.0	100.0	NUM
ajlm-1563	77	14	%	%	NOUN
ajlm-1563	77	15	)	)	PUNCT
ajlm-1563	77	16	vsccs	vsccs	NOUN
ajlm-1563	77	17	were	be	AUX
ajlm-1563	77	18	poorly	poorly	ADV
ajlm-1563	77	19	differentiated	differentiate	VERB
ajlm-1563	77	20	(	(	PUNCT
ajlm-1563	77	21	grade	grade	NOUN
ajlm-1563	77	22	3	3	NUM
ajlm-1563	77	23	)	)	PUNCT
ajlm-1563	77	24	.	.	PUNCT
ajlm-1563	78	1	among	among	ADP
ajlm-1563	78	2	the	the	DET
ajlm-1563	78	3	vscc	vscc	ADJ
ajlm-1563	78	4	cases	case	NOUN
ajlm-1563	78	5	,	,	PUNCT
ajlm-1563	78	6	16	16	NUM
ajlm-1563	78	7	(	(	PUNCT
ajlm-1563	78	8	76.2	76.2	NUM
ajlm-1563	78	9	%	%	NOUN
ajlm-1563	78	10	)	)	PUNCT
ajlm-1563	78	11	had	have	VERB
ajlm-1563	78	12	concurrent	concurrent	ADJ
ajlm-1563	78	13	hsil	hsil	NOUN
ajlm-1563	78	14	,	,	PUNCT
ajlm-1563	78	15	19	19	NUM
ajlm-1563	78	16	(	(	PUNCT
ajlm-1563	78	17	90.5	90.5	NUM
ajlm-1563	78	18	%	%	NOUN
ajlm-1563	78	19	)	)	PUNCT
ajlm-1563	78	20	had	have	VERB
ajlm-1563	78	21	a	a	DET
ajlm-1563	78	22	high	high	ADJ
ajlm-1563	78	23	ki-67	ki-67	ADJ
ajlm-1563	78	24	index	index	NOUN
ajlm-1563	78	25	(	(	PUNCT
ajlm-1563	78	26	30	30	NUM
ajlm-1563	78	27	%	%	NOUN
ajlm-1563	78	28	or	or	CCONJ
ajlm-1563	78	29	more	more	ADJ
ajlm-1563	78	30	)	)	PUNCT
ajlm-1563	78	31	,	,	PUNCT
ajlm-1563	78	32	one	one	NUM
ajlm-1563	78	33	(	(	PUNCT
ajlm-1563	78	34	4.8	4.8	NUM
ajlm-1563	78	35	%	%	NOUN
ajlm-1563	78	36	)	)	PUNCT
ajlm-1563	78	37	was	be	AUX
ajlm-1563	78	38	positive	positive	ADJ
ajlm-1563	78	39	for	for	ADP
ajlm-1563	78	40	p53	p53	NOUN
ajlm-1563	78	41	,	,	PUNCT
ajlm-1563	78	42	one	one	NUM
ajlm-1563	78	43	(	(	PUNCT
ajlm-1563	78	44	4.8	4.8	NUM
ajlm-1563	78	45	%	%	NOUN
ajlm-1563	78	46	)	)	PUNCT
ajlm-1563	78	47	had	have	VERB
ajlm-1563	78	48	vascular	vascular	ADJ
ajlm-1563	78	49	invasion	invasion	NOUN
ajlm-1563	78	50	,	,	PUNCT
ajlm-1563	78	51	and	and	CCONJ
ajlm-1563	78	52	one	one	NUM
ajlm-1563	78	53	(	(	PUNCT
ajlm-1563	78	54	4.8	4.8	NUM
ajlm-1563	78	55	%	%	NOUN
ajlm-1563	78	56	)	)	PUNCT
ajlm-1563	78	57	had	have	VERB
ajlm-1563	78	58	concurrent	concurrent	ADJ
ajlm-1563	78	59	herpes	herpe	NOUN
ajlm-1563	78	60	simplex	simplex	NOUN
ajlm-1563	78	61	viral	viral	ADJ
ajlm-1563	78	62	cytopathic	cytopathic	ADJ
ajlm-1563	78	63	effects	effect	NOUN
ajlm-1563	78	64	.	.	PUNCT
ajlm-1563	79	1	figure	figure	NOUN
ajlm-1563	79	2	1	1	NUM
ajlm-1563	79	3	:	:	PUNCT
ajlm-1563	79	4	histological	histological	ADJ
ajlm-1563	79	5	diagnosis	diagnosis	NOUN
ajlm-1563	79	6	of	of	ADP
ajlm-1563	79	7	vulvar	vulvar	NOUN
ajlm-1563	79	8	lesions	lesion	NOUN
ajlm-1563	79	9	from	from	ADP
ajlm-1563	79	10	women	woman	NOUN
ajlm-1563	79	11	attending	attend	VERB
ajlm-1563	79	12	the	the	DET
ajlm-1563	79	13	university	university	NOUN
ajlm-1563	79	14	teaching	teaching	NOUN
ajlm-1563	79	15	hospital	hospital	NOUN
ajlm-1563	79	16	’s	’s	PART
ajlm-1563	79	17	gynaecologic	gynaecologic	PROPN
ajlm-1563	79	18	clinic	clinic	PROPN
ajlm-1563	79	19	,	,	PUNCT
ajlm-1563	79	20	zambia	zambia	PROPN
ajlm-1563	79	21	,	,	PUNCT
ajlm-1563	79	22	2018	2018	NUM
ajlm-1563	79	23	.	.	PUNCT
ajlm-1563	80	1	figure	figure	NOUN
ajlm-1563	80	2	2	2	NUM
ajlm-1563	80	3	:	:	PUNCT
ajlm-1563	80	4	p53	p53	NOUN
ajlm-1563	80	5	and	and	CCONJ
ajlm-1563	80	6	ki-67	ki-67	ADJ
ajlm-1563	80	7	immunostaining	immunostaine	VERB
ajlm-1563	80	8	photomicrographs	photomicrograph	NOUN
ajlm-1563	80	9	of	of	ADP
ajlm-1563	80	10	warty	warty	NOUN
ajlm-1563	80	11	vulvar	vulvar	VERB
ajlm-1563	80	12	squamous	squamous	ADJ
ajlm-1563	80	13	cell	cell	NOUN
ajlm-1563	80	14	carcinoma	carcinoma	NOUN
ajlm-1563	80	15	and	and	CCONJ
ajlm-1563	80	16	basaloid	basaloid	VERB
ajlm-1563	80	17	vulvar	vulvar	NOUN
ajlm-1563	80	18	squamous	squamous	ADJ
ajlm-1563	80	19	cell	cell	NOUN
ajlm-1563	80	20	carcinoma	carcinoma	NOUN
ajlm-1563	80	21	among	among	ADP
ajlm-1563	80	22	women	woman	NOUN
ajlm-1563	80	23	attending	attend	VERB
ajlm-1563	80	24	the	the	DET
ajlm-1563	80	25	university	university	NOUN
ajlm-1563	80	26	teaching	teaching	NOUN
ajlm-1563	80	27	hospital	hospital	PROPN
ajlm-1563	80	28	,	,	PUNCT
ajlm-1563	80	29	zambia	zambia	PROPN
ajlm-1563	80	30	,	,	PUNCT
ajlm-1563	80	31	2018	2018	NUM
ajlm-1563	80	32	.	.	PUNCT
ajlm-1563	81	1	(	(	PUNCT
ajlm-1563	81	2	a	a	X
ajlm-1563	81	3	)	)	PUNCT
ajlm-1563	81	4	warty	warty	NOUN
ajlm-1563	81	5	vulvar	vulvar	VERB
ajlm-1563	81	6	squamous	squamous	ADJ
ajlm-1563	81	7	cell	cell	NOUN
ajlm-1563	81	8	carcinoma	carcinoma	NOUN
ajlm-1563	81	9	:	:	PUNCT
ajlm-1563	81	10	nests	nest	NOUN
ajlm-1563	81	11	of	of	ADP
ajlm-1563	81	12	malignant	malignant	ADJ
ajlm-1563	81	13	squamous	squamous	ADJ
ajlm-1563	81	14	cells	cell	NOUN
ajlm-1563	81	15	are	be	AUX
ajlm-1563	81	16	noted	note	VERB
ajlm-1563	81	17	surrounded	surround	VERB
ajlm-1563	81	18	by	by	ADP
ajlm-1563	81	19	a	a	DET
ajlm-1563	81	20	desmoplastic	desmoplastic	ADJ
ajlm-1563	81	21	stroma	stroma	NOUN
ajlm-1563	81	22	.	.	PUNCT
ajlm-1563	82	1	(	(	PUNCT
ajlm-1563	82	2	b	b	X
ajlm-1563	82	3	)	)	PUNCT
ajlm-1563	82	4	basaloid	basaloid	PROPN
ajlm-1563	82	5	vulvar	vulvar	NOUN
ajlm-1563	82	6	squamous	squamous	ADJ
ajlm-1563	82	7	cell	cell	NOUN
ajlm-1563	82	8	carcinoma	carcinoma	NOUN
ajlm-1563	82	9	:	:	PUNCT
ajlm-1563	82	10	sheets	sheet	NOUN
ajlm-1563	82	11	of	of	ADP
ajlm-1563	82	12	cells	cell	NOUN
ajlm-1563	82	13	with	with	ADP
ajlm-1563	82	14	hyperchromatic	hyperchromatic	ADJ
ajlm-1563	82	15	nuclei	nucleus	NOUN
ajlm-1563	82	16	and	and	CCONJ
ajlm-1563	82	17	scant	scant	ADJ
ajlm-1563	82	18	to	to	ADP
ajlm-1563	82	19	no	no	DET
ajlm-1563	82	20	cytoplasm	cytoplasm	NOUN
ajlm-1563	82	21	are	be	AUX
ajlm-1563	82	22	seen	see	VERB
ajlm-1563	82	23	with	with	ADP
ajlm-1563	82	24	overlying	overlie	VERB
ajlm-1563	82	25	atypical	atypical	ADJ
ajlm-1563	82	26	surface	surface	NOUN
ajlm-1563	82	27	epithelium	epithelium	NOUN
ajlm-1563	82	28	.	.	PUNCT
ajlm-1563	83	1	(	(	PUNCT
ajlm-1563	83	2	c	c	X
ajlm-1563	83	3	)	)	PUNCT
ajlm-1563	83	4	p53	p53	NOUN
ajlm-1563	83	5	immunostaining	immunostaining	NOUN
ajlm-1563	83	6	in	in	ADP
ajlm-1563	83	7	warty	warty	NOUN
ajlm-1563	83	8	vulvar	vulvar	NOUN
ajlm-1563	83	9	squamous	squamous	ADJ
ajlm-1563	83	10	cell	cell	NOUN
ajlm-1563	83	11	carcinoma	carcinoma	NOUN
ajlm-1563	83	12	.	.	PUNCT
ajlm-1563	84	1	focal	focal	ADJ
ajlm-1563	84	2	staining	staining	NOUN
ajlm-1563	84	3	is	be	AUX
ajlm-1563	84	4	noted	note	VERB
ajlm-1563	84	5	.	.	PUNCT
ajlm-1563	85	1	(	(	PUNCT
ajlm-1563	85	2	d	d	X
ajlm-1563	85	3	)	)	PUNCT
ajlm-1563	85	4	ki-67	ki-67	ADJ
ajlm-1563	85	5	stain	stain	NOUN
ajlm-1563	85	6	.	.	PUNCT
ajlm-1563	86	1	a	a	DET
ajlm-1563	86	2	diffuse	diffuse	ADJ
ajlm-1563	86	3	nuclear	nuclear	ADJ
ajlm-1563	86	4	staining	stain	VERB
ajlm-1563	86	5	pattern	pattern	NOUN
ajlm-1563	86	6	is	be	AUX
ajlm-1563	86	7	noted	note	VERB
ajlm-1563	86	8	.	.	PUNCT
ajlm-1563	87	1	demographic	demographic	ADJ
ajlm-1563	87	2	characteristics	characteristic	NOUN
ajlm-1563	87	3	of	of	ADP
ajlm-1563	87	4	participants	participant	NOUN
ajlm-1563	87	5	with	with	ADP
ajlm-1563	87	6	vscc	vscc	NOUN
ajlm-1563	87	7	and	and	CCONJ
ajlm-1563	87	8	uvin	uvin	NOUN
ajlm-1563	87	9	compared	compare	VERB
ajlm-1563	87	10	to	to	ADP
ajlm-1563	87	11	those	those	PRON
ajlm-1563	87	12	with	with	ADP
ajlm-1563	87	13	nnl	nnl	NOUN
ajlm-1563	87	14	approximately	approximately	ADV
ajlm-1563	87	15	three	three	NUM
ajlm-1563	87	16	-	-	PUNCT
ajlm-1563	87	17	quarters	quarter	NOUN
ajlm-1563	87	18	(	(	PUNCT
ajlm-1563	87	19	39/50	39/50	NUM
ajlm-1563	87	20	,	,	PUNCT
ajlm-1563	87	21	78.0	78.0	NUM
ajlm-1563	87	22	%	%	NOUN
ajlm-1563	87	23	)	)	PUNCT
ajlm-1563	87	24	of	of	ADP
ajlm-1563	87	25	the	the	DET
ajlm-1563	87	26	study	study	NOUN
ajlm-1563	87	27	participants	participant	NOUN
ajlm-1563	87	28	were	be	AUX
ajlm-1563	87	29	residents	resident	NOUN
ajlm-1563	87	30	of	of	ADP
ajlm-1563	87	31	lusaka	lusaka	PROPN
ajlm-1563	87	32	;	;	PUNCT
ajlm-1563	87	33	21/50	21/50	NUM
ajlm-1563	87	34	(	(	PUNCT
ajlm-1563	87	35	42.0	42.0	NUM
ajlm-1563	87	36	%	%	NOUN
ajlm-1563	87	37	)	)	PUNCT
ajlm-1563	87	38	were	be	AUX
ajlm-1563	87	39	married	married	ADJ
ajlm-1563	87	40	and	and	CCONJ
ajlm-1563	87	41	32/50	32/50	NUM
ajlm-1563	87	42	(	(	PUNCT
ajlm-1563	87	43	64.0	64.0	NUM
ajlm-1563	87	44	%	%	NOUN
ajlm-1563	87	45	)	)	PUNCT
ajlm-1563	87	46	were	be	AUX
ajlm-1563	87	47	employed	employ	VERB
ajlm-1563	87	48	(	(	PUNCT
ajlm-1563	87	49	table	table	NOUN
ajlm-1563	87	50	1	1	NUM
ajlm-1563	87	51	)	)	PUNCT
ajlm-1563	87	52	.	.	PUNCT
ajlm-1563	88	1	there	there	PRON
ajlm-1563	88	2	was	be	VERB
ajlm-1563	88	3	no	no	DET
ajlm-1563	88	4	difference	difference	NOUN
ajlm-1563	88	5	in	in	ADP
ajlm-1563	88	6	employment	employment	NOUN
ajlm-1563	88	7	(	(	PUNCT
ajlm-1563	88	8	uvin	uvin	PROPN
ajlm-1563	88	9	vs	vs	ADP
ajlm-1563	88	10	nnl	nnl	PROPN
ajlm-1563	88	11	:	:	PUNCT
ajlm-1563	88	12	p	p	X
ajlm-1563	88	13	=	=	NOUN
ajlm-1563	88	14	0.205	0.205	NUM
ajlm-1563	88	15	;	;	PUNCT
ajlm-1563	88	16	vscc	vscc	NOUN
ajlm-1563	88	17	vs	vs	ADP
ajlm-1563	88	18	nnl	nnl	PROPN
ajlm-1563	88	19	:	:	PUNCT
ajlm-1563	88	20	p	p	X
ajlm-1563	88	21	=	=	NOUN
ajlm-1563	88	22	0.443	0.443	NUM
ajlm-1563	88	23	)	)	PUNCT
ajlm-1563	88	24	or	or	CCONJ
ajlm-1563	88	25	marital	marital	ADJ
ajlm-1563	88	26	status	status	NOUN
ajlm-1563	88	27	(	(	PUNCT
ajlm-1563	88	28	uvin	uvin	PROPN
ajlm-1563	88	29	vs	vs	ADP
ajlm-1563	88	30	nnl	nnl	PROPN
ajlm-1563	88	31	:	:	PUNCT
ajlm-1563	88	32	p	p	X
ajlm-1563	88	33	=	=	NOUN
ajlm-1563	88	34	0.439	0.439	NUM
ajlm-1563	88	35	;	;	PUNCT
ajlm-1563	88	36	vscc	vscc	NOUN
ajlm-1563	88	37	vs	vs	ADP
ajlm-1563	88	38	nnl	nnl	PROPN
ajlm-1563	88	39	:	:	PUNCT
ajlm-1563	88	40	p	p	X
ajlm-1563	88	41	=	=	NOUN
ajlm-1563	88	42	0.389	0.389	NUM
ajlm-1563	88	43	)	)	PUNCT
ajlm-1563	88	44	between	between	ADP
ajlm-1563	88	45	the	the	DET
ajlm-1563	88	46	study	study	NOUN
ajlm-1563	88	47	participants	participant	NOUN
ajlm-1563	88	48	with	with	ADP
ajlm-1563	88	49	nnl	nnl	NOUN
ajlm-1563	88	50	and	and	CCONJ
ajlm-1563	88	51	participants	participant	NOUN
ajlm-1563	88	52	with	with	ADP
ajlm-1563	88	53	uvin	uvin	NOUN
ajlm-1563	88	54	or	or	CCONJ
ajlm-1563	88	55	vscc	vscc	ADJ
ajlm-1563	88	56	.	.	PUNCT
ajlm-1563	89	1	over	over	ADP
ajlm-1563	89	2	half	half	NOUN
ajlm-1563	89	3	(	(	PUNCT
ajlm-1563	89	4	27/50	27/50	NUM
ajlm-1563	89	5	,	,	PUNCT
ajlm-1563	89	6	54.0	54.0	NUM
ajlm-1563	89	7	%	%	NOUN
ajlm-1563	89	8	)	)	PUNCT
ajlm-1563	89	9	were	be	AUX
ajlm-1563	89	10	aged	age	VERB
ajlm-1563	89	11	between	between	ADP
ajlm-1563	89	12	20	20	NUM
ajlm-1563	89	13	years	year	NOUN
ajlm-1563	89	14	and	and	CCONJ
ajlm-1563	89	15	39	39	NUM
ajlm-1563	89	16	years	year	NOUN
ajlm-1563	89	17	,	,	PUNCT
ajlm-1563	89	18	and	and	CCONJ
ajlm-1563	89	19	46.0	46.0	NUM
ajlm-1563	89	20	%	%	NOUN
ajlm-1563	89	21	(	(	PUNCT
ajlm-1563	89	22	23/50	23/50	NUM
ajlm-1563	89	23	)	)	PUNCT
ajlm-1563	89	24	were	be	AUX
ajlm-1563	89	25	40	40	NUM
ajlm-1563	89	26	years	year	NOUN
ajlm-1563	89	27	or	or	CCONJ
ajlm-1563	89	28	older	old	ADJ
ajlm-1563	89	29	.	.	PUNCT
ajlm-1563	90	1	the	the	DET
ajlm-1563	90	2	mean	mean	ADJ
ajlm-1563	90	3	age	age	NOUN
ajlm-1563	90	4	of	of	ADP
ajlm-1563	90	5	the	the	DET
ajlm-1563	90	6	participants	participant	NOUN
ajlm-1563	90	7	was	be	AUX
ajlm-1563	90	8	40	40	NUM
ajlm-1563	90	9	years	year	NOUN
ajlm-1563	90	10	(	(	PUNCT
ajlm-1563	90	11	range	range	NOUN
ajlm-1563	90	12	:	:	PUNCT
ajlm-1563	90	13	23–63	23–63	NUM
ajlm-1563	90	14	years	year	NOUN
ajlm-1563	90	15	)	)	PUNCT
ajlm-1563	90	16	.	.	PUNCT
ajlm-1563	91	1	vscc	vscc	PROPN
ajlm-1563	91	2	was	be	AUX
ajlm-1563	91	3	significantly	significantly	ADV
ajlm-1563	91	4	more	more	ADV
ajlm-1563	91	5	common	common	ADJ
ajlm-1563	91	6	among	among	ADP
ajlm-1563	91	7	participants	participant	NOUN
ajlm-1563	91	8	aged	age	VERB
ajlm-1563	91	9	≥	≥	NUM
ajlm-1563	91	10	40	40	NUM
ajlm-1563	91	11	years	year	NOUN
ajlm-1563	91	12	(	(	PUNCT
ajlm-1563	91	13	p	p	X
ajlm-1563	91	14	=	=	NOUN
ajlm-1563	91	15	0.014	0.014	NUM
ajlm-1563	91	16	)	)	PUNCT
ajlm-1563	91	17	than	than	ADP
ajlm-1563	91	18	among	among	ADP
ajlm-1563	91	19	participants	participant	NOUN
ajlm-1563	91	20	aged	age	VERB
ajlm-1563	91	21	between	between	ADP
ajlm-1563	91	22	20	20	NUM
ajlm-1563	91	23	and	and	CCONJ
ajlm-1563	91	24	39	39	NUM
ajlm-1563	91	25	years	year	NOUN
ajlm-1563	91	26	.	.	PUNCT
ajlm-1563	92	1	the	the	DET
ajlm-1563	92	2	mean	mean	ADJ
ajlm-1563	92	3	age	age	NOUN
ajlm-1563	92	4	was	be	AUX
ajlm-1563	92	5	also	also	ADV
ajlm-1563	92	6	significantly	significantly	ADV
ajlm-1563	92	7	higher	high	ADJ
ajlm-1563	92	8	among	among	ADP
ajlm-1563	92	9	participants	participant	NOUN
ajlm-1563	92	10	with	with	ADP
ajlm-1563	92	11	vscc	vscc	NOUN
ajlm-1563	92	12	(	(	PUNCT
ajlm-1563	92	13	43	43	NUM
ajlm-1563	92	14	vs	vs	ADP
ajlm-1563	92	15	33	33	NUM
ajlm-1563	92	16	years	year	NOUN
ajlm-1563	92	17	,	,	PUNCT
ajlm-1563	92	18	p	p	NOUN
ajlm-1563	92	19	=	=	NOUN
ajlm-1563	92	20	0.004	0.004	NUM
ajlm-1563	92	21	)	)	PUNCT
ajlm-1563	92	22	compared	compare	VERB
ajlm-1563	92	23	to	to	ADP
ajlm-1563	92	24	those	those	PRON
ajlm-1563	92	25	with	with	ADP
ajlm-1563	92	26	nnl	nnl	PROPN
ajlm-1563	92	27	.	.	PUNCT
ajlm-1563	93	1	there	there	PRON
ajlm-1563	93	2	was	be	VERB
ajlm-1563	93	3	no	no	DET
ajlm-1563	93	4	difference	difference	NOUN
ajlm-1563	93	5	between	between	ADP
ajlm-1563	93	6	the	the	DET
ajlm-1563	93	7	mean	mean	ADJ
ajlm-1563	93	8	ages	age	NOUN
ajlm-1563	93	9	of	of	ADP
ajlm-1563	93	10	participants	participant	NOUN
ajlm-1563	93	11	with	with	ADP
ajlm-1563	93	12	uvin	uvin	PROPN
ajlm-1563	93	13	and	and	CCONJ
ajlm-1563	93	14	nnl	nnl	PROPN
ajlm-1563	93	15	(	(	PUNCT
ajlm-1563	93	16	uvin	uvin	PROPN
ajlm-1563	93	17	:	:	PUNCT
ajlm-1563	93	18	40	40	NUM
ajlm-1563	93	19	years	year	NOUN
ajlm-1563	93	20	vs	vs	ADP
ajlm-1563	93	21	nnl	nnl	NOUN
ajlm-1563	93	22	:	:	PUNCT
ajlm-1563	93	23	33	33	NUM
ajlm-1563	93	24	years	year	NOUN
ajlm-1563	93	25	,	,	PUNCT
ajlm-1563	93	26	p	p	NOUN
ajlm-1563	93	27	=	=	PROPN
ajlm-1563	93	28	0.110	0.110	NUM
ajlm-1563	93	29	)	)	PUNCT
ajlm-1563	93	30	.	.	PUNCT
ajlm-1563	94	1	the	the	DET
ajlm-1563	94	2	majority	majority	NOUN
ajlm-1563	94	3	(	(	PUNCT
ajlm-1563	94	4	23/50	23/50	NUM
ajlm-1563	94	5	,	,	PUNCT
ajlm-1563	94	6	46.0	46.0	NUM
ajlm-1563	94	7	%	%	NOUN
ajlm-1563	94	8	)	)	PUNCT
ajlm-1563	94	9	of	of	ADP
ajlm-1563	94	10	participants	participant	NOUN
ajlm-1563	94	11	reported	report	VERB
ajlm-1563	94	12	primary	primary	ADJ
ajlm-1563	94	13	level	level	NOUN
ajlm-1563	94	14	as	as	ADP
ajlm-1563	94	15	their	their	PRON
ajlm-1563	94	16	highest	high	ADJ
ajlm-1563	94	17	level	level	NOUN
ajlm-1563	94	18	of	of	ADP
ajlm-1563	94	19	education	education	NOUN
ajlm-1563	94	20	;	;	PUNCT
ajlm-1563	94	21	however	however	ADV
ajlm-1563	94	22	,	,	PUNCT
ajlm-1563	94	23	the	the	DET
ajlm-1563	94	24	tests	test	NOUN
ajlm-1563	94	25	of	of	ADP
ajlm-1563	94	26	association	association	NOUN
ajlm-1563	94	27	could	could	AUX
ajlm-1563	94	28	not	not	PART
ajlm-1563	94	29	be	be	AUX
ajlm-1563	94	30	performed	perform	VERB
ajlm-1563	94	31	as	as	SCONJ
ajlm-1563	94	32	the	the	DET
ajlm-1563	94	33	assumptions	assumption	NOUN
ajlm-1563	94	34	for	for	ADP
ajlm-1563	94	35	χ2	χ2	PROPN
ajlm-1563	94	36	and	and	CCONJ
ajlm-1563	94	37	fisher	fisher	PROPN
ajlm-1563	94	38	’s	’s	PART
ajlm-1563	94	39	exact	exact	ADJ
ajlm-1563	94	40	tests	test	NOUN
ajlm-1563	94	41	were	be	AUX
ajlm-1563	94	42	not	not	PART
ajlm-1563	94	43	met	meet	VERB
ajlm-1563	94	44	.	.	PUNCT
ajlm-1563	95	1	table	table	NOUN
ajlm-1563	95	2	1	1	NUM
ajlm-1563	95	3	:	:	PUNCT
ajlm-1563	95	4	 	 	SPACE
ajlm-1563	95	5	characteristics	characteristic	NOUN
ajlm-1563	95	6	of	of	ADP
ajlm-1563	95	7	participants	participant	NOUN
ajlm-1563	95	8	diagnosed	diagnose	VERB
ajlm-1563	95	9	with	with	ADP
ajlm-1563	95	10	usual	usual	ADJ
ajlm-1563	95	11	uvin	uvin	NOUN
ajlm-1563	95	12	,	,	PUNCT
ajlm-1563	95	13	vscc	vscc	NOUN
ajlm-1563	95	14	and	and	CCONJ
ajlm-1563	95	15	nnl	nnl	NOUN
ajlm-1563	95	16	at	at	ADP
ajlm-1563	95	17	the	the	DET
ajlm-1563	95	18	university	university	NOUN
ajlm-1563	95	19	teaching	teaching	NOUN
ajlm-1563	95	20	hospital	hospital	NOUN
ajlm-1563	95	21	’s	’s	PART
ajlm-1563	95	22	gynaecologic	gynaecologic	PROPN
ajlm-1563	95	23	clinic	clinic	PROPN
ajlm-1563	95	24	,	,	PUNCT
ajlm-1563	95	25	zambia	zambia	PROPN
ajlm-1563	95	26	,	,	PUNCT
ajlm-1563	95	27	2018	2018	NUM
ajlm-1563	95	28	.	.	PUNCT
ajlm-1563	96	1	risk	risk	NOUN
ajlm-1563	96	2	factors	factor	NOUN
ajlm-1563	96	3	among	among	ADP
ajlm-1563	96	4	participants	participant	NOUN
ajlm-1563	96	5	with	with	ADP
ajlm-1563	96	6	vscc	vscc	NOUN
ajlm-1563	96	7	and	and	CCONJ
ajlm-1563	96	8	uvin	uvin	NOUN
ajlm-1563	96	9	compared	compare	VERB
ajlm-1563	96	10	to	to	ADP
ajlm-1563	96	11	those	those	PRON
ajlm-1563	96	12	with	with	ADP
ajlm-1563	96	13	nnl	nnl	NOUN
ajlm-1563	96	14	there	there	PRON
ajlm-1563	96	15	was	be	VERB
ajlm-1563	96	16	no	no	DET
ajlm-1563	96	17	association	association	NOUN
ajlm-1563	96	18	between	between	ADP
ajlm-1563	96	19	the	the	DET
ajlm-1563	96	20	selected	select	VERB
ajlm-1563	96	21	risk	risk	NOUN
ajlm-1563	96	22	factors	factor	NOUN
ajlm-1563	96	23	and	and	CCONJ
ajlm-1563	96	24	the	the	DET
ajlm-1563	96	25	diagnosis	diagnosis	NOUN
ajlm-1563	96	26	of	of	ADP
ajlm-1563	96	27	vscc	vscc	NOUN
ajlm-1563	96	28	or	or	CCONJ
ajlm-1563	96	29	uvin	uvin	NOUN
ajlm-1563	96	30	:	:	PUNCT
ajlm-1563	96	31	history	history	NOUN
ajlm-1563	96	32	of	of	ADP
ajlm-1563	96	33	alcohol	alcohol	NOUN
ajlm-1563	96	34	intake	intake	NOUN
ajlm-1563	96	35	(	(	PUNCT
ajlm-1563	96	36	uvin	uvin	PROPN
ajlm-1563	96	37	vs	vs	ADP
ajlm-1563	96	38	nnl	nnl	PROPN
ajlm-1563	96	39	:	:	PUNCT
ajlm-1563	96	40	p	p	X
ajlm-1563	96	41	=	=	NOUN
ajlm-1563	96	42	0.675	0.675	NUM
ajlm-1563	96	43	;	;	PUNCT
ajlm-1563	96	44	vscc	vscc	NOUN
ajlm-1563	96	45	vs	vs	ADP
ajlm-1563	96	46	nnl	nnl	PROPN
ajlm-1563	96	47	:	:	PUNCT
ajlm-1563	96	48	p	p	X
ajlm-1563	96	49	=	=	PROPN
ajlm-1563	96	50	0.681	0.681	NUM
ajlm-1563	96	51	)	)	PUNCT
ajlm-1563	96	52	,	,	PUNCT
ajlm-1563	96	53	oral	oral	ADJ
ajlm-1563	96	54	contraceptive	contraceptive	NOUN
ajlm-1563	96	55	intake	intake	NOUN
ajlm-1563	96	56	(	(	PUNCT
ajlm-1563	96	57	uvin	uvin	PROPN
ajlm-1563	96	58	vs	vs	ADP
ajlm-1563	96	59	nnl	nnl	PROPN
ajlm-1563	96	60	:	:	PUNCT
ajlm-1563	96	61	p	p	X
ajlm-1563	96	62	=	=	NOUN
ajlm-1563	96	63	0.568	0.568	NUM
ajlm-1563	96	64	;	;	PUNCT
ajlm-1563	96	65	vscc	vscc	ADJ
ajlm-1563	96	66	vs	vs	ADP
ajlm-1563	96	67	nnl	nnl	PROPN
ajlm-1563	96	68	:	:	PUNCT
ajlm-1563	96	69	1.000	1.000	NUM
ajlm-1563	96	70	)	)	PUNCT
ajlm-1563	96	71	,	,	PUNCT
ajlm-1563	96	72	cigarette	cigarette	NOUN
ajlm-1563	96	73	smoking	smoking	NOUN
ajlm-1563	96	74	(	(	PUNCT
ajlm-1563	96	75	uvin	uvin	PROPN
ajlm-1563	96	76	vs	vs	ADP
ajlm-1563	96	77	nnl	nnl	PROPN
ajlm-1563	96	78	:	:	PUNCT
ajlm-1563	96	79	p	p	X
ajlm-1563	96	80	=	=	NOUN
ajlm-1563	96	81	0.532	0.532	NUM
ajlm-1563	96	82	;	;	PUNCT
ajlm-1563	96	83	vscc	vscc	NOUN
ajlm-1563	96	84	vs	vs	ADP
ajlm-1563	96	85	nnl	nnl	PROPN
ajlm-1563	96	86	:	:	PUNCT
ajlm-1563	96	87	0.517	0.517	NUM
ajlm-1563	96	88	)	)	PUNCT
ajlm-1563	96	89	.	.	PUNCT
ajlm-1563	97	1	the	the	DET
ajlm-1563	97	2	median	median	ADJ
ajlm-1563	97	3	age	age	NOUN
ajlm-1563	97	4	at	at	ADP
ajlm-1563	97	5	first	first	ADJ
ajlm-1563	97	6	sexual	sexual	ADJ
ajlm-1563	97	7	intercourse	intercourse	NOUN
ajlm-1563	97	8	was	be	AUX
ajlm-1563	97	9	significantly	significantly	ADV
ajlm-1563	97	10	lower	low	ADJ
ajlm-1563	97	11	among	among	ADP
ajlm-1563	97	12	participants	participant	NOUN
ajlm-1563	97	13	with	with	ADP
ajlm-1563	97	14	uvin	uvin	NOUN
ajlm-1563	97	15	than	than	ADP
ajlm-1563	97	16	those	those	PRON
ajlm-1563	97	17	with	with	ADP
ajlm-1563	97	18	nnl	nnl	PROPN
ajlm-1563	97	19	(	(	PUNCT
ajlm-1563	97	20	uvin	uvin	PROPN
ajlm-1563	97	21	:	:	PUNCT
ajlm-1563	97	22	18	18	NUM
ajlm-1563	97	23	years	year	NOUN
ajlm-1563	97	24	vs	vs	ADP
ajlm-1563	97	25	nnl	nnl	NOUN
ajlm-1563	97	26	:	:	PUNCT
ajlm-1563	97	27	19	19	NUM
ajlm-1563	97	28	years	year	NOUN
ajlm-1563	97	29	;	;	PUNCT
ajlm-1563	97	30	p	p	X
ajlm-1563	97	31	=	=	NOUN
ajlm-1563	97	32	0.048	0.048	NUM
ajlm-1563	97	33	)	)	PUNCT
ajlm-1563	97	34	.	.	PUNCT
ajlm-1563	98	1	only	only	ADV
ajlm-1563	98	2	a	a	DET
ajlm-1563	98	3	few	few	ADJ
ajlm-1563	98	4	(	(	PUNCT
ajlm-1563	98	5	3/50	3/50	NUM
ajlm-1563	98	6	,	,	PUNCT
ajlm-1563	98	7	6.0	6.0	NUM
ajlm-1563	98	8	%	%	NOUN
ajlm-1563	98	9	)	)	PUNCT
ajlm-1563	98	10	participants	participant	NOUN
ajlm-1563	98	11	reported	report	VERB
ajlm-1563	98	12	smoking	smoke	VERB
ajlm-1563	98	13	.	.	PUNCT
ajlm-1563	99	1	the	the	DET
ajlm-1563	99	2	median	median	ADJ
ajlm-1563	99	3	number	number	NOUN
ajlm-1563	99	4	of	of	ADP
ajlm-1563	99	5	lifetime	lifetime	NOUN
ajlm-1563	99	6	sexual	sexual	ADJ
ajlm-1563	99	7	partners	partner	NOUN
ajlm-1563	99	8	reported	report	VERB
ajlm-1563	99	9	among	among	ADP
ajlm-1563	99	10	all	all	DET
ajlm-1563	99	11	participants	participant	NOUN
ajlm-1563	99	12	was	be	AUX
ajlm-1563	99	13	four	four	NUM
ajlm-1563	99	14	(	(	PUNCT
ajlm-1563	99	15	95	95	NUM
ajlm-1563	99	16	%	%	NOUN
ajlm-1563	99	17	confidence	confidence	NOUN
ajlm-1563	99	18	interval	interval	NOUN
ajlm-1563	100	1	[	[	X
ajlm-1563	100	2	ci	ci	X
ajlm-1563	100	3	]	]	X
ajlm-1563	100	4	:	:	PUNCT
ajlm-1563	100	5	2–6	2–6	NUM
ajlm-1563	100	6	)	)	PUNCT
ajlm-1563	100	7	;	;	PUNCT
ajlm-1563	100	8	four	four	NUM
ajlm-1563	100	9	partners	partner	NOUN
ajlm-1563	100	10	(	(	PUNCT
ajlm-1563	100	11	95	95	NUM
ajlm-1563	100	12	%	%	NOUN
ajlm-1563	100	13	ci	ci	NOUN
ajlm-1563	100	14	:	:	PUNCT
ajlm-1563	100	15	2–6	2–6	NUM
ajlm-1563	100	16	)	)	PUNCT
ajlm-1563	100	17	among	among	ADP
ajlm-1563	100	18	participants	participant	NOUN
ajlm-1563	100	19	with	with	ADP
ajlm-1563	100	20	vscc	vscc	ADJ
ajlm-1563	100	21	,	,	PUNCT
ajlm-1563	100	22	four	four	NUM
ajlm-1563	100	23	partners	partner	NOUN
ajlm-1563	100	24	(	(	PUNCT
ajlm-1563	100	25	95	95	NUM
ajlm-1563	100	26	%	%	NOUN
ajlm-1563	100	27	ci	ci	NOUN
ajlm-1563	100	28	:	:	PUNCT
ajlm-1563	100	29	2–6	2–6	NUM
ajlm-1563	100	30	)	)	PUNCT
ajlm-1563	100	31	among	among	ADP
ajlm-1563	100	32	participants	participant	NOUN
ajlm-1563	100	33	with	with	ADP
ajlm-1563	100	34	uvin	uvin	PROPN
ajlm-1563	100	35	and	and	CCONJ
ajlm-1563	100	36	three	three	NUM
ajlm-1563	100	37	partners	partner	NOUN
ajlm-1563	100	38	(	(	PUNCT
ajlm-1563	100	39	95	95	NUM
ajlm-1563	100	40	%	%	NOUN
ajlm-1563	100	41	ci	ci	NOUN
ajlm-1563	100	42	:	:	PUNCT
ajlm-1563	100	43	2–4	2–4	NUM
ajlm-1563	100	44	)	)	PUNCT
ajlm-1563	100	45	among	among	ADP
ajlm-1563	100	46	participants	participant	NOUN
ajlm-1563	100	47	with	with	ADP
ajlm-1563	100	48	nnl	nnl	PROPN
ajlm-1563	100	49	.	.	PROPN
ajlm-1563	100	50	hiv	hiv	PROPN
ajlm-1563	100	51	characteristics	characteristic	NOUN
ajlm-1563	100	52	and	and	CCONJ
ajlm-1563	100	53	history	history	NOUN
ajlm-1563	100	54	of	of	ADP
ajlm-1563	100	55	cervical	cervical	ADJ
ajlm-1563	100	56	cancer	cancer	NOUN
ajlm-1563	100	57	screening	screen	VERB
ajlm-1563	100	58	all	all	DET
ajlm-1563	100	59	participants	participant	NOUN
ajlm-1563	100	60	diagnosed	diagnose	VERB
ajlm-1563	100	61	with	with	ADP
ajlm-1563	100	62	uvin	uvin	PROPN
ajlm-1563	100	63	(	(	PUNCT
ajlm-1563	100	64	20/20	20/20	NUM
ajlm-1563	100	65	,	,	PUNCT
ajlm-1563	100	66	100.0	100.0	NUM
ajlm-1563	100	67	%	%	NOUN
ajlm-1563	100	68	)	)	PUNCT
ajlm-1563	100	69	and	and	CCONJ
ajlm-1563	100	70	vscc	vscc	ADJ
ajlm-1563	100	71	(	(	PUNCT
ajlm-1563	100	72	21/21	21/21	NUM
ajlm-1563	100	73	,	,	PUNCT
ajlm-1563	100	74	100.0	100.0	NUM
ajlm-1563	100	75	%	%	NOUN
ajlm-1563	100	76	)	)	PUNCT
ajlm-1563	100	77	were	be	AUX
ajlm-1563	100	78	on	on	ADP
ajlm-1563	100	79	art	art	NOUN
ajlm-1563	100	80	,	,	PUNCT
ajlm-1563	100	81	while	while	SCONJ
ajlm-1563	100	82	seven	seven	NUM
ajlm-1563	100	83	(	(	PUNCT
ajlm-1563	100	84	7/9	7/9	NUM
ajlm-1563	100	85	;	;	PUNCT
ajlm-1563	100	86	77.8	77.8	NUM
ajlm-1563	100	87	%	%	NOUN
ajlm-1563	100	88	)	)	PUNCT
ajlm-1563	100	89	of	of	ADP
ajlm-1563	100	90	those	those	PRON
ajlm-1563	100	91	diagnosed	diagnose	VERB
ajlm-1563	100	92	with	with	ADP
ajlm-1563	100	93	nnl	nnl	NOUN
ajlm-1563	100	94	were	be	AUX
ajlm-1563	100	95	on	on	ADP
ajlm-1563	100	96	art	art	NOUN
ajlm-1563	100	97	.	.	PUNCT
ajlm-1563	101	1	the	the	DET
ajlm-1563	101	2	majority	majority	NOUN
ajlm-1563	101	3	of	of	ADP
ajlm-1563	101	4	the	the	DET
ajlm-1563	101	5	participants	participant	NOUN
ajlm-1563	101	6	(	(	PUNCT
ajlm-1563	101	7	39/50	39/50	NUM
ajlm-1563	101	8	,	,	PUNCT
ajlm-1563	101	9	78.0	78.0	NUM
ajlm-1563	101	10	%	%	NOUN
ajlm-1563	101	11	)	)	PUNCT
ajlm-1563	101	12	had	have	AUX
ajlm-1563	101	13	been	be	AUX
ajlm-1563	101	14	on	on	ADP
ajlm-1563	101	15	art	art	NOUN
ajlm-1563	101	16	for	for	ADP
ajlm-1563	101	17	longer	long	ADJ
ajlm-1563	101	18	than	than	ADP
ajlm-1563	101	19	one	one	NUM
ajlm-1563	101	20	year	year	NOUN
ajlm-1563	101	21	(	(	PUNCT
ajlm-1563	101	22	mean	mean	NOUN
ajlm-1563	101	23	:	:	PUNCT
ajlm-1563	101	24	7	7	NUM
ajlm-1563	101	25	±	±	NUM
ajlm-1563	101	26	4	4	NUM
ajlm-1563	101	27	years	year	NOUN
ajlm-1563	101	28	)	)	PUNCT
ajlm-1563	101	29	.	.	PUNCT
ajlm-1563	102	1	the	the	DET
ajlm-1563	102	2	cd4	cd4	PROPN
ajlm-1563	102	3	count	count	NOUN
ajlm-1563	102	4	distribution	distribution	NOUN
ajlm-1563	102	5	was	be	AUX
ajlm-1563	102	6	approximately	approximately	ADV
ajlm-1563	102	7	normal	normal	ADJ
ajlm-1563	102	8	(	(	PUNCT
ajlm-1563	102	9	shapiro	shapiro	NOUN
ajlm-1563	102	10	-	-	PUNCT
ajlm-1563	102	11	wilk	wilk	NOUN
ajlm-1563	102	12	test	test	NOUN
ajlm-1563	102	13	:	:	PUNCT
ajlm-1563	102	14	0.952	0.952	NUM
ajlm-1563	102	15	[	[	NOUN
ajlm-1563	102	16	degree	degree	NOUN
ajlm-1563	102	17	of	of	ADP
ajlm-1563	102	18	freedom{df	freedom{df	NOUN
ajlm-1563	102	19	}	}	PUNCT
ajlm-1563	102	20	=	=	PUNCT
ajlm-1563	102	21	46	46	NUM
ajlm-1563	102	22	]	]	PUNCT
ajlm-1563	102	23	,	,	PUNCT
ajlm-1563	102	24	p	p	X
ajlm-1563	102	25	=	=	NOUN
ajlm-1563	102	26	0.055	0.055	NUM
ajlm-1563	102	27	)	)	PUNCT
ajlm-1563	102	28	.	.	PUNCT
ajlm-1563	103	1	the	the	DET
ajlm-1563	103	2	overall	overall	ADJ
ajlm-1563	103	3	mean	mean	NOUN
ajlm-1563	103	4	cd4	cd4	PROPN
ajlm-1563	103	5	count	count	NOUN
ajlm-1563	103	6	was	be	AUX
ajlm-1563	103	7	387.2	387.2	NUM
ajlm-1563	103	8	±	±	NUM
ajlm-1563	103	9	237.2	237.2	NUM
ajlm-1563	103	10	cells/µl	cells/µl	NOUN
ajlm-1563	103	11	.	.	PUNCT
ajlm-1563	104	1	the	the	DET
ajlm-1563	104	2	average	average	ADJ
ajlm-1563	104	3	cd4	cd4	PROPN
ajlm-1563	104	4	count	count	NOUN
ajlm-1563	104	5	was	be	AUX
ajlm-1563	104	6	414.0	414.0	NUM
ajlm-1563	104	7	±	±	NUM
ajlm-1563	104	8	233.1	233.1	NUM
ajlm-1563	104	9	cells/µl	cells/µl	NOUN
ajlm-1563	104	10	among	among	ADP
ajlm-1563	104	11	participants	participant	NOUN
ajlm-1563	104	12	with	with	ADP
ajlm-1563	104	13	vscc	vscc	NOUN
ajlm-1563	104	14	,	,	PUNCT
ajlm-1563	104	15	359.5	359.5	NUM
ajlm-1563	104	16	±	±	NUM
ajlm-1563	104	17	225.7	225.7	NUM
ajlm-1563	104	18	cells/µl	cells/µl	NOUN
ajlm-1563	104	19	among	among	ADP
ajlm-1563	104	20	participants	participant	NOUN
ajlm-1563	104	21	with	with	ADP
ajlm-1563	104	22	uvin	uvin	NOUN
ajlm-1563	104	23	,	,	PUNCT
ajlm-1563	104	24	and	and	CCONJ
ajlm-1563	104	25	381.6	381.6	NUM
ajlm-1563	104	26	±	±	NUM
ajlm-1563	104	27	294.1	294.1	NUM
ajlm-1563	104	28	cells/µl	cells/µl	NOUN
ajlm-1563	104	29	among	among	ADP
ajlm-1563	104	30	participants	participant	NOUN
ajlm-1563	104	31	with	with	ADP
ajlm-1563	104	32	nnl	nnl	PROPN
ajlm-1563	104	33	.	.	PUNCT
ajlm-1563	105	1	there	there	PRON
ajlm-1563	105	2	was	be	VERB
ajlm-1563	105	3	no	no	DET
ajlm-1563	105	4	significant	significant	ADJ
ajlm-1563	105	5	difference	difference	NOUN
ajlm-1563	105	6	in	in	ADP
ajlm-1563	105	7	mean	mean	NOUN
ajlm-1563	105	8	cd4	cd4	PROPN
ajlm-1563	105	9	counts	count	NOUN
ajlm-1563	105	10	between	between	ADP
ajlm-1563	105	11	participants	participant	NOUN
ajlm-1563	105	12	with	with	ADP
ajlm-1563	105	13	nnl	nnl	NOUN
ajlm-1563	105	14	and	and	CCONJ
ajlm-1563	105	15	those	those	PRON
ajlm-1563	105	16	with	with	ADP
ajlm-1563	105	17	uvin	uvin	NOUN
ajlm-1563	105	18	(	(	PUNCT
ajlm-1563	105	19	t	t	NOUN
ajlm-1563	105	20	=	=	PUNCT
ajlm-1563	105	21	–	–	PUNCT
ajlm-1563	105	22	0.210	0.210	NUM
ajlm-1563	105	23	,	,	PUNCT
ajlm-1563	105	24	p	p	X
ajlm-1563	105	25	=	=	NOUN
ajlm-1563	105	26	0.835	0.835	NUM
ajlm-1563	105	27	)	)	PUNCT
ajlm-1563	105	28	or	or	CCONJ
ajlm-1563	105	29	vscc	vscc	NOUN
ajlm-1563	105	30	(	(	PUNCT
ajlm-1563	105	31	t	t	NOUN
ajlm-1563	105	32	=	=	NUM
ajlm-1563	105	33	0.312	0.312	NUM
ajlm-1563	105	34	,	,	PUNCT
ajlm-1563	105	35	p	p	X
ajlm-1563	105	36	=	=	NOUN
ajlm-1563	105	37	0.757	0.757	NUM
ajlm-1563	105	38	)	)	PUNCT
ajlm-1563	105	39	.	.	PUNCT
ajlm-1563	106	1	in	in	ADP
ajlm-1563	106	2	terms	term	NOUN
ajlm-1563	106	3	of	of	ADP
ajlm-1563	106	4	history	history	NOUN
ajlm-1563	106	5	of	of	ADP
ajlm-1563	106	6	cervical	cervical	ADJ
ajlm-1563	106	7	cancer	cancer	NOUN
ajlm-1563	106	8	screening	screening	NOUN
ajlm-1563	106	9	,	,	PUNCT
ajlm-1563	106	10	there	there	PRON
ajlm-1563	106	11	was	be	VERB
ajlm-1563	106	12	no	no	DET
ajlm-1563	106	13	difference	difference	NOUN
ajlm-1563	106	14	between	between	ADP
ajlm-1563	106	15	uvin	uvin	PROPN
ajlm-1563	106	16	and	and	CCONJ
ajlm-1563	106	17	nnl	nnl	PROPN
ajlm-1563	106	18	(	(	PUNCT
ajlm-1563	106	19	13/20	13/20	NUM
ajlm-1563	106	20	(	(	PUNCT
ajlm-1563	106	21	65.0	65.0	NUM
ajlm-1563	106	22	%	%	NOUN
ajlm-1563	106	23	)	)	PUNCT
ajlm-1563	106	24	vs	vs	ADP
ajlm-1563	106	25	7/9	7/9	NUM
ajlm-1563	106	26	(	(	PUNCT
ajlm-1563	106	27	77.8	77.8	NUM
ajlm-1563	106	28	%	%	NOUN
ajlm-1563	106	29	)	)	PUNCT
ajlm-1563	106	30	;	;	PUNCT
ajlm-1563	107	1	p	p	X
ajlm-1563	107	2	=	=	NOUN
ajlm-1563	107	3	0.694	0.694	NUM
ajlm-1563	107	4	)	)	PUNCT
ajlm-1563	107	5	or	or	CCONJ
ajlm-1563	107	6	between	between	ADP
ajlm-1563	107	7	vscc	vscc	NOUN
ajlm-1563	107	8	and	and	CCONJ
ajlm-1563	107	9	nnl	nnl	PROPN
ajlm-1563	107	10	(	(	PUNCT
ajlm-1563	107	11	13/21	13/21	NUM
ajlm-1563	108	1	[	[	X
ajlm-1563	108	2	61.9	61.9	NUM
ajlm-1563	108	3	%	%	NOUN
ajlm-1563	108	4	]	]	PUNCT
ajlm-1563	108	5	vs	vs	ADP
ajlm-1563	108	6	13/20	13/20	NUM
ajlm-1563	108	7	[	[	X
ajlm-1563	108	8	65.0	65.0	NUM
ajlm-1563	108	9	%	%	NOUN
ajlm-1563	108	10	]	]	X
ajlm-1563	108	11	;	;	PUNCT
ajlm-1563	108	12	p	p	X
ajlm-1563	108	13	=	=	NOUN
ajlm-1563	108	14	1.000	1.000	NUM
ajlm-1563	108	15	)	)	PUNCT
ajlm-1563	108	16	.	.	PUNCT
ajlm-1563	109	1	among	among	ADP
ajlm-1563	109	2	those	those	PRON
ajlm-1563	109	3	who	who	PRON
ajlm-1563	109	4	were	be	AUX
ajlm-1563	109	5	screened	screen	VERB
ajlm-1563	109	6	for	for	ADP
ajlm-1563	109	7	cervical	cervical	ADJ
ajlm-1563	109	8	cancer	cancer	NOUN
ajlm-1563	109	9	,	,	PUNCT
ajlm-1563	109	10	two	two	NUM
ajlm-1563	109	11	of	of	ADP
ajlm-1563	109	12	them	they	PRON
ajlm-1563	109	13	reported	report	VERB
ajlm-1563	109	14	that	that	SCONJ
ajlm-1563	109	15	they	they	PRON
ajlm-1563	109	16	had	have	AUX
ajlm-1563	109	17	been	be	AUX
ajlm-1563	109	18	diagnosed	diagnose	VERB
ajlm-1563	109	19	with	with	ADP
ajlm-1563	109	20	cervical	cervical	ADJ
ajlm-1563	109	21	cancer	cancer	NOUN
ajlm-1563	109	22	(	(	PUNCT
ajlm-1563	109	23	one	one	NOUN
ajlm-1563	109	24	with	with	ADP
ajlm-1563	109	25	uvin	uvin	PROPN
ajlm-1563	109	26	and	and	CCONJ
ajlm-1563	109	27	the	the	DET
ajlm-1563	109	28	other	other	ADJ
ajlm-1563	109	29	with	with	ADP
ajlm-1563	109	30	vscc	vscc	NOUN
ajlm-1563	109	31	)	)	PUNCT
ajlm-1563	109	32	.	.	PUNCT
ajlm-1563	110	1	symptoms	symptom	NOUN
ajlm-1563	110	2	of	of	ADP
ajlm-1563	110	3	participants	participant	NOUN
ajlm-1563	110	4	with	with	ADP
ajlm-1563	110	5	uvin	uvin	NOUN
ajlm-1563	110	6	,	,	PUNCT
ajlm-1563	110	7	vscc	vscc	ADJ
ajlm-1563	110	8	and	and	CCONJ
ajlm-1563	110	9	nnl	nnl	NOUN
ajlm-1563	110	10	approximately	approximately	ADV
ajlm-1563	110	11	three	three	NUM
ajlm-1563	110	12	-	-	PUNCT
ajlm-1563	110	13	quarters	quarter	NOUN
ajlm-1563	110	14	(	(	PUNCT
ajlm-1563	110	15	37/50	37/50	NUM
ajlm-1563	110	16	,	,	PUNCT
ajlm-1563	110	17	74.0	74.0	NUM
ajlm-1563	110	18	%	%	NOUN
ajlm-1563	110	19	)	)	PUNCT
ajlm-1563	110	20	of	of	ADP
ajlm-1563	110	21	the	the	DET
ajlm-1563	110	22	participants	participant	NOUN
ajlm-1563	110	23	had	have	AUX
ajlm-1563	110	24	had	have	VERB
ajlm-1563	110	25	vulvar	vulvar	NOUN
ajlm-1563	110	26	symptoms	symptom	NOUN
ajlm-1563	110	27	for	for	ADP
ajlm-1563	110	28	at	at	ADV
ajlm-1563	110	29	least	least	ADV
ajlm-1563	110	30	1	1	NUM
ajlm-1563	110	31	year	year	NOUN
ajlm-1563	110	32	.	.	PUNCT
ajlm-1563	111	1	although	although	SCONJ
ajlm-1563	111	2	a	a	DET
ajlm-1563	111	3	larger	large	ADJ
ajlm-1563	111	4	proportion	proportion	NOUN
ajlm-1563	111	5	of	of	ADP
ajlm-1563	111	6	the	the	DET
ajlm-1563	111	7	participants	participant	NOUN
ajlm-1563	111	8	with	with	ADP
ajlm-1563	111	9	vscc	vscc	NOUN
ajlm-1563	111	10	(	(	PUNCT
ajlm-1563	111	11	17/21	17/21	NUM
ajlm-1563	111	12	,	,	PUNCT
ajlm-1563	111	13	80.9	80.9	NUM
ajlm-1563	111	14	%	%	NOUN
ajlm-1563	111	15	;	;	PUNCT
ajlm-1563	111	16	p	p	X
ajlm-1563	111	17	=	=	NOUN
ajlm-1563	111	18	0.082	0.082	NUM
ajlm-1563	111	19	)	)	PUNCT
ajlm-1563	111	20	and	and	CCONJ
ajlm-1563	111	21	uvin	uvin	PROPN
ajlm-1563	111	22	(	(	PUNCT
ajlm-1563	111	23	16/20	16/20	NUM
ajlm-1563	111	24	,	,	PUNCT
ajlm-1563	111	25	80.0	80.0	NUM
ajlm-1563	111	26	%	%	NOUN
ajlm-1563	111	27	;	;	PUNCT
ajlm-1563	111	28	p	p	NOUN
ajlm-1563	111	29	=	=	NOUN
ajlm-1563	111	30	0.088	0.088	NUM
ajlm-1563	111	31	)	)	PUNCT
ajlm-1563	111	32	had	have	VERB
ajlm-1563	111	33	symptoms	symptom	NOUN
ajlm-1563	111	34	for	for	ADP
ajlm-1563	111	35	≥	≥	NOUN
ajlm-1563	111	36	1	1	NUM
ajlm-1563	111	37	year	year	NOUN
ajlm-1563	111	38	compared	compare	VERB
ajlm-1563	111	39	to	to	ADP
ajlm-1563	111	40	participants	participant	NOUN
ajlm-1563	111	41	with	with	ADP
ajlm-1563	111	42	nnl	nnl	PROPN
ajlm-1563	111	43	(	(	PUNCT
ajlm-1563	111	44	4/9	4/9	NUM
ajlm-1563	111	45	,	,	PUNCT
ajlm-1563	111	46	44.4	44.4	NUM
ajlm-1563	111	47	%	%	NOUN
ajlm-1563	111	48	)	)	PUNCT
ajlm-1563	111	49	,	,	PUNCT
ajlm-1563	111	50	these	these	DET
ajlm-1563	111	51	differences	difference	NOUN
ajlm-1563	111	52	were	be	AUX
ajlm-1563	111	53	not	not	PART
ajlm-1563	111	54	statistically	statistically	ADV
ajlm-1563	111	55	significant	significant	ADJ
ajlm-1563	111	56	.	.	PUNCT
ajlm-1563	112	1	among	among	ADP
ajlm-1563	112	2	all	all	DET
ajlm-1563	112	3	the	the	DET
ajlm-1563	112	4	participants	participant	NOUN
ajlm-1563	112	5	,	,	PUNCT
ajlm-1563	112	6	the	the	DET
ajlm-1563	112	7	most	most	ADV
ajlm-1563	112	8	frequently	frequently	ADV
ajlm-1563	112	9	reported	report	VERB
ajlm-1563	112	10	first	first	ADJ
ajlm-1563	112	11	symptom	symptom	NOUN
ajlm-1563	112	12	was	be	AUX
ajlm-1563	112	13	itching	itch	VERB
ajlm-1563	112	14	(	(	PUNCT
ajlm-1563	112	15	23/50	23/50	NUM
ajlm-1563	112	16	,	,	PUNCT
ajlm-1563	112	17	46.0	46.0	NUM
ajlm-1563	112	18	%	%	NOUN
ajlm-1563	112	19	)	)	PUNCT
ajlm-1563	112	20	.	.	PUNCT
ajlm-1563	113	1	the	the	DET
ajlm-1563	113	2	frequency	frequency	NOUN
ajlm-1563	113	3	of	of	ADP
ajlm-1563	113	4	itching	itching	NOUN
ajlm-1563	113	5	as	as	ADP
ajlm-1563	113	6	a	a	DET
ajlm-1563	113	7	first	first	ADJ
ajlm-1563	113	8	symptom	symptom	NOUN
ajlm-1563	113	9	was	be	AUX
ajlm-1563	113	10	similar	similar	ADJ
ajlm-1563	113	11	across	across	ADP
ajlm-1563	113	12	all	all	DET
ajlm-1563	113	13	groups	group	NOUN
ajlm-1563	113	14	of	of	ADP
ajlm-1563	113	15	participants	participant	NOUN
ajlm-1563	113	16	(	(	PUNCT
ajlm-1563	113	17	uvin	uvin	ADJ
ajlm-1563	113	18	:	:	PUNCT
ajlm-1563	113	19	9/20	9/20	NUM
ajlm-1563	113	20	,	,	PUNCT
ajlm-1563	113	21	45.0	45.0	NUM
ajlm-1563	113	22	%	%	NOUN
ajlm-1563	113	23	;	;	PUNCT
ajlm-1563	113	24	nnl	nnl	NOUN
ajlm-1563	113	25	:	:	PUNCT
ajlm-1563	113	26	4/9	4/9	NUM
ajlm-1563	113	27	,	,	PUNCT
ajlm-1563	113	28	44.4	44.4	NUM
ajlm-1563	113	29	%	%	NOUN
ajlm-1563	113	30	;	;	PUNCT
ajlm-1563	113	31	vscc	vscc	ADJ
ajlm-1563	113	32	:	:	PUNCT
ajlm-1563	113	33	10/21	10/21	NUM
ajlm-1563	113	34	,	,	PUNCT
ajlm-1563	113	35	47.6	47.6	NUM
ajlm-1563	113	36	%	%	NOUN
ajlm-1563	113	37	)	)	PUNCT
ajlm-1563	113	38	.	.	PUNCT
ajlm-1563	114	1	the	the	DET
ajlm-1563	114	2	overall	overall	ADJ
ajlm-1563	114	3	most	most	ADV
ajlm-1563	114	4	common	common	ADJ
ajlm-1563	114	5	symptoms	symptom	NOUN
ajlm-1563	114	6	reported	report	VERB
ajlm-1563	114	7	among	among	ADP
ajlm-1563	114	8	the	the	DET
ajlm-1563	114	9	study	study	NOUN
ajlm-1563	114	10	participants	participant	NOUN
ajlm-1563	114	11	were	be	AUX
ajlm-1563	114	12	itching	itch	VERB
ajlm-1563	114	13	(	(	PUNCT
ajlm-1563	114	14	44/50	44/50	NUM
ajlm-1563	114	15	,	,	PUNCT
ajlm-1563	114	16	88.0	88.0	NUM
ajlm-1563	114	17	%	%	NOUN
ajlm-1563	114	18	)	)	PUNCT
ajlm-1563	114	19	and	and	CCONJ
ajlm-1563	114	20	pain	pain	NOUN
ajlm-1563	114	21	(	(	PUNCT
ajlm-1563	114	22	39/50	39/50	NUM
ajlm-1563	114	23	,	,	PUNCT
ajlm-1563	114	24	78.0	78.0	NUM
ajlm-1563	114	25	%	%	NOUN
ajlm-1563	114	26	)	)	PUNCT
ajlm-1563	114	27	.	.	PUNCT
ajlm-1563	115	1	there	there	PRON
ajlm-1563	115	2	was	be	VERB
ajlm-1563	115	3	no	no	DET
ajlm-1563	115	4	significant	significant	ADJ
ajlm-1563	115	5	association	association	NOUN
ajlm-1563	115	6	between	between	ADP
ajlm-1563	115	7	the	the	DET
ajlm-1563	115	8	diagnostic	diagnostic	ADJ
ajlm-1563	115	9	groups	group	NOUN
ajlm-1563	115	10	and	and	CCONJ
ajlm-1563	115	11	symptoms	symptom	NOUN
ajlm-1563	115	12	experienced	experience	VERB
ajlm-1563	115	13	.	.	PUNCT
ajlm-1563	116	1	location	location	NOUN
ajlm-1563	116	2	,	,	PUNCT
ajlm-1563	116	3	sizes	size	NOUN
ajlm-1563	116	4	and	and	CCONJ
ajlm-1563	116	5	types	type	NOUN
ajlm-1563	116	6	of	of	ADP
ajlm-1563	116	7	lesions	lesion	NOUN
ajlm-1563	116	8	overall	overall	ADV
ajlm-1563	116	9	,	,	PUNCT
ajlm-1563	116	10	most	most	ADJ
ajlm-1563	116	11	lesions	lesion	NOUN
ajlm-1563	116	12	involved	involve	VERB
ajlm-1563	116	13	the	the	DET
ajlm-1563	116	14	labia	labia	NOUN
ajlm-1563	116	15	majora	majora	NOUN
ajlm-1563	116	16	(	(	PUNCT
ajlm-1563	116	17	42/50	42/50	NUM
ajlm-1563	116	18	,	,	PUNCT
ajlm-1563	116	19	84.0	84.0	NUM
ajlm-1563	116	20	%	%	NOUN
ajlm-1563	116	21	)	)	PUNCT
ajlm-1563	116	22	,	,	PUNCT
ajlm-1563	116	23	followed	follow	VERB
ajlm-1563	116	24	by	by	ADP
ajlm-1563	116	25	the	the	DET
ajlm-1563	116	26	labia	labia	NOUN
ajlm-1563	116	27	minora	minora	NOUN
ajlm-1563	116	28	(	(	PUNCT
ajlm-1563	116	29	36/50	36/50	NUM
ajlm-1563	116	30	,	,	PUNCT
ajlm-1563	116	31	72.0	72.0	NUM
ajlm-1563	116	32	%	%	NOUN
ajlm-1563	116	33	)	)	PUNCT
ajlm-1563	116	34	and	and	CCONJ
ajlm-1563	116	35	clitoris	clitoris	PROPN
ajlm-1563	116	36	(	(	PUNCT
ajlm-1563	116	37	14/50	14/50	NUM
ajlm-1563	116	38	,	,	PUNCT
ajlm-1563	116	39	28.0	28.0	NUM
ajlm-1563	116	40	%	%	NOUN
ajlm-1563	116	41	)	)	PUNCT
ajlm-1563	116	42	.	.	PUNCT
ajlm-1563	117	1	the	the	DET
ajlm-1563	117	2	labia	labia	PROPN
ajlm-1563	117	3	majora	majora	NOUN
ajlm-1563	117	4	was	be	AUX
ajlm-1563	117	5	affected	affect	VERB
ajlm-1563	117	6	in	in	ADP
ajlm-1563	117	7	all	all	DET
ajlm-1563	117	8	women	woman	NOUN
ajlm-1563	117	9	with	with	ADP
ajlm-1563	117	10	nnl	nnl	PROPN
ajlm-1563	117	11	(	(	PUNCT
ajlm-1563	117	12	9/9	9/9	NUM
ajlm-1563	117	13	,	,	PUNCT
ajlm-1563	117	14	100	100	NUM
ajlm-1563	117	15	%	%	NOUN
ajlm-1563	117	16	)	)	PUNCT
ajlm-1563	117	17	,	,	PUNCT
ajlm-1563	117	18	90.0	90.0	NUM
ajlm-1563	117	19	%	%	NOUN
ajlm-1563	117	20	(	(	PUNCT
ajlm-1563	117	21	19/21	19/21	NUM
ajlm-1563	117	22	)	)	PUNCT
ajlm-1563	117	23	of	of	ADP
ajlm-1563	117	24	women	woman	NOUN
ajlm-1563	117	25	with	with	ADP
ajlm-1563	117	26	vscc	vscc	NOUN
ajlm-1563	117	27	,	,	PUNCT
ajlm-1563	117	28	and	and	CCONJ
ajlm-1563	117	29	70.0	70.0	NUM
ajlm-1563	117	30	%	%	NOUN
ajlm-1563	117	31	(	(	PUNCT
ajlm-1563	117	32	14/20	14/20	NUM
ajlm-1563	117	33	)	)	PUNCT
ajlm-1563	117	34	of	of	ADP
ajlm-1563	117	35	women	woman	NOUN
ajlm-1563	117	36	with	with	ADP
ajlm-1563	117	37	uvin	uvin	NOUN
ajlm-1563	117	38	.	.	PUNCT
ajlm-1563	118	1	the	the	DET
ajlm-1563	118	2	vagina	vagina	ADJ
ajlm-1563	118	3	,	,	PUNCT
ajlm-1563	118	4	perineum	perineum	NOUN
ajlm-1563	118	5	and	and	CCONJ
ajlm-1563	118	6	anus	anus	NOUN
ajlm-1563	118	7	were	be	AUX
ajlm-1563	118	8	also	also	ADV
ajlm-1563	118	9	involved	involve	VERB
ajlm-1563	118	10	in	in	ADP
ajlm-1563	118	11	participants	participant	NOUN
ajlm-1563	118	12	with	with	ADP
ajlm-1563	118	13	uvin	uvin	PROPN
ajlm-1563	118	14	and	and	CCONJ
ajlm-1563	118	15	vscc	vscc	ADJ
ajlm-1563	118	16	.	.	PUNCT
ajlm-1563	119	1	overall	overall	ADV
ajlm-1563	119	2	,	,	PUNCT
ajlm-1563	119	3	the	the	DET
ajlm-1563	119	4	majority	majority	NOUN
ajlm-1563	119	5	of	of	ADP
ajlm-1563	119	6	participants	participant	NOUN
ajlm-1563	119	7	(	(	PUNCT
ajlm-1563	119	8	41/50	41/50	NUM
ajlm-1563	119	9	,	,	PUNCT
ajlm-1563	119	10	82.0	82.0	NUM
ajlm-1563	119	11	%	%	NOUN
ajlm-1563	119	12	)	)	PUNCT
ajlm-1563	119	13	had	have	VERB
ajlm-1563	119	14	multifocal	multifocal	ADJ
ajlm-1563	119	15	rather	rather	ADV
ajlm-1563	119	16	than	than	ADP
ajlm-1563	119	17	unifocal	unifocal	ADJ
ajlm-1563	119	18	lesions	lesion	NOUN
ajlm-1563	119	19	.	.	PUNCT
ajlm-1563	120	1	all	all	DET
ajlm-1563	120	2	nnl	nnl	NOUN
ajlm-1563	120	3	were	be	AUX
ajlm-1563	120	4	multifocal	multifocal	ADJ
ajlm-1563	120	5	;	;	PUNCT
ajlm-1563	120	6	comparatively	comparatively	ADV
ajlm-1563	120	7	,	,	PUNCT
ajlm-1563	120	8	18	18	NUM
ajlm-1563	120	9	(	(	PUNCT
ajlm-1563	120	10	80.0	80.0	NUM
ajlm-1563	120	11	%	%	NOUN
ajlm-1563	120	12	)	)	PUNCT
ajlm-1563	120	13	women	woman	NOUN
ajlm-1563	120	14	with	with	ADP
ajlm-1563	120	15	uvin	uvin	NOUN
ajlm-1563	120	16	,	,	PUNCT
ajlm-1563	120	17	and	and	CCONJ
ajlm-1563	120	18	16	16	NUM
ajlm-1563	120	19	(	(	PUNCT
ajlm-1563	120	20	76.2	76.2	NUM
ajlm-1563	120	21	%	%	NOUN
ajlm-1563	120	22	)	)	PUNCT
ajlm-1563	120	23	women	woman	NOUN
ajlm-1563	120	24	with	with	ADP
ajlm-1563	120	25	vscc	vscc	NOUN
ajlm-1563	120	26	had	have	VERB
ajlm-1563	120	27	multifocal	multifocal	ADJ
ajlm-1563	120	28	lesions	lesion	NOUN
ajlm-1563	120	29	.	.	PUNCT
ajlm-1563	121	1	the	the	DET
ajlm-1563	121	2	majority	majority	NOUN
ajlm-1563	121	3	of	of	ADP
ajlm-1563	121	4	the	the	DET
ajlm-1563	121	5	participants	participant	NOUN
ajlm-1563	121	6	(	(	PUNCT
ajlm-1563	121	7	42/50	42/50	NUM
ajlm-1563	121	8	,	,	PUNCT
ajlm-1563	121	9	84	84	NUM
ajlm-1563	121	10	%	%	NOUN
ajlm-1563	121	11	)	)	PUNCT
ajlm-1563	121	12	had	have	VERB
ajlm-1563	121	13	vulvar	vulvar	NOUN
ajlm-1563	121	14	lesion	lesion	NOUN
ajlm-1563	121	15	sizes	size	NOUN
ajlm-1563	121	16	>	>	X
ajlm-1563	121	17	2	2	NUM
ajlm-1563	121	18	cm	cm	NOUN
ajlm-1563	121	19	.	.	PUNCT
ajlm-1563	122	1	nineteen	nineteen	NUM
ajlm-1563	122	2	(	(	PUNCT
ajlm-1563	122	3	19/21	19/21	NUM
ajlm-1563	122	4	;	;	PUNCT
ajlm-1563	122	5	90.5	90.5	NUM
ajlm-1563	122	6	%	%	NOUN
ajlm-1563	122	7	)	)	PUNCT
ajlm-1563	122	8	women	woman	NOUN
ajlm-1563	122	9	with	with	ADP
ajlm-1563	122	10	vscc	vscc	NOUN
ajlm-1563	122	11	had	have	VERB
ajlm-1563	122	12	lesions	lesion	NOUN
ajlm-1563	122	13	>	>	X
ajlm-1563	122	14	2	2	NUM
ajlm-1563	122	15	cm	cm	NOUN
ajlm-1563	122	16	compared	compare	VERB
ajlm-1563	122	17	to	to	ADP
ajlm-1563	122	18	eight	eight	NUM
ajlm-1563	122	19	(	(	PUNCT
ajlm-1563	122	20	88.9	88.9	NUM
ajlm-1563	122	21	%	%	NOUN
ajlm-1563	122	22	)	)	PUNCT
ajlm-1563	122	23	women	woman	NOUN
ajlm-1563	122	24	with	with	ADP
ajlm-1563	122	25	nnl	nnl	PROPN
ajlm-1563	122	26	,	,	PUNCT
ajlm-1563	122	27	and	and	CCONJ
ajlm-1563	122	28	15	15	NUM
ajlm-1563	122	29	(	(	PUNCT
ajlm-1563	122	30	75.0	75.0	NUM
ajlm-1563	122	31	%	%	NOUN
ajlm-1563	122	32	)	)	PUNCT
ajlm-1563	122	33	women	woman	NOUN
ajlm-1563	122	34	with	with	ADP
ajlm-1563	122	35	uvin	uvin	NOUN
ajlm-1563	122	36	.	.	PUNCT
ajlm-1563	123	1	the	the	DET
ajlm-1563	123	2	overall	overall	ADJ
ajlm-1563	123	3	most	most	ADV
ajlm-1563	123	4	common	common	ADJ
ajlm-1563	123	5	type	type	NOUN
ajlm-1563	123	6	of	of	ADP
ajlm-1563	123	7	vulvar	vulvar	NOUN
ajlm-1563	123	8	lesion	lesion	NOUN
ajlm-1563	123	9	was	be	AUX
ajlm-1563	123	10	the	the	DET
ajlm-1563	123	11	warty	warty	NOUN
ajlm-1563	123	12	type	type	NOUN
ajlm-1563	123	13	(	(	PUNCT
ajlm-1563	123	14	17/50	17/50	NUM
ajlm-1563	123	15	,	,	PUNCT
ajlm-1563	123	16	34.0	34.0	NUM
ajlm-1563	123	17	%	%	NOUN
ajlm-1563	123	18	)	)	PUNCT
ajlm-1563	123	19	,	,	PUNCT
ajlm-1563	123	20	followed	follow	VERB
ajlm-1563	123	21	by	by	ADP
ajlm-1563	123	22	the	the	DET
ajlm-1563	123	23	fungating	fungating	NOUN
ajlm-1563	123	24	(	(	PUNCT
ajlm-1563	123	25	12/50	12/50	NUM
ajlm-1563	123	26	,	,	PUNCT
ajlm-1563	123	27	24.0	24.0	NUM
ajlm-1563	123	28	%	%	NOUN
ajlm-1563	123	29	)	)	PUNCT
ajlm-1563	123	30	,	,	PUNCT
ajlm-1563	123	31	smooth	smooth	ADJ
ajlm-1563	123	32	exophytic	exophytic	ADJ
ajlm-1563	123	33	(	(	PUNCT
ajlm-1563	123	34	10/50	10/50	NUM
ajlm-1563	123	35	,	,	PUNCT
ajlm-1563	123	36	20.0	20.0	NUM
ajlm-1563	123	37	%	%	NOUN
ajlm-1563	123	38	)	)	PUNCT
ajlm-1563	123	39	,	,	PUNCT
ajlm-1563	123	40	ulcerated	ulcerated	ADJ
ajlm-1563	123	41	(	(	PUNCT
ajlm-1563	123	42	8/50	8/50	NUM
ajlm-1563	123	43	,	,	PUNCT
ajlm-1563	123	44	16.0	16.0	NUM
ajlm-1563	123	45	%	%	NOUN
ajlm-1563	123	46	)	)	PUNCT
ajlm-1563	123	47	and	and	CCONJ
ajlm-1563	123	48	flat	flat	ADJ
ajlm-1563	123	49	(	(	PUNCT
ajlm-1563	123	50	3/50	3/50	NUM
ajlm-1563	123	51	,	,	PUNCT
ajlm-1563	123	52	6.0	6.0	NUM
ajlm-1563	123	53	%	%	NOUN
ajlm-1563	123	54	)	)	PUNCT
ajlm-1563	123	55	types	type	NOUN
ajlm-1563	123	56	.	.	PUNCT
ajlm-1563	124	1	among	among	ADP
ajlm-1563	124	2	women	woman	NOUN
ajlm-1563	124	3	with	with	ADP
ajlm-1563	124	4	uvin	uvin	NOUN
ajlm-1563	124	5	,	,	PUNCT
ajlm-1563	124	6	11/20	11/20	NUM
ajlm-1563	124	7	(	(	PUNCT
ajlm-1563	124	8	55.0	55.0	NUM
ajlm-1563	124	9	%	%	NOUN
ajlm-1563	124	10	)	)	PUNCT
ajlm-1563	124	11	lesions	lesion	NOUN
ajlm-1563	124	12	were	be	AUX
ajlm-1563	124	13	warty	warty	NOUN
ajlm-1563	124	14	,	,	PUNCT
ajlm-1563	124	15	and	and	CCONJ
ajlm-1563	124	16	3/20	3/20	NUM
ajlm-1563	124	17	(	(	PUNCT
ajlm-1563	124	18	15.0	15.0	NUM
ajlm-1563	124	19	%	%	NOUN
ajlm-1563	124	20	)	)	PUNCT
ajlm-1563	124	21	were	be	AUX
ajlm-1563	124	22	flat	flat	ADJ
ajlm-1563	124	23	;	;	PUNCT
ajlm-1563	124	24	smooth	smooth	ADJ
ajlm-1563	124	25	exophytic	exophytic	ADJ
ajlm-1563	124	26	,	,	PUNCT
ajlm-1563	124	27	fungating	fungating	NOUN
ajlm-1563	124	28	,	,	PUNCT
ajlm-1563	124	29	and	and	CCONJ
ajlm-1563	124	30	ulcerated	ulcerated	ADJ
ajlm-1563	124	31	lesions	lesion	NOUN
ajlm-1563	124	32	each	each	PRON
ajlm-1563	124	33	accounted	account	VERB
ajlm-1563	124	34	for	for	ADP
ajlm-1563	124	35	2/20	2/20	NUM
ajlm-1563	124	36	(	(	PUNCT
ajlm-1563	124	37	10.0	10.0	NUM
ajlm-1563	124	38	%	%	NOUN
ajlm-1563	124	39	)	)	PUNCT
ajlm-1563	124	40	of	of	ADP
ajlm-1563	124	41	the	the	DET
ajlm-1563	124	42	cases	case	NOUN
ajlm-1563	124	43	.	.	PUNCT
ajlm-1563	125	1	on	on	ADP
ajlm-1563	125	2	the	the	DET
ajlm-1563	125	3	other	other	ADJ
ajlm-1563	125	4	hand	hand	NOUN
ajlm-1563	125	5	,	,	PUNCT
ajlm-1563	125	6	the	the	DET
ajlm-1563	125	7	most	most	ADV
ajlm-1563	125	8	common	common	ADJ
ajlm-1563	125	9	type	type	NOUN
ajlm-1563	125	10	of	of	ADP
ajlm-1563	125	11	vulvar	vulvar	NOUN
ajlm-1563	125	12	lesion	lesion	NOUN
ajlm-1563	125	13	among	among	ADP
ajlm-1563	125	14	participants	participant	NOUN
ajlm-1563	125	15	with	with	ADP
ajlm-1563	125	16	vscc	vscc	NOUN
ajlm-1563	125	17	was	be	AUX
ajlm-1563	125	18	the	the	DET
ajlm-1563	125	19	fungating	fungating	NOUN
ajlm-1563	125	20	type	type	NOUN
ajlm-1563	125	21	(	(	PUNCT
ajlm-1563	125	22	9/21	9/21	NUM
ajlm-1563	125	23	,	,	PUNCT
ajlm-1563	125	24	42.9	42.9	NUM
ajlm-1563	125	25	%	%	NOUN
ajlm-1563	125	26	)	)	PUNCT
ajlm-1563	125	27	,	,	PUNCT
ajlm-1563	125	28	followed	follow	VERB
ajlm-1563	125	29	by	by	ADP
ajlm-1563	125	30	the	the	DET
ajlm-1563	125	31	smooth	smooth	ADJ
ajlm-1563	125	32	exophytic	exophytic	ADJ
ajlm-1563	125	33	lesion	lesion	NOUN
ajlm-1563	125	34	(	(	PUNCT
ajlm-1563	125	35	6/21	6/21	NUM
ajlm-1563	125	36	,	,	PUNCT
ajlm-1563	125	37	28.6	28.6	NUM
ajlm-1563	125	38	%	%	NOUN
ajlm-1563	125	39	)	)	PUNCT
ajlm-1563	125	40	;	;	PUNCT
ajlm-1563	125	41	warty	warty	NOUN
ajlm-1563	125	42	and	and	CCONJ
ajlm-1563	125	43	ulcerated	ulcerated	ADJ
ajlm-1563	125	44	lesions	lesion	NOUN
ajlm-1563	125	45	each	each	PRON
ajlm-1563	125	46	accounted	account	VERB
ajlm-1563	125	47	for	for	ADP
ajlm-1563	125	48	14.3	14.3	NUM
ajlm-1563	125	49	%	%	NOUN
ajlm-1563	125	50	(	(	PUNCT
ajlm-1563	125	51	3/21	3/21	NUM
ajlm-1563	125	52	)	)	PUNCT
ajlm-1563	125	53	.	.	PUNCT
ajlm-1563	126	1	prevalence	prevalence	NOUN
ajlm-1563	126	2	of	of	ADP
ajlm-1563	126	3	hrhpv	hrhpv	ADJ
ajlm-1563	126	4	infection	infection	NOUN
ajlm-1563	126	5	among	among	ADP
ajlm-1563	126	6	participants	participant	NOUN
ajlm-1563	126	7	with	with	ADP
ajlm-1563	126	8	neoplastic	neoplastic	ADJ
ajlm-1563	126	9	lesions	lesion	NOUN
ajlm-1563	126	10	among	among	ADP
ajlm-1563	126	11	the	the	DET
ajlm-1563	126	12	samples	sample	NOUN
ajlm-1563	126	13	collected	collect	VERB
ajlm-1563	126	14	for	for	ADP
ajlm-1563	126	15	hrhpv	hrhpv	ADJ
ajlm-1563	126	16	dna	dna	PROPN
ajlm-1563	126	17	analysis	analysis	NOUN
ajlm-1563	126	18	,	,	PUNCT
ajlm-1563	126	19	we	we	PRON
ajlm-1563	126	20	were	be	AUX
ajlm-1563	126	21	able	able	ADJ
ajlm-1563	126	22	to	to	PART
ajlm-1563	126	23	extract	extract	VERB
ajlm-1563	126	24	sufficient	sufficient	ADJ
ajlm-1563	126	25	dna	dna	NOUN
ajlm-1563	126	26	from	from	ADP
ajlm-1563	126	27	38	38	NUM
ajlm-1563	126	28	tissue	tissue	NOUN
ajlm-1563	126	29	samples	sample	NOUN
ajlm-1563	126	30	;	;	PUNCT
ajlm-1563	126	31	these	these	PRON
ajlm-1563	126	32	included	include	VERB
ajlm-1563	126	33	samples	sample	NOUN
ajlm-1563	126	34	from	from	ADP
ajlm-1563	126	35	17	17	NUM
ajlm-1563	126	36	patients	patient	NOUN
ajlm-1563	126	37	with	with	ADP
ajlm-1563	126	38	uvin	uvin	NOUN
ajlm-1563	126	39	,	,	PUNCT
ajlm-1563	126	40	18	18	NUM
ajlm-1563	126	41	with	with	ADP
ajlm-1563	126	42	vscc	vscc	NOUN
ajlm-1563	126	43	and	and	CCONJ
ajlm-1563	126	44	three	three	NUM
ajlm-1563	126	45	with	with	ADP
ajlm-1563	126	46	condylomata	condylomata	ADJ
ajlm-1563	126	47	acuminatum	acuminatum	NOUN
ajlm-1563	126	48	.	.	PUNCT
ajlm-1563	127	1	the	the	DET
ajlm-1563	127	2	prevalence	prevalence	NOUN
ajlm-1563	127	3	of	of	ADP
ajlm-1563	127	4	any	any	DET
ajlm-1563	127	5	type	type	NOUN
ajlm-1563	127	6	of	of	ADP
ajlm-1563	127	7	hrhpv	hrhpv	NOUN
ajlm-1563	127	8	among	among	ADP
ajlm-1563	127	9	all	all	DET
ajlm-1563	127	10	participants	participant	NOUN
ajlm-1563	127	11	was	be	AUX
ajlm-1563	127	12	81.6	81.6	NUM
ajlm-1563	127	13	%	%	NOUN
ajlm-1563	127	14	(	(	PUNCT
ajlm-1563	127	15	31/38	31/38	NUM
ajlm-1563	127	16	)	)	PUNCT
ajlm-1563	127	17	;	;	PUNCT
ajlm-1563	127	18	82.4	82.4	NUM
ajlm-1563	127	19	%	%	NOUN
ajlm-1563	127	20	(	(	PUNCT
ajlm-1563	127	21	14/17	14/17	NUM
ajlm-1563	127	22	)	)	PUNCT
ajlm-1563	127	23	among	among	ADP
ajlm-1563	127	24	women	woman	NOUN
ajlm-1563	127	25	with	with	ADP
ajlm-1563	127	26	uvin	uvin	PROPN
ajlm-1563	127	27	(	(	PUNCT
ajlm-1563	127	28	1/4	1/4	NUM
ajlm-1563	127	29	,	,	PUNCT
ajlm-1563	127	30	25	25	NUM
ajlm-1563	127	31	%	%	NOUN
ajlm-1563	127	32	in	in	ADP
ajlm-1563	127	33	lsil	lsil	NOUN
ajlm-1563	127	34	,	,	PUNCT
ajlm-1563	127	35	and	and	CCONJ
ajlm-1563	127	36	13/13	13/13	NUM
ajlm-1563	127	37	,	,	PUNCT
ajlm-1563	127	38	100	100	NUM
ajlm-1563	127	39	%	%	NOUN
ajlm-1563	127	40	in	in	ADP
ajlm-1563	127	41	hsil	hsil	NOUN
ajlm-1563	127	42	)	)	PUNCT
ajlm-1563	127	43	and	and	CCONJ
ajlm-1563	127	44	88.9	88.9	NUM
ajlm-1563	127	45	%	%	NOUN
ajlm-1563	127	46	(	(	PUNCT
ajlm-1563	127	47	16/18	16/18	NUM
ajlm-1563	127	48	)	)	PUNCT
ajlm-1563	127	49	among	among	ADP
ajlm-1563	127	50	women	woman	NOUN
ajlm-1563	127	51	with	with	ADP
ajlm-1563	127	52	vscc	vscc	NOUN
ajlm-1563	127	53	(	(	PUNCT
ajlm-1563	127	54	table	table	NOUN
ajlm-1563	127	55	2	2	NUM
ajlm-1563	127	56	)	)	PUNCT
ajlm-1563	127	57	.	.	PUNCT
ajlm-1563	128	1	the	the	DET
ajlm-1563	128	2	most	most	ADV
ajlm-1563	128	3	prevalent	prevalent	ADJ
ajlm-1563	128	4	genotype	genotype	NOUN
ajlm-1563	128	5	of	of	ADP
ajlm-1563	128	6	hrhpv	hrhpv	NOUN
ajlm-1563	128	7	among	among	ADP
ajlm-1563	128	8	all	all	DET
ajlm-1563	128	9	participants	participant	NOUN
ajlm-1563	128	10	was	be	AUX
ajlm-1563	128	11	hpv16	hpv16	NOUN
ajlm-1563	128	12	(	(	PUNCT
ajlm-1563	128	13	20/38	20/38	NUM
ajlm-1563	128	14	,	,	PUNCT
ajlm-1563	128	15	52.6	52.6	NUM
ajlm-1563	128	16	%	%	NOUN
ajlm-1563	128	17	)	)	PUNCT
ajlm-1563	128	18	,	,	PUNCT
ajlm-1563	128	19	followed	follow	VERB
ajlm-1563	128	20	by	by	ADP
ajlm-1563	128	21	p3	p3	PROPN
ajlm-1563	128	22	(	(	PUNCT
ajlm-1563	128	23	13/38	13/38	NUM
ajlm-1563	128	24	,	,	PUNCT
ajlm-1563	128	25	34.2	34.2	NUM
ajlm-1563	128	26	%	%	NOUN
ajlm-1563	128	27	)	)	PUNCT
ajlm-1563	128	28	(	(	PUNCT
ajlm-1563	128	29	table	table	NOUN
ajlm-1563	128	30	3	3	NUM
ajlm-1563	128	31	)	)	PUNCT
ajlm-1563	128	32	.	.	PUNCT
ajlm-1563	129	1	only	only	ADV
ajlm-1563	129	2	hpv16	hpv16	NOUN
ajlm-1563	129	3	,	,	PUNCT
ajlm-1563	129	4	p3	p3	NOUN
ajlm-1563	129	5	and	and	CCONJ
ajlm-1563	129	6	p5	p5	ADJ
ajlm-1563	129	7	genotypes	genotype	NOUN
ajlm-1563	129	8	were	be	AUX
ajlm-1563	129	9	present	present	ADJ
ajlm-1563	129	10	in	in	ADP
ajlm-1563	129	11	hsil	hsil	NOUN
ajlm-1563	129	12	;	;	PUNCT
ajlm-1563	129	13	only	only	ADV
ajlm-1563	129	14	hpv16	hpv16	NOUN
ajlm-1563	129	15	was	be	AUX
ajlm-1563	129	16	detected	detect	VERB
ajlm-1563	129	17	in	in	ADP
ajlm-1563	129	18	lsil	lsil	NOUN
ajlm-1563	129	19	cases	case	NOUN
ajlm-1563	129	20	.	.	PUNCT
ajlm-1563	130	1	the	the	DET
ajlm-1563	130	2	hpv	hpv	NOUN
ajlm-1563	130	3	genotypes	genotype	NOUN
ajlm-1563	130	4	that	that	PRON
ajlm-1563	130	5	were	be	AUX
ajlm-1563	130	6	detected	detect	VERB
ajlm-1563	130	7	in	in	ADP
ajlm-1563	130	8	vscc	vscc	ADJ
ajlm-1563	130	9	cases	case	NOUN
ajlm-1563	130	10	were	be	AUX
ajlm-1563	130	11	hpv16	hpv16	NOUN
ajlm-1563	130	12	,	,	PUNCT
ajlm-1563	130	13	hpv18_45	hpv18_45	NUM
ajlm-1563	130	14	,	,	PUNCT
ajlm-1563	130	15	p3	p3	NOUN
ajlm-1563	130	16	and	and	CCONJ
ajlm-1563	130	17	p5	p5	ADJ
ajlm-1563	130	18	.	.	PUNCT
ajlm-1563	131	1	hpv16	hpv16	NOUN
ajlm-1563	131	2	occurred	occur	VERB
ajlm-1563	131	3	as	as	ADP
ajlm-1563	131	4	a	a	DET
ajlm-1563	131	5	co	co	NOUN
ajlm-1563	131	6	-	-	NOUN
ajlm-1563	131	7	infection	infection	NOUN
ajlm-1563	131	8	with	with	ADP
ajlm-1563	131	9	other	other	ADJ
ajlm-1563	131	10	hpvs	hpvs	NOUN
ajlm-1563	131	11	(	(	PUNCT
ajlm-1563	131	12	p3	p3	NOUN
ajlm-1563	131	13	and	and	CCONJ
ajlm-1563	131	14	p5	p5	ADJ
ajlm-1563	131	15	)	)	PUNCT
ajlm-1563	131	16	in	in	ADP
ajlm-1563	131	17	both	both	PRON
ajlm-1563	131	18	uvin	uvin	ADJ
ajlm-1563	131	19	(	(	PUNCT
ajlm-1563	131	20	hsil	hsil	NOUN
ajlm-1563	131	21	)	)	PUNCT
ajlm-1563	131	22	and	and	CCONJ
ajlm-1563	131	23	vscc	vscc	ADJ
ajlm-1563	131	24	.	.	PUNCT
ajlm-1563	132	1	table	table	NOUN
ajlm-1563	132	2	2	2	NUM
ajlm-1563	132	3	:	:	PUNCT
ajlm-1563	132	4	 	 	SPACE
ajlm-1563	132	5	prevalence	prevalence	NOUN
ajlm-1563	132	6	of	of	ADP
ajlm-1563	132	7	high	high	ADJ
ajlm-1563	132	8	-	-	PUNCT
ajlm-1563	132	9	risk	risk	NOUN
ajlm-1563	132	10	human	human	ADJ
ajlm-1563	132	11	papillomavirus	papillomavirus	NOUN
ajlm-1563	132	12	among	among	ADP
ajlm-1563	132	13	women	woman	NOUN
ajlm-1563	132	14	with	with	ADP
ajlm-1563	132	15	condyloma	condyloma	PROPN
ajlm-1563	132	16	acuminatum	acuminatum	NOUN
ajlm-1563	132	17	,	,	PUNCT
ajlm-1563	132	18	uvin	uvin	PROPN
ajlm-1563	132	19	(	(	PUNCT
ajlm-1563	132	20	lsil	lsil	PROPN
ajlm-1563	132	21	,	,	PUNCT
ajlm-1563	132	22	hsil	hsil	NOUN
ajlm-1563	132	23	)	)	PUNCT
ajlm-1563	132	24	and	and	CCONJ
ajlm-1563	132	25	vscc	vscc	NOUN
ajlm-1563	132	26	at	at	ADP
ajlm-1563	132	27	the	the	DET
ajlm-1563	132	28	university	university	NOUN
ajlm-1563	132	29	teaching	teaching	NOUN
ajlm-1563	132	30	hospital	hospital	NOUN
ajlm-1563	132	31	’s	’s	PART
ajlm-1563	132	32	gynaecologic	gynaecologic	PROPN
ajlm-1563	132	33	clinic	clinic	PROPN
ajlm-1563	132	34	,	,	PUNCT
ajlm-1563	132	35	zambia	zambia	PROPN
ajlm-1563	132	36	,	,	PUNCT
ajlm-1563	132	37	2018	2018	NUM
ajlm-1563	132	38	.	.	PUNCT
ajlm-1563	133	1	table	table	NOUN
ajlm-1563	133	2	3	3	NUM
ajlm-1563	133	3	:	:	PUNCT
ajlm-1563	133	4	 	 	SPACE
ajlm-1563	133	5	frequency	frequency	NOUN
ajlm-1563	133	6	of	of	ADP
ajlm-1563	133	7	high	high	ADJ
ajlm-1563	133	8	-	-	PUNCT
ajlm-1563	133	9	risk	risk	NOUN
ajlm-1563	133	10	human	human	ADJ
ajlm-1563	133	11	papillomavirus	papillomavirus	NOUN
ajlm-1563	133	12	genotypes	genotype	NOUN
ajlm-1563	133	13	among	among	ADP
ajlm-1563	133	14	women	woman	NOUN
ajlm-1563	133	15	with	with	ADP
ajlm-1563	133	16	condylomata	condylomata	ADJ
ajlm-1563	133	17	acuminatum	acuminatum	NOUN
ajlm-1563	133	18	,	,	PUNCT
ajlm-1563	133	19	uvin	uvin	NOUN
ajlm-1563	133	20	and	and	CCONJ
ajlm-1563	133	21	vscc	vscc	NOUN
ajlm-1563	133	22	at	at	ADP
ajlm-1563	133	23	the	the	DET
ajlm-1563	133	24	university	university	NOUN
ajlm-1563	133	25	teaching	teaching	NOUN
ajlm-1563	133	26	hospital	hospital	NOUN
ajlm-1563	133	27	’s	’s	PART
ajlm-1563	133	28	gynaecologic	gynaecologic	PROPN
ajlm-1563	133	29	clinic	clinic	PROPN
ajlm-1563	133	30	,	,	PUNCT
ajlm-1563	133	31	zambia	zambia	PROPN
ajlm-1563	133	32	,	,	PUNCT
ajlm-1563	133	33	2018	2018	NUM
ajlm-1563	133	34	.	.	PUNCT
ajlm-1563	134	1	discussion	discussion	NOUN
ajlm-1563	134	2	to	to	ADP
ajlm-1563	134	3	the	the	DET
ajlm-1563	134	4	best	good	ADJ
ajlm-1563	134	5	of	of	ADP
ajlm-1563	134	6	our	our	PRON
ajlm-1563	134	7	knowledge	knowledge	NOUN
ajlm-1563	134	8	,	,	PUNCT
ajlm-1563	134	9	this	this	PRON
ajlm-1563	134	10	is	be	AUX
ajlm-1563	134	11	the	the	DET
ajlm-1563	134	12	first	first	ADJ
ajlm-1563	134	13	study	study	NOUN
ajlm-1563	134	14	to	to	PART
ajlm-1563	134	15	describe	describe	VERB
ajlm-1563	134	16	vulvar	vulvar	NOUN
ajlm-1563	134	17	lesions	lesion	NOUN
ajlm-1563	134	18	and	and	CCONJ
ajlm-1563	134	19	to	to	PART
ajlm-1563	134	20	compare	compare	VERB
ajlm-1563	134	21	vulvar	vulvar	NOUN
ajlm-1563	134	22	neoplasia	neoplasia	NOUN
ajlm-1563	134	23	with	with	ADP
ajlm-1563	134	24	nnl	nnl	NOUN
ajlm-1563	134	25	among	among	ADP
ajlm-1563	134	26	any	any	DET
ajlm-1563	134	27	cohort	cohort	NOUN
ajlm-1563	134	28	of	of	ADP
ajlm-1563	134	29	women	woman	NOUN
ajlm-1563	134	30	living	live	VERB
ajlm-1563	134	31	with	with	ADP
ajlm-1563	134	32	hiv	hiv	PROPN
ajlm-1563	134	33	at	at	ADP
ajlm-1563	134	34	any	any	DET
ajlm-1563	134	35	hospital	hospital	NOUN
ajlm-1563	134	36	in	in	ADP
ajlm-1563	134	37	zambia	zambia	PROPN
ajlm-1563	134	38	.	.	PUNCT
ajlm-1563	135	1	most	most	ADJ
ajlm-1563	135	2	of	of	ADP
ajlm-1563	135	3	the	the	DET
ajlm-1563	135	4	studies	study	NOUN
ajlm-1563	135	5	in	in	ADP
ajlm-1563	135	6	other	other	ADJ
ajlm-1563	135	7	african	african	ADJ
ajlm-1563	135	8	countries	country	NOUN
ajlm-1563	135	9	largely	largely	ADV
ajlm-1563	135	10	focused	focus	VERB
ajlm-1563	135	11	on	on	ADP
ajlm-1563	135	12	vulvar	vulvar	NOUN
ajlm-1563	135	13	cancer	cancer	NOUN
ajlm-1563	135	14	or	or	CCONJ
ajlm-1563	135	15	hpv.22,25	hpv.22,25	NOUN
ajlm-1563	135	16	among	among	ADP
ajlm-1563	135	17	the	the	DET
ajlm-1563	135	18	cohort	cohort	NOUN
ajlm-1563	135	19	of	of	ADP
ajlm-1563	135	20	women	woman	NOUN
ajlm-1563	135	21	living	live	VERB
ajlm-1563	135	22	with	with	ADP
ajlm-1563	135	23	hiv	hiv	PROPN
ajlm-1563	135	24	in	in	ADP
ajlm-1563	135	25	our	our	PRON
ajlm-1563	135	26	study	study	NOUN
ajlm-1563	135	27	,	,	PUNCT
ajlm-1563	135	28	both	both	CCONJ
ajlm-1563	135	29	neoplastic	neoplastic	ADJ
ajlm-1563	135	30	(	(	PUNCT
ajlm-1563	135	31	condylomata	condylomata	ADJ
ajlm-1563	135	32	acuminatum	acuminatum	NOUN
ajlm-1563	135	33	,	,	PUNCT
ajlm-1563	135	34	uvin	uvin	NOUN
ajlm-1563	135	35	,	,	PUNCT
ajlm-1563	135	36	and	and	CCONJ
ajlm-1563	135	37	vscc	vscc	NOUN
ajlm-1563	135	38	)	)	PUNCT
ajlm-1563	135	39	and	and	CCONJ
ajlm-1563	135	40	nnl	nnl	NOUN
ajlm-1563	135	41	were	be	AUX
ajlm-1563	135	42	detected	detect	VERB
ajlm-1563	135	43	.	.	PUNCT
ajlm-1563	136	1	this	this	DET
ajlm-1563	136	2	study	study	NOUN
ajlm-1563	136	3	showed	show	VERB
ajlm-1563	136	4	that	that	SCONJ
ajlm-1563	136	5	vscc	vscc	NOUN
ajlm-1563	136	6	can	can	AUX
ajlm-1563	136	7	not	not	PART
ajlm-1563	136	8	be	be	AUX
ajlm-1563	136	9	distinguished	distinguish	VERB
ajlm-1563	136	10	from	from	ADP
ajlm-1563	136	11	nnl	nnl	NOUN
ajlm-1563	136	12	on	on	ADP
ajlm-1563	136	13	account	account	NOUN
ajlm-1563	136	14	of	of	ADP
ajlm-1563	136	15	clinical	clinical	ADJ
ajlm-1563	136	16	features	feature	NOUN
ajlm-1563	136	17	,	,	PUNCT
ajlm-1563	136	18	although	although	SCONJ
ajlm-1563	136	19	vscc	vscc	PROPN
ajlm-1563	136	20	was	be	AUX
ajlm-1563	136	21	associated	associate	VERB
ajlm-1563	136	22	with	with	ADP
ajlm-1563	136	23	women	woman	NOUN
ajlm-1563	136	24	aged	age	VERB
ajlm-1563	136	25	≥	≥	NUM
ajlm-1563	136	26	40	40	NUM
ajlm-1563	136	27	years	year	NOUN
ajlm-1563	136	28	.	.	PUNCT
ajlm-1563	137	1	the	the	DET
ajlm-1563	137	2	prevalence	prevalence	NOUN
ajlm-1563	137	3	of	of	ADP
ajlm-1563	137	4	hrhpv	hrhpv	NOUN
ajlm-1563	137	5	in	in	ADP
ajlm-1563	137	6	both	both	CCONJ
ajlm-1563	137	7	vscc	vscc	NOUN
ajlm-1563	137	8	and	and	CCONJ
ajlm-1563	137	9	uvin	uvin	PROPN
ajlm-1563	137	10	(	(	PUNCT
ajlm-1563	137	11	accounted	account	VERB
ajlm-1563	137	12	for	for	ADP
ajlm-1563	137	13	by	by	ADP
ajlm-1563	137	14	hsil	hsil	NOUN
ajlm-1563	137	15	)	)	PUNCT
ajlm-1563	137	16	was	be	AUX
ajlm-1563	137	17	high	high	ADJ
ajlm-1563	137	18	.	.	PUNCT
ajlm-1563	138	1	vscc	vscc	PROPN
ajlm-1563	138	2	was	be	AUX
ajlm-1563	138	3	significantly	significantly	ADV
ajlm-1563	138	4	more	more	ADV
ajlm-1563	138	5	common	common	ADJ
ajlm-1563	138	6	among	among	ADP
ajlm-1563	138	7	women	woman	NOUN
ajlm-1563	138	8	aged	age	VERB
ajlm-1563	138	9	≥	≥	NUM
ajlm-1563	138	10	40	40	NUM
ajlm-1563	138	11	years	year	NOUN
ajlm-1563	138	12	compared	compare	VERB
ajlm-1563	138	13	to	to	ADP
ajlm-1563	138	14	nnl	nnl	PROPN
ajlm-1563	138	15	.	.	PROPN
ajlm-1563	138	16	similarly	similarly	ADV
ajlm-1563	138	17	,	,	PUNCT
ajlm-1563	138	18	a	a	DET
ajlm-1563	138	19	study	study	NOUN
ajlm-1563	138	20	in	in	ADP
ajlm-1563	138	21	tunisia	tunisia	PROPN
ajlm-1563	138	22	found	find	VERB
ajlm-1563	138	23	that	that	SCONJ
ajlm-1563	138	24	vulvar	vulvar	NOUN
ajlm-1563	138	25	cancer	cancer	NOUN
ajlm-1563	138	26	was	be	AUX
ajlm-1563	138	27	more	more	ADV
ajlm-1563	138	28	common	common	ADJ
ajlm-1563	138	29	in	in	ADP
ajlm-1563	138	30	older	old	ADJ
ajlm-1563	138	31	women	woman	NOUN
ajlm-1563	138	32	(	(	PUNCT
ajlm-1563	138	33	86.9	86.9	NUM
ajlm-1563	138	34	%	%	NOUN
ajlm-1563	138	35	of	of	ADP
ajlm-1563	138	36	patients	patient	NOUN
ajlm-1563	138	37	were	be	AUX
ajlm-1563	138	38	more	more	ADJ
ajlm-1563	138	39	than	than	ADP
ajlm-1563	138	40	55	55	NUM
ajlm-1563	138	41	years	year	NOUN
ajlm-1563	138	42	old	old	ADJ
ajlm-1563	138	43	)	)	PUNCT
ajlm-1563	138	44	although	although	SCONJ
ajlm-1563	138	45	none	none	NOUN
ajlm-1563	138	46	of	of	ADP
ajlm-1563	138	47	the	the	DET
ajlm-1563	138	48	patients	patient	NOUN
ajlm-1563	138	49	was	be	AUX
ajlm-1563	138	50	hiv	hiv	NOUN
ajlm-1563	138	51	-	-	PUNCT
ajlm-1563	138	52	positive.26	positive.26	ADJ
ajlm-1563	138	53	clinicians	clinician	NOUN
ajlm-1563	138	54	should	should	AUX
ajlm-1563	138	55	therefore	therefore	ADV
ajlm-1563	138	56	evaluate	evaluate	VERB
ajlm-1563	138	57	and	and	CCONJ
ajlm-1563	138	58	biopsy	biopsy	VERB
ajlm-1563	138	59	the	the	DET
ajlm-1563	138	60	vulva	vulva	NOUN
ajlm-1563	138	61	in	in	ADP
ajlm-1563	138	62	women	woman	NOUN
ajlm-1563	138	63	who	who	PRON
ajlm-1563	138	64	present	present	VERB
ajlm-1563	138	65	with	with	ADP
ajlm-1563	138	66	vulvar	vulvar	NOUN
ajlm-1563	138	67	symptoms	symptom	NOUN
ajlm-1563	138	68	,	,	PUNCT
ajlm-1563	138	69	especially	especially	ADV
ajlm-1563	138	70	those	those	PRON
ajlm-1563	138	71	who	who	PRON
ajlm-1563	138	72	are	be	AUX
ajlm-1563	138	73	older	old	ADJ
ajlm-1563	138	74	than	than	ADP
ajlm-1563	138	75	40	40	NUM
ajlm-1563	138	76	years	year	NOUN
ajlm-1563	138	77	.	.	PUNCT
ajlm-1563	139	1	the	the	DET
ajlm-1563	139	2	ages	age	NOUN
ajlm-1563	139	3	of	of	ADP
ajlm-1563	139	4	women	woman	NOUN
ajlm-1563	139	5	affected	affect	VERB
ajlm-1563	139	6	with	with	ADP
ajlm-1563	139	7	uvin	uvin	NOUN
ajlm-1563	139	8	in	in	ADP
ajlm-1563	139	9	our	our	PRON
ajlm-1563	139	10	study	study	NOUN
ajlm-1563	139	11	were	be	AUX
ajlm-1563	139	12	similar	similar	ADJ
ajlm-1563	139	13	to	to	ADP
ajlm-1563	139	14	the	the	DET
ajlm-1563	139	15	ages	age	NOUN
ajlm-1563	139	16	reported	report	VERB
ajlm-1563	139	17	in	in	ADP
ajlm-1563	139	18	other	other	ADJ
ajlm-1563	139	19	studies	study	NOUN
ajlm-1563	139	20	for	for	ADP
ajlm-1563	139	21	hsil.27	hsil.27	ADJ
ajlm-1563	139	22	this	this	DET
ajlm-1563	139	23	study	study	NOUN
ajlm-1563	139	24	demonstrated	demonstrate	VERB
ajlm-1563	139	25	that	that	SCONJ
ajlm-1563	139	26	there	there	PRON
ajlm-1563	139	27	was	be	VERB
ajlm-1563	139	28	no	no	DET
ajlm-1563	139	29	difference	difference	NOUN
ajlm-1563	139	30	in	in	ADP
ajlm-1563	139	31	age	age	NOUN
ajlm-1563	139	32	between	between	ADP
ajlm-1563	139	33	women	woman	NOUN
ajlm-1563	139	34	with	with	ADP
ajlm-1563	139	35	uvin	uvin	PROPN
ajlm-1563	139	36	and	and	CCONJ
ajlm-1563	139	37	those	those	PRON
ajlm-1563	139	38	with	with	ADP
ajlm-1563	139	39	nnl	nnl	PROPN
ajlm-1563	139	40	.	.	PUNCT
ajlm-1563	140	1	our	our	PRON
ajlm-1563	140	2	study	study	NOUN
ajlm-1563	140	3	supports	support	VERB
ajlm-1563	140	4	the	the	DET
ajlm-1563	140	5	view	view	NOUN
ajlm-1563	140	6	that	that	SCONJ
ajlm-1563	140	7	vulvar	vulvar	NOUN
ajlm-1563	140	8	cancer	cancer	NOUN
ajlm-1563	140	9	can	can	AUX
ajlm-1563	140	10	not	not	PART
ajlm-1563	140	11	be	be	AUX
ajlm-1563	140	12	differentiated	differentiate	VERB
ajlm-1563	140	13	from	from	ADP
ajlm-1563	140	14	nnl	nnl	NOUN
ajlm-1563	140	15	based	base	VERB
ajlm-1563	140	16	on	on	ADP
ajlm-1563	140	17	clinical	clinical	ADJ
ajlm-1563	140	18	evaluation	evaluation	NOUN
ajlm-1563	140	19	alone.26	alone.26	ADP
ajlm-1563	140	20	vulvar	vulvar	NOUN
ajlm-1563	140	21	pruritus	pruritus	NOUN
ajlm-1563	140	22	,	,	PUNCT
ajlm-1563	140	23	pain	pain	NOUN
ajlm-1563	140	24	,	,	PUNCT
ajlm-1563	140	25	and	and	CCONJ
ajlm-1563	140	26	other	other	ADJ
ajlm-1563	140	27	gross	gross	ADJ
ajlm-1563	140	28	features	feature	NOUN
ajlm-1563	140	29	of	of	ADP
ajlm-1563	140	30	vulvar	vulvar	NOUN
ajlm-1563	140	31	lesions	lesion	NOUN
ajlm-1563	140	32	are	be	AUX
ajlm-1563	140	33	not	not	PART
ajlm-1563	140	34	cancer	cancer	NOUN
ajlm-1563	140	35	-	-	PUNCT
ajlm-1563	140	36	specific	specific	ADJ
ajlm-1563	140	37	symptoms	symptom	NOUN
ajlm-1563	140	38	.	.	PUNCT
ajlm-1563	141	1	this	this	DET
ajlm-1563	141	2	similarity	similarity	NOUN
ajlm-1563	141	3	of	of	ADP
ajlm-1563	141	4	vulvar	vulvar	NOUN
ajlm-1563	141	5	cancer	cancer	NOUN
ajlm-1563	141	6	signs	sign	NOUN
ajlm-1563	141	7	and	and	CCONJ
ajlm-1563	141	8	symptoms	symptom	NOUN
ajlm-1563	141	9	with	with	ADP
ajlm-1563	141	10	those	those	PRON
ajlm-1563	141	11	of	of	ADP
ajlm-1563	141	12	nnl	nnl	PROPN
ajlm-1563	141	13	has	have	AUX
ajlm-1563	141	14	been	be	AUX
ajlm-1563	141	15	cited	cite	VERB
ajlm-1563	141	16	as	as	ADP
ajlm-1563	141	17	a	a	DET
ajlm-1563	141	18	possible	possible	ADJ
ajlm-1563	141	19	reason	reason	NOUN
ajlm-1563	141	20	for	for	ADP
ajlm-1563	141	21	the	the	DET
ajlm-1563	141	22	delay	delay	NOUN
ajlm-1563	141	23	in	in	ADP
ajlm-1563	141	24	the	the	DET
ajlm-1563	141	25	diagnosis	diagnosis	NOUN
ajlm-1563	141	26	of	of	ADP
ajlm-1563	141	27	gynaecologic	gynaecologic	ADJ
ajlm-1563	141	28	malignancies	malignancy	NOUN
ajlm-1563	141	29	by	by	ADP
ajlm-1563	141	30	clinicians.28,29,30	clinicians.28,29,30	PROPN
ajlm-1563	141	31	it	it	PRON
ajlm-1563	141	32	is	be	AUX
ajlm-1563	141	33	therefore	therefore	ADV
ajlm-1563	141	34	imperative	imperative	ADJ
ajlm-1563	141	35	that	that	SCONJ
ajlm-1563	141	36	all	all	DET
ajlm-1563	141	37	vulvar	vulvar	NOUN
ajlm-1563	141	38	lesions	lesion	NOUN
ajlm-1563	141	39	are	be	AUX
ajlm-1563	141	40	biopsied	biopsie	VERB
ajlm-1563	141	41	as	as	ADV
ajlm-1563	141	42	soon	soon	ADV
ajlm-1563	141	43	as	as	ADP
ajlm-1563	141	44	possible	possible	ADJ
ajlm-1563	141	45	,	,	PUNCT
ajlm-1563	141	46	especially	especially	ADV
ajlm-1563	141	47	among	among	ADP
ajlm-1563	141	48	women	woman	NOUN
ajlm-1563	141	49	living	live	VERB
ajlm-1563	141	50	with	with	ADP
ajlm-1563	141	51	hiv	hiv	PROPN
ajlm-1563	141	52	.	.	PUNCT
ajlm-1563	142	1	although	although	SCONJ
ajlm-1563	142	2	they	they	PRON
ajlm-1563	142	3	have	have	AUX
ajlm-1563	142	4	been	be	AUX
ajlm-1563	142	5	identified	identify	VERB
ajlm-1563	142	6	as	as	ADP
ajlm-1563	142	7	risk	risk	NOUN
ajlm-1563	142	8	factors	factor	NOUN
ajlm-1563	142	9	of	of	ADP
ajlm-1563	142	10	vulvar	vulvar	NOUN
ajlm-1563	142	11	cancer	cancer	NOUN
ajlm-1563	142	12	,	,	PUNCT
ajlm-1563	142	13	the	the	DET
ajlm-1563	142	14	smoking	smoking	NOUN
ajlm-1563	142	15	of	of	ADP
ajlm-1563	142	16	cigarettes	cigarette	NOUN
ajlm-1563	142	17	,	,	PUNCT
ajlm-1563	142	18	alcohol	alcohol	NOUN
ajlm-1563	142	19	use	use	NOUN
ajlm-1563	142	20	,	,	PUNCT
ajlm-1563	142	21	use	use	NOUN
ajlm-1563	142	22	of	of	ADP
ajlm-1563	142	23	oral	oral	ADJ
ajlm-1563	142	24	contraceptives	contraceptive	NOUN
ajlm-1563	142	25	,	,	PUNCT
ajlm-1563	142	26	and	and	CCONJ
ajlm-1563	142	27	early	early	ADJ
ajlm-1563	142	28	sexual	sexual	ADJ
ajlm-1563	142	29	debut	debut	NOUN
ajlm-1563	142	30	were	be	AUX
ajlm-1563	142	31	not	not	PART
ajlm-1563	142	32	associated	associate	VERB
ajlm-1563	142	33	with	with	ADP
ajlm-1563	142	34	vscc	vscc	NOUN
ajlm-1563	142	35	or	or	CCONJ
ajlm-1563	142	36	uvin	uvin	ADJ
ajlm-1563	142	37	in	in	ADP
ajlm-1563	142	38	our	our	PRON
ajlm-1563	142	39	cohort	cohort	NOUN
ajlm-1563	142	40	of	of	ADP
ajlm-1563	142	41	participants.31,32	participants.31,32	NOUN
ajlm-1563	142	42	also	also	ADV
ajlm-1563	142	43	,	,	PUNCT
ajlm-1563	142	44	the	the	DET
ajlm-1563	142	45	finding	finding	NOUN
ajlm-1563	142	46	that	that	SCONJ
ajlm-1563	142	47	90	90	NUM
ajlm-1563	142	48	%	%	NOUN
ajlm-1563	142	49	of	of	ADP
ajlm-1563	142	50	patients	patient	NOUN
ajlm-1563	142	51	with	with	ADP
ajlm-1563	142	52	vscc	vscc	NOUN
ajlm-1563	142	53	had	have	AUX
ajlm-1563	142	54	been	be	AUX
ajlm-1563	142	55	on	on	ADP
ajlm-1563	142	56	art	art	NOUN
ajlm-1563	142	57	for	for	ADP
ajlm-1563	142	58	over	over	ADP
ajlm-1563	142	59	a	a	PRON
ajlm-1563	142	60	year	year	NOUN
ajlm-1563	142	61	supports	support	VERB
ajlm-1563	142	62	previous	previous	ADJ
ajlm-1563	142	63	reports	report	NOUN
ajlm-1563	142	64	that	that	SCONJ
ajlm-1563	142	65	art	art	NOUN
ajlm-1563	142	66	does	do	AUX
ajlm-1563	142	67	not	not	PART
ajlm-1563	142	68	affect	affect	VERB
ajlm-1563	142	69	the	the	DET
ajlm-1563	142	70	regression	regression	NOUN
ajlm-1563	142	71	of	of	ADP
ajlm-1563	142	72	lowor	lowor	ADJ
ajlm-1563	142	73	high	high	ADJ
ajlm-1563	142	74	-	-	PUNCT
ajlm-1563	142	75	grade	grade	NOUN
ajlm-1563	142	76	lesions	lesion	NOUN
ajlm-1563	142	77	and	and	CCONJ
ajlm-1563	142	78	has	have	VERB
ajlm-1563	142	79	no	no	DET
ajlm-1563	142	80	effect	effect	NOUN
ajlm-1563	142	81	on	on	ADP
ajlm-1563	142	82	the	the	DET
ajlm-1563	142	83	prevention	prevention	NOUN
ajlm-1563	142	84	or	or	CCONJ
ajlm-1563	142	85	elimination	elimination	NOUN
ajlm-1563	142	86	of	of	ADP
ajlm-1563	142	87	hpv	hpv	PROPN
ajlm-1563	142	88	infection.33,34,35,36	infection.33,34,35,36	PROPN
ajlm-1563	142	89	in	in	ADP
ajlm-1563	142	90	our	our	PRON
ajlm-1563	142	91	study	study	NOUN
ajlm-1563	142	92	,	,	PUNCT
ajlm-1563	142	93	the	the	DET
ajlm-1563	142	94	mean	mean	NOUN
ajlm-1563	142	95	cd4	cd4	PROPN
ajlm-1563	142	96	count	count	NOUN
ajlm-1563	142	97	among	among	ADP
ajlm-1563	142	98	women	woman	NOUN
ajlm-1563	142	99	with	with	ADP
ajlm-1563	142	100	vscc	vscc	NOUN
ajlm-1563	142	101	was	be	AUX
ajlm-1563	142	102	above	above	ADP
ajlm-1563	142	103	the	the	DET
ajlm-1563	142	104	aids	aids	PROPN
ajlm-1563	142	105	diagnosis	diagnosis	NOUN
ajlm-1563	142	106	threshold	threshold	NOUN
ajlm-1563	142	107	:	:	PUNCT
ajlm-1563	142	108	200	200	NUM
ajlm-1563	142	109	cells/µl.37	cells/µl.37	NOUN
ajlm-1563	142	110	in	in	ADP
ajlm-1563	142	111	contrast	contrast	NOUN
ajlm-1563	142	112	,	,	PUNCT
ajlm-1563	142	113	in	in	ADP
ajlm-1563	142	114	a	a	DET
ajlm-1563	142	115	2014	2014	NUM
ajlm-1563	142	116	study	study	NOUN
ajlm-1563	142	117	in	in	ADP
ajlm-1563	142	118	botswana	botswana	PROPN
ajlm-1563	142	119	,	,	PUNCT
ajlm-1563	142	120	35	35	NUM
ajlm-1563	142	121	%	%	NOUN
ajlm-1563	142	122	of	of	ADP
ajlm-1563	142	123	women	woman	NOUN
ajlm-1563	142	124	living	live	VERB
ajlm-1563	142	125	with	with	ADP
ajlm-1563	142	126	hiv	hiv	PROPN
ajlm-1563	142	127	with	with	ADP
ajlm-1563	142	128	vulvar	vulvar	NOUN
ajlm-1563	142	129	cancer	cancer	NOUN
ajlm-1563	142	130	had	have	VERB
ajlm-1563	142	131	cd4	cd4	PROPN
ajlm-1563	142	132	counts	count	NOUN
ajlm-1563	142	133	below	below	ADP
ajlm-1563	142	134	200	200	NUM
ajlm-1563	142	135	cells/µl	cells/µl	NOUN
ajlm-1563	142	136	(	(	PUNCT
ajlm-1563	142	137	range	range	NOUN
ajlm-1563	142	138	:	:	PUNCT
ajlm-1563	142	139	68–854).22	68–854).22	NUM
ajlm-1563	142	140	in	in	ADP
ajlm-1563	142	141	another	another	DET
ajlm-1563	142	142	study	study	NOUN
ajlm-1563	142	143	in	in	ADP
ajlm-1563	142	144	ethiopia	ethiopia	PROPN
ajlm-1563	142	145	in	in	ADP
ajlm-1563	142	146	2018	2018	NUM
ajlm-1563	142	147	,	,	PUNCT
ajlm-1563	142	148	the	the	DET
ajlm-1563	142	149	range	range	NOUN
ajlm-1563	142	150	of	of	ADP
ajlm-1563	142	151	cd4	cd4	PROPN
ajlm-1563	142	152	counts	count	NOUN
ajlm-1563	142	153	was	be	AUX
ajlm-1563	142	154	above	above	ADP
ajlm-1563	142	155	the	the	DET
ajlm-1563	142	156	aids	aids	PROPN
ajlm-1563	142	157	diagnosis	diagnosis	NOUN
ajlm-1563	142	158	threshold	threshold	NOUN
ajlm-1563	142	159	(	(	PUNCT
ajlm-1563	142	160	230	230	NUM
ajlm-1563	142	161	cells/µl	cells/µl	NOUN
ajlm-1563	142	162	–	–	PUNCT
ajlm-1563	142	163	600	600	NUM
ajlm-1563	142	164	cells/µl).27	cells/µl).27	NOUN
ajlm-1563	142	165	our	our	PRON
ajlm-1563	142	166	study	study	NOUN
ajlm-1563	142	167	was	be	AUX
ajlm-1563	142	168	unique	unique	ADJ
ajlm-1563	142	169	in	in	ADP
ajlm-1563	142	170	that	that	SCONJ
ajlm-1563	142	171	it	it	PRON
ajlm-1563	142	172	showed	show	VERB
ajlm-1563	142	173	that	that	SCONJ
ajlm-1563	142	174	there	there	PRON
ajlm-1563	142	175	was	be	VERB
ajlm-1563	142	176	no	no	DET
ajlm-1563	142	177	association	association	NOUN
ajlm-1563	142	178	between	between	ADP
ajlm-1563	142	179	cd4	cd4	PROPN
ajlm-1563	142	180	count	count	NOUN
ajlm-1563	142	181	and	and	CCONJ
ajlm-1563	142	182	the	the	DET
ajlm-1563	142	183	diagnosis	diagnosis	NOUN
ajlm-1563	142	184	of	of	ADP
ajlm-1563	142	185	vscc	vscc	NOUN
ajlm-1563	142	186	.	.	PUNCT
ajlm-1563	143	1	this	this	DET
ajlm-1563	143	2	study	study	NOUN
ajlm-1563	143	3	supports	support	VERB
ajlm-1563	143	4	previous	previous	ADJ
ajlm-1563	143	5	findings	finding	NOUN
ajlm-1563	143	6	that	that	PRON
ajlm-1563	143	7	itching	itching	NOUN
ajlm-1563	143	8	is	be	AUX
ajlm-1563	143	9	the	the	DET
ajlm-1563	143	10	most	most	ADV
ajlm-1563	143	11	frequent	frequent	ADJ
ajlm-1563	143	12	symptom	symptom	NOUN
ajlm-1563	143	13	of	of	ADP
ajlm-1563	143	14	uvin	uvin	PROPN
ajlm-1563	143	15	and	and	CCONJ
ajlm-1563	143	16	vscc7,38	vscc7,38	PROPN
ajlm-1563	143	17	and	and	CCONJ
ajlm-1563	143	18	demonstrated	demonstrate	VERB
ajlm-1563	143	19	that	that	SCONJ
ajlm-1563	143	20	vscc	vscc	PROPN
ajlm-1563	143	21	presents	present	NOUN
ajlm-1563	143	22	with	with	ADP
ajlm-1563	143	23	multifocal	multifocal	ADJ
ajlm-1563	143	24	growth	growth	NOUN
ajlm-1563	143	25	patterns.39,40,41	patterns.39,40,41	ADV
ajlm-1563	143	26	the	the	DET
ajlm-1563	143	27	finding	finding	NOUN
ajlm-1563	143	28	of	of	ADP
ajlm-1563	143	29	concurrent	concurrent	ADJ
ajlm-1563	143	30	hsil	hsil	NOUN
ajlm-1563	143	31	and	and	CCONJ
ajlm-1563	143	32	a	a	DET
ajlm-1563	143	33	high	high	ADJ
ajlm-1563	143	34	ki-67	ki-67	ADJ
ajlm-1563	143	35	proliferation	proliferation	NOUN
ajlm-1563	143	36	index	index	NOUN
ajlm-1563	143	37	with	with	ADP
ajlm-1563	143	38	a	a	DET
ajlm-1563	143	39	diffuse	diffuse	NOUN
ajlm-1563	143	40	pattern	pattern	NOUN
ajlm-1563	143	41	among	among	ADP
ajlm-1563	143	42	vscc	vscc	NOUN
ajlm-1563	143	43	was	be	AUX
ajlm-1563	143	44	indicative	indicative	ADJ
ajlm-1563	143	45	of	of	ADP
ajlm-1563	143	46	a	a	DET
ajlm-1563	143	47	bad	bad	ADJ
ajlm-1563	143	48	prognosis.42	prognosis.42	NOUN
ajlm-1563	143	49	however	however	ADV
ajlm-1563	143	50	,	,	PUNCT
ajlm-1563	143	51	an	an	DET
ajlm-1563	143	52	evaluation	evaluation	NOUN
ajlm-1563	143	53	of	of	ADP
ajlm-1563	143	54	the	the	DET
ajlm-1563	143	55	correlation	correlation	NOUN
ajlm-1563	143	56	between	between	ADP
ajlm-1563	143	57	patients	patient	NOUN
ajlm-1563	143	58	’	'	PUNCT
ajlm-1563	143	59	clinical	clinical	ADJ
ajlm-1563	143	60	outcomes	outcome	NOUN
ajlm-1563	143	61	and	and	CCONJ
ajlm-1563	143	62	these	these	DET
ajlm-1563	143	63	prognostic	prognostic	ADJ
ajlm-1563	143	64	factors	factor	NOUN
ajlm-1563	143	65	was	be	AUX
ajlm-1563	143	66	beyond	beyond	ADP
ajlm-1563	143	67	the	the	DET
ajlm-1563	143	68	scope	scope	NOUN
ajlm-1563	143	69	of	of	ADP
ajlm-1563	143	70	this	this	DET
ajlm-1563	143	71	study	study	NOUN
ajlm-1563	143	72	.	.	PUNCT
ajlm-1563	144	1	although	although	SCONJ
ajlm-1563	144	2	polymerase	polymerase	NOUN
ajlm-1563	144	3	chain	chain	NOUN
ajlm-1563	144	4	reaction	reaction	NOUN
ajlm-1563	144	5	showed	show	VERB
ajlm-1563	144	6	that	that	SCONJ
ajlm-1563	144	7	hrhpv	hrhpv	NOUN
ajlm-1563	144	8	was	be	AUX
ajlm-1563	144	9	present	present	ADJ
ajlm-1563	144	10	in	in	ADP
ajlm-1563	144	11	the	the	DET
ajlm-1563	144	12	biopsy	biopsy	NOUN
ajlm-1563	144	13	tissue	tissue	NOUN
ajlm-1563	144	14	,	,	PUNCT
ajlm-1563	144	15	it	it	PRON
ajlm-1563	144	16	did	do	AUX
ajlm-1563	144	17	not	not	PART
ajlm-1563	144	18	prove	prove	VERB
ajlm-1563	144	19	that	that	SCONJ
ajlm-1563	144	20	hrhpv	hrhpv	NOUN
ajlm-1563	144	21	was	be	AUX
ajlm-1563	144	22	incorporated	incorporate	VERB
ajlm-1563	144	23	into	into	ADP
ajlm-1563	144	24	the	the	DET
ajlm-1563	144	25	host	host	NOUN
ajlm-1563	144	26	genome	genome	NOUN
ajlm-1563	144	27	.	.	PUNCT
ajlm-1563	145	1	nevertheless	nevertheless	ADV
ajlm-1563	145	2	,	,	PUNCT
ajlm-1563	145	3	the	the	DET
ajlm-1563	145	4	pcr	pcr	ADJ
ajlm-1563	145	5	findings	finding	NOUN
ajlm-1563	145	6	were	be	AUX
ajlm-1563	145	7	supported	support	VERB
ajlm-1563	145	8	by	by	ADP
ajlm-1563	145	9	the	the	DET
ajlm-1563	145	10	histologic	histologic	ADJ
ajlm-1563	145	11	examination	examination	NOUN
ajlm-1563	145	12	which	which	PRON
ajlm-1563	145	13	detected	detect	VERB
ajlm-1563	145	14	uvin	uvin	NOUN
ajlm-1563	145	15	,	,	PUNCT
ajlm-1563	145	16	as	as	ADV
ajlm-1563	145	17	well	well	ADV
ajlm-1563	145	18	as	as	ADP
ajlm-1563	145	19	warty	warty	NOUN
ajlm-1563	145	20	and	and	CCONJ
ajlm-1563	145	21	basaloid	basaloid	NOUN
ajlm-1563	145	22	vscc	vscc	NOUN
ajlm-1563	145	23	,	,	PUNCT
ajlm-1563	145	24	all	all	PRON
ajlm-1563	145	25	of	of	ADP
ajlm-1563	145	26	which	which	PRON
ajlm-1563	145	27	are	be	AUX
ajlm-1563	145	28	known	know	VERB
ajlm-1563	145	29	to	to	PART
ajlm-1563	145	30	be	be	AUX
ajlm-1563	145	31	associated	associate	VERB
ajlm-1563	145	32	with	with	ADP
ajlm-1563	145	33	hrhpv.5	hrhpv.5	NOUN
ajlm-1563	145	34	the	the	DET
ajlm-1563	145	35	high	high	ADJ
ajlm-1563	145	36	prevalence	prevalence	NOUN
ajlm-1563	145	37	of	of	ADP
ajlm-1563	145	38	hrhpv	hrhpv	NOUN
ajlm-1563	145	39	in	in	ADP
ajlm-1563	145	40	vscc	vscc	NOUN
ajlm-1563	145	41	and	and	CCONJ
ajlm-1563	145	42	hsil	hsil	NOUN
ajlm-1563	145	43	in	in	ADP
ajlm-1563	145	44	our	our	PRON
ajlm-1563	145	45	cohort	cohort	NOUN
ajlm-1563	145	46	of	of	ADP
ajlm-1563	145	47	women	woman	NOUN
ajlm-1563	145	48	living	live	VERB
ajlm-1563	145	49	with	with	ADP
ajlm-1563	145	50	hiv	hiv	PROPN
ajlm-1563	145	51	is	be	AUX
ajlm-1563	145	52	premised	premise	VERB
ajlm-1563	145	53	on	on	ADP
ajlm-1563	145	54	the	the	DET
ajlm-1563	145	55	extensively	extensively	ADV
ajlm-1563	145	56	described	describe	VERB
ajlm-1563	145	57	interactions	interaction	NOUN
ajlm-1563	145	58	between	between	ADP
ajlm-1563	145	59	hpv	hpv	NOUN
ajlm-1563	145	60	infection	infection	NOUN
ajlm-1563	145	61	and	and	CCONJ
ajlm-1563	145	62	hiv.43,44,45,46	hiv.43,44,45,46	NOUN
ajlm-1563	145	63	on	on	ADP
ajlm-1563	145	64	one	one	NUM
ajlm-1563	145	65	hand	hand	NOUN
ajlm-1563	145	66	,	,	PUNCT
ajlm-1563	145	67	women	woman	NOUN
ajlm-1563	145	68	who	who	PRON
ajlm-1563	145	69	are	be	AUX
ajlm-1563	145	70	infected	infect	VERB
ajlm-1563	145	71	with	with	ADP
ajlm-1563	145	72	hpv	hpv	PROPN
ajlm-1563	145	73	have	have	VERB
ajlm-1563	145	74	a	a	DET
ajlm-1563	145	75	higher	high	ADJ
ajlm-1563	145	76	risk	risk	NOUN
ajlm-1563	145	77	of	of	ADP
ajlm-1563	145	78	infection	infection	NOUN
ajlm-1563	145	79	with	with	ADP
ajlm-1563	145	80	hiv.36	hiv.36	VERB
ajlm-1563	145	81	on	on	ADP
ajlm-1563	145	82	the	the	DET
ajlm-1563	145	83	other	other	ADJ
ajlm-1563	145	84	hand	hand	NOUN
ajlm-1563	145	85	,	,	PUNCT
ajlm-1563	145	86	hiv	hiv	PROPN
ajlm-1563	145	87	-	-	PUNCT
ajlm-1563	145	88	positive	positive	ADJ
ajlm-1563	145	89	persons	person	NOUN
ajlm-1563	145	90	are	be	AUX
ajlm-1563	145	91	at	at	ADP
ajlm-1563	145	92	higher	high	ADJ
ajlm-1563	145	93	risk	risk	NOUN
ajlm-1563	145	94	of	of	ADP
ajlm-1563	145	95	developing	develop	VERB
ajlm-1563	145	96	hpv	hpv	ADJ
ajlm-1563	145	97	infection	infection	NOUN
ajlm-1563	145	98	through	through	ADP
ajlm-1563	145	99	various	various	ADJ
ajlm-1563	145	100	mechanisms	mechanism	NOUN
ajlm-1563	145	101	.	.	PUNCT
ajlm-1563	146	1	one	one	NUM
ajlm-1563	146	2	of	of	ADP
ajlm-1563	146	3	these	these	DET
ajlm-1563	146	4	mechanisms	mechanism	NOUN
ajlm-1563	146	5	involves	involve	VERB
ajlm-1563	146	6	the	the	DET
ajlm-1563	146	7	secretion	secretion	NOUN
ajlm-1563	146	8	of	of	ADP
ajlm-1563	146	9	a	a	DET
ajlm-1563	146	10	viral	viral	ADJ
ajlm-1563	146	11	transactivator	transactivator	NOUN
ajlm-1563	146	12	protein	protein	NOUN
ajlm-1563	146	13	and	and	CCONJ
ajlm-1563	146	14	gp120	gp120	NOUN
ajlm-1563	146	15	by	by	ADP
ajlm-1563	146	16	hiv	hiv	PROPN
ajlm-1563	146	17	-	-	PUNCT
ajlm-1563	146	18	infected	infect	VERB
ajlm-1563	146	19	cells	cell	NOUN
ajlm-1563	146	20	,	,	PUNCT
ajlm-1563	146	21	which	which	PRON
ajlm-1563	146	22	disrupt	disrupt	VERB
ajlm-1563	146	23	epithelial	epithelial	ADJ
ajlm-1563	146	24	tight	tight	ADJ
ajlm-1563	146	25	junctions	junction	NOUN
ajlm-1563	146	26	and	and	CCONJ
ajlm-1563	146	27	enhance	enhance	VERB
ajlm-1563	146	28	intercellular	intercellular	ADJ
ajlm-1563	146	29	penetration	penetration	NOUN
ajlm-1563	146	30	of	of	ADP
ajlm-1563	146	31	the	the	DET
ajlm-1563	146	32	hpv	hpv	NOUN
ajlm-1563	146	33	to	to	ADP
ajlm-1563	146	34	the	the	DET
ajlm-1563	146	35	target	target	NOUN
ajlm-1563	146	36	cells.36	cells.36	NOUN
ajlm-1563	146	37	because	because	SCONJ
ajlm-1563	146	38	of	of	ADP
ajlm-1563	146	39	defective	defective	ADJ
ajlm-1563	146	40	immunity	immunity	NOUN
ajlm-1563	146	41	in	in	ADP
ajlm-1563	146	42	the	the	DET
ajlm-1563	146	43	host	host	NOUN
ajlm-1563	146	44	,	,	PUNCT
ajlm-1563	146	45	hpv	hpv	PROPN
ajlm-1563	146	46	evades	evade	VERB
ajlm-1563	146	47	the	the	DET
ajlm-1563	146	48	host	host	NOUN
ajlm-1563	146	49	immunity	immunity	NOUN
ajlm-1563	146	50	,	,	PUNCT
ajlm-1563	146	51	and	and	CCONJ
ajlm-1563	146	52	the	the	DET
ajlm-1563	146	53	suppressed	suppress	VERB
ajlm-1563	146	54	immunity	immunity	NOUN
ajlm-1563	146	55	further	further	ADJ
ajlm-1563	146	56	enhances	enhance	NOUN
ajlm-1563	146	57	increased	increase	VERB
ajlm-1563	146	58	hpv	hpv	ADJ
ajlm-1563	146	59	viral	viral	ADJ
ajlm-1563	146	60	loads	load	NOUN
ajlm-1563	146	61	,	,	PUNCT
ajlm-1563	146	62	infection	infection	NOUN
ajlm-1563	146	63	with	with	ADP
ajlm-1563	146	64	multiple	multiple	ADJ
ajlm-1563	146	65	hpv	hpv	ADJ
ajlm-1563	146	66	types	type	NOUN
ajlm-1563	146	67	,	,	PUNCT
ajlm-1563	146	68	reactivation	reactivation	NOUN
ajlm-1563	146	69	of	of	ADP
ajlm-1563	146	70	latent	latent	NOUN
ajlm-1563	146	71	hpv	hpv	NOUN
ajlm-1563	146	72	infection	infection	NOUN
ajlm-1563	146	73	,	,	PUNCT
ajlm-1563	146	74	and	and	CCONJ
ajlm-1563	146	75	persistence	persistence	NOUN
ajlm-1563	146	76	of	of	ADP
ajlm-1563	146	77	hpv	hpv	NOUN
ajlm-1563	146	78	-	-	PUNCT
ajlm-1563	146	79	associated	associate	VERB
ajlm-1563	146	80	disease	disease	NOUN
ajlm-1563	146	81	.	.	PUNCT
ajlm-1563	147	1	the	the	DET
ajlm-1563	147	2	prevalence	prevalence	NOUN
ajlm-1563	147	3	of	of	ADP
ajlm-1563	147	4	hrhpv	hrhpv	NOUN
ajlm-1563	147	5	in	in	ADP
ajlm-1563	147	6	vscc	vscc	NOUN
ajlm-1563	147	7	in	in	ADP
ajlm-1563	147	8	our	our	PRON
ajlm-1563	147	9	study	study	NOUN
ajlm-1563	147	10	(	(	PUNCT
ajlm-1563	147	11	88.9	88.9	NUM
ajlm-1563	147	12	%	%	NOUN
ajlm-1563	147	13	)	)	PUNCT
ajlm-1563	147	14	was	be	AUX
ajlm-1563	147	15	higher	high	ADJ
ajlm-1563	147	16	than	than	ADP
ajlm-1563	147	17	the	the	DET
ajlm-1563	147	18	prevalence	prevalence	NOUN
ajlm-1563	147	19	reported	report	VERB
ajlm-1563	147	20	in	in	ADP
ajlm-1563	147	21	botswana	botswana	PROPN
ajlm-1563	147	22	(	(	PUNCT
ajlm-1563	147	23	82.9%).19	82.9%).19	NUM
ajlm-1563	147	24	worldwide	worldwide	ADV
ajlm-1563	147	25	,	,	PUNCT
ajlm-1563	147	26	the	the	DET
ajlm-1563	147	27	prevalence	prevalence	NOUN
ajlm-1563	147	28	of	of	ADP
ajlm-1563	147	29	hpv	hpv	NOUN
ajlm-1563	147	30	in	in	ADP
ajlm-1563	147	31	vscc	vscc	NOUN
ajlm-1563	147	32	varied	varied	ADJ
ajlm-1563	147	33	from	from	ADP
ajlm-1563	147	34	15.0	15.0	NUM
ajlm-1563	147	35	%	%	NOUN
ajlm-1563	147	36	to	to	ADP
ajlm-1563	147	37	79.0%.5	79.0%.5	NOUN
ajlm-1563	147	38	the	the	DET
ajlm-1563	147	39	prevalence	prevalence	NOUN
ajlm-1563	147	40	of	of	ADP
ajlm-1563	147	41	hpv16	hpv16	NOUN
ajlm-1563	147	42	in	in	ADP
ajlm-1563	147	43	vscc	vscc	NOUN
ajlm-1563	147	44	in	in	ADP
ajlm-1563	147	45	this	this	DET
ajlm-1563	147	46	study	study	NOUN
ajlm-1563	147	47	was	be	AUX
ajlm-1563	147	48	low	low	ADJ
ajlm-1563	147	49	(	(	PUNCT
ajlm-1563	147	50	44.4%)47	44.4%)47	NUM
ajlm-1563	147	51	compared	compare	VERB
ajlm-1563	147	52	to	to	ADP
ajlm-1563	147	53	that	that	PRON
ajlm-1563	147	54	reported	report	VERB
ajlm-1563	147	55	by	by	ADP
ajlm-1563	147	56	a	a	DET
ajlm-1563	147	57	study	study	NOUN
ajlm-1563	147	58	in	in	ADP
ajlm-1563	147	59	botswana	botswana	PROPN
ajlm-1563	147	60	(	(	PUNCT
ajlm-1563	147	61	82.9	82.9	NUM
ajlm-1563	147	62	%	%	NOUN
ajlm-1563	147	63	)	)	PUNCT
ajlm-1563	147	64	but	but	CCONJ
ajlm-1563	147	65	similar	similar	ADJ
ajlm-1563	147	66	to	to	ADP
ajlm-1563	147	67	the	the	DET
ajlm-1563	147	68	prevalence	prevalence	NOUN
ajlm-1563	147	69	reported	report	VERB
ajlm-1563	147	70	worldwide	worldwide	ADV
ajlm-1563	147	71	(	(	PUNCT
ajlm-1563	147	72	29.3	29.3	NUM
ajlm-1563	147	73	%	%	NOUN
ajlm-1563	147	74	–	–	PUNCT
ajlm-1563	147	75	50.0%).22,48,49,50	50.0%).22,48,49,50	NUM
ajlm-1563	147	76	we	we	PRON
ajlm-1563	147	77	reported	report	VERB
ajlm-1563	147	78	a	a	DET
ajlm-1563	147	79	prevalence	prevalence	NOUN
ajlm-1563	147	80	of	of	ADP
ajlm-1563	147	81	44.4	44.4	NUM
ajlm-1563	147	82	%	%	NOUN
ajlm-1563	147	83	for	for	ADP
ajlm-1563	147	84	the	the	DET
ajlm-1563	147	85	group	group	NOUN
ajlm-1563	147	86	p3	p3	NOUN
ajlm-1563	147	87	genotypes	genotype	NOUN
ajlm-1563	147	88	(	(	PUNCT
ajlm-1563	147	89	hpv31	hpv31	PROPN
ajlm-1563	147	90	,	,	PUNCT
ajlm-1563	147	91	33	33	NUM
ajlm-1563	147	92	,	,	PUNCT
ajlm-1563	147	93	35	35	NUM
ajlm-1563	147	94	,	,	PUNCT
ajlm-1563	147	95	52	52	NUM
ajlm-1563	147	96	and	and	CCONJ
ajlm-1563	147	97	58	58	NUM
ajlm-1563	147	98	)	)	PUNCT
ajlm-1563	147	99	among	among	ADP
ajlm-1563	147	100	patients	patient	NOUN
ajlm-1563	147	101	with	with	ADP
ajlm-1563	147	102	vscc	vscc	NOUN
ajlm-1563	147	103	.	.	PUNCT
ajlm-1563	148	1	this	this	PRON
ajlm-1563	148	2	was	be	AUX
ajlm-1563	148	3	lower	low	ADJ
ajlm-1563	148	4	than	than	ADP
ajlm-1563	148	5	the	the	DET
ajlm-1563	148	6	prevalence	prevalence	NOUN
ajlm-1563	148	7	rate	rate	NOUN
ajlm-1563	148	8	of	of	ADP
ajlm-1563	148	9	hpv31	hpv31	PROPN
ajlm-1563	148	10	(	(	PUNCT
ajlm-1563	148	11	51.4	51.4	NUM
ajlm-1563	148	12	%	%	NOUN
ajlm-1563	148	13	)	)	PUNCT
ajlm-1563	148	14	and	and	CCONJ
ajlm-1563	148	15	higher	high	ADJ
ajlm-1563	148	16	than	than	ADP
ajlm-1563	148	17	the	the	DET
ajlm-1563	148	18	prevalence	prevalence	NOUN
ajlm-1563	148	19	rate	rate	NOUN
ajlm-1563	148	20	of	of	ADP
ajlm-1563	148	21	hpv33	hpv33	PROPN
ajlm-1563	148	22	(	(	PUNCT
ajlm-1563	148	23	11.4	11.4	NUM
ajlm-1563	148	24	%	%	NOUN
ajlm-1563	148	25	)	)	PUNCT
ajlm-1563	148	26	reported	report	VERB
ajlm-1563	148	27	in	in	ADP
ajlm-1563	148	28	a	a	DET
ajlm-1563	148	29	botswanan	botswanan	NOUN
ajlm-1563	148	30	study	study	NOUN
ajlm-1563	148	31	;	;	PUNCT
ajlm-1563	148	32	it	it	PRON
ajlm-1563	148	33	was	be	AUX
ajlm-1563	148	34	also	also	ADV
ajlm-1563	148	35	higher	high	ADJ
ajlm-1563	148	36	than	than	SCONJ
ajlm-1563	148	37	the	the	DET
ajlm-1563	148	38	prevalence	prevalence	NOUN
ajlm-1563	148	39	rates	rate	NOUN
ajlm-1563	148	40	reported	report	VERB
ajlm-1563	148	41	worldwide	worldwide	ADV
ajlm-1563	148	42	(	(	PUNCT
ajlm-1563	148	43	0.8	0.8	NUM
ajlm-1563	148	44	%	%	NOUN
ajlm-1563	148	45	–	–	PUNCT
ajlm-1563	148	46	1.7	1.7	NUM
ajlm-1563	148	47	%	%	NOUN
ajlm-1563	148	48	for	for	ADP
ajlm-1563	148	49	hpv31	hpv31	NOUN
ajlm-1563	148	50	and	and	CCONJ
ajlm-1563	148	51	3.3	3.3	NUM
ajlm-1563	148	52	%	%	NOUN
ajlm-1563	148	53	–	–	PUNCT
ajlm-1563	148	54	3.5	3.5	NUM
ajlm-1563	148	55	%	%	NOUN
ajlm-1563	148	56	for	for	ADP
ajlm-1563	148	57	hpv33).48,49	hpv33).48,49	NOUN
ajlm-1563	148	58	a	a	DET
ajlm-1563	148	59	further	further	ADJ
ajlm-1563	148	60	evaluation	evaluation	NOUN
ajlm-1563	148	61	of	of	ADP
ajlm-1563	148	62	the	the	DET
ajlm-1563	148	63	exact	exact	ADJ
ajlm-1563	148	64	genotypes	genotype	NOUN
ajlm-1563	148	65	that	that	PRON
ajlm-1563	148	66	are	be	AUX
ajlm-1563	148	67	prevalent	prevalent	ADJ
ajlm-1563	148	68	in	in	ADP
ajlm-1563	148	69	zambian	zambian	ADJ
ajlm-1563	148	70	patients	patient	NOUN
ajlm-1563	148	71	is	be	AUX
ajlm-1563	148	72	imperative	imperative	ADJ
ajlm-1563	148	73	.	.	PUNCT
ajlm-1563	149	1	the	the	DET
ajlm-1563	149	2	prevalence	prevalence	NOUN
ajlm-1563	149	3	of	of	ADP
ajlm-1563	149	4	hpv18/45	hpv18/45	PROPN
ajlm-1563	149	5	(	(	PUNCT
ajlm-1563	149	6	5.6	5.6	NUM
ajlm-1563	149	7	%	%	NOUN
ajlm-1563	149	8	)	)	PUNCT
ajlm-1563	149	9	among	among	ADP
ajlm-1563	149	10	patients	patient	NOUN
ajlm-1563	149	11	with	with	ADP
ajlm-1563	149	12	vscc	vscc	NOUN
ajlm-1563	149	13	in	in	ADP
ajlm-1563	149	14	our	our	PRON
ajlm-1563	149	15	study	study	NOUN
ajlm-1563	149	16	is	be	AUX
ajlm-1563	149	17	difficult	difficult	ADJ
ajlm-1563	149	18	to	to	PART
ajlm-1563	149	19	compare	compare	VERB
ajlm-1563	149	20	with	with	ADP
ajlm-1563	149	21	other	other	ADJ
ajlm-1563	149	22	regional	regional	ADJ
ajlm-1563	149	23	studies	study	NOUN
ajlm-1563	149	24	as	as	SCONJ
ajlm-1563	149	25	such	such	ADJ
ajlm-1563	149	26	studies	study	NOUN
ajlm-1563	149	27	measured	measure	VERB
ajlm-1563	149	28	the	the	DET
ajlm-1563	149	29	prevalence	prevalence	NOUN
ajlm-1563	149	30	rates	rate	NOUN
ajlm-1563	149	31	of	of	ADP
ajlm-1563	149	32	hpv18	hpv18	NOUN
ajlm-1563	149	33	and	and	CCONJ
ajlm-1563	149	34	hpv45	hpv45	NOUN
ajlm-1563	149	35	separately	separately	ADV
ajlm-1563	149	36	.	.	PUNCT
ajlm-1563	150	1	for	for	ADP
ajlm-1563	150	2	example	example	NOUN
ajlm-1563	150	3	,	,	PUNCT
ajlm-1563	150	4	the	the	DET
ajlm-1563	150	5	botswanan	botswanan	NOUN
ajlm-1563	150	6	study	study	NOUN
ajlm-1563	150	7	in	in	ADP
ajlm-1563	150	8	2014	2014	NUM
ajlm-1563	150	9	reported	report	VERB
ajlm-1563	150	10	a	a	DET
ajlm-1563	150	11	37.1	37.1	NUM
ajlm-1563	150	12	%	%	NOUN
ajlm-1563	150	13	hpv18	hpv18	NOUN
ajlm-1563	150	14	prevalence	prevalence	NOUN
ajlm-1563	150	15	and	and	CCONJ
ajlm-1563	150	16	an	an	DET
ajlm-1563	150	17	8.6	8.6	NUM
ajlm-1563	150	18	%	%	NOUN
ajlm-1563	150	19	hpv45	hpv45	NOUN
ajlm-1563	150	20	prevalence.22	prevalence.22	VERB
ajlm-1563	150	21	in	in	ADP
ajlm-1563	150	22	this	this	DET
ajlm-1563	150	23	study	study	NOUN
ajlm-1563	150	24	,	,	PUNCT
ajlm-1563	150	25	the	the	DET
ajlm-1563	150	26	prevalence	prevalence	NOUN
ajlm-1563	150	27	of	of	ADP
ajlm-1563	150	28	hrhpv	hrhpv	NOUN
ajlm-1563	150	29	was	be	AUX
ajlm-1563	150	30	high	high	ADJ
ajlm-1563	150	31	(	(	PUNCT
ajlm-1563	150	32	100	100	NUM
ajlm-1563	150	33	%	%	NOUN
ajlm-1563	150	34	)	)	PUNCT
ajlm-1563	150	35	among	among	ADP
ajlm-1563	150	36	hsil	hsil	ADJ
ajlm-1563	150	37	cases	case	NOUN
ajlm-1563	150	38	and	and	CCONJ
ajlm-1563	150	39	low	low	ADJ
ajlm-1563	150	40	among	among	ADP
ajlm-1563	150	41	lsil	lsil	NOUN
ajlm-1563	150	42	cases	case	NOUN
ajlm-1563	150	43	(	(	PUNCT
ajlm-1563	150	44	25.0	25.0	NUM
ajlm-1563	150	45	%	%	NOUN
ajlm-1563	150	46	)	)	PUNCT
ajlm-1563	150	47	;	;	PUNCT
ajlm-1563	150	48	the	the	DET
ajlm-1563	150	49	overall	overall	ADJ
ajlm-1563	150	50	prevalence	prevalence	NOUN
ajlm-1563	150	51	of	of	ADP
ajlm-1563	150	52	hrhpv	hrhpv	NOUN
ajlm-1563	150	53	among	among	ADP
ajlm-1563	150	54	uvin	uvin	ADJ
ajlm-1563	150	55	cases	case	NOUN
ajlm-1563	150	56	was	be	AUX
ajlm-1563	150	57	82.4	82.4	NUM
ajlm-1563	150	58	%	%	NOUN
ajlm-1563	150	59	.	.	PUNCT
ajlm-1563	151	1	this	this	PRON
ajlm-1563	151	2	was	be	AUX
ajlm-1563	151	3	in	in	ADP
ajlm-1563	151	4	keeping	keeping	NOUN
ajlm-1563	151	5	with	with	ADP
ajlm-1563	151	6	previous	previous	ADJ
ajlm-1563	151	7	studies	study	NOUN
ajlm-1563	151	8	worldwide	worldwide	ADV
ajlm-1563	151	9	that	that	PRON
ajlm-1563	151	10	showed	show	VERB
ajlm-1563	151	11	that	that	SCONJ
ajlm-1563	151	12	hpv	hpv	ADJ
ajlm-1563	151	13	prevalence	prevalence	NOUN
ajlm-1563	151	14	varied	varied	ADJ
ajlm-1563	151	15	from	from	ADP
ajlm-1563	151	16	52.0	52.0	NUM
ajlm-1563	151	17	%	%	NOUN
ajlm-1563	151	18	to	to	ADP
ajlm-1563	151	19	100.0	100.0	NUM
ajlm-1563	151	20	%	%	NOUN
ajlm-1563	151	21	in	in	ADP
ajlm-1563	151	22	uvin.5	uvin.5	PROPN
ajlm-1563	151	23	the	the	DET
ajlm-1563	151	24	64.7	64.7	NUM
ajlm-1563	151	25	%	%	NOUN
ajlm-1563	151	26	prevalence	prevalence	NOUN
ajlm-1563	151	27	of	of	ADP
ajlm-1563	151	28	hpv16	hpv16	NOUN
ajlm-1563	151	29	among	among	ADP
ajlm-1563	151	30	uvin	uvin	ADJ
ajlm-1563	151	31	cases	case	NOUN
ajlm-1563	151	32	in	in	ADP
ajlm-1563	151	33	this	this	DET
ajlm-1563	151	34	study	study	NOUN
ajlm-1563	151	35	is	be	AUX
ajlm-1563	151	36	lower	low	ADJ
ajlm-1563	151	37	than	than	ADP
ajlm-1563	151	38	the	the	DET
ajlm-1563	151	39	74.6	74.6	NUM
ajlm-1563	151	40	%	%	NOUN
ajlm-1563	151	41	prevalence	prevalence	NOUN
ajlm-1563	151	42	reported	report	VERB
ajlm-1563	151	43	worldwide	worldwide	ADV
ajlm-1563	151	44	among	among	ADP
ajlm-1563	151	45	uvin	uvin	PROPN
ajlm-1563	151	46	cases.5,51	cases.5,51	PROPN
ajlm-1563	151	47	the	the	DET
ajlm-1563	151	48	presence	presence	NOUN
ajlm-1563	151	49	of	of	ADP
ajlm-1563	151	50	hpv	hpv	PROPN
ajlm-1563	151	51	group	group	PROPN
ajlm-1563	151	52	p3	p3	PROPN
ajlm-1563	151	53	and	and	CCONJ
ajlm-1563	151	54	the	the	DET
ajlm-1563	151	55	absence	absence	NOUN
ajlm-1563	151	56	of	of	ADP
ajlm-1563	151	57	hpv18/45	hpv18/45	PROPN
ajlm-1563	151	58	among	among	ADP
ajlm-1563	151	59	hsil	hsil	ADJ
ajlm-1563	151	60	cases	case	NOUN
ajlm-1563	151	61	suggests	suggest	VERB
ajlm-1563	151	62	that	that	SCONJ
ajlm-1563	151	63	hpv31	hpv31	NOUN
ajlm-1563	151	64	,	,	PUNCT
ajlm-1563	151	65	33	33	NUM
ajlm-1563	151	66	,	,	PUNCT
ajlm-1563	151	67	35	35	NUM
ajlm-1563	151	68	,	,	PUNCT
ajlm-1563	151	69	52	52	NUM
ajlm-1563	151	70	and	and	CCONJ
ajlm-1563	151	71	58	58	NUM
ajlm-1563	151	72	may	may	AUX
ajlm-1563	151	73	have	have	VERB
ajlm-1563	151	74	a	a	DET
ajlm-1563	151	75	higher	high	ADJ
ajlm-1563	151	76	pathogenic	pathogenic	ADJ
ajlm-1563	151	77	role	role	NOUN
ajlm-1563	151	78	in	in	ADP
ajlm-1563	151	79	causing	cause	VERB
ajlm-1563	151	80	hsil	hsil	NOUN
ajlm-1563	151	81	than	than	ADP
ajlm-1563	151	82	hpv18/45	hpv18/45	PROPN
ajlm-1563	151	83	.	.	PUNCT
ajlm-1563	152	1	vaccination	vaccination	NOUN
ajlm-1563	152	2	against	against	ADP
ajlm-1563	152	3	hpv	hpv	NOUN
ajlm-1563	152	4	is	be	AUX
ajlm-1563	152	5	effective	effective	ADJ
ajlm-1563	152	6	in	in	ADP
ajlm-1563	152	7	preventing	prevent	VERB
ajlm-1563	152	8	hpv	hpv	NOUN
ajlm-1563	152	9	-	-	PUNCT
ajlm-1563	152	10	related	relate	VERB
ajlm-1563	152	11	cancer	cancer	NOUN
ajlm-1563	152	12	.	.	PUNCT
ajlm-1563	153	1	for	for	ADP
ajlm-1563	153	2	instance	instance	NOUN
ajlm-1563	153	3	,	,	PUNCT
ajlm-1563	153	4	in	in	ADP
ajlm-1563	153	5	scotland	scotland	NOUN
ajlm-1563	153	6	,	,	PUNCT
ajlm-1563	153	7	there	there	PRON
ajlm-1563	153	8	were	be	VERB
ajlm-1563	153	9	statistically	statistically	ADV
ajlm-1563	153	10	significant	significant	ADJ
ajlm-1563	153	11	reductions	reduction	NOUN
ajlm-1563	153	12	in	in	ADP
ajlm-1563	153	13	all	all	DET
ajlm-1563	153	14	grades	grade	NOUN
ajlm-1563	153	15	of	of	ADP
ajlm-1563	153	16	cervical	cervical	ADJ
ajlm-1563	153	17	intraepithelial	intraepithelial	ADJ
ajlm-1563	153	18	neoplasia	neoplasia	NOUN
ajlm-1563	153	19	.	.	PUNCT
ajlm-1563	154	1	the	the	DET
ajlm-1563	154	2	vaccine	vaccine	NOUN
ajlm-1563	154	3	was	be	AUX
ajlm-1563	154	4	estimated	estimate	VERB
ajlm-1563	154	5	to	to	PART
ajlm-1563	154	6	be	be	AUX
ajlm-1563	154	7	≥	≥	NUM
ajlm-1563	154	8	80	80	NUM
ajlm-1563	154	9	%	%	NOUN
ajlm-1563	154	10	effective	effective	ADJ
ajlm-1563	154	11	in	in	ADP
ajlm-1563	154	12	preventing	prevent	VERB
ajlm-1563	154	13	cervical	cervical	ADJ
ajlm-1563	154	14	intraepithelial	intraepithelial	ADJ
ajlm-1563	154	15	lesions	lesion	NOUN
ajlm-1563	154	16	when	when	SCONJ
ajlm-1563	154	17	administered	administer	VERB
ajlm-1563	154	18	routinely	routinely	ADV
ajlm-1563	154	19	to	to	ADP
ajlm-1563	154	20	girls	girl	NOUN
ajlm-1563	154	21	aged	age	VERB
ajlm-1563	154	22	12–13	12–13	NUM
ajlm-1563	154	23	years	year	NOUN
ajlm-1563	154	24	in	in	ADP
ajlm-1563	154	25	the	the	DET
ajlm-1563	154	26	targeted	target	VERB
ajlm-1563	154	27	population.52	population.52	ADJ
ajlm-1563	154	28	different	different	ADJ
ajlm-1563	154	29	types	type	NOUN
ajlm-1563	154	30	of	of	ADP
ajlm-1563	154	31	hpv	hpv	ADJ
ajlm-1563	154	32	vaccines	vaccine	NOUN
ajlm-1563	154	33	are	be	AUX
ajlm-1563	154	34	available	available	ADJ
ajlm-1563	154	35	,	,	PUNCT
ajlm-1563	154	36	including	include	VERB
ajlm-1563	154	37	the	the	DET
ajlm-1563	154	38	quadrivalent	quadrivalent	ADJ
ajlm-1563	154	39	hpv	hpv	NOUN
ajlm-1563	154	40	vaccine	vaccine	NOUN
ajlm-1563	154	41	,	,	PUNCT
ajlm-1563	154	42	gardasil	gardasil	PROPN
ajlm-1563	154	43	®	®	NOUN
ajlm-1563	154	44	9	9	NUM
ajlm-1563	154	45	(	(	PUNCT
ajlm-1563	154	46	sanofi	sanofi	PROPN
ajlm-1563	154	47	pasteur	pasteur	PROPN
ajlm-1563	154	48	msd)/silgard	msd)/silgard	NOUN
ajlm-1563	154	49	®	®	NOUN
ajlm-1563	154	50	(	(	PUNCT
ajlm-1563	154	51	merck	merck	PROPN
ajlm-1563	154	52	sharp	sharp	PROPN
ajlm-1563	154	53	&	&	CCONJ
ajlm-1563	154	54	dohme	dohme	PROPN
ajlm-1563	154	55	)	)	PUNCT
ajlm-1563	154	56	,	,	PUNCT
ajlm-1563	154	57	and	and	CCONJ
ajlm-1563	154	58	the	the	DET
ajlm-1563	154	59	bivalent	bivalent	ADJ
ajlm-1563	154	60	hpv	hpv	ADJ
ajlm-1563	154	61	vaccine	vaccine	NOUN
ajlm-1563	154	62	,	,	PUNCT
ajlm-1563	154	63	cervarix	cervarix	NOUN
ajlm-1563	154	64	®	®	NOUN
ajlm-1563	154	65	(	(	PUNCT
ajlm-1563	154	66	glaxosmithkline	glaxosmithkline	PROPN
ajlm-1563	154	67	biologicals	biological	NOUN
ajlm-1563	154	68	)	)	PUNCT
ajlm-1563	154	69	.	.	PUNCT
ajlm-1563	155	1	in	in	ADP
ajlm-1563	155	2	europe	europe	PROPN
ajlm-1563	155	3	,	,	PUNCT
ajlm-1563	155	4	these	these	DET
ajlm-1563	155	5	vaccines	vaccine	NOUN
ajlm-1563	155	6	were	be	AUX
ajlm-1563	155	7	indicated	indicate	VERB
ajlm-1563	155	8	for	for	ADP
ajlm-1563	155	9	the	the	DET
ajlm-1563	155	10	prevention	prevention	NOUN
ajlm-1563	155	11	of	of	ADP
ajlm-1563	155	12	cervical	cervical	ADJ
ajlm-1563	155	13	,	,	PUNCT
ajlm-1563	155	14	vulvar	vulvar	NOUN
ajlm-1563	155	15	and	and	CCONJ
ajlm-1563	155	16	vaginal	vaginal	ADJ
ajlm-1563	155	17	premalignant	premalignant	ADJ
ajlm-1563	155	18	lesions	lesion	NOUN
ajlm-1563	155	19	and	and	CCONJ
ajlm-1563	155	20	cervical	cervical	ADJ
ajlm-1563	155	21	cancer	cancer	NOUN
ajlm-1563	155	22	related	relate	VERB
ajlm-1563	155	23	to	to	PART
ajlm-1563	155	24	hpv16/18	hpv16/18	VERB
ajlm-1563	155	25	.	.	PUNCT
ajlm-1563	156	1	the	the	DET
ajlm-1563	156	2	quadrivalent	quadrivalent	ADJ
ajlm-1563	156	3	hpv	hpv	NOUN
ajlm-1563	156	4	vaccine	vaccine	NOUN
ajlm-1563	156	5	was	be	AUX
ajlm-1563	156	6	also	also	ADV
ajlm-1563	156	7	indicated	indicate	VERB
ajlm-1563	156	8	against	against	ADP
ajlm-1563	156	9	premalignant	premalignant	ADJ
ajlm-1563	156	10	anal	anal	ADJ
ajlm-1563	156	11	lesions	lesion	NOUN
ajlm-1563	156	12	and	and	CCONJ
ajlm-1563	156	13	anal	anal	ADJ
ajlm-1563	156	14	cancer	cancer	NOUN
ajlm-1563	156	15	and	and	CCONJ
ajlm-1563	156	16	protected	protect	VERB
ajlm-1563	156	17	against	against	ADP
ajlm-1563	156	18	low	low	ADJ
ajlm-1563	156	19	-	-	PUNCT
ajlm-1563	156	20	risk	risk	NOUN
ajlm-1563	156	21	hpv6/11	hpv6/11	NOUN
ajlm-1563	156	22	,	,	PUNCT
ajlm-1563	156	23	which	which	PRON
ajlm-1563	156	24	are	be	AUX
ajlm-1563	156	25	responsible	responsible	ADJ
ajlm-1563	156	26	for	for	ADP
ajlm-1563	156	27	about	about	ADV
ajlm-1563	156	28	90	90	NUM
ajlm-1563	156	29	%	%	NOUN
ajlm-1563	156	30	of	of	ADP
ajlm-1563	156	31	genital	genital	ADJ
ajlm-1563	156	32	warts.53	warts.53	PROPN
ajlm-1563	156	33	zambia	zambia	PROPN
ajlm-1563	156	34	initially	initially	ADV
ajlm-1563	156	35	introduced	introduce	VERB
ajlm-1563	156	36	the	the	DET
ajlm-1563	156	37	hpv	hpv	ADJ
ajlm-1563	156	38	vaccine	vaccine	NOUN
ajlm-1563	156	39	on	on	ADP
ajlm-1563	156	40	a	a	DET
ajlm-1563	156	41	pilot	pilot	ADJ
ajlm-1563	156	42	basis	basis	NOUN
ajlm-1563	156	43	in	in	ADP
ajlm-1563	156	44	2013	2013	NUM
ajlm-1563	156	45	and	and	CCONJ
ajlm-1563	156	46	by	by	ADP
ajlm-1563	156	47	2020	2020	NUM
ajlm-1563	156	48	,	,	PUNCT
ajlm-1563	156	49	the	the	DET
ajlm-1563	156	50	country	country	NOUN
ajlm-1563	156	51	had	have	AUX
ajlm-1563	156	52	integrated	integrate	VERB
ajlm-1563	156	53	it	it	PRON
ajlm-1563	156	54	into	into	ADP
ajlm-1563	156	55	the	the	DET
ajlm-1563	156	56	routine	routine	ADJ
ajlm-1563	156	57	immunisation	immunisation	NOUN
ajlm-1563	156	58	programme	programme	NOUN
ajlm-1563	156	59	using	use	VERB
ajlm-1563	156	60	a	a	DET
ajlm-1563	156	61	system	system	NOUN
ajlm-1563	156	62	that	that	PRON
ajlm-1563	156	63	offers	offer	VERB
ajlm-1563	156	64	two	two	NUM
ajlm-1563	156	65	doses	dose	NOUN
ajlm-1563	156	66	of	of	ADP
ajlm-1563	156	67	the	the	DET
ajlm-1563	156	68	quadrivalent	quadrivalent	NOUN
ajlm-1563	156	69	hpv	hpv	PROPN
ajlm-1563	156	70	vaccine.54	vaccine.54	PROPN
ajlm-1563	156	71	based	base	VERB
ajlm-1563	156	72	on	on	ADP
ajlm-1563	156	73	the	the	DET
ajlm-1563	156	74	preliminary	preliminary	ADJ
ajlm-1563	156	75	findings	finding	NOUN
ajlm-1563	156	76	of	of	ADP
ajlm-1563	156	77	our	our	PRON
ajlm-1563	156	78	study	study	NOUN
ajlm-1563	156	79	,	,	PUNCT
ajlm-1563	156	80	more	more	ADJ
ajlm-1563	156	81	research	research	NOUN
ajlm-1563	156	82	needs	need	VERB
ajlm-1563	156	83	to	to	PART
ajlm-1563	156	84	be	be	AUX
ajlm-1563	156	85	conducted	conduct	VERB
ajlm-1563	156	86	to	to	PART
ajlm-1563	156	87	determine	determine	VERB
ajlm-1563	156	88	the	the	DET
ajlm-1563	156	89	specific	specific	ADJ
ajlm-1563	156	90	genotypes	genotype	NOUN
ajlm-1563	156	91	of	of	ADP
ajlm-1563	156	92	hrhpv	hrhpv	NOUN
ajlm-1563	156	93	that	that	PRON
ajlm-1563	156	94	are	be	AUX
ajlm-1563	156	95	prevalent	prevalent	ADJ
ajlm-1563	156	96	in	in	ADP
ajlm-1563	156	97	the	the	DET
ajlm-1563	156	98	population	population	NOUN
ajlm-1563	156	99	affected	affect	VERB
ajlm-1563	156	100	by	by	ADP
ajlm-1563	156	101	either	either	CCONJ
ajlm-1563	156	102	cervical	cervical	ADJ
ajlm-1563	156	103	or	or	CCONJ
ajlm-1563	156	104	vulvar	vulvar	NOUN
ajlm-1563	156	105	cancer	cancer	NOUN
ajlm-1563	156	106	to	to	PART
ajlm-1563	156	107	inform	inform	VERB
ajlm-1563	156	108	current	current	ADJ
ajlm-1563	156	109	vaccination	vaccination	NOUN
ajlm-1563	156	110	efforts	effort	NOUN
ajlm-1563	156	111	.	.	PUNCT
ajlm-1563	157	1	limitations	limitation	NOUN
ajlm-1563	157	2	even	even	ADV
ajlm-1563	157	3	though	though	SCONJ
ajlm-1563	157	4	university	university	NOUN
ajlm-1563	157	5	teaching	teaching	NOUN
ajlm-1563	157	6	hospital	hospital	NOUN
ajlm-1563	157	7	is	be	AUX
ajlm-1563	157	8	zambia	zambia	PROPN
ajlm-1563	157	9	’s	’s	PART
ajlm-1563	157	10	highest	high	ADJ
ajlm-1563	157	11	level	level	NOUN
ajlm-1563	157	12	referral	referral	ADJ
ajlm-1563	157	13	centre	centre	NOUN
ajlm-1563	157	14	for	for	ADP
ajlm-1563	157	15	the	the	DET
ajlm-1563	157	16	treatment	treatment	NOUN
ajlm-1563	157	17	of	of	ADP
ajlm-1563	157	18	major	major	ADJ
ajlm-1563	157	19	ailments	ailment	NOUN
ajlm-1563	157	20	,	,	PUNCT
ajlm-1563	157	21	a	a	DET
ajlm-1563	157	22	multicentre	multicentre	NOUN
ajlm-1563	157	23	study	study	NOUN
ajlm-1563	157	24	would	would	AUX
ajlm-1563	157	25	have	have	AUX
ajlm-1563	157	26	represented	represent	VERB
ajlm-1563	157	27	the	the	DET
ajlm-1563	157	28	country	country	NOUN
ajlm-1563	157	29	’s	’s	PART
ajlm-1563	157	30	population	population	NOUN
ajlm-1563	157	31	better	well	ADV
ajlm-1563	157	32	.	.	PUNCT
ajlm-1563	158	1	the	the	DET
ajlm-1563	158	2	responses	response	NOUN
ajlm-1563	158	3	given	give	VERB
ajlm-1563	158	4	by	by	ADP
ajlm-1563	158	5	the	the	DET
ajlm-1563	158	6	participants	participant	NOUN
ajlm-1563	158	7	may	may	AUX
ajlm-1563	158	8	have	have	AUX
ajlm-1563	158	9	been	be	AUX
ajlm-1563	158	10	negatively	negatively	ADV
ajlm-1563	158	11	influenced	influence	VERB
ajlm-1563	158	12	by	by	ADP
ajlm-1563	158	13	their	their	PRON
ajlm-1563	158	14	recall	recall	NOUN
ajlm-1563	158	15	bias	bias	NOUN
ajlm-1563	158	16	.	.	PUNCT
ajlm-1563	159	1	one	one	NUM
ajlm-1563	159	2	downside	downside	NOUN
ajlm-1563	159	3	with	with	ADP
ajlm-1563	159	4	our	our	PRON
ajlm-1563	159	5	methodology	methodology	NOUN
ajlm-1563	159	6	is	be	AUX
ajlm-1563	159	7	that	that	SCONJ
ajlm-1563	159	8	genexpert	genexpert	PROPN
ajlm-1563	159	9	reports	report	NOUN
ajlm-1563	159	10	pooled	pool	VERB
ajlm-1563	159	11	hpv	hpv	ADJ
ajlm-1563	159	12	genotypes	genotype	NOUN
ajlm-1563	159	13	and	and	CCONJ
ajlm-1563	159	14	hence	hence	ADV
ajlm-1563	159	15	we	we	PRON
ajlm-1563	159	16	could	could	AUX
ajlm-1563	159	17	not	not	PART
ajlm-1563	159	18	report	report	VERB
ajlm-1563	159	19	the	the	DET
ajlm-1563	159	20	specific	specific	ADJ
ajlm-1563	159	21	genotypes	genotype	NOUN
ajlm-1563	159	22	in	in	ADP
ajlm-1563	159	23	the	the	DET
ajlm-1563	159	24	p3	p3	NOUN
ajlm-1563	159	25	,	,	PUNCT
ajlm-1563	159	26	p4	p4	ADJ
ajlm-1563	159	27	or	or	CCONJ
ajlm-1563	159	28	p5	p5	ADJ
ajlm-1563	159	29	groups	group	NOUN
ajlm-1563	159	30	.	.	PUNCT
ajlm-1563	160	1	furthermore	furthermore	ADV
ajlm-1563	160	2	,	,	PUNCT
ajlm-1563	160	3	we	we	PRON
ajlm-1563	160	4	did	do	AUX
ajlm-1563	160	5	not	not	PART
ajlm-1563	160	6	evaluate	evaluate	VERB
ajlm-1563	160	7	viral	viral	ADJ
ajlm-1563	160	8	load	load	NOUN
ajlm-1563	160	9	,	,	PUNCT
ajlm-1563	160	10	which	which	PRON
ajlm-1563	160	11	is	be	AUX
ajlm-1563	160	12	considered	consider	VERB
ajlm-1563	160	13	a	a	DET
ajlm-1563	160	14	better	well	ADJ
ajlm-1563	160	15	marker	marker	NOUN
ajlm-1563	160	16	of	of	ADP
ajlm-1563	160	17	immunologic	immunologic	ADJ
ajlm-1563	160	18	status	status	NOUN
ajlm-1563	160	19	.	.	PUNCT
ajlm-1563	161	1	also	also	ADV
ajlm-1563	161	2	,	,	PUNCT
ajlm-1563	161	3	we	we	PRON
ajlm-1563	161	4	did	do	AUX
ajlm-1563	161	5	not	not	PART
ajlm-1563	161	6	successfully	successfully	ADV
ajlm-1563	161	7	determine	determine	VERB
ajlm-1563	161	8	viral	viral	ADJ
ajlm-1563	161	9	dna	dna	NOUN
ajlm-1563	161	10	incorporation	incorporation	NOUN
ajlm-1563	161	11	into	into	ADP
ajlm-1563	161	12	the	the	DET
ajlm-1563	161	13	host	host	NOUN
ajlm-1563	161	14	genome	genome	NOUN
ajlm-1563	161	15	using	use	VERB
ajlm-1563	161	16	either	either	CCONJ
ajlm-1563	161	17	p16	p16	NOUN
ajlm-1563	161	18	immunohistochemistry	immunohistochemistry	NOUN
ajlm-1563	161	19	or	or	CCONJ
ajlm-1563	161	20	in	in	ADP
ajlm-1563	161	21	situ	situ	ADJ
ajlm-1563	161	22	hybridisation	hybridisation	NOUN
ajlm-1563	161	23	.	.	PUNCT
ajlm-1563	162	1	conclusion	conclusion	NOUN
ajlm-1563	162	2	vscc	vscc	PROPN
ajlm-1563	162	3	was	be	AUX
ajlm-1563	162	4	associated	associate	VERB
ajlm-1563	162	5	with	with	ADP
ajlm-1563	162	6	women	woman	NOUN
ajlm-1563	162	7	aged	age	VERB
ajlm-1563	162	8	above	above	ADP
ajlm-1563	162	9	40	40	NUM
ajlm-1563	162	10	years	year	NOUN
ajlm-1563	162	11	.	.	PUNCT
ajlm-1563	163	1	the	the	DET
ajlm-1563	163	2	prevalence	prevalence	NOUN
ajlm-1563	163	3	of	of	ADP
ajlm-1563	163	4	hrhpv	hrhpv	NOUN
ajlm-1563	163	5	in	in	ADP
ajlm-1563	163	6	vscc	vscc	NOUN
ajlm-1563	163	7	and	and	CCONJ
ajlm-1563	163	8	hsil	hsil	NOUN
ajlm-1563	163	9	was	be	AUX
ajlm-1563	163	10	high	high	ADJ
ajlm-1563	163	11	.	.	PUNCT
ajlm-1563	164	1	we	we	PRON
ajlm-1563	164	2	recommend	recommend	VERB
ajlm-1563	164	3	that	that	SCONJ
ajlm-1563	164	4	women	woman	NOUN
ajlm-1563	164	5	living	live	VERB
ajlm-1563	164	6	with	with	ADP
ajlm-1563	164	7	hiv	hiv	PROPN
ajlm-1563	164	8	,	,	PUNCT
ajlm-1563	164	9	especially	especially	ADV
ajlm-1563	164	10	women	woman	NOUN
ajlm-1563	164	11	aged	age	VERB
ajlm-1563	164	12	above	above	ADP
ajlm-1563	164	13	40	40	NUM
ajlm-1563	164	14	years	year	NOUN
ajlm-1563	164	15	,	,	PUNCT
ajlm-1563	164	16	should	should	AUX
ajlm-1563	164	17	have	have	VERB
ajlm-1563	164	18	a	a	DET
ajlm-1563	164	19	close	close	ADJ
ajlm-1563	164	20	clinical	clinical	ADJ
ajlm-1563	164	21	follow	follow	NOUN
ajlm-1563	164	22	-	-	PUNCT
ajlm-1563	164	23	up	up	NOUN
ajlm-1563	164	24	with	with	ADP
ajlm-1563	164	25	routine	routine	ADJ
ajlm-1563	164	26	evaluation	evaluation	NOUN
ajlm-1563	164	27	of	of	ADP
ajlm-1563	164	28	the	the	DET
ajlm-1563	164	29	vulva	vulva	NOUN
ajlm-1563	164	30	and	and	CCONJ
ajlm-1563	164	31	biopsy	biopsy	NOUN
ajlm-1563	164	32	of	of	ADP
ajlm-1563	164	33	all	all	DET
ajlm-1563	164	34	lesions	lesion	NOUN
ajlm-1563	164	35	.	.	PUNCT
ajlm-1563	165	1	we	we	PRON
ajlm-1563	165	2	recommend	recommend	VERB
ajlm-1563	165	3	a	a	DET
ajlm-1563	165	4	multicentre	multicentre	NOUN
ajlm-1563	165	5	study	study	NOUN
ajlm-1563	165	6	to	to	PART
ajlm-1563	165	7	further	far	ADV
ajlm-1563	165	8	evaluate	evaluate	VERB
ajlm-1563	165	9	vulvar	vulvar	ADJ
ajlm-1563	165	10	neoplastic	neoplastic	ADJ
ajlm-1563	165	11	lesions	lesion	NOUN
ajlm-1563	165	12	in	in	ADP
ajlm-1563	165	13	zambia	zambia	PROPN
ajlm-1563	165	14	and	and	CCONJ
ajlm-1563	165	15	determine	determine	VERB
ajlm-1563	165	16	other	other	ADJ
ajlm-1563	165	17	genotypes	genotype	NOUN
ajlm-1563	165	18	other	other	ADJ
ajlm-1563	165	19	than	than	ADP
ajlm-1563	165	20	hpv16	hpv16	NOUN
ajlm-1563	165	21	to	to	PART
ajlm-1563	165	22	inform	inform	VERB
ajlm-1563	165	23	current	current	ADJ
ajlm-1563	165	24	vaccination	vaccination	NOUN
ajlm-1563	165	25	efforts	effort	NOUN
ajlm-1563	165	26	.	.	PUNCT
ajlm-1563	166	1	human	human	ADJ
ajlm-1563	166	2	papillomavirus	papillomavirus	NOUN
ajlm-1563	166	3	vaccination	vaccination	NOUN
ajlm-1563	166	4	of	of	ADP
ajlm-1563	166	5	adolescent	adolescent	ADJ
ajlm-1563	166	6	girls	girl	NOUN
ajlm-1563	166	7	should	should	AUX
ajlm-1563	166	8	be	be	AUX
ajlm-1563	166	9	supported	support	VERB
ajlm-1563	166	10	as	as	ADP
ajlm-1563	166	11	a	a	DET
ajlm-1563	166	12	public	public	ADJ
ajlm-1563	166	13	health	health	NOUN
ajlm-1563	166	14	approach	approach	NOUN
ajlm-1563	166	15	to	to	ADP
ajlm-1563	166	16	the	the	DET
ajlm-1563	166	17	elimination	elimination	NOUN
ajlm-1563	166	18	of	of	ADP
ajlm-1563	166	19	vulvar	vulvar	NOUN
ajlm-1563	166	20	neoplasia	neoplasia	NOUN
ajlm-1563	166	21	.	.	PUNCT
ajlm-1563	167	1	acknowledgements	acknowledgement	NOUN
ajlm-1563	167	2	we	we	PRON
ajlm-1563	167	3	acknowledge	acknowledge	VERB
ajlm-1563	167	4	the	the	DET
ajlm-1563	167	5	support	support	NOUN
ajlm-1563	167	6	of	of	ADP
ajlm-1563	167	7	the	the	DET
ajlm-1563	167	8	university	university	PROPN
ajlm-1563	167	9	of	of	ADP
ajlm-1563	167	10	north	north	PROPN
ajlm-1563	167	11	carolina	carolina	PROPN
ajlm-1563	167	12	global	global	PROPN
ajlm-1563	167	13	projects	project	NOUN
ajlm-1563	167	14	zambia	zambia	PROPN
ajlm-1563	167	15	team	team	PROPN
ajlm-1563	167	16	and	and	CCONJ
ajlm-1563	167	17	the	the	DET
ajlm-1563	167	18	university	university	PROPN
ajlm-1563	167	19	of	of	ADP
ajlm-1563	167	20	zambia	zambia	PROPN
ajlm-1563	167	21	,	,	PUNCT
ajlm-1563	167	22	school	school	NOUN
ajlm-1563	167	23	of	of	ADP
ajlm-1563	167	24	medicine	medicine	NOUN
ajlm-1563	167	25	.	.	PUNCT
ajlm-1563	168	1	competing	compete	VERB
ajlm-1563	168	2	interests	interest	NOUN
ajlm-1563	168	3	the	the	DET
ajlm-1563	168	4	authors	author	NOUN
ajlm-1563	168	5	declare	declare	VERB
ajlm-1563	168	6	that	that	SCONJ
ajlm-1563	168	7	they	they	PRON
ajlm-1563	168	8	have	have	VERB
ajlm-1563	168	9	no	no	DET
ajlm-1563	168	10	financial	financial	ADJ
ajlm-1563	168	11	or	or	CCONJ
ajlm-1563	168	12	personal	personal	ADJ
ajlm-1563	168	13	relationships	relationship	NOUN
ajlm-1563	168	14	that	that	PRON
ajlm-1563	168	15	may	may	AUX
ajlm-1563	168	16	have	have	AUX
ajlm-1563	168	17	inappropriately	inappropriately	ADV
ajlm-1563	168	18	influenced	influence	VERB
ajlm-1563	168	19	them	they	PRON
ajlm-1563	168	20	in	in	ADP
ajlm-1563	168	21	writing	write	VERB
ajlm-1563	168	22	this	this	DET
ajlm-1563	168	23	article	article	NOUN
ajlm-1563	168	24	.	.	PUNCT
ajlm-1563	169	1	author	author	PROPN
ajlm-1563	169	2	’s	’s	PART
ajlm-1563	169	3	contributions	contribution	NOUN
ajlm-1563	169	4	all	all	DET
ajlm-1563	169	5	the	the	DET
ajlm-1563	169	6	authors	author	NOUN
ajlm-1563	169	7	contributed	contribute	VERB
ajlm-1563	169	8	to	to	ADP
ajlm-1563	169	9	the	the	DET
ajlm-1563	169	10	conceptualisation	conceptualisation	NOUN
ajlm-1563	169	11	of	of	ADP
ajlm-1563	169	12	the	the	DET
ajlm-1563	169	13	article	article	NOUN
ajlm-1563	169	14	.	.	PUNCT
ajlm-1563	170	1	f.m	f.m	PROPN
ajlm-1563	170	2	.	.	PROPN
ajlm-1563	170	3	wrote	write	VERB
ajlm-1563	170	4	the	the	DET
ajlm-1563	170	5	initial	initial	ADJ
ajlm-1563	170	6	draft	draft	NOUN
ajlm-1563	170	7	,	,	PUNCT
ajlm-1563	170	8	while	while	SCONJ
ajlm-1563	170	9	the	the	DET
ajlm-1563	170	10	rest	rest	NOUN
ajlm-1563	170	11	of	of	ADP
ajlm-1563	170	12	the	the	DET
ajlm-1563	170	13	authors	author	NOUN
ajlm-1563	170	14	reviewed	review	VERB
ajlm-1563	170	15	and	and	CCONJ
ajlm-1563	170	16	revised	revise	VERB
ajlm-1563	170	17	it	it	PRON
ajlm-1563	170	18	.	.	PUNCT
ajlm-1563	171	1	f.m	f.m	PROPN
ajlm-1563	171	2	.	.	PROPN
ajlm-1563	171	3	,	,	PUNCT
ajlm-1563	171	4	p.j	p.j	PROPN
ajlm-1563	171	5	.	.	PROPN
ajlm-1563	171	6	,	,	PUNCT
ajlm-1563	171	7	l.p	l.p	PROPN
ajlm-1563	171	8	.	.	PROPN
ajlm-1563	171	9	,	,	PUNCT
ajlm-1563	171	10	m.m	m.m	PROPN
ajlm-1563	171	11	.	.	PROPN
ajlm-1563	171	12	and	and	CCONJ
ajlm-1563	171	13	g.p	g.p	PROPN
ajlm-1563	171	14	.	.	PROPN
ajlm-1563	171	15	conducted	conduct	VERB
ajlm-1563	171	16	the	the	DET
ajlm-1563	171	17	investigations	investigation	NOUN
ajlm-1563	171	18	.	.	PUNCT
ajlm-1563	172	1	formal	formal	ADJ
ajlm-1563	172	2	analysis	analysis	NOUN
ajlm-1563	172	3	was	be	AUX
ajlm-1563	172	4	conducted	conduct	VERB
ajlm-1563	172	5	by	by	ADP
ajlm-1563	172	6	all	all	DET
ajlm-1563	172	7	authors	author	NOUN
ajlm-1563	172	8	.	.	PUNCT
ajlm-1563	173	1	l.p	l.p	PROPN
ajlm-1563	173	2	.	.	PROPN
ajlm-1563	173	3	,	,	PUNCT
ajlm-1563	173	4	t.k	t.k	PROPN
ajlm-1563	173	5	.	.	PROPN
ajlm-1563	173	6	,	,	PUNCT
ajlm-1563	173	7	m.m	m.m	PROPN
ajlm-1563	173	8	.	.	PROPN
ajlm-1563	173	9	,	,	PUNCT
ajlm-1563	173	10	p.j	p.j	PROPN
ajlm-1563	173	11	.	.	PROPN
ajlm-1563	173	12	and	and	CCONJ
ajlm-1563	173	13	g.p	g.p	PROPN
ajlm-1563	173	14	.	.	PROPN
ajlm-1563	173	15	provided	provide	VERB
ajlm-1563	173	16	supervision	supervision	NOUN
ajlm-1563	173	17	.	.	PUNCT
ajlm-1563	174	1	s.s	s.s	PROPN
ajlm-1563	174	2	conducted	conduct	VERB
ajlm-1563	174	3	statistical	statistical	ADJ
ajlm-1563	174	4	analysis	analysis	NOUN
ajlm-1563	174	5	and	and	CCONJ
ajlm-1563	174	6	review	review	NOUN
ajlm-1563	174	7	of	of	ADP
ajlm-1563	174	8	the	the	DET
ajlm-1563	174	9	article	article	NOUN
ajlm-1563	174	10	.	.	PUNCT
ajlm-1563	175	1	f.m	f.m	PROPN
ajlm-1563	175	2	.	.	PROPN
ajlm-1563	175	3	was	be	AUX
ajlm-1563	175	4	the	the	DET
ajlm-1563	175	5	project	project	NOUN
ajlm-1563	175	6	administrator	administrator	NOUN
ajlm-1563	175	7	and	and	CCONJ
ajlm-1563	175	8	co	co	ADJ
ajlm-1563	175	9	-	-	ADJ
ajlm-1563	175	10	principal	principal	ADJ
ajlm-1563	175	11	investigator	investigator	NOUN
ajlm-1563	175	12	with	with	ADP
ajlm-1563	175	13	g.p	g.p	PROPN
ajlm-1563	175	14	.	.	PROPN
ajlm-1563	175	15	sources	source	NOUN
ajlm-1563	175	16	of	of	ADP
ajlm-1563	175	17	support	support	NOUN
ajlm-1563	175	18	this	this	DET
ajlm-1563	175	19	study	study	NOUN
ajlm-1563	175	20	was	be	AUX
ajlm-1563	175	21	partly	partly	ADV
ajlm-1563	175	22	funded	fund	VERB
ajlm-1563	175	23	through	through	ADP
ajlm-1563	175	24	the	the	DET
ajlm-1563	175	25	university	university	PROPN
ajlm-1563	175	26	of	of	ADP
ajlm-1563	175	27	north	north	PROPN
ajlm-1563	175	28	carolina	carolina	PROPN
ajlm-1563	175	29	at	at	ADP
ajlm-1563	175	30	chapel	chapel	PROPN
ajlm-1563	175	31	hill	hill	PROPN
ajlm-1563	175	32	,	,	PUNCT
ajlm-1563	175	33	johns	johns	PROPN
ajlm-1563	175	34	hopkins	hopkins	PROPN
ajlm-1563	175	35	university	university	PROPN
ajlm-1563	175	36	,	,	PUNCT
ajlm-1563	175	37	morehouse	morehouse	PROPN
ajlm-1563	175	38	school	school	NOUN
ajlm-1563	175	39	of	of	ADP
ajlm-1563	175	40	medicine	medicine	NOUN
ajlm-1563	175	41	,	,	PUNCT
ajlm-1563	175	42	and	and	CCONJ
ajlm-1563	175	43	tulane	tulane	PROPN
ajlm-1563	175	44	university	university	PROPN
ajlm-1563	175	45	fogarty	fogarty	PROPN
ajlm-1563	175	46	global	global	PROPN
ajlm-1563	175	47	health	health	PROPN
ajlm-1563	175	48	fellowship	fellowship	NOUN
ajlm-1563	175	49	program	program	NOUN
ajlm-1563	175	50	(	(	PUNCT
ajlm-1563	175	51	grant	grant	NOUN
ajlm-1563	175	52	number	number	NOUN
ajlm-1563	175	53	r25	r25	NOUN
ajlm-1563	175	54	tw009340	tw009340	NOUN
ajlm-1563	175	55	)	)	PUNCT
ajlm-1563	175	56	financial	financial	ADJ
ajlm-1563	175	57	support	support	NOUN
ajlm-1563	175	58	.	.	PUNCT
ajlm-1563	176	1	data	datum	NOUN
ajlm-1563	176	2	availability	availability	NOUN
ajlm-1563	176	3	data	datum	NOUN
ajlm-1563	176	4	supporting	support	VERB
ajlm-1563	176	5	the	the	DET
ajlm-1563	176	6	findings	finding	NOUN
ajlm-1563	176	7	of	of	ADP
ajlm-1563	176	8	this	this	DET
ajlm-1563	176	9	study	study	NOUN
ajlm-1563	176	10	are	be	AUX
ajlm-1563	176	11	available	available	ADJ
ajlm-1563	176	12	from	from	ADP
ajlm-1563	176	13	the	the	DET
ajlm-1563	176	14	corresponding	corresponding	ADJ
ajlm-1563	176	15	author	author	NOUN
ajlm-1563	176	16	,	,	PUNCT
ajlm-1563	176	17	f.m	f.m	PROPN
ajlm-1563	176	18	.	.	PROPN
ajlm-1563	176	19	,	,	PUNCT
ajlm-1563	176	20	on	on	ADP
ajlm-1563	176	21	request	request	NOUN
ajlm-1563	176	22	.	.	PUNCT
ajlm-1563	177	1	disclaimer	disclaimer	VERB
ajlm-1563	177	2	the	the	DET
ajlm-1563	177	3	views	view	NOUN
ajlm-1563	177	4	and	and	CCONJ
ajlm-1563	177	5	opinions	opinion	NOUN
ajlm-1563	177	6	expressed	express	VERB
ajlm-1563	177	7	in	in	ADP
ajlm-1563	177	8	this	this	DET
ajlm-1563	177	9	article	article	NOUN
ajlm-1563	177	10	are	be	AUX
ajlm-1563	177	11	those	those	PRON
ajlm-1563	177	12	of	of	ADP
ajlm-1563	177	13	the	the	DET
ajlm-1563	177	14	authors	author	NOUN
ajlm-1563	177	15	and	and	CCONJ
ajlm-1563	177	16	do	do	AUX
ajlm-1563	177	17	not	not	PART
ajlm-1563	177	18	necessary	necessary	ADJ
ajlm-1563	177	19	reflect	reflect	VERB
ajlm-1563	177	20	the	the	DET
ajlm-1563	177	21	official	official	ADJ
ajlm-1563	177	22	policy	policy	NOUN
ajlm-1563	177	23	or	or	CCONJ
ajlm-1563	177	24	position	position	NOUN
ajlm-1563	177	25	of	of	ADP
ajlm-1563	177	26	the	the	DET
ajlm-1563	177	27	affiliated	affiliated	ADJ
ajlm-1563	177	28	agency	agency	NOUN
ajlm-1563	177	29	of	of	ADP
ajlm-1563	177	30	the	the	DET
ajlm-1563	177	31	authors	author	NOUN
ajlm-1563	177	32	.	.	PUNCT
ajlm-1563	178	1	references	reference	NOUN
ajlm-1563	178	2	dasgupta	dasgupta	PROPN
ajlm-1563	178	3	s	s	PROPN
ajlm-1563	178	4	,	,	PUNCT
ajlm-1563	178	5	ewing	ewing	ADJ
ajlm-1563	178	6	-	-	PUNCT
ajlm-1563	178	7	graham	graham	PROPN
ajlm-1563	178	8	pc	pc	PROPN
ajlm-1563	178	9	,	,	PUNCT
ajlm-1563	178	10	swagemakers	swagemaker	NOUN
ajlm-1563	178	11	sma	sma	VERB
ajlm-1563	178	12	,	,	PUNCT
ajlm-1563	178	13	et	et	PROPN
ajlm-1563	178	14	al	al	PROPN
ajlm-1563	178	15	.	.	PUNCT
ajlm-1563	179	1	precursor	precursor	NOUN
ajlm-1563	179	2	lesions	lesion	NOUN
ajlm-1563	179	3	of	of	ADP
ajlm-1563	179	4	vulvar	vulvar	ADJ
ajlm-1563	179	5	squamous	squamous	ADJ
ajlm-1563	179	6	cell	cell	NOUN
ajlm-1563	179	7	carcinoma	carcinoma	NOUN
ajlm-1563	179	8	–	–	PUNCT
ajlm-1563	179	9	histology	histology	NOUN
ajlm-1563	179	10	and	and	CCONJ
ajlm-1563	179	11	biomarkers	biomarker	NOUN
ajlm-1563	179	12	:	:	PUNCT
ajlm-1563	179	13	a	a	DET
ajlm-1563	179	14	systematic	systematic	ADJ
ajlm-1563	179	15	review	review	NOUN
ajlm-1563	179	16	.	.	PUNCT
ajlm-1563	180	1	crit	crit	PROPN
ajlm-1563	180	2	rev	rev	VERB
ajlm-1563	180	3	oncol	oncol	ADJ
ajlm-1563	180	4	hematol	hematol	NOUN
ajlm-1563	180	5	.	.	PUNCT
ajlm-1563	181	1	2020;147:102866	2020;147:102866	X
ajlm-1563	181	2	.	.	PUNCT
ajlm-1563	182	1	https://doi.org/10.1016/j.critrevonc.2020.102866	https://doi.org/10.1016/j.critrevonc.2020.102866	PROPN
ajlm-1563	182	2	alkatout	alkatout	PROPN
ajlm-1563	182	3	i	i	PROPN
ajlm-1563	182	4	,	,	PUNCT
ajlm-1563	182	5	schubert	schubert	PROPN
ajlm-1563	182	6	m	m	PROPN
ajlm-1563	182	7	,	,	PUNCT
ajlm-1563	182	8	weigel	weigel	PROPN
ajlm-1563	182	9	mt	mt	PROPN
ajlm-1563	182	10	,	,	PUNCT
ajlm-1563	182	11	mundhenke	mundhenke	PROPN
ajlm-1563	182	12	c	c	PROPN
ajlm-1563	182	13	,	,	PUNCT
ajlm-1563	182	14	günther	günther	VERB
ajlm-1563	182	15	v.	v.	ADP
ajlm-1563	182	16	vulvar	vulvar	NOUN
ajlm-1563	182	17	cancer	cancer	NOUN
ajlm-1563	182	18	:	:	PUNCT
ajlm-1563	182	19	epidemiology	epidemiology	NOUN
ajlm-1563	182	20	,	,	PUNCT
ajlm-1563	182	21	clinical	clinical	ADJ
ajlm-1563	182	22	presentation	presentation	NOUN
ajlm-1563	182	23	,	,	PUNCT
ajlm-1563	182	24	and	and	CCONJ
ajlm-1563	182	25	management	management	NOUN
ajlm-1563	182	26	options	option	NOUN
ajlm-1563	182	27	.	.	PUNCT
ajlm-1563	183	1	int	int	NOUN
ajlm-1563	183	2	j	j	PROPN
ajlm-1563	183	3	women	woman	NOUN
ajlm-1563	183	4	’s	’s	PART
ajlm-1563	183	5	heal	heal	NOUN
ajlm-1563	183	6	.	.	PUNCT
ajlm-1563	184	1	2015;7:305–313	2015;7:305–313	NUM
ajlm-1563	184	2	.	.	PUNCT
ajlm-1563	185	1	https://doi.org/10.2147/ijwh.s68979	https://doi.org/10.2147/ijwh.s68979	PROPN
ajlm-1563	185	2	allbritton	allbritton	PROPN
ajlm-1563	185	3	ji	ji	PROPN
ajlm-1563	185	4	.	.	PROPN
ajlm-1563	185	5	vulvar	vulvar	PROPN
ajlm-1563	185	6	neoplasms	neoplasm	NOUN
ajlm-1563	185	7	,	,	PUNCT
ajlm-1563	185	8	benign	benign	ADJ
ajlm-1563	185	9	and	and	CCONJ
ajlm-1563	185	10	malignant	malignant	ADJ
ajlm-1563	185	11	.	.	PUNCT
ajlm-1563	186	1	obstet	obstet	PROPN
ajlm-1563	186	2	gynecol	gynecol	PROPN
ajlm-1563	186	3	clin	clin	PROPN
ajlm-1563	186	4	north	north	PROPN
ajlm-1563	186	5	am	am	PROPN
ajlm-1563	186	6	.	.	PUNCT
ajlm-1563	187	1	2017;44(3):339–352	2017;44(3):339–352	X
ajlm-1563	187	2	.	.	PUNCT
ajlm-1563	188	1	https://doi.org/10.1016/j.ogc.2017.04.002	https://doi.org/10.1016/j.ogc.2017.04.002	PROPN
ajlm-1563	188	2	de	de	PROPN
ajlm-1563	188	3	bie	bie	PROPN
ajlm-1563	188	4	rp	rp	PROPN
ajlm-1563	188	5	,	,	PUNCT
ajlm-1563	188	6	van	van	PROPN
ajlm-1563	188	7	de	de	X
ajlm-1563	188	8	nieuwenhof	nieuwenhof	PROPN
ajlm-1563	188	9	hp	hp	PROPN
ajlm-1563	188	10	,	,	PUNCT
ajlm-1563	188	11	bekkers	bekkers	PROPN
ajlm-1563	188	12	rlm	rlm	PROPN
ajlm-1563	188	13	,	,	PUNCT
ajlm-1563	188	14	et	et	PROPN
ajlm-1563	188	15	al	al	PROPN
ajlm-1563	188	16	.	.	PUNCT
ajlm-1563	189	1	patients	patient	NOUN
ajlm-1563	189	2	with	with	ADP
ajlm-1563	189	3	usual	usual	ADJ
ajlm-1563	189	4	vulvar	vulvar	NOUN
ajlm-1563	189	5	intraepithelial	intraepithelial	ADJ
ajlm-1563	189	6	neoplasia	neoplasia	NOUN
ajlm-1563	189	7	-	-	PUNCT
ajlm-1563	189	8	related	relate	VERB
ajlm-1563	189	9	vulvar	vulvar	NOUN
ajlm-1563	189	10	cancer	cancer	NOUN
ajlm-1563	189	11	have	have	VERB
ajlm-1563	189	12	an	an	DET
ajlm-1563	189	13	increased	increase	VERB
ajlm-1563	189	14	risk	risk	NOUN
ajlm-1563	189	15	of	of	ADP
ajlm-1563	189	16	cervical	cervical	ADJ
ajlm-1563	189	17	abnormalities	abnormality	NOUN
ajlm-1563	189	18	.	.	PUNCT
ajlm-1563	190	1	br	br	PROPN
ajlm-1563	190	2	j	j	PROPN
ajlm-1563	190	3	cancer	cancer	NOUN
ajlm-1563	190	4	.	.	PUNCT
ajlm-1563	191	1	2009;101(1):27–31	2009;101(1):27–31	NUM
ajlm-1563	191	2	.	.	PUNCT
ajlm-1563	192	1	https://doi.org/10.1038/sj.bjc.6605124	https://doi.org/10.1038/sj.bjc.6605124	NOUN
ajlm-1563	192	2	pino	pino	PROPN
ajlm-1563	192	3	m	m	PROPN
ajlm-1563	192	4	,	,	PUNCT
ajlm-1563	192	5	rodriguez	rodriguez	NOUN
ajlm-1563	192	6	-	-	PUNCT
ajlm-1563	192	7	carunchio	carunchio	PROPN
ajlm-1563	192	8	l	l	PROPN
ajlm-1563	192	9	,	,	PUNCT
ajlm-1563	192	10	ordi	ordi	PROPN
ajlm-1563	192	11	j.	j.	PROPN
ajlm-1563	192	12	pathways	pathways	PROPN
ajlm-1563	192	13	of	of	ADP
ajlm-1563	192	14	vulvar	vulvar	NOUN
ajlm-1563	192	15	intraepithelial	intraepithelial	ADJ
ajlm-1563	192	16	neoplasia	neoplasia	NOUN
ajlm-1563	192	17	and	and	CCONJ
ajlm-1563	192	18	squamous	squamous	ADJ
ajlm-1563	192	19	cell	cell	NOUN
ajlm-1563	192	20	carcinoma	carcinoma	NOUN
ajlm-1563	192	21	.	.	PUNCT
ajlm-1563	193	1	histopathology	histopathology	NOUN
ajlm-1563	193	2	.	.	PUNCT
ajlm-1563	194	1	2013;(62):161–175	2013;(62):161–175	NUM
ajlm-1563	194	2	.	.	PUNCT
ajlm-1563	195	1	https://doi.org/10.1111/his.12034	https://doi.org/10.1111/his.12034	PROPN
ajlm-1563	195	2	preti	preti	PROPN
ajlm-1563	195	3	m	m	PROPN
ajlm-1563	195	4	,	,	PUNCT
ajlm-1563	195	5	igidbashian	igidbashian	PROPN
ajlm-1563	195	6	s	s	NOUN
ajlm-1563	195	7	,	,	PUNCT
ajlm-1563	195	8	costa	costa	PROPN
ajlm-1563	195	9	s	s	PART
ajlm-1563	195	10	,	,	PUNCT
ajlm-1563	195	11	et	et	PROPN
ajlm-1563	195	12	al	al	PROPN
ajlm-1563	195	13	.	.	PROPN
ajlm-1563	196	1	vin	vin	PROPN
ajlm-1563	196	2	usual	usual	ADJ
ajlm-1563	196	3	type	type	NOUN
ajlm-1563	196	4	-	-	PUNCT
ajlm-1563	196	5	from	from	ADP
ajlm-1563	196	6	the	the	DET
ajlm-1563	196	7	past	past	NOUN
ajlm-1563	196	8	to	to	ADP
ajlm-1563	196	9	the	the	DET
ajlm-1563	196	10	future	future	NOUN
ajlm-1563	196	11	.	.	PUNCT
ajlm-1563	197	1	ecancermedicalscience	ecancermedicalscience	NOUN
ajlm-1563	197	2	.	.	PUNCT
ajlm-1563	198	1	2015;9:531	2015;9:531	NUM
ajlm-1563	198	2	.	.	PUNCT
ajlm-1563	199	1	https://doi.org/10.3332/ecancer.2015.531	https://doi.org/10.3332/ecancer.2015.531	PROPN
ajlm-1563	199	2	léonard	léonard	PROPN
ajlm-1563	199	3	b	b	NOUN
ajlm-1563	199	4	,	,	PUNCT
ajlm-1563	199	5	kridelka	kridelka	NOUN
ajlm-1563	199	6	f	f	NOUN
ajlm-1563	199	7	,	,	PUNCT
ajlm-1563	199	8	delbecque	delbecque	ADJ
ajlm-1563	199	9	k	k	PROPN
ajlm-1563	199	10	,	,	PUNCT
ajlm-1563	199	11	et	et	PROPN
ajlm-1563	199	12	al	al	PROPN
ajlm-1563	199	13	.	.	PUNCT
ajlm-1563	200	1	a	a	DET
ajlm-1563	200	2	clinical	clinical	ADJ
ajlm-1563	200	3	and	and	CCONJ
ajlm-1563	200	4	pathological	pathological	ADJ
ajlm-1563	200	5	overview	overview	NOUN
ajlm-1563	200	6	of	of	ADP
ajlm-1563	200	7	vulvar	vulvar	NOUN
ajlm-1563	200	8	condyloma	condyloma	PROPN
ajlm-1563	200	9	acuminatum	acuminatum	NOUN
ajlm-1563	200	10	,	,	PUNCT
ajlm-1563	200	11	intraepithelial	intraepithelial	ADJ
ajlm-1563	200	12	neoplasia	neoplasia	NOUN
ajlm-1563	200	13	,	,	PUNCT
ajlm-1563	200	14	and	and	CCONJ
ajlm-1563	200	15	squamous	squamous	ADJ
ajlm-1563	200	16	cell	cell	NOUN
ajlm-1563	200	17	carcinoma	carcinoma	NOUN
ajlm-1563	200	18	.	.	PUNCT
ajlm-1563	201	1	hindawi	hindawi	PROPN
ajlm-1563	201	2	publ	publ	PROPN
ajlm-1563	201	3	corp	corp	PROPN
ajlm-1563	201	4	biomed	biome	VERB
ajlm-1563	201	5	res	re	NOUN
ajlm-1563	201	6	int	int	NOUN
ajlm-1563	201	7	.	.	PUNCT
ajlm-1563	202	1	2014;2014	2014;2014	X
ajlm-1563	202	2	.	.	PUNCT
ajlm-1563	203	1	https://doi.org/10.1155/2014/480573	https://doi.org/10.1155/2014/480573	PROPN
ajlm-1563	203	2	international	international	ADJ
ajlm-1563	203	3	agency	agency	PROPN
ajlm-1563	203	4	for	for	ADP
ajlm-1563	203	5	research	research	NOUN
ajlm-1563	203	6	on	on	ADP
ajlm-1563	203	7	cancer	cancer	NOUN
ajlm-1563	203	8	i.	i.	PROPN
ajlm-1563	203	9	iarc	iarc	PROPN
ajlm-1563	203	10	monographs	monograph	NOUN
ajlm-1563	203	11	on	on	ADP
ajlm-1563	203	12	the	the	DET
ajlm-1563	203	13	evaluation	evaluation	NOUN
ajlm-1563	203	14	of	of	ADP
ajlm-1563	203	15	carcinogenic	carcinogenic	ADJ
ajlm-1563	203	16	risks	risk	NOUN
ajlm-1563	203	17	to	to	ADP
ajlm-1563	203	18	humans	human	NOUN
ajlm-1563	203	19	volume	volume	VERB
ajlm-1563	203	20	90	90	NUM
ajlm-1563	203	21	human	human	ADJ
ajlm-1563	203	22	papillomaviruses	papillomaviruse	NOUN
ajlm-1563	203	23	.	.	PUNCT
ajlm-1563	204	1	lyon	lyon	PROPN
ajlm-1563	204	2	:	:	PUNCT
ajlm-1563	204	3	international	international	ADJ
ajlm-1563	204	4	agency	agency	NOUN
ajlm-1563	204	5	for	for	ADP
ajlm-1563	204	6	research	research	NOUN
ajlm-1563	204	7	on	on	ADP
ajlm-1563	204	8	cancer	cancer	NOUN
ajlm-1563	204	9	(	(	PUNCT
ajlm-1563	204	10	iarc	iarc	NOUN
ajlm-1563	204	11	)	)	PUNCT
ajlm-1563	204	12	69372	69372	NUM
ajlm-1563	204	13	lyon	lyon	PROPN
ajlm-1563	204	14	cedex	cedex	PROPN
ajlm-1563	204	15	08	08	PROPN
ajlm-1563	204	16	,	,	PUNCT
ajlm-1563	204	17	france	france	PROPN
ajlm-1563	204	18	;	;	PUNCT
ajlm-1563	204	19	2007	2007	NUM
ajlm-1563	204	20	.	.	PUNCT
ajlm-1563	205	1	ellenson	ellenson	PROPN
ajlm-1563	205	2	lh	lh	PROPN
ajlm-1563	205	3	,	,	PUNCT
ajlm-1563	205	4	pirog	pirog	VERB
ajlm-1563	205	5	ec	ec	PROPN
ajlm-1563	205	6	.	.	PUNCT
ajlm-1563	205	7	robbins	robbins	PROPN
ajlm-1563	205	8	and	and	CCONJ
ajlm-1563	205	9	cotran	cotran	VERB
ajlm-1563	205	10	pathologic	pathologic	ADJ
ajlm-1563	205	11	basis	basis	NOUN
ajlm-1563	205	12	of	of	ADP
ajlm-1563	205	13	disease	disease	NOUN
ajlm-1563	205	14	.	.	PUNCT
ajlm-1563	206	1	9th	9th	ADJ
ajlm-1563	206	2	ed	ed	NOUN
ajlm-1563	206	3	.	.	PUNCT
ajlm-1563	207	1	kumar	kumar	PROPN
ajlm-1563	207	2	v	v	PROPN
ajlm-1563	207	3	,	,	PUNCT
ajlm-1563	207	4	abbas	abbas	PROPN
ajlm-1563	207	5	ak	ak	PROPN
ajlm-1563	207	6	,	,	PUNCT
ajlm-1563	207	7	aster	aster	NOUN
ajlm-1563	207	8	jc	jc	PROPN
ajlm-1563	207	9	,	,	PUNCT
ajlm-1563	207	10	editors	editor	NOUN
ajlm-1563	207	11	.	.	PUNCT
ajlm-1563	208	1	philadelphia	philadelphia	PROPN
ajlm-1563	208	2	,	,	PUNCT
ajlm-1563	208	3	pa	pa	PROPN
ajlm-1563	208	4	:	:	PUNCT
ajlm-1563	208	5	elsevier	elsevier	PROPN
ajlm-1563	208	6	saunders	saunder	NOUN
ajlm-1563	208	7	,	,	PUNCT
ajlm-1563	208	8	2015	2015	NUM
ajlm-1563	208	9	;	;	PUNCT
ajlm-1563	208	10	991–1042	991–1042	NUM
ajlm-1563	208	11	p.	p.	NOUN
ajlm-1563	208	12	crum	crum	PROPN
ajlm-1563	209	1	cp	cp	PROPN
ajlm-1563	209	2	,	,	PUNCT
ajlm-1563	209	3	herrington	herrington	PROPN
ajlm-1563	209	4	cs	cs	PROPN
ajlm-1563	209	5	,	,	PUNCT
ajlm-1563	209	6	mccluggage	mccluggage	NOUN
ajlm-1563	209	7	wg	wg	PROPN
ajlm-1563	209	8	,	,	PUNCT
ajlm-1563	209	9	wilkingson	wilkingson	PROPN
ajlm-1563	209	10	ej	ej	PROPN
ajlm-1563	209	11	.	.	PROPN
ajlm-1563	209	12	world	world	PROPN
ajlm-1563	209	13	health	health	PROPN
ajlm-1563	209	14	organization	organization	PROPN
ajlm-1563	209	15	classification	classification	NOUN
ajlm-1563	209	16	of	of	ADP
ajlm-1563	209	17	tumours	tumour	NOUN
ajlm-1563	209	18	of	of	ADP
ajlm-1563	209	19	female	female	ADJ
ajlm-1563	209	20	reproductive	reproductive	ADJ
ajlm-1563	209	21	organs	organ	NOUN
ajlm-1563	209	22	.	.	PUNCT
ajlm-1563	210	1	4th	4th	ADJ
ajlm-1563	210	2	ed	ed	NOUN
ajlm-1563	210	3	.	.	PUNCT
ajlm-1563	211	1	kurman	kurman	PROPN
ajlm-1563	211	2	rj	rj	PROPN
ajlm-1563	211	3	,	,	PUNCT
ajlm-1563	211	4	carcangiu	carcangiu	PROPN
ajlm-1563	211	5	ml	ml	PROPN
ajlm-1563	211	6	,	,	PUNCT
ajlm-1563	211	7	herrington	herrington	PROPN
ajlm-1563	211	8	sc	sc	PROPN
ajlm-1563	211	9	,	,	PUNCT
ajlm-1563	211	10	young	young	ADJ
ajlm-1563	211	11	,	,	PUNCT
ajlm-1563	211	12	robert	robert	PROPN
ajlm-1563	211	13	h	h	PROPN
ajlm-1563	211	14	,	,	PUNCT
ajlm-1563	211	15	editors	editor	NOUN
ajlm-1563	211	16	.	.	PUNCT
ajlm-1563	212	1	lyon	lyon	PROPN
ajlm-1563	212	2	:	:	PUNCT
ajlm-1563	212	3	international	international	ADJ
ajlm-1563	212	4	agency	agency	NOUN
ajlm-1563	212	5	for	for	ADP
ajlm-1563	212	6	research	research	NOUN
ajlm-1563	212	7	on	on	ADP
ajlm-1563	212	8	cancer	cancer	NOUN
ajlm-1563	212	9	(	(	PUNCT
ajlm-1563	212	10	iarc	iarc	NOUN
ajlm-1563	212	11	)	)	PUNCT
ajlm-1563	212	12	69372	69372	NUM
ajlm-1563	212	13	lyon	lyon	PROPN
ajlm-1563	212	14	cedex	cedex	PROPN
ajlm-1563	212	15	08	08	PROPN
ajlm-1563	212	16	,	,	PUNCT
ajlm-1563	212	17	france	france	PROPN
ajlm-1563	212	18	,	,	PUNCT
ajlm-1563	212	19	2014	2014	NUM
ajlm-1563	212	20	;	;	PUNCT
ajlm-1563	212	21	229–298	229–298	NUM
ajlm-1563	212	22	p.	p.	NOUN
ajlm-1563	212	23	carrone	carrone	PROPN
ajlm-1563	213	1	a	a	PRON
ajlm-1563	213	2	,	,	PUNCT
ajlm-1563	213	3	riganelli	riganelli	NOUN
ajlm-1563	213	4	l	l	NOUN
ajlm-1563	213	5	,	,	PUNCT
ajlm-1563	213	6	savone	savone	ADJ
ajlm-1563	213	7	d	d	NOUN
ajlm-1563	213	8	,	,	PUNCT
ajlm-1563	213	9	et	et	PROPN
ajlm-1563	213	10	al	al	PROPN
ajlm-1563	213	11	.	.	PROPN
ajlm-1563	213	12	hpv	hpv	PROPN
ajlm-1563	213	13	-	-	PUNCT
ajlm-1563	213	14	related	relate	VERB
ajlm-1563	213	15	vulvar	vulvar	NOUN
ajlm-1563	213	16	diseases	disease	NOUN
ajlm-1563	213	17	and	and	CCONJ
ajlm-1563	213	18	perspectives	perspective	NOUN
ajlm-1563	213	19	of	of	ADP
ajlm-1563	213	20	p16ink4a	p16ink4a	PROPN
ajlm-1563	213	21	immunochemistry	immunochemistry	PROPN
ajlm-1563	213	22	:	:	PUNCT
ajlm-1563	213	23	a	a	DET
ajlm-1563	213	24	review	review	NOUN
ajlm-1563	213	25	of	of	ADP
ajlm-1563	213	26	the	the	DET
ajlm-1563	213	27	literature	literature	NOUN
ajlm-1563	213	28	.	.	PUNCT
ajlm-1563	214	1	tumori	tumori	PROPN
ajlm-1563	214	2	j.	j.	PROPN
ajlm-1563	214	3	2017;103(6):511–515	2017;103(6):511–515	PROPN
ajlm-1563	214	4	.	.	PUNCT
ajlm-1563	215	1	https://doi.org/10.5301/tj.5000642	https://doi.org/10.5301/tj.5000642	X
ajlm-1563	215	2	rakislova	rakislova	PROPN
ajlm-1563	215	3	n	n	CCONJ
ajlm-1563	215	4	,	,	PUNCT
ajlm-1563	215	5	clavero	clavero	NOUN
ajlm-1563	215	6	o	o	NOUN
ajlm-1563	215	7	,	,	PUNCT
ajlm-1563	215	8	alemany	alemany	PROPN
ajlm-1563	215	9	l	l	NOUN
ajlm-1563	215	10	,	,	PUNCT
ajlm-1563	215	11	et	et	PROPN
ajlm-1563	215	12	al	al	PROPN
ajlm-1563	215	13	.	.	PROPN
ajlm-1563	216	1	histological	histological	ADJ
ajlm-1563	216	2	characteristics	characteristic	NOUN
ajlm-1563	216	3	of	of	ADP
ajlm-1563	216	4	hpv	hpv	NOUN
ajlm-1563	216	5	-	-	PUNCT
ajlm-1563	216	6	associated	associate	VERB
ajlm-1563	216	7	and	and	CCONJ
ajlm-1563	216	8	-independent	-independent	ADJ
ajlm-1563	216	9	squamous	squamous	ADJ
ajlm-1563	216	10	cell	cell	NOUN
ajlm-1563	216	11	carcinomas	carcinoma	NOUN
ajlm-1563	216	12	of	of	ADP
ajlm-1563	216	13	the	the	DET
ajlm-1563	216	14	vulva	vulva	NOUN
ajlm-1563	216	15	:	:	PUNCT
ajlm-1563	216	16	a	a	DET
ajlm-1563	216	17	study	study	NOUN
ajlm-1563	216	18	of	of	ADP
ajlm-1563	216	19	1594	1594	NUM
ajlm-1563	216	20	cases	case	NOUN
ajlm-1563	216	21	.	.	PUNCT
ajlm-1563	217	1	int	int	NOUN
ajlm-1563	217	2	j	j	PROPN
ajlm-1563	217	3	cancer	cancer	NOUN
ajlm-1563	217	4	.	.	PUNCT
ajlm-1563	218	1	2017;141(12):2517–2527	2017;141(12):2517–2527	NUM
ajlm-1563	218	2	.	.	PUNCT
ajlm-1563	219	1	https://doi.org/10.1002/ijc.31006	https://doi.org/10.1002/ijc.31006	PROPN
ajlm-1563	219	2	bromfield	bromfield	PROPN
ajlm-1563	219	3	me	i	PRON
ajlm-1563	219	4	,	,	PUNCT
ajlm-1563	219	5	gibson	gibson	PROPN
ajlm-1563	219	6	tn	tn	PROPN
ajlm-1563	219	7	,	,	PUNCT
ajlm-1563	219	8	hanchard	hanchard	PROPN
ajlm-1563	219	9	b	b	PROPN
ajlm-1563	219	10	,	,	PUNCT
ajlm-1563	219	11	waugh	waugh	PROPN
ajlm-1563	219	12	n	n	CCONJ
ajlm-1563	219	13	,	,	PUNCT
ajlm-1563	219	14	mcnaughton	mcnaughton	PROPN
ajlm-1563	219	15	d.	d.	PROPN
ajlm-1563	219	16	a	a	DET
ajlm-1563	219	17	thirty	thirty	NUM
ajlm-1563	219	18	-	-	PUNCT
ajlm-1563	219	19	year	year	NOUN
ajlm-1563	219	20	review	review	NOUN
ajlm-1563	219	21	of	of	ADP
ajlm-1563	219	22	vulvar	vulvar	NOUN
ajlm-1563	219	23	cancer	cancer	NOUN
ajlm-1563	219	24	in	in	ADP
ajlm-1563	219	25	jamaica	jamaica	PROPN
ajlm-1563	219	26	,	,	PUNCT
ajlm-1563	219	27	1978	1978	NUM
ajlm-1563	219	28	to	to	ADP
ajlm-1563	219	29	2007	2007	NUM
ajlm-1563	219	30	.	.	PUNCT
ajlm-1563	220	1	west	west	PROPN
ajlm-1563	220	2	indian	indian	PROPN
ajlm-1563	220	3	med	med	PROPN
ajlm-1563	220	4	j.	j.	PROPN
ajlm-1563	220	5	2014;63(2):134–137	2014;63(2):134–137	PROPN
ajlm-1563	220	6	.	.	PUNCT
ajlm-1563	221	1	https://doi.org/10.1002/ijc.31006	https://doi.org/10.1002/ijc.31006	PROPN
ajlm-1563	221	2	hami	hami	PROPN
ajlm-1563	221	3	lt	lt	PROPN
ajlm-1563	221	4	,	,	PUNCT
ajlm-1563	221	5	lampe	lampe	PROPN
ajlm-1563	221	6	b	b	PROPN
ajlm-1563	221	7	,	,	PUNCT
ajlm-1563	221	8	mallmann	mallmann	ADJ
ajlm-1563	221	9	p	p	NOUN
ajlm-1563	221	10	,	,	PUNCT
ajlm-1563	221	11	forner	forner	NOUN
ajlm-1563	221	12	dm	dm	PROPN
ajlm-1563	221	13	.	.	PUNCT
ajlm-1563	222	1	the	the	DET
ajlm-1563	222	2	impact	impact	NOUN
ajlm-1563	222	3	of	of	ADP
ajlm-1563	222	4	age	age	NOUN
ajlm-1563	222	5	on	on	ADP
ajlm-1563	222	6	the	the	DET
ajlm-1563	222	7	prognosis	prognosis	NOUN
ajlm-1563	222	8	of	of	ADP
ajlm-1563	222	9	vulvar	vulvar	NOUN
ajlm-1563	222	10	cancer	cancer	NOUN
ajlm-1563	222	11	.	.	PUNCT
ajlm-1563	223	1	oncol	oncol	ADJ
ajlm-1563	223	2	res	re	NOUN
ajlm-1563	223	3	treat	treat	NOUN
ajlm-1563	223	4	.	.	PUNCT
ajlm-1563	224	1	2018;41(9):520–524	2018;41(9):520–524	X
ajlm-1563	224	2	.	.	PUNCT
ajlm-1563	225	1	https://doi.org/10.1002/ijc.31006	https://doi.org/10.1002/ijc.31006	PROPN
ajlm-1563	225	2	pirog	pirog	PROPN
ajlm-1563	225	3	ec	ec	PROPN
ajlm-1563	225	4	.	.	PUNCT
ajlm-1563	226	1	pathology	pathology	PROPN
ajlm-1563	226	2	of	of	ADP
ajlm-1563	226	3	vulvar	vulvar	NOUN
ajlm-1563	226	4	neoplasms	neoplasm	NOUN
ajlm-1563	226	5	.	.	PUNCT
ajlm-1563	227	1	surg	surg	NOUN
ajlm-1563	227	2	pathol	pathol	NOUN
ajlm-1563	227	3	.	.	PUNCT
ajlm-1563	228	1	2011;4(1):87–111	2011;4(1):87–111	X
ajlm-1563	228	2	.	.	PUNCT
ajlm-1563	228	3	https://doi.org/10.1016/j.path.2010.03.001	https://doi.org/10.1016/j.path.2010.03.001	VERB
ajlm-1563	228	4	ferris	ferris	PROPN
ajlm-1563	228	5	dg	dg	PROPN
ajlm-1563	228	6	,	,	PUNCT
ajlm-1563	228	7	brown	brown	PROPN
ajlm-1563	228	8	dr	dr	PROPN
ajlm-1563	228	9	,	,	PUNCT
ajlm-1563	228	10	giuliano	giuliano	PROPN
ajlm-1563	228	11	ar	ar	PROPN
ajlm-1563	228	12	,	,	PUNCT
ajlm-1563	228	13	et	et	PROPN
ajlm-1563	228	14	al	al	PROPN
ajlm-1563	228	15	.	.	PUNCT
ajlm-1563	228	16	prevalence	prevalence	NOUN
ajlm-1563	228	17	,	,	PUNCT
ajlm-1563	228	18	incidence	incidence	NOUN
ajlm-1563	228	19	,	,	PUNCT
ajlm-1563	228	20	and	and	CCONJ
ajlm-1563	228	21	natural	natural	ADJ
ajlm-1563	228	22	history	history	NOUN
ajlm-1563	228	23	of	of	ADP
ajlm-1563	228	24	hpv	hpv	ADJ
ajlm-1563	228	25	infection	infection	NOUN
ajlm-1563	228	26	in	in	ADP
ajlm-1563	228	27	adult	adult	NOUN
ajlm-1563	228	28	women	woman	NOUN
ajlm-1563	228	29	ages	age	NOUN
ajlm-1563	228	30	24	24	NUM
ajlm-1563	228	31	to	to	PART
ajlm-1563	228	32	45	45	NUM
ajlm-1563	228	33	participating	participate	VERB
ajlm-1563	228	34	in	in	ADP
ajlm-1563	228	35	a	a	DET
ajlm-1563	228	36	vaccine	vaccine	NOUN
ajlm-1563	228	37	trial	trial	NOUN
ajlm-1563	228	38	.	.	PUNCT
ajlm-1563	229	1	papillomavirus	papillomavirus	NOUN
ajlm-1563	229	2	res	re	NOUN
ajlm-1563	229	3	.	.	PUNCT
ajlm-1563	230	1	2020;10:100202	2020;10:100202	NUM
ajlm-1563	230	2	.	.	PUNCT
ajlm-1563	231	1	https://doi.org/10.1016/j.pvr.2020.100202	https://doi.org/10.1016/j.pvr.2020.100202	PROPN
ajlm-1563	231	2	dunne	dunne	PROPN
ajlm-1563	231	3	ef	ef	PROPN
ajlm-1563	231	4	,	,	PUNCT
ajlm-1563	231	5	unger	unger	PROPN
ajlm-1563	231	6	er	er	INTJ
ajlm-1563	231	7	,	,	PUNCT
ajlm-1563	231	8	sternberg	sternberg	PROPN
ajlm-1563	231	9	m	m	PROPN
ajlm-1563	231	10	,	,	PUNCT
ajlm-1563	231	11	et	et	PROPN
ajlm-1563	231	12	al	al	PROPN
ajlm-1563	231	13	.	.	PUNCT
ajlm-1563	232	1	prevalence	prevalence	NOUN
ajlm-1563	232	2	of	of	ADP
ajlm-1563	232	3	hpv	hpv	ADJ
ajlm-1563	232	4	infection	infection	NOUN
ajlm-1563	232	5	among	among	ADP
ajlm-1563	232	6	females	female	NOUN
ajlm-1563	232	7	in	in	ADP
ajlm-1563	232	8	the	the	DET
ajlm-1563	232	9	united	united	PROPN
ajlm-1563	232	10	states	states	PROPN
ajlm-1563	232	11	.	.	PUNCT
ajlm-1563	233	1	jama	jama	PROPN
ajlm-1563	233	2	.	.	PUNCT
ajlm-1563	234	1	2007;297(8):813–819	2007;297(8):813–819	X
ajlm-1563	234	2	.	.	PUNCT
ajlm-1563	235	1	https://doi.org/10.1001/jama.297.8.813	https://doi.org/10.1001/jama.297.8.813	PROPN
ajlm-1563	235	2	reuschenbach	reuschenbach	PROPN
ajlm-1563	235	3	m	m	PROPN
ajlm-1563	235	4	,	,	PUNCT
ajlm-1563	235	5	mihm	mihm	PROPN
ajlm-1563	235	6	s	s	PART
ajlm-1563	235	7	,	,	PUNCT
ajlm-1563	235	8	wölle	wölle	NOUN
ajlm-1563	235	9	r	r	NOUN
ajlm-1563	235	10	,	,	PUNCT
ajlm-1563	235	11	et	et	PROPN
ajlm-1563	235	12	al	al	PROPN
ajlm-1563	235	13	.	.	PUNCT
ajlm-1563	235	14	burden	burden	NOUN
ajlm-1563	235	15	of	of	ADP
ajlm-1563	235	16	hpv	hpv	ADJ
ajlm-1563	235	17	related	relate	VERB
ajlm-1563	235	18	anogenital	anogenital	ADJ
ajlm-1563	235	19	diseases	disease	NOUN
ajlm-1563	235	20	in	in	ADP
ajlm-1563	235	21	young	young	ADJ
ajlm-1563	235	22	women	woman	NOUN
ajlm-1563	235	23	in	in	ADP
ajlm-1563	235	24	germany	germany	PROPN
ajlm-1563	235	25	–	–	PUNCT
ajlm-1563	235	26	an	an	DET
ajlm-1563	235	27	analysis	analysis	NOUN
ajlm-1563	235	28	of	of	ADP
ajlm-1563	235	29	german	german	ADJ
ajlm-1563	235	30	statutory	statutory	ADJ
ajlm-1563	235	31	health	health	NOUN
ajlm-1563	235	32	insurance	insurance	NOUN
ajlm-1563	235	33	claims	claim	VERB
ajlm-1563	235	34	data	datum	NOUN
ajlm-1563	235	35	from	from	ADP
ajlm-1563	235	36	2012	2012	NUM
ajlm-1563	235	37	to	to	ADP
ajlm-1563	235	38	2017	2017	NUM
ajlm-1563	235	39	.	.	PUNCT
ajlm-1563	236	1	bmc	bmc	PROPN
ajlm-1563	236	2	infect	infect	PROPN
ajlm-1563	236	3	dis	dis	PROPN
ajlm-1563	236	4	.	.	PUNCT
ajlm-1563	237	1	2020;20(1):297	2020;20(1):297	X
ajlm-1563	237	2	.	.	PUNCT
ajlm-1563	238	1	https://doi.org/10.1186/s12879-020-05002-w	https://doi.org/10.1186/s12879-020-05002-w	PROPN
ajlm-1563	238	2	rumbold	rumbold	PROPN
ajlm-1563	238	3	ar	ar	PROPN
ajlm-1563	238	4	,	,	PUNCT
ajlm-1563	238	5	tan	tan	PROPN
ajlm-1563	238	6	se	se	X
ajlm-1563	238	7	,	,	PUNCT
ajlm-1563	238	8	condon	condon	PROPN
ajlm-1563	238	9	jr	jr	PROPN
ajlm-1563	238	10	,	,	PUNCT
ajlm-1563	238	11	et	et	PROPN
ajlm-1563	238	12	al	al	PROPN
ajlm-1563	238	13	.	.	PUNCT
ajlm-1563	239	1	investigating	investigate	VERB
ajlm-1563	239	2	a	a	DET
ajlm-1563	239	3	cluster	cluster	NOUN
ajlm-1563	239	4	of	of	ADP
ajlm-1563	239	5	vulvar	vulvar	NOUN
ajlm-1563	239	6	cancer	cancer	NOUN
ajlm-1563	239	7	in	in	ADP
ajlm-1563	239	8	young	young	ADJ
ajlm-1563	239	9	women	woman	NOUN
ajlm-1563	239	10	:	:	PUNCT
ajlm-1563	239	11	a	a	DET
ajlm-1563	239	12	cross	cross	ADJ
ajlm-1563	239	13	-	-	ADJ
ajlm-1563	239	14	sectional	sectional	ADJ
ajlm-1563	239	15	study	study	NOUN
ajlm-1563	239	16	of	of	ADP
ajlm-1563	239	17	genital	genital	ADJ
ajlm-1563	239	18	human	human	ADJ
ajlm-1563	239	19	papillomavirus	papillomavirus	NOUN
ajlm-1563	239	20	prevalence	prevalence	NOUN
ajlm-1563	239	21	.	.	PUNCT
ajlm-1563	240	1	bmc	bmc	PROPN
ajlm-1563	240	2	infect	infect	PROPN
ajlm-1563	240	3	dis	dis	PROPN
ajlm-1563	240	4	.	.	PUNCT
ajlm-1563	241	1	2012;12(1):1	2012;12(1):1	NUM
ajlm-1563	241	2	.	.	PUNCT
ajlm-1563	242	1	https://doi.org/10.1186/1471-2334-12-243	https://doi.org/10.1186/1471-2334-12-243	VERB
ajlm-1563	242	2	the	the	DET
ajlm-1563	242	3	global	global	ADJ
ajlm-1563	242	4	cancer	cancer	NOUN
ajlm-1563	242	5	observatory	observatory	NOUN
ajlm-1563	242	6	g.	g.	PROPN
ajlm-1563	242	7	vulva	vulva	PROPN
ajlm-1563	243	1	[	[	X
ajlm-1563	243	2	homepage	homepage	NOUN
ajlm-1563	243	3	on	on	ADP
ajlm-1563	243	4	the	the	DET
ajlm-1563	243	5	internet	internet	NOUN
ajlm-1563	243	6	]	]	PUNCT
ajlm-1563	243	7	.	.	PUNCT
ajlm-1563	244	1	world	world	PROPN
ajlm-1563	244	2	health	health	PROPN
ajlm-1563	244	3	organization	organization	NOUN
ajlm-1563	244	4	;	;	PUNCT
ajlm-1563	244	5	2019	2019	NUM
ajlm-1563	244	6	.	.	PUNCT
ajlm-1563	245	1	available	available	ADJ
ajlm-1563	245	2	from	from	ADP
ajlm-1563	245	3	:	:	PUNCT
ajlm-1563	245	4	http://gco.iarc.fr/today/data/factsheets/cancers/21-vulva-fact-sheet.pdf	http://gco.iarc.fr/today/data/factsheets/cancers/21-vulva-fact-sheet.pdf	NOUN
ajlm-1563	245	5	kalubula	kalubula	NOUN
ajlm-1563	245	6	m	m	PROPN
ajlm-1563	245	7	,	,	PUNCT
ajlm-1563	245	8	shen	shen	PROPN
ajlm-1563	245	9	h	h	PROPN
ajlm-1563	245	10	,	,	PUNCT
ajlm-1563	245	11	makasa	makasa	PROPN
ajlm-1563	245	12	m	m	PROPN
ajlm-1563	245	13	,	,	PUNCT
ajlm-1563	245	14	liu	liu	PROPN
ajlm-1563	245	15	l.	l.	PROPN
ajlm-1563	245	16	epidemiology	epidemiology	PROPN
ajlm-1563	245	17	of	of	ADP
ajlm-1563	245	18	cancers	cancer	NOUN
ajlm-1563	245	19	in	in	ADP
ajlm-1563	245	20	zambia	zambia	PROPN
ajlm-1563	245	21	:	:	PUNCT
ajlm-1563	245	22	a	a	DET
ajlm-1563	245	23	significant	significant	ADJ
ajlm-1563	245	24	variation	variation	NOUN
ajlm-1563	245	25	in	in	ADP
ajlm-1563	245	26	cancer	cancer	NOUN
ajlm-1563	245	27	incidence	incidence	NOUN
ajlm-1563	245	28	and	and	CCONJ
ajlm-1563	245	29	prevalence	prevalence	NOUN
ajlm-1563	245	30	across	across	ADP
ajlm-1563	245	31	the	the	DET
ajlm-1563	245	32	nation	nation	NOUN
ajlm-1563	245	33	authors	author	NOUN
ajlm-1563	245	34	.	.	PUNCT
ajlm-1563	246	1	biorxiv	biorxiv	NOUN
ajlm-1563	246	2	.	.	PUNCT
ajlm-1563	247	1	2018;(86	2018;(86	NUM
ajlm-1563	247	2	)	)	PUNCT
ajlm-1563	247	3	.	.	PUNCT
ajlm-1563	248	1	https://doi.org/10.1101/402628	https://doi.org/10.1101/402628	X
ajlm-1563	249	1	tesfalul	tesfalul	NOUN
ajlm-1563	249	2	m	m	PROPN
ajlm-1563	249	3	,	,	PUNCT
ajlm-1563	249	4	simbiri	simbiri	PROPN
ajlm-1563	249	5	k	k	PROPN
ajlm-1563	249	6	,	,	PUNCT
ajlm-1563	249	7	wheat	wheat	NOUN
ajlm-1563	249	8	cm	cm	PROPN
ajlm-1563	249	9	,	,	PUNCT
ajlm-1563	249	10	et	et	PROPN
ajlm-1563	249	11	al	al	PROPN
ajlm-1563	249	12	.	.	PUNCT
ajlm-1563	250	1	oncogenic	oncogenic	ADJ
ajlm-1563	250	2	viral	viral	ADJ
ajlm-1563	250	3	prevalence	prevalence	NOUN
ajlm-1563	250	4	in	in	ADP
ajlm-1563	250	5	invasive	invasive	ADJ
ajlm-1563	250	6	vulvar	vulvar	NOUN
ajlm-1563	250	7	cancer	cancer	NOUN
ajlm-1563	250	8	specimens	specimen	NOUN
ajlm-1563	250	9	from	from	ADP
ajlm-1563	250	10	human	human	ADJ
ajlm-1563	250	11	immunodeficiency	immunodeficiency	NOUN
ajlm-1563	250	12	virus	virus	NOUN
ajlm-1563	250	13	-	-	PUNCT
ajlm-1563	250	14	positive	positive	ADJ
ajlm-1563	250	15	and	and	CCONJ
ajlm-1563	250	16	-negative	-negative	ADJ
ajlm-1563	250	17	women	woman	NOUN
ajlm-1563	250	18	in	in	ADP
ajlm-1563	250	19	botswana	botswana	PROPN
ajlm-1563	250	20	.	.	PUNCT
ajlm-1563	251	1	int	int	PROPN
ajlm-1563	251	2	j	j	PROPN
ajlm-1563	251	3	gynecol	gynecol	ADJ
ajlm-1563	251	4	cancer	cancer	NOUN
ajlm-1563	251	5	.	.	PUNCT
ajlm-1563	252	1	2014;24(4):758–765	2014;24(4):758–765	X
ajlm-1563	252	2	.	.	PUNCT
ajlm-1563	253	1	https://doi.org/10.1186/1471-2334-12-243	https://doi.org/10.1186/1471-2334-12-243	NOUN
ajlm-1563	253	2	casolati	casolati	NOUN
ajlm-1563	253	3	e	e	NOUN
ajlm-1563	253	4	,	,	PUNCT
ajlm-1563	253	5	agarossi	agarossi	PROPN
ajlm-1563	253	6	a	a	PRON
ajlm-1563	253	7	,	,	PUNCT
ajlm-1563	253	8	valieri	valieri	PROPN
ajlm-1563	253	9	m	m	PROPN
ajlm-1563	253	10	,	,	PUNCT
ajlm-1563	253	11	ferrazzi	ferrazzi	PROPN
ajlm-1563	253	12	e.	e.	PROPN
ajlm-1563	253	13	vulvar	vulvar	PROPN
ajlm-1563	253	14	neoplasia	neoplasia	NOUN
ajlm-1563	253	15	in	in	ADP
ajlm-1563	253	16	hiv	hiv	PROPN
ajlm-1563	253	17	positive	positive	ADJ
ajlm-1563	253	18	women	woman	NOUN
ajlm-1563	253	19	:	:	PUNCT
ajlm-1563	253	20	a	a	DET
ajlm-1563	253	21	review	review	NOUN
ajlm-1563	253	22	.	.	PUNCT
ajlm-1563	254	1	med	med	PROPN
ajlm-1563	254	2	wieku	wieku	PROPN
ajlm-1563	254	3	rozwoj	rozwoj	NOUN
ajlm-1563	254	4	.	.	PUNCT
ajlm-1563	255	1	2003;7(4	2003;7(4	NUM
ajlm-1563	255	2	pt	pt	NOUN
ajlm-1563	255	3	1):487–493	1):487–493	NUM
ajlm-1563	255	4	.	.	PUNCT
ajlm-1563	256	1	bornstein	bornstein	PROPN
ajlm-1563	256	2	j	j	PROPN
ajlm-1563	256	3	,	,	PUNCT
ajlm-1563	256	4	bogliatto	bogliatto	PROPN
ajlm-1563	256	5	f	f	PROPN
ajlm-1563	256	6	,	,	PUNCT
ajlm-1563	256	7	haefner	haefner	PROPN
ajlm-1563	256	8	hk	hk	PROPN
ajlm-1563	256	9	,	,	PUNCT
ajlm-1563	256	10	et	et	PROPN
ajlm-1563	256	11	al	al	PROPN
ajlm-1563	256	12	.	.	PUNCT
ajlm-1563	257	1	the	the	DET
ajlm-1563	257	2	2015	2015	NUM
ajlm-1563	257	3	international	international	ADJ
ajlm-1563	257	4	society	society	NOUN
ajlm-1563	257	5	for	for	ADP
ajlm-1563	257	6	the	the	DET
ajlm-1563	257	7	study	study	NOUN
ajlm-1563	257	8	of	of	ADP
ajlm-1563	257	9	vulvovaginal	vulvovaginal	ADJ
ajlm-1563	257	10	disease	disease	NOUN
ajlm-1563	257	11	(	(	PUNCT
ajlm-1563	257	12	issvd	issvd	ADJ
ajlm-1563	257	13	)	)	PUNCT
ajlm-1563	257	14	terminology	terminology	NOUN
ajlm-1563	257	15	of	of	ADP
ajlm-1563	257	16	vulvar	vulvar	ADJ
ajlm-1563	257	17	squamous	squamous	ADJ
ajlm-1563	257	18	intraepithelial	intraepithelial	ADJ
ajlm-1563	257	19	lesions	lesion	NOUN
ajlm-1563	257	20	.	.	PUNCT
ajlm-1563	258	1	j	j	PROPN
ajlm-1563	258	2	low	low	ADJ
ajlm-1563	258	3	genit	genit	NOUN
ajlm-1563	258	4	tract	tract	NOUN
ajlm-1563	258	5	dis	dis	PROPN
ajlm-1563	258	6	.	.	PUNCT
ajlm-1563	259	1	2016;20(1):11–14	2016;20(1):11–14	X
ajlm-1563	259	2	.	.	PUNCT
ajlm-1563	259	3	https://doi.org/10.1097/lgt.0000000000000169	https://doi.org/10.1097/lgt.0000000000000169	PROPN
ajlm-1563	259	4	butt	butt	PROPN
ajlm-1563	259	5	jl	jl	PROPN
ajlm-1563	259	6	,	,	PUNCT
ajlm-1563	259	7	botha	botha	PROPN
ajlm-1563	259	8	mh	mh	PROPN
ajlm-1563	259	9	.	.	PROPN
ajlm-1563	260	1	vulvar	vulvar	PROPN
ajlm-1563	260	2	cancer	cancer	NOUN
ajlm-1563	260	3	is	be	AUX
ajlm-1563	260	4	not	not	PART
ajlm-1563	260	5	a	a	DET
ajlm-1563	260	6	disease	disease	NOUN
ajlm-1563	260	7	of	of	ADP
ajlm-1563	260	8	the	the	DET
ajlm-1563	260	9	elderly	elderly	ADJ
ajlm-1563	260	10	:	:	PUNCT
ajlm-1563	260	11	treatment	treatment	NOUN
ajlm-1563	260	12	and	and	CCONJ
ajlm-1563	260	13	outcome	outcome	NOUN
ajlm-1563	260	14	at	at	ADP
ajlm-1563	260	15	a	a	DET
ajlm-1563	260	16	tertiary	tertiary	ADJ
ajlm-1563	260	17	referral	referral	NOUN
ajlm-1563	260	18	centre	centre	NOUN
ajlm-1563	260	19	in	in	ADP
ajlm-1563	260	20	south	south	PROPN
ajlm-1563	260	21	africa	africa	PROPN
ajlm-1563	260	22	.	.	PUNCT
ajlm-1563	261	1	s	s	PROPN
ajlm-1563	261	2	afr	afr	PROPN
ajlm-1563	261	3	med	med	PROPN
ajlm-1563	261	4	j.	j.	PROPN
ajlm-1563	261	5	2017;107(11):1000	2017;107(11):1000	NUM
ajlm-1563	261	6	.	.	PUNCT
ajlm-1563	262	1	https://doi.org/10.7196/samj.2017.v107i11.12497	https://doi.org/10.7196/samj.2017.v107i11.12497	NOUN
ajlm-1563	262	2	canavan	canavan	NOUN
ajlm-1563	262	3	pt	pt	PROPN
ajlm-1563	262	4	,	,	PUNCT
ajlm-1563	262	5	cohen	cohen	PROPN
ajlm-1563	262	6	d.	d.	PROPN
ajlm-1563	262	7	vulvar	vulvar	PROPN
ajlm-1563	262	8	cancer	cancer	NOUN
ajlm-1563	262	9	.	.	PUNCT
ajlm-1563	263	1	pract	pract	PROPN
ajlm-1563	263	2	gynecol	gynecol	PROPN
ajlm-1563	263	3	oncol	oncol	ADJ
ajlm-1563	263	4	.	.	PUNCT
ajlm-1563	264	1	2004;3:543–582	2004;3:543–582	NUM
ajlm-1563	264	2	.	.	PUNCT
ajlm-1563	265	1	cullis	cullis	PROPN
ajlm-1563	265	2	p	p	SYM
ajlm-1563	265	3	,	,	PUNCT
ajlm-1563	265	4	mudzamiri	mudzamiri	PROPN
ajlm-1563	265	5	t	t	PROPN
ajlm-1563	265	6	,	,	PUNCT
ajlm-1563	266	1	millan	millan	PROPN
ajlm-1563	266	2	d	d	PROPN
ajlm-1563	266	3	,	,	PUNCT
ajlm-1563	266	4	siddiqui	siddiqui	PROPN
ajlm-1563	266	5	n.	n.	PROPN
ajlm-1563	266	6	vulval	vulval	PROPN
ajlm-1563	266	7	intraepithelial	intraepithelial	ADJ
ajlm-1563	266	8	neoplasia	neoplasia	NOUN
ajlm-1563	266	9	:	:	PUNCT
ajlm-1563	266	10	making	make	VERB
ajlm-1563	266	11	sense	sense	NOUN
ajlm-1563	266	12	of	of	ADP
ajlm-1563	266	13	the	the	DET
ajlm-1563	266	14	literature	literature	NOUN
ajlm-1563	266	15	.	.	PUNCT
ajlm-1563	267	1	obstet	obstet	PROPN
ajlm-1563	267	2	gynaecol	gynaecol	PROPN
ajlm-1563	267	3	.	.	PUNCT
ajlm-1563	268	1	2011;13(2):73–78	2011;13(2):73–78	X
ajlm-1563	268	2	.	.	PUNCT
ajlm-1563	268	3	https://doi.org/10.1576/toag.13.2.73.27649	https://doi.org/10.1576/toag.13.2.73.27649	PROPN
ajlm-1563	268	4	vandborg	vandborg	PROPN
ajlm-1563	268	5	mp	mp	PROPN
ajlm-1563	268	6	,	,	PUNCT
ajlm-1563	268	7	depont	depont	ADJ
ajlm-1563	268	8	cr	cr	PROPN
ajlm-1563	268	9	,	,	PUNCT
ajlm-1563	268	10	kragstrup	kragstrup	VERB
ajlm-1563	268	11	j	j	PROPN
ajlm-1563	268	12	,	,	PUNCT
ajlm-1563	268	13	et	et	PROPN
ajlm-1563	268	14	al	al	PROPN
ajlm-1563	268	15	.	.	PUNCT
ajlm-1563	268	16	reasons	reason	NOUN
ajlm-1563	268	17	for	for	ADP
ajlm-1563	268	18	diagnostic	diagnostic	ADJ
ajlm-1563	268	19	delay	delay	NOUN
ajlm-1563	268	20	in	in	ADP
ajlm-1563	268	21	gynecological	gynecological	ADJ
ajlm-1563	268	22	malignancies	malignancy	NOUN
ajlm-1563	268	23	.	.	PUNCT
ajlm-1563	269	1	int	int	PROPN
ajlm-1563	269	2	j	j	PROPN
ajlm-1563	269	3	gynecol	gynecol	ADJ
ajlm-1563	269	4	cancer	cancer	NOUN
ajlm-1563	269	5	.	.	PUNCT
ajlm-1563	270	1	2011;21(6):967–974	2011;21(6):967–974	NUM
ajlm-1563	270	2	.	.	PUNCT
ajlm-1563	270	3	https://doi.org/10.1097/igc.0b013e31821d2770	https://doi.org/10.1097/igc.0b013e31821d2770	PROPN
ajlm-1563	270	4	jones	jones	PROPN
ajlm-1563	270	5	rw	rw	PROPN
ajlm-1563	270	6	,	,	PUNCT
ajlm-1563	270	7	joura	joura	NOUN
ajlm-1563	270	8	ea	ea	NOUN
ajlm-1563	270	9	.	.	PUNCT
ajlm-1563	271	1	analyzing	analyze	VERB
ajlm-1563	271	2	prior	prior	ADJ
ajlm-1563	271	3	clinical	clinical	ADJ
ajlm-1563	271	4	events	event	NOUN
ajlm-1563	271	5	at	at	ADP
ajlm-1563	271	6	presentation	presentation	NOUN
ajlm-1563	271	7	in	in	ADP
ajlm-1563	271	8	102	102	NUM
ajlm-1563	271	9	women	woman	NOUN
ajlm-1563	271	10	with	with	ADP
ajlm-1563	271	11	vulvar	vulvar	NOUN
ajlm-1563	271	12	carcinoma	carcinoma	NOUN
ajlm-1563	271	13	.	.	PUNCT
ajlm-1563	272	1	evidence	evidence	NOUN
ajlm-1563	272	2	of	of	ADP
ajlm-1563	272	3	diagnostic	diagnostic	ADJ
ajlm-1563	272	4	delays	delay	NOUN
ajlm-1563	272	5	.	.	PUNCT
ajlm-1563	273	1	j	j	PROPN
ajlm-1563	273	2	reprod	reprod	PROPN
ajlm-1563	273	3	med	med	PROPN
ajlm-1563	273	4	.	.	PUNCT
ajlm-1563	274	1	1999;44(9):766–768	1999;44(9):766–768	NUM
ajlm-1563	274	2	.	.	PUNCT
ajlm-1563	275	1	muigai	muigai	PROPN
ajlm-1563	275	2	j	j	PROPN
ajlm-1563	275	3	,	,	PUNCT
ajlm-1563	275	4	jacob	jacob	PROPN
ajlm-1563	275	5	l	l	PROPN
ajlm-1563	275	6	,	,	PUNCT
ajlm-1563	275	7	dinas	dinas	PROPN
ajlm-1563	275	8	k	k	NOUN
ajlm-1563	275	9	,	,	PUNCT
ajlm-1563	275	10	kostev	kostev	PROPN
ajlm-1563	275	11	k.	k.	PROPN
ajlm-1563	275	12	potential	potential	ADJ
ajlm-1563	275	13	delay	delay	NOUN
ajlm-1563	275	14	in	in	ADP
ajlm-1563	275	15	the	the	DET
ajlm-1563	275	16	diagnosis	diagnosis	NOUN
ajlm-1563	275	17	of	of	ADP
ajlm-1563	275	18	vulvar	vulvar	NOUN
ajlm-1563	275	19	cancer	cancer	NOUN
ajlm-1563	275	20	and	and	CCONJ
ajlm-1563	275	21	associated	associate	VERB
ajlm-1563	275	22	risk	risk	NOUN
ajlm-1563	275	23	factors	factor	NOUN
ajlm-1563	275	24	in	in	ADP
ajlm-1563	275	25	women	woman	NOUN
ajlm-1563	275	26	treated	treat	VERB
ajlm-1563	275	27	in	in	ADP
ajlm-1563	275	28	german	german	ADJ
ajlm-1563	275	29	gynecological	gynecological	ADJ
ajlm-1563	275	30	practices	practice	NOUN
ajlm-1563	275	31	.	.	PUNCT
ajlm-1563	276	1	oncotarget	oncotarget	NOUN
ajlm-1563	276	2	.	.	PUNCT
ajlm-1563	277	1	2018;9(9):8725–8730	2018;9(9):8725–8730	NUM
ajlm-1563	277	2	.	.	PUNCT
ajlm-1563	277	3	https://doi.org/10.18632/oncotarget.23848	https://doi.org/10.18632/oncotarget.23848	PROPN
ajlm-1563	277	4	xiao	xiao	PROPN
ajlm-1563	277	5	x	x	PROPN
ajlm-1563	277	6	,	,	PUNCT
ajlm-1563	277	7	meng	meng	PROPN
ajlm-1563	277	8	y	y	PROPN
ajlm-1563	277	9	-	-	PUNCT
ajlm-1563	277	10	b	b	PROPN
ajlm-1563	277	11	,	,	PUNCT
ajlm-1563	277	12	bai	bai	PROPN
ajlm-1563	277	13	p	p	X
ajlm-1563	277	14	,	,	PUNCT
ajlm-1563	277	15	et	et	PROPN
ajlm-1563	277	16	al	al	PROPN
ajlm-1563	277	17	.	.	PROPN
ajlm-1563	277	18	vulvar	vulvar	PROPN
ajlm-1563	277	19	cancer	cancer	NOUN
ajlm-1563	277	20	in	in	ADP
ajlm-1563	277	21	china	china	PROPN
ajlm-1563	277	22	:	:	PUNCT
ajlm-1563	277	23	epidemiological	epidemiological	ADJ
ajlm-1563	277	24	features	feature	NOUN
ajlm-1563	277	25	and	and	CCONJ
ajlm-1563	277	26	risk	risk	NOUN
ajlm-1563	277	27	analysis	analysis	NOUN
ajlm-1563	277	28	.	.	PUNCT
ajlm-1563	278	1	j	j	PROPN
ajlm-1563	278	2	cancer	cancer	NOUN
ajlm-1563	278	3	.	.	PUNCT
ajlm-1563	279	1	2017;8(15):2950–2958	2017;8(15):2950–2958	NOUN
ajlm-1563	279	2	.	.	PUNCT
ajlm-1563	280	1	https://doi.org/10.7150/jca.20496	https://doi.org/10.7150/jca.20496	NOUN
ajlm-1563	280	2	madeleine	madeleine	PROPN
ajlm-1563	280	3	mm	mm	PROPN
ajlm-1563	280	4	,	,	PUNCT
ajlm-1563	280	5	daling	dale	VERB
ajlm-1563	280	6	jr	jr	PROPN
ajlm-1563	280	7	,	,	PUNCT
ajlm-1563	280	8	schwartz	schwartz	PROPN
ajlm-1563	280	9	sm	sm	PROPN
ajlm-1563	280	10	,	,	PUNCT
ajlm-1563	280	11	et	et	PROPN
ajlm-1563	280	12	al	al	PROPN
ajlm-1563	280	13	.	.	PUNCT
ajlm-1563	281	1	cofactors	cofactor	NOUN
ajlm-1563	281	2	with	with	ADP
ajlm-1563	281	3	human	human	ADJ
ajlm-1563	281	4	papillomavirus	papillomavirus	NOUN
ajlm-1563	281	5	in	in	ADP
ajlm-1563	281	6	a	a	DET
ajlm-1563	281	7	population	population	NOUN
ajlm-1563	281	8	-	-	PUNCT
ajlm-1563	281	9	based	base	VERB
ajlm-1563	281	10	study	study	NOUN
ajlm-1563	281	11	of	of	ADP
ajlm-1563	281	12	vulvar	vulvar	NOUN
ajlm-1563	281	13	cancer	cancer	NOUN
ajlm-1563	281	14	.	.	PUNCT
ajlm-1563	282	1	jnci	jnci	PROPN
ajlm-1563	282	2	j	j	PROPN
ajlm-1563	282	3	natl	natl	PROPN
ajlm-1563	282	4	cancer	cancer	PROPN
ajlm-1563	282	5	inst	inst	PROPN
ajlm-1563	282	6	.	.	PUNCT
ajlm-1563	283	1	1997;89(20):1516–1523	1997;89(20):1516–1523	PROPN
ajlm-1563	283	2	.	.	PUNCT
ajlm-1563	284	1	https://doi.org/10.1093/jnci/89.20.1516	https://doi.org/10.1093/jnci/89.20.1516	PROPN
ajlm-1563	285	1	ahdieh	ahdieh	PROPN
ajlm-1563	285	2	l	l	PROPN
ajlm-1563	285	3	,	,	PUNCT
ajlm-1563	285	4	klein	klein	PROPN
ajlm-1563	285	5	rs	rs	PROPN
ajlm-1563	285	6	,	,	PUNCT
ajlm-1563	285	7	burk	burk	PROPN
ajlm-1563	285	8	r	r	PROPN
ajlm-1563	285	9	,	,	PUNCT
ajlm-1563	285	10	et	et	PROPN
ajlm-1563	285	11	al	al	PROPN
ajlm-1563	285	12	.	.	PUNCT
ajlm-1563	286	1	prevalence	prevalence	NOUN
ajlm-1563	286	2	,	,	PUNCT
ajlm-1563	286	3	incidence	incidence	NOUN
ajlm-1563	286	4	,	,	PUNCT
ajlm-1563	286	5	and	and	CCONJ
ajlm-1563	286	6	type	type	NOUN
ajlm-1563	286	7	-	-	PUNCT
ajlm-1563	286	8	specific	specific	ADJ
ajlm-1563	286	9	persistence	persistence	NOUN
ajlm-1563	286	10	of	of	ADP
ajlm-1563	286	11	human	human	ADJ
ajlm-1563	286	12	papillomavirus	papillomavirus	NOUN
ajlm-1563	286	13	in	in	ADP
ajlm-1563	286	14	human	human	ADJ
ajlm-1563	286	15	immunodeficiency	immunodeficiency	NOUN
ajlm-1563	286	16	virus	virus	NOUN
ajlm-1563	286	17	(	(	PUNCT
ajlm-1563	286	18	hiv)-positive	hiv)-positive	ADJ
ajlm-1563	286	19	and	and	CCONJ
ajlm-1563	286	20	hiv	hiv	NOUN
ajlm-1563	286	21	-	-	PUNCT
ajlm-1563	286	22	negative	negative	ADJ
ajlm-1563	286	23	women	woman	NOUN
ajlm-1563	286	24	.	.	PUNCT
ajlm-1563	287	1	j	j	PROPN
ajlm-1563	287	2	infect	infect	VERB
ajlm-1563	287	3	dis	dis	PROPN
ajlm-1563	287	4	.	.	PUNCT
ajlm-1563	288	1	2001;184(6):682–690	2001;184(6):682–690	X
ajlm-1563	288	2	.	.	PUNCT
ajlm-1563	289	1	https://doi.org/10.1086/323081	https://doi.org/10.1086/323081	PROPN
ajlm-1563	289	2	menon	menon	PROPN
ajlm-1563	289	3	s	s	PROPN
ajlm-1563	289	4	,	,	PUNCT
ajlm-1563	289	5	rossi	rossi	ADJ
ajlm-1563	289	6	r	r	NOUN
ajlm-1563	289	7	,	,	PUNCT
ajlm-1563	289	8	kariisa	kariisa	NOUN
ajlm-1563	289	9	m	m	PROPN
ajlm-1563	289	10	,	,	PUNCT
ajlm-1563	289	11	et	et	PROPN
ajlm-1563	289	12	al	al	PROPN
ajlm-1563	289	13	.	.	PROPN
ajlm-1563	289	14	relationship	relationship	NOUN
ajlm-1563	289	15	between	between	ADP
ajlm-1563	289	16	highly	highly	ADV
ajlm-1563	289	17	active	active	ADJ
ajlm-1563	289	18	antiretroviral	antiretroviral	ADJ
ajlm-1563	289	19	therapy	therapy	NOUN
ajlm-1563	289	20	(	(	PUNCT
ajlm-1563	289	21	haart	haart	PROPN
ajlm-1563	289	22	)	)	PUNCT
ajlm-1563	289	23	and	and	CCONJ
ajlm-1563	289	24	human	human	ADJ
ajlm-1563	289	25	papillomavirus	papillomavirus	NOUN
ajlm-1563	289	26	type	type	NOUN
ajlm-1563	289	27	16	16	NUM
ajlm-1563	289	28	(	(	PUNCT
ajlm-1563	289	29	hpv16	hpv16	NOUN
ajlm-1563	289	30	)	)	PUNCT
ajlm-1563	289	31	infection	infection	NOUN
ajlm-1563	289	32	among	among	ADP
ajlm-1563	289	33	women	woman	NOUN
ajlm-1563	289	34	in	in	ADP
ajlm-1563	289	35	sub	sub	ADJ
ajlm-1563	289	36	-	-	ADJ
ajlm-1563	289	37	saharan	saharan	ADJ
ajlm-1563	289	38	africa	africa	PROPN
ajlm-1563	289	39	and	and	CCONJ
ajlm-1563	289	40	public	public	ADJ
ajlm-1563	289	41	health	health	NOUN
ajlm-1563	289	42	implications	implication	NOUN
ajlm-1563	289	43	:	:	PUNCT
ajlm-1563	289	44	a	a	DET
ajlm-1563	289	45	systematic	systematic	ADJ
ajlm-1563	289	46	review	review	NOUN
ajlm-1563	289	47	.	.	PUNCT
ajlm-1563	290	1	plos	plos	PROPN
ajlm-1563	290	2	one	one	NUM
ajlm-1563	290	3	.	.	PUNCT
ajlm-1563	291	1	2019;14(3):e0213086	2019;14(3):e0213086	X
ajlm-1563	291	2	.	.	PUNCT
ajlm-1563	291	3	https://doi.org/10.1371/journal.pone.0213086	https://doi.org/10.1371/journal.pone.0213086	VERB
ajlm-1563	291	4	del	del	PROPN
ajlm-1563	291	5	ma	ma	PROPN
ajlm-1563	291	6	,	,	PUNCT
ajlm-1563	291	7	bertorelle	bertorelle	VERB
ajlm-1563	291	8	r	r	NOUN
ajlm-1563	291	9	,	,	PUNCT
ajlm-1563	291	10	franzetti	franzetti	PROPN
ajlm-1563	291	11	m	m	PROPN
ajlm-1563	291	12	,	,	PUNCT
ajlm-1563	291	13	et	et	PROPN
ajlm-1563	291	14	al	al	PROPN
ajlm-1563	291	15	.	.	PROPN
ajlm-1563	291	16	antiretroviral	antiretroviral	ADJ
ajlm-1563	291	17	therapy	therapy	NOUN
ajlm-1563	291	18	and	and	CCONJ
ajlm-1563	291	19	the	the	DET
ajlm-1563	291	20	clinical	clinical	ADJ
ajlm-1563	291	21	evolution	evolution	NOUN
ajlm-1563	291	22	of	of	ADP
ajlm-1563	291	23	human	human	ADJ
ajlm-1563	291	24	papillomavirus	papillomavirus	NOUN
ajlm-1563	291	25	–	–	PUNCT
ajlm-1563	291	26	associated	associate	VERB
ajlm-1563	291	27	genital	genital	ADJ
ajlm-1563	291	28	lesions	lesion	NOUN
ajlm-1563	291	29	in	in	ADP
ajlm-1563	291	30	hiv	hiv	PROPN
ajlm-1563	291	31	-	-	PUNCT
ajlm-1563	291	32	positive	positive	ADJ
ajlm-1563	291	33	women	woman	NOUN
ajlm-1563	291	34	.	.	PUNCT
ajlm-1563	292	1	clin	clin	PROPN
ajlm-1563	292	2	infect	infect	PROPN
ajlm-1563	292	3	dis	dis	PROPN
ajlm-1563	292	4	.	.	PUNCT
ajlm-1563	293	1	2004;38(5):737–742	2004;38(5):737–742	NUM
ajlm-1563	293	2	.	.	PUNCT
ajlm-1563	294	1	https://doi.org/10.1086/381681	https://doi.org/10.1086/381681	VERB
ajlm-1563	294	2	saidu	saidu	PROPN
ajlm-1563	294	3	r.	r.	PROPN
ajlm-1563	294	4	vulvar	vulvar	PROPN
ajlm-1563	294	5	cancer	cancer	NOUN
ajlm-1563	294	6	,	,	PUNCT
ajlm-1563	294	7	hpv	hpv	NOUN
ajlm-1563	294	8	infection	infection	NOUN
ajlm-1563	294	9	,	,	PUNCT
ajlm-1563	294	10	and	and	CCONJ
ajlm-1563	294	11	hiv	hiv	PROPN
ajlm-1563	294	12	status	status	NOUN
ajlm-1563	294	13	.	.	PUNCT
ajlm-1563	295	1	curr	curr	PROPN
ajlm-1563	295	2	obstet	obstet	PROPN
ajlm-1563	295	3	gynecol	gynecol	PROPN
ajlm-1563	295	4	rep	rep	PROPN
ajlm-1563	295	5	.	.	PROPN
ajlm-1563	295	6	2016;5(3):196–202	2016;5(3):196–202	NUM
ajlm-1563	295	7	.	.	PROPN
ajlm-1563	295	8	https://doi.org/10.1007/s13669-016-0164-0	https://doi.org/10.1007/s13669-016-0164-0	VERB
ajlm-1563	295	9	cdc	cdc	PROPN
ajlm-1563	295	10	.	.	PUNCT
ajlm-1563	296	1	hiv	hiv	PROPN
ajlm-1563	297	1	[	[	X
ajlm-1563	297	2	homepage	homepage	NOUN
ajlm-1563	297	3	on	on	ADP
ajlm-1563	297	4	the	the	DET
ajlm-1563	297	5	internet	internet	NOUN
ajlm-1563	297	6	]	]	PUNCT
ajlm-1563	297	7	.	.	PUNCT
ajlm-1563	298	1	2022	2022	NUM
ajlm-1563	299	1	[	[	X
ajlm-1563	299	2	cited	cite	VERB
ajlm-1563	299	3	2022	2022	NUM
ajlm-1563	299	4	jan	jan	PROPN
ajlm-1563	299	5	11	11	NUM
ajlm-1563	299	6	]	]	PUNCT
ajlm-1563	299	7	.	.	PUNCT
ajlm-1563	300	1	available	available	ADJ
ajlm-1563	300	2	from	from	ADP
ajlm-1563	300	3	:	:	PUNCT
ajlm-1563	300	4	https://www.cdc.gov/hiv/basics/whatishiv.html#:~:text=hiv%28humanimmunodeficiencyvirus%29isavirusthat,itcanleadtoaids%28acquiredimmunodeficiencysyndrome%29	https://www.cdc.gov/hiv/basics/whatishiv.html#:~:text=hiv%28humanimmunodeficiencyvirus%29isavirusthat,itcanleadtoaids%28acquiredimmunodeficiencysyndrome%29	NOUN
ajlm-1563	300	5	kulkarni	kulkarni	PROPN
ajlm-1563	300	6	ka	ka	PROPN
ajlm-1563	300	7	,	,	PUNCT
ajlm-1563	300	8	acharya	acharya	PROPN
ajlm-1563	300	9	g	g	PROPN
ajlm-1563	300	10	,	,	PUNCT
ajlm-1563	300	11	sumangala	sumangala	PROPN
ajlm-1563	300	12	g.	g.	PROPN
ajlm-1563	300	13	risk	risk	NOUN
ajlm-1563	300	14	factors	factor	NOUN
ajlm-1563	300	15	and	and	CCONJ
ajlm-1563	300	16	classification	classification	NOUN
ajlm-1563	300	17	of	of	ADP
ajlm-1563	300	18	vulvar	vulvar	ADJ
ajlm-1563	300	19	intraepithelial	intraepithelial	ADJ
ajlm-1563	300	20	lesions	lesion	NOUN
ajlm-1563	300	21	.	.	PUNCT
ajlm-1563	301	1	in	in	ADP
ajlm-1563	301	2	:	:	PUNCT
ajlm-1563	301	3	mehta	mehta	PROPN
ajlm-1563	301	4	s	s	PROPN
ajlm-1563	301	5	,	,	PUNCT
ajlm-1563	301	6	singla	singla	PRON
ajlm-1563	301	7	a	a	PRON
ajlm-1563	301	8	,	,	PUNCT
ajlm-1563	301	9	editors	editor	NOUN
ajlm-1563	301	10	.	.	PUNCT
ajlm-1563	302	1	preventive	preventive	ADJ
ajlm-1563	302	2	oncology	oncology	NOUN
ajlm-1563	302	3	for	for	ADP
ajlm-1563	302	4	the	the	DET
ajlm-1563	302	5	gynecologist	gynecologist	NOUN
ajlm-1563	303	1	[	[	X
ajlm-1563	303	2	homepage	homepage	NOUN
ajlm-1563	303	3	on	on	ADP
ajlm-1563	303	4	the	the	DET
ajlm-1563	303	5	internet	internet	NOUN
ajlm-1563	303	6	]	]	PUNCT
ajlm-1563	303	7	.	.	PUNCT
ajlm-1563	304	1	singapore	singapore	PROPN
ajlm-1563	304	2	:	:	PUNCT
ajlm-1563	304	3	springer	springer	NOUN
ajlm-1563	304	4	;	;	PUNCT
ajlm-1563	304	5	2019	2019	NUM
ajlm-1563	304	6	.	.	PUNCT
ajlm-1563	305	1	available	available	ADJ
ajlm-1563	305	2	from	from	ADP
ajlm-1563	305	3	:	:	PUNCT
ajlm-1563	305	4	https://link.springer.com/chapter/10.1007/978-981-13-3438-2_21#citeas	https://link.springer.com/chapter/10.1007/978-981-13-3438-2_21#citeas	PROPN
ajlm-1563	305	5	canavan	canavan	NOUN
ajlm-1563	305	6	tp	tp	PROPN
ajlm-1563	305	7	,	,	PUNCT
ajlm-1563	305	8	cohen	cohen	PROPN
ajlm-1563	305	9	d.	d.	PROPN
ajlm-1563	305	10	vulvar	vulvar	PROPN
ajlm-1563	305	11	cancer	cancer	NOUN
ajlm-1563	305	12	.	.	PUNCT
ajlm-1563	306	1	am	be	AUX
ajlm-1563	306	2	fam	fam	NOUN
ajlm-1563	306	3	physician	physician	NOUN
ajlm-1563	306	4	.	.	PUNCT
ajlm-1563	307	1	2002;66(7):1269–1274	2002;66(7):1269–1274	PROPN
ajlm-1563	307	2	.	.	PUNCT
ajlm-1563	308	1	college	college	PROPN
ajlm-1563	308	2	of	of	ADP
ajlm-1563	308	3	american	american	ADJ
ajlm-1563	308	4	pathologists	pathologist	NOUN
ajlm-1563	308	5	.	.	PUNCT
ajlm-1563	309	1	protocol	protocol	NOUN
ajlm-1563	309	2	for	for	ADP
ajlm-1563	309	3	the	the	DET
ajlm-1563	309	4	examination	examination	NOUN
ajlm-1563	309	5	of	of	ADP
ajlm-1563	309	6	specimens	specimen	NOUN
ajlm-1563	309	7	from	from	ADP
ajlm-1563	309	8	patients	patient	NOUN
ajlm-1563	309	9	with	with	ADP
ajlm-1563	309	10	primary	primary	ADJ
ajlm-1563	309	11	carcinoma	carcinoma	NOUN
ajlm-1563	309	12	of	of	ADP
ajlm-1563	309	13	the	the	DET
ajlm-1563	309	14	vulva	vulva	NOUN
ajlm-1563	310	1	[	[	X
ajlm-1563	310	2	internet	internet	NOUN
ajlm-1563	310	3	]	]	PUNCT
ajlm-1563	310	4	.	.	PUNCT
ajlm-1563	311	1	cancer	cancer	NOUN
ajlm-1563	311	2	-	-	PUNCT
ajlm-1563	311	3	protocol	protocol	NOUN
ajlm-1563	311	4	-	-	PUNCT
ajlm-1563	311	5	templates	template	NOUN
ajlm-1563	311	6	.	.	PUNCT
ajlm-1563	312	1	2020	2020	NUM
ajlm-1563	313	1	[	[	X
ajlm-1563	313	2	cited	cite	VERB
ajlm-1563	313	3	2020	2020	NUM
ajlm-1563	313	4	jun	jun	PROPN
ajlm-1563	313	5	6	6	NUM
ajlm-1563	313	6	]	]	PUNCT
ajlm-1563	313	7	.	.	PUNCT
ajlm-1563	314	1	available	available	ADJ
ajlm-1563	314	2	from	from	ADP
ajlm-1563	314	3	:	:	PUNCT
ajlm-1563	314	4	https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates	https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates	PROPN
ajlm-1563	314	5	hoang	hoang	PROPN
ajlm-1563	314	6	ln	ln	PROPN
ajlm-1563	314	7	,	,	PUNCT
ajlm-1563	314	8	park	park	NOUN
ajlm-1563	314	9	kj	kj	PROPN
ajlm-1563	314	10	,	,	PUNCT
ajlm-1563	314	11	soslow	soslow	PROPN
ajlm-1563	314	12	ra	ra	PROPN
ajlm-1563	314	13	,	,	PUNCT
ajlm-1563	314	14	murali	murali	PROPN
ajlm-1563	314	15	r.	r.	PROPN
ajlm-1563	314	16	squamous	squamous	ADJ
ajlm-1563	314	17	precursor	precursor	NOUN
ajlm-1563	314	18	lesions	lesion	NOUN
ajlm-1563	314	19	of	of	ADP
ajlm-1563	314	20	the	the	DET
ajlm-1563	314	21	vulva	vulva	NOUN
ajlm-1563	314	22	:	:	PUNCT
ajlm-1563	314	23	current	current	ADJ
ajlm-1563	314	24	classification	classification	NOUN
ajlm-1563	314	25	and	and	CCONJ
ajlm-1563	314	26	diagnostic	diagnostic	ADJ
ajlm-1563	314	27	challenges	challenge	NOUN
ajlm-1563	314	28	.	.	PUNCT
ajlm-1563	315	1	pathology	pathology	NOUN
ajlm-1563	315	2	.	.	PUNCT
ajlm-1563	316	1	2016;4(48):291–302	2016;4(48):291–302	NOUN
ajlm-1563	316	2	.	.	PUNCT
ajlm-1563	317	1	https://doi.org/10.1016/j.pathol.2016.02.015	https://doi.org/10.1016/j.pathol.2016.02.015	PROPN
ajlm-1563	317	2	kurman	kurman	PROPN
ajlm-1563	317	3	rj	rj	PROPN
ajlm-1563	317	4	,	,	PUNCT
ajlm-1563	317	5	ellenson	ellenson	PROPN
ajlm-1563	317	6	lh	lh	PROPN
ajlm-1563	317	7	,	,	PUNCT
ajlm-1563	317	8	ronnett	ronnett	PROPN
ajlm-1563	317	9	bm	bm	PROPN
ajlm-1563	317	10	,	,	PUNCT
ajlm-1563	317	11	editors	editor	NOUN
ajlm-1563	317	12	.	.	PUNCT
ajlm-1563	318	1	blaustein	blaustein	PROPN
ajlm-1563	318	2	’s	’s	PART
ajlm-1563	318	3	pathology	pathology	NOUN
ajlm-1563	318	4	of	of	ADP
ajlm-1563	318	5	the	the	DET
ajlm-1563	318	6	female	female	ADJ
ajlm-1563	318	7	genital	genital	ADJ
ajlm-1563	318	8	tract	tract	NOUN
ajlm-1563	318	9	.	.	PUNCT
ajlm-1563	319	1	6th	6th	ADJ
ajlm-1563	319	2	ed	ed	NOUN
ajlm-1563	319	3	.	.	PUNCT
ajlm-1563	320	1	pathology	pathology	PROPN
ajlm-1563	320	2	.	.	PUNCT
ajlm-1563	321	1	new	new	PROPN
ajlm-1563	321	2	york	york	PROPN
ajlm-1563	321	3	,	,	PUNCT
ajlm-1563	321	4	ny	ny	PROPN
ajlm-1563	321	5	:	:	PUNCT
ajlm-1563	321	6	springer	springer	NOUN
ajlm-1563	321	7	;	;	PUNCT
ajlm-1563	321	8	2011	2011	NUM
ajlm-1563	321	9	.	.	PUNCT
ajlm-1563	322	1	madeddu	madeddu	PROPN
ajlm-1563	322	2	g	g	PROPN
ajlm-1563	322	3	,	,	PUNCT
ajlm-1563	322	4	mameli	mameli	PROPN
ajlm-1563	322	5	g	g	PROPN
ajlm-1563	322	6	,	,	PUNCT
ajlm-1563	322	7	capobianco	capobianco	NOUN
ajlm-1563	322	8	g	g	NOUN
ajlm-1563	322	9	,	,	PUNCT
ajlm-1563	322	10	et	et	PROPN
ajlm-1563	322	11	al	al	PROPN
ajlm-1563	322	12	.	.	PROPN
ajlm-1563	322	13	hpv	hpv	PROPN
ajlm-1563	322	14	infection	infection	NOUN
ajlm-1563	322	15	in	in	ADP
ajlm-1563	322	16	hiv	hiv	PROPN
ajlm-1563	322	17	-	-	PUNCT
ajlm-1563	322	18	positive	positive	ADJ
ajlm-1563	322	19	females	female	NOUN
ajlm-1563	322	20	:	:	PUNCT
ajlm-1563	322	21	the	the	DET
ajlm-1563	322	22	need	need	NOUN
ajlm-1563	322	23	for	for	ADP
ajlm-1563	322	24	cervical	cervical	ADJ
ajlm-1563	322	25	cancer	cancer	NOUN
ajlm-1563	322	26	screening	screening	NOUN
ajlm-1563	322	27	including	include	VERB
ajlm-1563	322	28	hpv	hpv	PROPN
ajlm-1563	322	29	-	-	PUNCT
ajlm-1563	322	30	dna	dna	PROPN
ajlm-1563	322	31	detection	detection	NOUN
ajlm-1563	322	32	despite	despite	SCONJ
ajlm-1563	322	33	successful	successful	ADJ
ajlm-1563	322	34	haart	haart	PROPN
ajlm-1563	322	35	.	.	PUNCT
ajlm-1563	323	1	eur	eur	PROPN
ajlm-1563	323	2	rev	rev	PROPN
ajlm-1563	323	3	med	med	PROPN
ajlm-1563	323	4	pharmacol	pharmacol	PROPN
ajlm-1563	323	5	sci	sci	PROPN
ajlm-1563	323	6	.	.	PUNCT
ajlm-1563	324	1	2014;18(8):1277–1285	2014;18(8):1277–1285	NUM
ajlm-1563	324	2	.	.	PUNCT
ajlm-1563	325	1	liu	liu	PROPN
ajlm-1563	325	2	g	g	PROPN
ajlm-1563	325	3	,	,	PUNCT
ajlm-1563	325	4	sharma	sharma	PROPN
ajlm-1563	325	5	m	m	PROPN
ajlm-1563	325	6	,	,	PUNCT
ajlm-1563	325	7	tan	tan	PROPN
ajlm-1563	325	8	n	n	CCONJ
ajlm-1563	325	9	,	,	PUNCT
ajlm-1563	325	10	barnabas	barnabas	PROPN
ajlm-1563	325	11	r	r	PROPN
ajlm-1563	325	12	v.	v.	ADP
ajlm-1563	325	13	hiv	hiv	PROPN
ajlm-1563	325	14	-	-	PUNCT
ajlm-1563	325	15	positive	positive	ADJ
ajlm-1563	325	16	women	woman	NOUN
ajlm-1563	325	17	have	have	VERB
ajlm-1563	325	18	higher	high	ADJ
ajlm-1563	325	19	risk	risk	NOUN
ajlm-1563	325	20	of	of	ADP
ajlm-1563	325	21	human	human	ADJ
ajlm-1563	325	22	papilloma	papilloma	NOUN
ajlm-1563	325	23	virus	virus	NOUN
ajlm-1563	325	24	infection	infection	NOUN
ajlm-1563	325	25	,	,	PUNCT
ajlm-1563	325	26	precancerous	precancerous	ADJ
ajlm-1563	325	27	lesions	lesion	NOUN
ajlm-1563	325	28	,	,	PUNCT
ajlm-1563	325	29	and	and	CCONJ
ajlm-1563	325	30	cervical	cervical	ADJ
ajlm-1563	325	31	cancer	cancer	NOUN
ajlm-1563	325	32	.	.	PUNCT
ajlm-1563	326	1	aids	aids	PROPN
ajlm-1563	326	2	.	.	PUNCT
ajlm-1563	327	1	2018;32(6):795–808	2018;32(6):795–808	X
ajlm-1563	327	2	.	.	PUNCT
ajlm-1563	328	1	https://doi.org/10.1097/qad.0000000000001765	https://doi.org/10.1097/qad.0000000000001765	PROPN
ajlm-1563	328	2	moscicki	moscicki	NOUN
ajlm-1563	328	3	a	a	PROPN
ajlm-1563	328	4	-	-	PUNCT
ajlm-1563	328	5	b	b	NOUN
ajlm-1563	328	6	,	,	PUNCT
ajlm-1563	328	7	ellenberg	ellenberg	PROPN
ajlm-1563	328	8	jh	jh	PROPN
ajlm-1563	328	9	,	,	PUNCT
ajlm-1563	328	10	farhat	farhat	PROPN
ajlm-1563	328	11	s	s	PROPN
ajlm-1563	328	12	,	,	PUNCT
ajlm-1563	328	13	xu	xu	PROPN
ajlm-1563	328	14	j.	j.	PROPN
ajlm-1563	328	15	persistence	persistence	PROPN
ajlm-1563	328	16	of	of	ADP
ajlm-1563	328	17	human	human	ADJ
ajlm-1563	328	18	papillomavirus	papillomavirus	NOUN
ajlm-1563	328	19	infection	infection	NOUN
ajlm-1563	328	20	in	in	ADP
ajlm-1563	328	21	hiv	hiv	PROPN
ajlm-1563	328	22	-	-	PUNCT
ajlm-1563	328	23	infected	infect	VERB
ajlm-1563	328	24	and	and	CCONJ
ajlm-1563	328	25	-uninfected	-uninfected	ADJ
ajlm-1563	328	26	adolescent	adolescent	ADJ
ajlm-1563	328	27	girls	girl	NOUN
ajlm-1563	328	28	:	:	PUNCT
ajlm-1563	328	29	risk	risk	NOUN
ajlm-1563	328	30	factors	factor	NOUN
ajlm-1563	328	31	and	and	CCONJ
ajlm-1563	328	32	differences	difference	NOUN
ajlm-1563	328	33	,	,	PUNCT
ajlm-1563	328	34	by	by	ADP
ajlm-1563	328	35	phylogenetic	phylogenetic	ADJ
ajlm-1563	328	36	type	type	NOUN
ajlm-1563	328	37	.	.	PUNCT
ajlm-1563	329	1	j	j	PROPN
ajlm-1563	329	2	infect	infect	VERB
ajlm-1563	329	3	dis	dis	PROPN
ajlm-1563	329	4	.	.	PUNCT
ajlm-1563	330	1	2004;190(1):37–45	2004;190(1):37–45	X
ajlm-1563	330	2	.	.	PUNCT
ajlm-1563	330	3	https://doi.org/10.1086/421467	https://doi.org/10.1086/421467	AUX
ajlm-1563	330	4	lekoane	lekoane	PROPN
ajlm-1563	330	5	kmb	kmb	PROPN
ajlm-1563	330	6	,	,	PUNCT
ajlm-1563	330	7	kuupiel	kuupiel	PROPN
ajlm-1563	330	8	d	d	PROPN
ajlm-1563	330	9	,	,	PUNCT
ajlm-1563	330	10	mashamba	mashamba	ADJ
ajlm-1563	330	11	-	-	PUNCT
ajlm-1563	330	12	thompson	thompson	NOUN
ajlm-1563	330	13	tp	tp	NOUN
ajlm-1563	330	14	,	,	PUNCT
ajlm-1563	330	15	ginindza	ginindza	INTJ
ajlm-1563	330	16	tg	tg	PROPN
ajlm-1563	330	17	.	.	PUNCT
ajlm-1563	331	1	the	the	DET
ajlm-1563	331	2	interplay	interplay	NOUN
ajlm-1563	331	3	of	of	ADP
ajlm-1563	331	4	hiv	hiv	PROPN
ajlm-1563	331	5	and	and	CCONJ
ajlm-1563	331	6	human	human	ADJ
ajlm-1563	331	7	papillomavirus	papillomavirus	NOUN
ajlm-1563	331	8	-	-	PUNCT
ajlm-1563	331	9	related	relate	VERB
ajlm-1563	331	10	cancers	cancer	NOUN
ajlm-1563	331	11	in	in	ADP
ajlm-1563	331	12	sub	sub	ADJ
ajlm-1563	331	13	-	-	ADJ
ajlm-1563	331	14	saharan	saharan	ADJ
ajlm-1563	331	15	africa	africa	PROPN
ajlm-1563	331	16	:	:	PUNCT
ajlm-1563	331	17	scoping	scope	VERB
ajlm-1563	331	18	review	review	NOUN
ajlm-1563	331	19	.	.	PUNCT
ajlm-1563	332	1	syst	syst	PROPN
ajlm-1563	332	2	rev	rev	PROPN
ajlm-1563	332	3	.	.	PROPN
ajlm-1563	333	1	2020;9(1):88	2020;9(1):88	NUM
ajlm-1563	333	2	.	.	PUNCT
ajlm-1563	334	1	https://doi.org/10.1186/s13643-020-01354-1	https://doi.org/10.1186/s13643-020-01354-1	NUM
ajlm-1563	334	2	faber	faber	PROPN
ajlm-1563	334	3	mt	mt	PROPN
ajlm-1563	334	4	,	,	PUNCT
ajlm-1563	334	5	sand	sand	NOUN
ajlm-1563	334	6	fl	fl	NOUN
ajlm-1563	334	7	,	,	PUNCT
ajlm-1563	334	8	albieri	albieri	ADJ
ajlm-1563	334	9	v	v	PROPN
ajlm-1563	334	10	,	,	PUNCT
ajlm-1563	334	11	norrild	norrild	PROPN
ajlm-1563	334	12	b	b	NUM
ajlm-1563	334	13	,	,	PUNCT
ajlm-1563	334	14	kjær	kjær	NOUN
ajlm-1563	334	15	sk	sk	VERB
ajlm-1563	334	16	,	,	PUNCT
ajlm-1563	334	17	verdoodt	verdoodt	PROPN
ajlm-1563	334	18	f.	f.	PROPN
ajlm-1563	334	19	prevalence	prevalence	PROPN
ajlm-1563	334	20	and	and	CCONJ
ajlm-1563	334	21	type	type	NOUN
ajlm-1563	334	22	distribution	distribution	NOUN
ajlm-1563	334	23	of	of	ADP
ajlm-1563	334	24	human	human	ADJ
ajlm-1563	334	25	papillomavirus	papillomavirus	NOUN
ajlm-1563	334	26	in	in	ADP
ajlm-1563	334	27	squamous	squamous	ADJ
ajlm-1563	334	28	cell	cell	NOUN
ajlm-1563	334	29	carcinoma	carcinoma	NOUN
ajlm-1563	334	30	and	and	CCONJ
ajlm-1563	334	31	intraepithelial	intraepithelial	ADJ
ajlm-1563	334	32	neoplasia	neoplasia	NOUN
ajlm-1563	334	33	of	of	ADP
ajlm-1563	334	34	the	the	DET
ajlm-1563	334	35	vulva	vulva	NOUN
ajlm-1563	334	36	.	.	PUNCT
ajlm-1563	335	1	int	int	PROPN
ajlm-1563	335	2	j	j	PROPN
ajlm-1563	335	3	cancer	cancer	NOUN
ajlm-1563	335	4	.	.	PUNCT
ajlm-1563	336	1	2017;141(6):1161–1169	2017;141(6):1161–1169	NUM
ajlm-1563	336	2	.	.	PUNCT
ajlm-1563	337	1	https://doi.org/10.1002/ijc.30821	https://doi.org/10.1002/ijc.30821	PROPN
ajlm-1563	337	2	smith	smith	PROPN
ajlm-1563	337	3	js	js	PROPN
ajlm-1563	337	4	,	,	PUNCT
ajlm-1563	337	5	backes	backes	PROPN
ajlm-1563	337	6	dm	dm	PROPN
ajlm-1563	337	7	,	,	PUNCT
ajlm-1563	337	8	hoots	hoot	NOUN
ajlm-1563	337	9	be	be	VERB
ajlm-1563	337	10	,	,	PUNCT
ajlm-1563	337	11	kurman	kurman	PROPN
ajlm-1563	337	12	rj	rj	PROPN
ajlm-1563	337	13	,	,	PUNCT
ajlm-1563	337	14	pimenta	pimenta	PROPN
ajlm-1563	337	15	jm	jm	PROPN
ajlm-1563	337	16	.	.	PROPN
ajlm-1563	337	17	human	human	ADJ
ajlm-1563	337	18	papillomavirus	papillomavirus	NOUN
ajlm-1563	337	19	type	type	NOUN
ajlm-1563	337	20	-	-	PUNCT
ajlm-1563	337	21	distribution	distribution	NOUN
ajlm-1563	337	22	in	in	ADP
ajlm-1563	337	23	vulvar	vulvar	NOUN
ajlm-1563	337	24	and	and	CCONJ
ajlm-1563	337	25	vaginal	vaginal	ADJ
ajlm-1563	337	26	cancers	cancer	NOUN
ajlm-1563	337	27	and	and	CCONJ
ajlm-1563	337	28	their	their	PRON
ajlm-1563	337	29	associated	associated	ADJ
ajlm-1563	337	30	precursors	precursor	NOUN
ajlm-1563	337	31	.	.	PUNCT
ajlm-1563	338	1	obstet	obstet	PROPN
ajlm-1563	338	2	gynecol	gynecol	PROPN
ajlm-1563	338	3	.	.	PUNCT
ajlm-1563	339	1	2009;113(4):917–924	2009;113(4):917–924	NUM
ajlm-1563	339	2	.	.	PUNCT
ajlm-1563	339	3	https://doi.org/10.1097/aog.0b013e31819bd6e0	https://doi.org/10.1097/aog.0b013e31819bd6e0	PROPN
ajlm-1563	339	4	national	national	ADJ
ajlm-1563	339	5	heart	heart	NOUN
ajlm-1563	339	6	and	and	CCONJ
ajlm-1563	339	7	blood	blood	NOUN
ajlm-1563	339	8	institute	institute	NOUN
ajlm-1563	339	9	.	.	PUNCT
ajlm-1563	340	1	expert	expert	ADJ
ajlm-1563	340	2	panel	panel	NOUN
ajlm-1563	340	3	on	on	ADP
ajlm-1563	340	4	integrated	integrate	VERB
ajlm-1563	340	5	guidelines	guideline	NOUN
ajlm-1563	340	6	for	for	ADP
ajlm-1563	340	7	cardiovascular	cardiovascular	ADJ
ajlm-1563	340	8	health	health	NOUN
ajlm-1563	340	9	and	and	CCONJ
ajlm-1563	340	10	risk	risk	NOUN
ajlm-1563	340	11	reduction	reduction	NOUN
ajlm-1563	340	12	in	in	ADP
ajlm-1563	340	13	children	child	NOUN
ajlm-1563	340	14	and	and	CCONJ
ajlm-1563	340	15	adolescents	adolescent	NOUN
ajlm-1563	340	16	:	:	PUNCT
ajlm-1563	340	17	summary	summary	NOUN
ajlm-1563	340	18	report	report	NOUN
ajlm-1563	340	19	.	.	PUNCT
ajlm-1563	341	1	pediatrics	pediatric	NOUN
ajlm-1563	341	2	.	.	PUNCT
ajlm-1563	342	1	2011;128	2011;128	NUM
ajlm-1563	343	1	suppl	suppl	ADJ
ajlm-1563	343	2	5(suppl	5(suppl	PROPN
ajlm-1563	343	3	5):s213	5):s213	NUM
ajlm-1563	343	4	–	–	PUNCT
ajlm-1563	343	5	s256	s256	PROPN
ajlm-1563	343	6	.	.	PUNCT
ajlm-1563	344	1	https://doi.org/10.1542/peds.2009-2107c	https://doi.org/10.1542/peds.2009-2107c	PROPN
ajlm-1563	344	2	insinga	insinga	PROPN
ajlm-1563	344	3	rp	rp	PROPN
ajlm-1563	344	4	,	,	PUNCT
ajlm-1563	344	5	liaw	liaw	PROPN
ajlm-1563	344	6	kl	kl	PROPN
ajlm-1563	344	7	,	,	PUNCT
ajlm-1563	344	8	johnson	johnson	PROPN
ajlm-1563	344	9	lg	lg	PROPN
ajlm-1563	344	10	,	,	PUNCT
ajlm-1563	344	11	madeleine	madeleine	PROPN
ajlm-1563	344	12	mm	mm	PROPN
ajlm-1563	344	13	.	.	PUNCT
ajlm-1563	345	1	a	a	DET
ajlm-1563	345	2	systematic	systematic	ADJ
ajlm-1563	345	3	review	review	NOUN
ajlm-1563	345	4	of	of	ADP
ajlm-1563	345	5	the	the	DET
ajlm-1563	345	6	prevalence	prevalence	NOUN
ajlm-1563	345	7	and	and	CCONJ
ajlm-1563	345	8	attribution	attribution	NOUN
ajlm-1563	345	9	of	of	ADP
ajlm-1563	345	10	human	human	ADJ
ajlm-1563	345	11	papillomavirus	papillomavirus	NOUN
ajlm-1563	345	12	types	type	NOUN
ajlm-1563	345	13	among	among	ADP
ajlm-1563	345	14	cervical	cervical	ADJ
ajlm-1563	345	15	,	,	PUNCT
ajlm-1563	345	16	vaginal	vaginal	ADJ
ajlm-1563	345	17	,	,	PUNCT
ajlm-1563	345	18	and	and	CCONJ
ajlm-1563	345	19	vulvar	vulvar	NOUN
ajlm-1563	345	20	precancers	precancer	NOUN
ajlm-1563	345	21	and	and	CCONJ
ajlm-1563	345	22	cancers	cancer	NOUN
ajlm-1563	345	23	in	in	ADP
ajlm-1563	345	24	the	the	DET
ajlm-1563	345	25	united	united	PROPN
ajlm-1563	345	26	states	states	PROPN
ajlm-1563	345	27	[	[	X
ajlm-1563	345	28	homepage	homepage	NOUN
ajlm-1563	345	29	on	on	ADP
ajlm-1563	345	30	the	the	DET
ajlm-1563	345	31	internet	internet	NOUN
ajlm-1563	345	32	]	]	PUNCT
ajlm-1563	345	33	.	.	PUNCT
ajlm-1563	346	1	cancer	cancer	NOUN
ajlm-1563	346	2	epidemiology	epidemiology	NOUN
ajlm-1563	346	3	biomarkers	biomarker	NOUN
ajlm-1563	346	4	and	and	CCONJ
ajlm-1563	346	5	prevention	prevention	NOUN
ajlm-1563	346	6	.	.	PUNCT
ajlm-1563	347	1	2008	2008	NUM
ajlm-1563	348	1	[	[	X
ajlm-1563	348	2	cited	cite	VERB
ajlm-1563	348	3	2019	2019	NUM
ajlm-1563	348	4	mar	mar	PROPN
ajlm-1563	348	5	25	25	NUM
ajlm-1563	348	6	]	]	PUNCT
ajlm-1563	348	7	.	.	PUNCT
ajlm-1563	349	1	p.	p.	NOUN
ajlm-1563	349	2	1611–1622	1611–1622	NUM
ajlm-1563	349	3	.	.	PUNCT
ajlm-1563	350	1	available	available	ADJ
ajlm-1563	350	2	from	from	ADP
ajlm-1563	350	3	:	:	PUNCT
ajlm-1563	350	4	http://cebp.aacrjournals.org/content/17/7/1611.full#related-urls	http://cebp.aacrjournals.org/content/17/7/1611.full#related-urls	NUM
ajlm-1563	350	5	carter	carter	PROPN
ajlm-1563	350	6	jj	jj	PROPN
ajlm-1563	350	7	,	,	PUNCT
ajlm-1563	350	8	madeleine	madeleine	PROPN
ajlm-1563	350	9	mm	mm	PROPN
ajlm-1563	350	10	,	,	PUNCT
ajlm-1563	350	11	shera	shera	PROPN
ajlm-1563	350	12	k	k	PROPN
ajlm-1563	350	13	,	,	PUNCT
ajlm-1563	350	14	et	et	PROPN
ajlm-1563	350	15	al	al	PROPN
ajlm-1563	350	16	.	.	PUNCT
ajlm-1563	351	1	human	human	ADJ
ajlm-1563	351	2	papillomavirus	papillomavirus	NOUN
ajlm-1563	351	3	16	16	NUM
ajlm-1563	351	4	and	and	CCONJ
ajlm-1563	351	5	18	18	NUM
ajlm-1563	351	6	l1	l1	PROPN
ajlm-1563	351	7	serology	serology	NOUN
ajlm-1563	351	8	compared	compare	VERB
ajlm-1563	351	9	across	across	ADP
ajlm-1563	351	10	anogenital	anogenital	ADJ
ajlm-1563	351	11	cancer	cancer	NOUN
ajlm-1563	351	12	sites	site	NOUN
ajlm-1563	351	13	.	.	PUNCT
ajlm-1563	352	1	cancer	cancer	NOUN
ajlm-1563	352	2	res	re	NOUN
ajlm-1563	352	3	.	.	PUNCT
ajlm-1563	353	1	2001;61(5):1934–1940	2001;61(5):1934–1940	NUM
ajlm-1563	353	2	.	.	PUNCT
ajlm-1563	354	1	palmer	palmer	PROPN
ajlm-1563	354	2	t	t	PROPN
ajlm-1563	354	3	,	,	PUNCT
ajlm-1563	354	4	wallace	wallace	PROPN
ajlm-1563	354	5	l	l	PROPN
ajlm-1563	354	6	,	,	PUNCT
ajlm-1563	354	7	pollock	pollock	NOUN
ajlm-1563	354	8	kg	kg	PROPN
ajlm-1563	354	9	,	,	PUNCT
ajlm-1563	354	10	et	et	PROPN
ajlm-1563	354	11	al	al	PROPN
ajlm-1563	354	12	.	.	PUNCT
ajlm-1563	355	1	prevalence	prevalence	NOUN
ajlm-1563	355	2	of	of	ADP
ajlm-1563	355	3	cervical	cervical	ADJ
ajlm-1563	355	4	disease	disease	NOUN
ajlm-1563	355	5	at	at	ADP
ajlm-1563	355	6	age	age	NOUN
ajlm-1563	355	7	20	20	NUM
ajlm-1563	355	8	after	after	ADP
ajlm-1563	355	9	immunisation	immunisation	NOUN
ajlm-1563	355	10	with	with	ADP
ajlm-1563	355	11	bivalent	bivalent	ADJ
ajlm-1563	355	12	hpv	hpv	ADJ
ajlm-1563	355	13	vaccine	vaccine	NOUN
ajlm-1563	355	14	at	at	ADP
ajlm-1563	355	15	age	age	NOUN
ajlm-1563	355	16	12–13	12–13	NUM
ajlm-1563	355	17	in	in	ADP
ajlm-1563	355	18	scotland	scotland	PROPN
ajlm-1563	355	19	:	:	PUNCT
ajlm-1563	355	20	retrospective	retrospective	ADJ
ajlm-1563	355	21	population	population	NOUN
ajlm-1563	355	22	study	study	NOUN
ajlm-1563	355	23	.	.	PUNCT
ajlm-1563	356	1	bmj	bmj	PROPN
ajlm-1563	356	2	.	.	PUNCT
ajlm-1563	357	1	2019;365	2019;365	NOUN
ajlm-1563	357	2	:	:	PUNCT
ajlm-1563	357	3	l1161	l1161	ADJ
ajlm-1563	357	4	.	.	PUNCT
ajlm-1563	358	1	https://doi.org/10.1136/bmj.l1161	https://doi.org/10.1136/bmj.l1161	PROPN
ajlm-1563	358	2	hartwig	hartwig	PROPN
ajlm-1563	358	3	s	s	PROPN
ajlm-1563	358	4	,	,	PUNCT
ajlm-1563	358	5	baldauf	baldauf	PROPN
ajlm-1563	358	6	jj	jj	PROPN
ajlm-1563	358	7	,	,	PUNCT
ajlm-1563	358	8	dominiak	dominiak	NOUN
ajlm-1563	358	9	-	-	PUNCT
ajlm-1563	358	10	felden	felden	NOUN
ajlm-1563	358	11	g	g	NOUN
ajlm-1563	358	12	,	,	PUNCT
ajlm-1563	358	13	et	et	PROPN
ajlm-1563	358	14	al	al	PROPN
ajlm-1563	358	15	.	.	PUNCT
ajlm-1563	358	16	estimation	estimation	NOUN
ajlm-1563	358	17	of	of	ADP
ajlm-1563	358	18	the	the	DET
ajlm-1563	358	19	epidemiological	epidemiological	ADJ
ajlm-1563	358	20	burden	burden	NOUN
ajlm-1563	358	21	of	of	ADP
ajlm-1563	358	22	hpv	hpv	NOUN
ajlm-1563	358	23	-	-	PUNCT
ajlm-1563	358	24	related	relate	VERB
ajlm-1563	358	25	anogenital	anogenital	ADJ
ajlm-1563	358	26	cancers	cancer	NOUN
ajlm-1563	358	27	,	,	PUNCT
ajlm-1563	358	28	precancerous	precancerous	ADJ
ajlm-1563	358	29	lesions	lesion	NOUN
ajlm-1563	358	30	,	,	PUNCT
ajlm-1563	358	31	and	and	CCONJ
ajlm-1563	358	32	genital	genital	ADJ
ajlm-1563	358	33	warts	wart	NOUN
ajlm-1563	358	34	in	in	ADP
ajlm-1563	358	35	women	woman	NOUN
ajlm-1563	358	36	and	and	CCONJ
ajlm-1563	358	37	men	man	NOUN
ajlm-1563	358	38	in	in	ADP
ajlm-1563	358	39	europe	europe	PROPN
ajlm-1563	358	40	:	:	PUNCT
ajlm-1563	358	41	potential	potential	ADJ
ajlm-1563	358	42	additional	additional	ADJ
ajlm-1563	358	43	benefit	benefit	NOUN
ajlm-1563	358	44	of	of	ADP
ajlm-1563	358	45	a	a	DET
ajlm-1563	358	46	nine	nine	NUM
ajlm-1563	358	47	-	-	PUNCT
ajlm-1563	358	48	valent	valent	NOUN
ajlm-1563	358	49	second	second	ADJ
ajlm-1563	358	50	generation	generation	NOUN
ajlm-1563	358	51	hpv	hpv	NOUN
ajlm-1563	358	52	vaccine	vaccine	NOUN
ajlm-1563	358	53	compared	compare	VERB
ajlm-1563	358	54	to	to	ADP
ajlm-1563	358	55	first	first	ADJ
ajlm-1563	358	56	generation	generation	NOUN
ajlm-1563	358	57	hpv	hpv	ADJ
ajlm-1563	358	58	vaccines	vaccine	NOUN
ajlm-1563	358	59	.	.	PUNCT
ajlm-1563	359	1	papillomavirus	papillomavirus	NOUN
ajlm-1563	359	2	res	re	NOUN
ajlm-1563	359	3	.	.	PUNCT
ajlm-1563	360	1	2015;1:90–100	2015;1:90–100	NUM
ajlm-1563	360	2	.	.	PUNCT
ajlm-1563	361	1	https://doi.org/10.1016/j.pvr.2015.06.003	https://doi.org/10.1016/j.pvr.2015.06.003	NOUN
ajlm-1563	361	2	who	who	PRON
ajlm-1563	361	3	.	.	PUNCT
ajlm-1563	362	1	costing	cost	VERB
ajlm-1563	362	2	the	the	DET
ajlm-1563	362	3	national	national	ADJ
ajlm-1563	362	4	strategic	strategic	ADJ
ajlm-1563	362	5	plan	plan	NOUN
ajlm-1563	362	6	on	on	ADP
ajlm-1563	362	7	prevention	prevention	NOUN
ajlm-1563	362	8	and	and	CCONJ
ajlm-1563	362	9	control	control	NOUN
ajlm-1563	362	10	of	of	ADP
ajlm-1563	362	11	cervical	cervical	ADJ
ajlm-1563	362	12	cancer	cancer	NOUN
ajlm-1563	362	13	:	:	PUNCT
ajlm-1563	362	14	zambia	zambia	PROPN
ajlm-1563	362	15	,	,	PUNCT
ajlm-1563	362	16	2019–2023	2019–2023	NUM
ajlm-1563	362	17	.	.	PUNCT
ajlm-1563	362	18	2020	2020	NUM
ajlm-1563	362	19	.	.	PUNCT